BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
976252	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cn[nH]c1			351981	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(1H- pyrazol-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 1::US10822352, Comp No. 1::US9796741, cmp No. 1	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351981&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			91844719	386046389							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976253	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cncnc1	InChI=1S/C31H24ClF2N7O3/c32-23-6-2-1-4-20(23)21-5-3-7-24(28(21)34)38-31(44)26-11-19(33)14-40(26)27(42)15-41-25-9-8-17(18-12-36-16-37-13-18)10-22(25)29(39-41)30(35)43/h1-10,12-13,16,19,26H,11,14-15H2,(H2,35,43)(H,38,44)/t19-,26+/m1/s1	QZVHYUYIGIMKDN-BCHFMIIMSA-N	351982	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 2::US10822352, Comp No. 2::US9796741, cmp No. 2	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351982&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323644	386046390							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976254	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc(cc1)N1CCOCC1	InChI=1S/C30H29BrFN7O4/c31-25-2-1-3-26(34-25)35-30(42)24-15-20(32)16-38(24)27(40)17-39-23-9-6-19(14-22(23)28(36-39)29(33)41)18-4-7-21(8-5-18)37-10-12-43-13-11-37/h1-9,14,20,24H,10-13,15-17H2,(H2,33,41)(H,34,35,42)/t20-,24+/m1/s1	MKDACKDJTMRMBZ-YKSBVNFPSA-N	351984	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(4- morpholinophenyl)-1H- indazole-3-carboxamide::US10287301, Compound 3::US10822352, Comp No. 3::US9796741, cmp No. 3	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351984&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323710	386046392							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976255	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C25H21BrN8O3/c26-20-2-1-3-21(30-20)31-25(37)19-8-14-7-18(14)34(19)22(35)11-33-17-5-4-13(15-9-28-12-29-10-15)6-16(17)23(32-33)24(27)36/h1-6,9-10,12,14,18-19H,7-8,11H2,(H2,27,36)(H,30,31,37)/t14-,18-,19+/m1/s1	UEOSELNXXJLLHW-ZMYBRWDISA-N	351985	1-(2-((1R,3S,5R)-3-(6- bromopyridin-2- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 4::US10822352, Comp No. 4::US9796741, cmp No. 4	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351985&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323762	386046393							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976256	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C24H20BrFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-7-15(26)10-33(18)21(35)11-34-17-5-4-13(14-8-28-12-29-9-14)6-16(17)22(32-34)23(27)36/h1-6,8-9,12,15,18H,7,10-11H2,(H2,27,36)(H,30,31,37)/t15-,18+/m1/s1	NGYKWUPOYMWBHQ-QAPCUYQASA-N	351986	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 5::US10822352, Comp No. 5::US9796741, cmp No. 5	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351986&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323584	386046394							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976257	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cncnc1	InChI=1S/C32H25ClFN7O3/c33-23-6-2-1-4-20(23)21-5-3-7-24(29(21)34)38-32(44)27-12-18-11-26(18)41(27)28(42)15-40-25-9-8-17(19-13-36-16-37-14-19)10-22(25)30(39-40)31(35)43/h1-10,13-14,16,18,26-27H,11-12,15H2,(H2,35,43)(H,38,44)/t18-,26-,27+/m1/s1	LNSXCQAIRPBMBA-PNKDDGGRSA-N	351987	1-(2-((1R,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 6::US10822352, Comp No. 6::US9796741, cmp No. 6	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351987&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323568	386046395							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976258	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ncccn1	InChI=1S/C32H25ClFN7O3/c33-22-7-2-1-5-19(22)20-6-3-8-23(28(20)34)38-32(44)26-15-18-14-25(18)41(26)27(42)16-40-24-10-9-17(31-36-11-4-12-37-31)13-21(24)29(39-40)30(35)43/h1-13,18,25-26H,14-16H2,(H2,35,43)(H,38,44)/t18-,25-,26+/m1/s1	RGFOOCIKWLGMQS-IHMJZKOGSA-N	351988	1-(2-((1R,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-2-yl)-1H- indazole-3-carboxamide::US10287301, Compound 7::US10822352, Comp No. 7::US9796741, cmp No. 7	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351988&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323567	386046396							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976259	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cncnc1	InChI=1S/C27H21F4N7O4/c28-23-17(2-1-3-21(23)42-27(29,30)31)35-26(41)20-8-14-7-19(14)38(20)22(39)11-37-18-5-4-13(15-9-33-12-34-10-15)6-16(18)24(36-37)25(32)40/h1-6,9-10,12,14,19-20H,7-8,11H2,(H2,32,40)(H,35,41)/t14-,19-,20+/m1/s1	DGNSLVWDCQMJID-XMCHAPAWSA-N	351989	1-(2-((1R,3S,5R)-3-(2- fluoro-3- (trifluoromethoxy) phenylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 8::US10822352, Comp No. 8::US9796741, cmp No. 8	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351989&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323611	386046397							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976260	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cncnc1	InChI=1S/C26H20F5N7O4/c27-15-7-19(25(41)35-17-2-1-3-20(22(17)28)42-26(29,30)31)37(10-15)21(39)11-38-18-5-4-13(14-8-33-12-34-9-14)6-16(18)23(36-38)24(32)40/h1-6,8-9,12,15,19H,7,10-11H2,(H2,32,40)(H,35,41)/t15-,19+/m1/s1	LXCRMIOXUGVOFW-BEFAXECRSA-N	351990	1-(2-((2S,4R)-4-fluoro- 2-(2-fluoro-3- (trifluoromethoxy) phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyrimidin- 5-yl)-1H-indazole-3- carboxamide::US10287301, Compound 9::US10822352, Comp No. 9::US9796741, cmp No. 9	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351990&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323666	386046398							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976261	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)N1CCCC1	InChI=1S/C35H31ClF2N8O3/c36-26-8-2-1-6-23(26)24-7-5-9-27(31(24)38)42-34(49)29-15-22(37)18-45(29)30(47)19-46-28-11-10-20(14-25(28)32(43-46)33(39)48)21-16-40-35(41-17-21)44-12-3-4-13-44/h1-2,5-11,14,16-17,22,29H,3-4,12-13,15,18-19H2,(H2,39,48)(H,42,49)/t22-,29+/m1/s1	NEOHBOUCJJKPPP-MNNSJKJDSA-N	351991	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- (pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 10::US10822352, Comp No. 10::US9796741, cmp No. 10	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351991&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323740	386046399							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976262	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)N1CCCC1	InChI=1S/C29H28BrN9O3/c30-23-4-3-5-24(34-23)35-28(42)22-12-17-11-21(17)39(22)25(40)15-38-20-7-6-16(10-19(20)26(36-38)27(31)41)18-13-32-29(33-14-18)37-8-1-2-9-37/h3-7,10,13-14,17,21-22H,1-2,8-9,11-12,15H2,(H2,31,41)(H,34,35,42)/t17-,21-,22+/m1/s1	RJHGEHBGXZGCOG-YHYVQYDKSA-N	351992	1-(2-((1R,3S,5R)-3-(6- bromopyridin-2- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5-(2- (pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 11::US10822352, Comp No. 11::US9796741, cmp No. 11	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351992&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323686	386046400							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976263	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(F)nc1	InChI=1S/C32H24ClF3N6O3/c33-23-6-2-1-4-20(23)21-5-3-7-24(29(21)36)39-32(45)26-13-19(34)15-41(26)28(43)16-42-25-10-8-17(18-9-11-27(35)38-14-18)12-22(25)30(40-42)31(37)44/h1-12,14,19,26H,13,15-16H2,(H2,37,44)(H,39,45)/t19-,26+/m1/s1	QVKBQYCUNOUPDR-BCHFMIIMSA-N	351993	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(6- fluoropyridin-3-yl)-1H- indazole-3-carboxamide::US10287301, Compound 12::US10822352, Comp No. 12::US9796741, cmp No. 12	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351993&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323604	386046401							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976264	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(F)nc1	InChI=1S/C33H25ClF2N6O3/c34-23-6-2-1-4-20(23)21-5-3-7-24(30(21)36)39-33(45)27-14-19-13-26(19)42(27)29(43)16-41-25-10-8-17(18-9-11-28(35)38-15-18)12-22(25)31(40-41)32(37)44/h1-12,15,19,26-27H,13-14,16H2,(H2,37,44)(H,39,45)/t19-,26-,27+/m1/s1	SGRVMIDWOQDMOS-MERSGSKISA-N	351994	1-(2-((lR,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5-(6- fluoropyridin-3-yl)-1H- indazole-3-carboxamide::US10287301, Compound 13::US10822352, Comp No. 13::US9796741, cmp No. 13	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351994&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334293	386046402							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976265	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C26H22BrFN6O3/c1-15(35)20-12-33(21-6-5-16(7-19(20)21)17-9-29-14-30-10-17)13-25(36)34-11-18(28)8-22(34)26(37)32-24-4-2-3-23(27)31-24/h2-7,9-10,12,14,18,22H,8,11,13H2,1H3,(H,31,32,37)/t18-,22+/m1/s1	JZOXZNIXHYIHNY-GCJKJVERSA-N	351995	(2S,4R)-1-(2-(3-acetyl- 5-(pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 14::US10822352, Comp No. 14::US9796741, cmp No. 14	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351995&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323575	386046403							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976266	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cncnc1	InChI=1S/C34H27ClFN5O3/c1-19(42)26-16-40(29-10-9-20(11-25(26)29)22-14-37-18-38-15-22)17-32(43)41-30-12-21(30)13-31(41)34(44)39-28-8-4-6-24(33(28)36)23-5-2-3-7-27(23)35/h2-11,14-16,18,21,30-31H,12-13,17H2,1H3,(H,39,44)/t21-,30-,31+/m1/s1	XXCXEZAYRGRRQN-TUJMVGRMSA-N	351996	(1R,3S,5R)-2-(2-(3- acetyl-5-(pyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 2-azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 15::US10822352, Comp No. 15::US9796741, cmp No. 15	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351996&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323642	386046404							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976267	CC(=O)N1CCN(CC1)c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H34ClF2N5O4/c1-21(44)28-19-42(31-11-10-24(17-27(28)31)41-14-12-40(13-15-41)22(2)45)20-33(46)43-18-23(37)16-32(43)35(47)39-30-9-5-7-26(34(30)38)25-6-3-4-8-29(25)36/h3-11,17,19,23,32H,12-16,18,20H2,1-2H3,(H,39,47)/t23-,32+/m1/s1	AOCGXFJEHSMMKC-HEIROHQZSA-N	351997	(2S,4R)-1-(2-(3-acetyl- 5-(4-acetylpiperazin-1- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 16::US10822352, Comp No. 16::US9796741, cmp No. 16	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351997&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323377	386046405							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976268	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C27H23BrN6O3/c1-15(35)20-12-33(21-6-5-16(7-19(20)21)18-10-29-14-30-11-18)13-26(36)34-22-8-17(22)9-23(34)27(37)32-25-4-2-3-24(28)31-25/h2-7,10-12,14,17,22-23H,8-9,13H2,1H3,(H,31,32,37)/t17-,22-,23+/m1/s1	NSNZTQJAGQTRRO-ZQMYSKGWSA-N	351998	(1R,3S,5R)-2-(2-(3- acetyl-5-(pyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 17::US10822352, Comp No. 17::US9796741, cmp No. 17	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351998&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323764	386046406							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976269	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cnc(cc12)-c1cncnc1	InChI=1S/C25H21ClF2N8O3/c26-17-3-1-2-13(22(17)28)8-33-25(39)19-4-15(27)10-35(19)21(37)11-36-20-9-32-18(14-6-30-12-31-7-14)5-16(20)23(34-36)24(29)38/h1-3,5-7,9,12,15,19H,4,8,10-11H2,(H2,29,38)(H,33,39)/t15-,19+/m1/s1	TWQHRWLRYLRCMK-BEFAXECRSA-N	351999	1-(2-((2S,4R)-2-(3- chloro-2- fluorobenzylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- pyrazolo[3,4- c]pyridine-3- carboxamide::US10287301, Compound 18::US10822352, Comp No. 18::US9796741, cmp No. 18	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351999&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323607	386046407							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976270	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2cnc(cc12)-c1cncnc1	InChI=1S/C30H23ClF2N8O3/c31-21-6-2-1-4-18(21)19-5-3-7-22(27(19)33)38-30(44)24-8-17(32)13-40(24)26(42)14-41-25-12-37-23(16-10-35-15-36-11-16)9-20(25)28(39-41)29(34)43/h1-7,9-12,15,17,24H,8,13-14H2,(H2,34,43)(H,38,44)/t17-,24+/m1/s1	WYDLBVNRHQMQNW-OSPHWJPCSA-N	352000	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5-yl)-1H- pyrazolo[3,4- c]pyridine-3- carboxamide::US10287301, Compound 19::US10822352, Comp No. 19::US9796741, cmp No. 19	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352000&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323688	386046408							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976271	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H26ClF2N5O3/c1-19(42)26-17-40(29-10-9-20(13-25(26)29)21-11-12-37-38-15-21)18-31(43)41-16-22(35)14-30(41)33(44)39-28-8-4-6-24(32(28)36)23-5-2-3-7-27(23)34/h2-13,15,17,22,30H,14,16,18H2,1H3,(H,39,44)/t22-,30+/m1/s1	DDDZDWUGHJVCAJ-RCRUUEGKSA-N	352001	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acclyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 20::US10822352, Comp No. 20::US9796741, cmp No. 20	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352001&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323437	386046409							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976272	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C27H24BrFN6O4/c1-15(36)20-13-34(21-7-6-16(8-19(20)21)17-10-30-27(39-2)31-11-17)14-25(37)35-12-18(29)9-22(35)26(38)33-24-5-3-4-23(28)32-24/h3-8,10-11,13,18,22H,9,12,14H2,1-2H3,(H,32,33,38)/t18-,22+/m1/s1	PUGGYQZDKDFYBO-GCJKJVERSA-N	352002	(2S,4R)-1-(2-(3-acetyl- 5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 21::US10822352, Comp No. 21::US9796741, cmp No. 21	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352002&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323560	386046410							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976273	CN1CCC(=CC1)c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(N)=O)c2c1	InChI=1S/C27H28BrFN6O3/c1-33-9-7-16(8-10-33)17-5-6-21-19(11-17)20(26(30)37)14-34(21)15-25(36)35-13-18(29)12-22(35)27(38)32-24-4-2-3-23(28)31-24/h2-7,11,14,18,22H,8-10,12-13,15H2,1H3,(H2,30,37)(H,31,32,38)/t18-,22+/m1/s1	VJTPMFXCAKIMPJ-GCJKJVERSA-N	471733	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (1-methyl-1,2,3,6- tetrahydropyridin- 4-yl)-1H-indazole- 3-carboxamide::US10822352, Comp No. 22	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471733&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313981	441610736							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976274	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClFN6O3/c1-15(35)20-13-33(21-6-5-16(9-19(20)21)17-7-8-29-30-11-17)14-25(36)34-12-18(28)10-22(34)26(37)32-24-4-2-3-23(27)31-24/h2-9,11,13,18,22H,10,12,14H2,1H3,(H,31,32,37)/t18-,22+/m1/s1	LOWVSOZSDFEWBG-GCJKJVERSA-N	352004	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- chloropyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 23::US10822352, Comp No. 23::US9796741, cmp No. 23	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352004&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323476	386046412							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976275	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20ClFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-9-15(26)11-33(18)21(35)12-34-17-5-4-13(14-6-7-28-29-10-14)8-16(17)22(32-34)23(27)36/h1-8,10,15,18H,9,11-12H2,(H2,27,36)(H,30,31,37)/t15-,18+/m1/s1	BINXWYYLRCFYQE-QAPCUYQASA-N	352005	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 24::US10822352, Comp No. 24::US9796741, cmp No. 24	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352005&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323705	386046413							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976276	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20BrFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-9-15(26)11-33(18)21(35)12-34-17-5-4-13(14-6-7-28-29-10-14)8-16(17)22(32-34)23(27)36/h1-8,10,15,18H,9,11-12H2,(H2,27,36)(H,30,31,37)/t15-,18+/m1/s1	GJSTWHZZGWGQOH-QAPCUYQASA-N	352006	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 25::US10822352, Comp No. 25::US9796741, cmp No. 25	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352006&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323746	386046414							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976277	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)N1CCCC1	InChI=1S/C37H33ClF2N6O3/c1-22(47)29-20-45(32-12-11-23(15-28(29)32)24-17-41-37(42-18-24)44-13-4-5-14-44)21-34(48)46-19-25(39)16-33(46)36(49)43-31-10-6-8-27(35(31)40)26-7-2-3-9-30(26)38/h2-3,6-12,15,17-18,20,25,33H,4-5,13-14,16,19,21H2,1H3,(H,43,49)/t25-,33+/m1/s1	ZAHRFVARVRLDEK-HPMVVLTCSA-N	352007	(2S,4R)-1-(2-(3-acetyl- 5-(2-(pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 26::US9796741, cmp No. 26	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352007&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323473	386046415							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976278	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C34H28ClF2N5O4/c1-19(43)26-17-41(29-11-10-20(12-25(26)29)21-14-38-34(46-2)39-15-21)18-31(44)42-16-22(36)13-30(42)33(45)40-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,40,45)/t22-,30+/m1/s1	PLFKTJMZIVECGM-RCRUUEGKSA-N	352010	(2S,4R)-1-(2-(3-acetyl- 5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 27::US10822352, Comp No. 27::US9796741, cmp No. 27	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352010&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323501	386046418							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976279	CC(=O)N1CCC(=CC1)c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C36H33ClF2N4O4/c1-21(44)29-19-42(32-11-10-24(16-28(29)32)23-12-14-41(15-13-23)22(2)45)20-34(46)43-18-25(38)17-33(43)36(47)40-31-9-5-7-27(35(31)39)26-6-3-4-8-30(26)37/h3-12,16,19,25,33H,13-15,17-18,20H2,1-2H3,(H,40,47)/t25-,33+/m1/s1	JCMJPXPJGAFUHO-HPMVVLTCSA-N	386092	(2S,4R)-1-(2-(3- acetyl-5-(1-acetyl- 1,2,3,6- tetrahydropyridin- 4-yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 28::US10822352, Comp No. 28	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386092&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323572	404855251							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976280	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)nc(C(N)=O)c2c1	InChI=1S/C32H26ClF2N7O4/c1-46-32-37-13-18(14-38-32)17-9-10-25-22(11-17)29(30(36)44)40-42(25)16-27(43)41-15-19(34)12-26(41)31(45)39-24-8-4-6-21(28(24)35)20-5-2-3-7-23(20)33/h2-11,13-14,19,26H,12,15-16H2,1H3,(H2,36,44)(H,39,45)/t19-,26+/m1/s1	AYYRKGGGZICMKK-BCHFMIIMSA-N	386093	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methoxypyrimidin- 5-yl)-1H-indazole- 3-carboxamide::US10287301, Compound 29::US10822352, Comp No. 29	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386093&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323482	404855252							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976281	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Cl)n3)nc(C(N)=O)c2c1	InChI=1S/C25H22ClFN8O4/c1-39-25-29-9-14(10-30-25)13-5-6-17-16(7-13)22(23(28)37)33-35(17)12-21(36)34-11-15(27)8-18(34)24(38)32-20-4-2-3-19(26)31-20/h2-7,9-10,15,18H,8,11-12H2,1H3,(H2,28,37)(H,31,32,38)/t15-,18+/m1/s1	YIOXCNSFXATOSG-QAPCUYQASA-N	352378	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methoxypyrimidin-5- yl)-1H-indazole-3- carboxamide::US10287301, Compound 30::US10822352, Comp No. 30::US9796741, cmp No. 30	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352378&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323582	386046754							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976282	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCN(CC1)c1ncccn1	InChI=1S/C37H34ClF2N7O3/c1-23(48)29-21-46(32-11-10-25(19-28(29)32)44-14-16-45(17-15-44)37-41-12-5-13-42-37)22-34(49)47-20-24(39)18-33(47)36(50)43-31-9-4-7-27(35(31)40)26-6-2-3-8-30(26)38/h2-13,19,21,24,33H,14-18,20,22H2,1H3,(H,43,50)/t24-,33+/m1/s1	IGGASGOYYVOTTI-IANOAQMISA-N	352379	(2S,4R)-1-(2-(3-acetyl- 5-(4-(pyrimidin-2- yl)piperazin-1-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 31::US10822352, Comp No. 31::US9796741, cmp No. 31	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352379&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323358	386046755							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976283	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCN(CC1)c1ncc(F)cn1	InChI=1S/C37H33ClF3N7O3/c1-22(49)29-20-47(32-10-9-25(16-28(29)32)45-11-13-46(14-12-45)37-42-17-24(40)18-43-37)21-34(50)48-19-23(39)15-33(48)36(51)44-31-8-4-6-27(35(31)41)26-5-2-3-7-30(26)38/h2-10,16-18,20,23,33H,11-15,19,21H2,1H3,(H,44,51)/t23-,33+/m1/s1	YHPWGSMIMXJFSC-NHRFMIRVSA-N	352488	(2S,4R)-1-(2-(3-acetyl- 5-(4-(5- fluoropyrimidin-2- yl)piperazin-1-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 32::US10822352, Comp No. 32::US9796741, cmp No. 32	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352488&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323744	386046794							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976284	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCN(CC1)S(C)(=O)=O	InChI=1S/C34H34ClF2N5O5S/c1-21(43)27-19-40(30-11-10-23(17-26(27)30)39-12-14-41(15-13-39)48(2,46)47)20-32(44)42-18-22(36)16-31(42)34(45)38-29-9-5-7-25(33(29)37)24-6-3-4-8-28(24)35/h3-11,17,19,22,31H,12-16,18,20H2,1-2H3,(H,38,45)/t22-,31+/m1/s1	PRCPMFMTBRKSGU-UVDDSOTQSA-N	353069	(2S,4R)-1-(2-(3-acetyl- 5-(4-(methylsulfonyl) piperazin-1-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 33::US10822352, Comp No. 33::US9796741, cmp No. 33	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353069&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323721	386046808							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976285	CC(=O)c1cn(CC(=O)N2CC(F)CC2C(=O)Nc2ccccc2-c2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H27FN6O3S/c1-20(42)26-18-40(29-11-10-21(14-25(26)29)22-12-13-36-37-16-22)19-32(43)41-17-23(35)15-30(41)33(44)38-27-7-3-2-6-24(27)34-39-28-8-4-5-9-31(28)45-34/h2-14,16,18,23,30H,15,17,19H2,1H3,(H,38,44)	FCPVSJBXKGLKSY-UHFFFAOYSA-N	471745	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-N-(2- (benzo[d]thiazol-2- yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 34	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471745&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334299	441610748							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976286	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H25FN6O3S/c1-17(37)22-15-35(24-7-6-18(10-21(22)24)19-8-9-32-33-12-19)16-28(38)36-14-20(30)11-25(36)29(39)31-13-27-34-23-4-2-3-5-26(23)40-27/h2-10,12,15,20,25H,11,13-14,16H2,1H3,(H,31,39)/t20-,25+/m1/s1	UTHKOMZXWNHBID-NLFFAJNJSA-N	353071	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (benzo[d]thiazol-2- ylmethyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 35::US10822352, Comp No. 35::US9796741, cmp No. 35	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353071&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323621	386046810							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976287	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCc3c2c(F)ccc3F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H26F3N5O3/c1-16(39)22-14-37(26-7-2-17(10-21(22)26)18-8-9-34-35-12-18)15-28(40)38-13-19(31)11-27(38)30(41)36-25-6-3-20-23(32)4-5-24(33)29(20)25/h2,4-5,7-10,12,14,19,25,27H,3,6,11,13,15H2,1H3,(H,36,41)/t19-,25?,27+/m1/s1	GVJWNYLEYQYIIK-PDPYFOFASA-N	353074	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (4,7-difluoro-2,3- dihydro-1H-inden-1- yl)-4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 36::US10822352, Comp No. 36::US9796741, cmp No. 36	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353074&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323658	386046813							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976288	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O3/c1-16(34)22-14-32(23-5-4-17(9-21(22)23)18-6-8-29-30-11-18)15-25(35)33-13-19(27)10-24(33)26(36)31-20-3-2-7-28-12-20/h2-9,11-12,14,19,24H,10,13,15H2,1H3,(H,31,36)/t19-,24+/m1/s1	PRTVFUIFKBTFDU-DVECYGJZSA-N	353155	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 37::US10822352, Comp No. 37::US9796741, cmp No. 37	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353155&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323636	386046894							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976289	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H25FN6O3/c1-17(35)23-15-33(24-6-5-18(10-22(23)24)19-7-9-31-32-12-19)16-26(36)34-14-20(28)11-25(34)27(37)30-13-21-4-2-3-8-29-21/h2-10,12,15,20,25H,11,13-14,16H2,1H3,(H,30,37)/t20-,25+/m1/s1	LPMPCWFSXZCJON-NLFFAJNJSA-N	353441	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-2- ylmethyl)pyrrolidine-2- carboxamide::US10287301, Compound 38::US10822352, Comp No. 38::US9796741, cmp No. 38	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353441&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323623	386047180							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976290	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H23FN8O3/c26-18-9-21(25(37)29-11-15-2-1-6-28-10-15)33(13-18)22(35)14-34-20-4-3-16(17-5-7-30-31-12-17)8-19(20)23(32-34)24(27)36/h1-8,10,12,18,21H,9,11,13-14H2,(H2,27,36)(H,29,37)/t18-,21+/m1/s1	LRWUUNJGJSVTAT-NQIIRXRSSA-N	353442	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-3- ylmethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 39::US10822352, Comp No. 39::US9796741, cmp No. 39	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353442&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323470	386047181							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976291	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccncc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H25FN6O3/c1-17(35)23-15-33(24-3-2-19(10-22(23)24)20-6-9-31-32-13-20)16-26(36)34-14-21(28)11-25(34)27(37)30-12-18-4-7-29-8-5-18/h2-10,13,15,21,25H,11-12,14,16H2,1H3,(H,30,37)/t21-,25+/m1/s1	WTXZETDBYHUBCP-BWKNWUBXSA-N	353443	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-4- ylmethyl)pyrrolidine-2- carboxamide::US10822352, Comp No. 40::US9796741, cmp No. 40	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353443&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323519	386047182							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976292	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H25FN8O3S/c33-20-14-26(31(44)37-23-6-2-1-5-21(23)32-38-24-7-3-4-8-27(24)45-32)40(16-20)28(42)17-41-25-10-9-18(19-11-12-35-36-15-19)13-22(25)29(39-41)30(34)43/h1-13,15,20,26H,14,16-17H2,(H2,34,43)(H,37,44)/t20-,26+/m1/s1	KTSLCTKDXGPQBN-IBVKSMDESA-N	386107	1-(2-((2S,4R)-2-(2- (benzo[d]thiazol-2- yl)phenylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 41::US10822352, Comp No. 41	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386107&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323620	404855266							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976293	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc3cc(ccc23)C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H22F4N6O4/c1-15(40)22-13-38(23-5-2-16(8-21(22)23)17-6-7-34-35-11-17)14-26(41)39-12-19(30)10-24(39)28(42)36-27-20-4-3-18(29(31,32)33)9-25(20)43-37-27/h2-9,11,13,19,24H,10,12,14H2,1H3,(H,36,37,42)/t19-,24+/m1/s1	WSSSSGFQWSDRSS-DVECYGJZSA-N	354133	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethyl)benzo [d]isoxazol-3- yl)pyrrolidine-2- carboxamide::US10822352, Comp No. 42::US9796741, cmp No. 42	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354133&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323699	386047865							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976294	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCc3c2c(F)ccc3F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H24F3N7O3/c29-16-10-23(28(41)35-21-5-2-17-19(30)3-4-20(31)25(17)21)37(12-16)24(39)13-38-22-6-1-14(15-7-8-33-34-11-15)9-18(22)26(36-38)27(32)40/h1,3-4,6-9,11,16,21,23H,2,5,10,12-13H2,(H2,32,40)(H,35,41)/t16-,21?,23+/m1/s1	NCARUIHAVGZELZ-WRCFPPIZSA-N	354134	1-(2-((2S,4R)-2-(4,7- difluoro-2,3-dihydro- 1H-inden-1- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 43::US10822352, Comp No. 43::US9796741, cmp No. 43	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354134&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323736	386047866							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976295	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H25ClFN5O3/c1-17(36)24-15-34(25-6-5-19(10-23(24)25)20-7-8-32-33-13-20)16-27(37)35-14-22(30)11-26(35)28(38)31-12-18-3-2-4-21(29)9-18/h2-10,13,15,22,26H,11-12,14,16H2,1H3,(H,31,38)/t22-,26+/m1/s1	DNRIFSQFGNHDJQ-GJZUVCINSA-N	354135	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chlorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 44::US10822352, Comp No. 44::US9796741, cmp No. 44	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354135&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323743	386047867							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976296	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H24ClFN6O3/c28-19-3-1-2-16(8-19)11-31-27(38)24-10-20(29)13-35(24)25(36)15-34-14-22(26(30)37)21-9-17(4-5-23(21)34)18-6-7-32-33-12-18/h1-9,12,14,20,24H,10-11,13,15H2,(H2,30,37)(H,31,38)/t20-,24+/m1/s1	BOMQJVNMHXBLBZ-YKSBVNFPSA-N	471760	1-(2-((2S,4R)-2-(3- chlorobenzyl- carbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 45	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471760&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314113	441610762							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976297	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H24ClF2N5O3/c1-16(37)24-14-35(25-3-2-18(8-23(24)25)19-4-5-33-34-12-19)15-27(38)36-13-22(31)10-26(36)28(39)32-11-17-6-20(29)9-21(30)7-17/h2-9,12,14,22,26H,10-11,13,15H2,1H3,(H,32,39)/t22-,26+/m1/s1	ZGNKOFKSDMNRBF-GJZUVCINSA-N	354137	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chloro-5-fluorobenzyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 46::US10822352, Comp No. 46::US9796741, cmp No. 46	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354137&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323558	386047869							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976298	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H22FN7O3/c1-15(34)24-20-9-16(17-6-8-28-29-11-17)4-5-21(20)33(31-24)14-23(35)32-13-18(26)10-22(32)25(36)30-19-3-2-7-27-12-19/h2-9,11-12,18,22H,10,13-14H2,1H3,(H,30,36)/t18-,22+/m1/s1	DQMCXWUPAJZJST-GCJKJVERSA-N	471762	1-(2-((2S,4R)-2- fluoro-2-(pyridin-3- ylcarbamoyl)pyrroli- din-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 47	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471762&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314110	441610764							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976299	CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)cc2C1=O	InChI=1S/C29H27FN8O4/c1-2-36-13-18-3-5-20(11-21(18)29(36)42)34-28(41)24-10-19(30)14-37(24)25(39)15-38-23-6-4-16(17-7-8-32-33-12-17)9-22(23)26(35-38)27(31)40/h3-9,11-12,19,24H,2,10,13-15H2,1H3,(H2,31,40)(H,34,41)/t19-,24+/m1/s1	LLTGCHLKDXDRGR-DVECYGJZSA-N	354139	1-(2-((2S,4R)-2-(2- ethyl-3-oxoisoindolin- 5-ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 48::US10822352, Comp No. 48::US9796741, cmp No. 48	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354139&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323683	386047871							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976300	CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(ccc34)-c3ccnnc3)cc2C1=O	InChI=1S/C31H29FN6O4/c1-3-36-14-21-4-6-23(12-24(21)31(36)42)35-30(41)28-11-22(32)15-38(28)29(40)17-37-16-26(18(2)39)25-10-19(5-7-27(25)37)20-8-9-33-34-13-20/h4-10,12-13,16,22,28H,3,11,14-15,17H2,1-2H3,(H,35,41)/t22-,28+/m1/s1	COEXMOUYCYGEKN-DFHRPNOPSA-N	354141	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(2- ethyl-3-oxoisoindolin- 5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 49::US10822352, Comp No. 49::US9796741, cmp No. 49	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354141&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323731	386047873							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976301	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ncsc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H21FN8O3S/c27-16-8-21(26(38)32-17-2-3-19-22(9-17)39-13-29-19)34(11-16)23(36)12-35-20-4-1-14(15-5-6-30-31-10-15)7-18(20)24(33-35)25(28)37/h1-7,9-10,13,16,21H,8,11-12H2,(H2,28,37)(H,32,38)/t16-,21+/m1/s1	RSQCUKUXQKMAMV-IERDGZPVSA-N	354142	1-(2-((2S,4R)-2- (benzo[d]thiazol-6- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 50::US10822352, Comp No. 50::US9796741, cmp No. 50	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354142&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323528	386047874							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976302	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCCC2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H32FN7O4/c32-22-14-26(31(42)36-24-7-4-8-27(24)43-18-19-5-2-1-3-6-19)38(16-22)28(40)17-39-25-10-9-20(21-11-12-34-35-15-21)13-23(25)29(37-39)30(33)41/h1-3,5-6,9-13,15,22,24,26-27H,4,7-8,14,16-18H2,(H2,33,41)(H,36,42)/t22-,24-,26+,27?/m1/s1	CWLLZRQDATYGCG-KAXQLXEHSA-N	354143	1-(2-((2S,4R)-2- ((1R,2S)-2- (benzyloxy)cyclopentyl carbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 51::US10822352, Comp No. 51::US9796741, cmp No. 51	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354143&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334304	386047875							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976303	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H23FN8O3S/c28-17-10-21(27(39)30-12-23-33-19-3-1-2-4-22(19)40-23)35(13-17)24(37)14-36-20-6-5-15(16-7-8-31-32-11-16)9-18(20)25(34-36)26(29)38/h1-9,11,17,21H,10,12-14H2,(H2,29,38)(H,30,39)/t17-,21+/m1/s1	IZYRRVJHKUUBKW-UTKZUKDTSA-N	354145	1-(2-((2S,4R)-2- (benzo[d]thiazol-2- ylmethylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 52::US10822352, Comp No. 52::US9796741, cmp No. 52	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354145&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323702	386047877							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976304	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3[nH]c(C)c(C)c3c2)c2ccc(cc12)-c1ccnnc1			354147	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (2,3-dimethyl-1H- indol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 53::US10822352, Comp No. 53::US9796741, cmp No. 53	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354147&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323511	386047879							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976305	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccc3CCCCc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H31FN6O3S/c1-20(42)28-17-40(30-9-8-23(13-27(28)30)25-10-11-36-37-15-25)18-32(43)41-16-26(35)14-31(41)33(44)39-34-38-29(19-45-34)24-7-6-21-4-2-3-5-22(21)12-24/h6-13,15,17,19,26,31H,2-5,14,16,18H2,1H3,(H,38,39,44)/t26-,31+/m1/s1	ZGCDAXKPEVMWKD-NEEKEDPPSA-N	354149	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(4-(5,6,7,8- tetrahydronaphthalen- 2-yl)thiazol-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 54::US10822352, Comp No. 54::US9796741, cmp No. 54	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354149&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323531	386047881							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976306	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccc3CCCCc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H30FN7O3S/c34-24-13-29(32(44)39-33-38-27(18-45-33)22-6-5-19-3-1-2-4-20(19)11-22)41(15-24)30(42)17-40-16-26(31(35)43)25-12-21(7-8-28(25)40)23-9-10-36-37-14-23/h5-12,14,16,18,24,29H,1-4,13,15,17H2,(H2,35,43)(H,38,39,44)/t24-,29+/m1/s1	HAHRJIHNFQOMLD-GIGWZHCTSA-N	471770	1-(2-((2S,4R)-4- fluoro-2-(4- (5,6,7,8- tetrahydronaphthalen- 2-yl)thiazol-2- ylcarbamoyl)pyrroli- din-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 55	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471770&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314324	441610772							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976307	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ncsc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H23FN6O3S/c1-16(36)22-13-34(24-5-2-17(8-21(22)24)18-6-7-31-32-11-18)14-27(37)35-12-19(29)9-25(35)28(38)33-20-3-4-23-26(10-20)39-15-30-23/h2-8,10-11,13,15,19,25H,9,12,14H2,1H3,(H,33,38)/t19-,25+/m1/s1	IUPKZZXZHNYBFP-CLOONOSVSA-N	354152	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (benzo[d]thiazol-6-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 56::US10822352, Comp No. 56::US9796741, cmp No. 56	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354152&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323778	386047884							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976308	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2c(C)nc3sccn23)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H25FN8O3S2/c1-16-27(38-7-8-43-30(38)34-16)23-15-44-29(35-23)36-28(42)25-10-20(31)12-39(25)26(41)14-37-13-22(17(2)40)21-9-18(3-4-24(21)37)19-5-6-32-33-11-19/h3-9,11,13,15,20,25H,10,12,14H2,1-2H3,(H,35,36,42)/t20-,25+/m1/s1	APRHJQJOENSTFN-NLFFAJNJSA-N	354153	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(4-(6- methylimidazo[2,1- b]thiazol-5-yl)thiazol-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 57::US10822352, Comp No. 57::US9796741, cmp No. 57	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354153&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323657	386047885							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976309	Cc1nc2sccn2c1-c1csc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)n1	InChI=1S/C28H23FN10O3S2/c1-14-24(37-6-7-43-28(37)33-14)19-13-44-27(34-19)35-26(42)21-9-17(29)11-38(21)22(40)12-39-20-3-2-15(16-4-5-31-32-10-16)8-18(20)23(36-39)25(30)41/h2-8,10,13,17,21H,9,11-12H2,1H3,(H2,30,41)(H,34,35,42)/t17-,21+/m1/s1	HJZHXKYJLTXXAZ-UTKZUKDTSA-N	386124	1-(2-((2S,4R)-4- fluoro-2-(4-(6- methylimidazo[2,1- b]thiazol-5- yl)thiazol-2- ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 58::US10822352, Comp No. 58	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386124&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323554	404855283							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976310	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H25FN6O3/c1-17(35)23-15-33(24-5-4-19(9-22(23)24)20-6-8-31-32-13-20)16-26(36)34-14-21(28)10-25(34)27(37)30-12-18-3-2-7-29-11-18/h2-9,11,13,15,21,25H,10,12,14,16H2,1H3,(H,30,37)/t21-,25+/m1/s1	HZJCSMACFHSXHU-BWKNWUBXSA-N	354155	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-3- ylmethyl)pyrrolidine-2- carboxamide::US10287301, Compound 59::US10822352, Comp No. 59::US9796741, cmp No. 59	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354155&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323624	386047887							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976311	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OCc3ccccc3)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H29FN6O4/c1-21(41)27-18-39(28-11-10-23(14-26(27)28)24-12-13-35-36-16-24)19-32(42)40-17-25(34)15-29(40)33(43)38-30-8-5-9-31(37-30)44-20-22-6-3-2-4-7-22/h2-14,16,18,25,29H,15,17,19-20H2,1H3,(H,37,38,43)/t25-,29+/m1/s1	AWFJBLOSMYVPPL-IRPSRAIASA-N	386126	(2s,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-N-(6- (benzyloxy)pyridin- 2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 60::US10822352, Comp No. 60	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386126&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323662	404855285							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976312	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(CNC(=O)OCC3c4ccccc4-c4ccccc34)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C43H37FN6O5/c1-26(51)37-23-49(39-15-12-28(18-36(37)39)29-16-17-46-47-21-29)24-41(52)50-22-30(44)19-40(50)42(53)48-31-13-10-27(11-14-31)20-45-43(54)55-25-38-34-8-4-2-6-32(34)33-7-3-5-9-35(33)38/h2-18,21,23,30,38,40H,19-20,22,24-25H2,1H3,(H,45,54)(H,48,53)/t30-,40+/m1/s1	COKNEXNJLKGNRS-FRRBMJAGSA-N	354157	(9H-fluoren-9- yl)methyl(4-((2S,4R)- 1-(2-(3-acetyl-5- (pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoropyrrolidine-2- carboxamido) benzyl)carbamate::US10287301, Compound 61::US10822352, Comp No. 61::US9796741, cmp No. 61	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354157&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118346645	386047889							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976313	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClF2N7O3/c27-17-5-14(6-18(28)8-17)10-31-26(39)22-9-19(29)12-35(22)23(37)13-36-21-2-1-15(16-3-4-32-33-11-16)7-20(21)24(34-36)25(30)38/h1-8,11,19,22H,9-10,12-13H2,(H2,30,38)(H,31,39)/t19-,22+/m1/s1	OZPQAIYIVUYLTF-KNQAVFIVSA-N	354158	1-(2-((2S,4R)-2-(3- chloro-5- fluorobenzylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 62::US10822352, Comp No. 62::US9796741, cmp No. 62	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354158&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323700	386047890							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976314	Cc1[nH]c2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)cc2c1C			354159	1-(2-((2S,4R)-2-(2,3- dimethyl-1H-indol-5- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 63::US10822352, Comp No. 63::US9796741, cmp No. 63	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354159&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323761	386047891							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976315	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2N2CCOC2=O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H27FN6O5/c1-18(38)23-16-35(25-7-6-19(12-22(23)25)20-8-9-32-33-14-20)17-28(39)37-15-21(31)13-27(37)29(40)34-24-4-2-3-5-26(24)36-10-11-42-30(36)41/h2-9,12,14,16,21,27H,10-11,13,15,17H2,1H3,(H,34,40)/t21-,27+/m1/s1	PTWGEDNBHHMEIC-ZBLYBZFDSA-N	354160	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(2- oxooxazolidin-3- yl)phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 64::US10822352, Comp No. 64::US9796741, cmp No. 64	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354160&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323645	386047892							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976316	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2N2CCOC2=O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H25FN8O5/c29-18-12-23(27(40)33-20-3-1-2-4-22(20)35-9-10-42-28(35)41)36(14-18)24(38)15-37-21-6-5-16(17-7-8-31-32-13-17)11-19(21)25(34-37)26(30)39/h1-8,11,13,18,23H,9-10,12,14-15H2,(H2,30,39)(H,33,40)/t18-,23+/m1/s1	KQRUIHGEEHIGBM-JPYJTQIMSA-N	354161	1-(2-((2S,4R)-4-fluoro- 2-(2-(2-oxooxazolidin- 3-yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 65::US10822352, Comp No. 65::US9796741, cmp No. 65	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354161&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323615	386047893							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976317	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClFN6O3/c1-15(35)22-13-33(23-3-2-16(6-21(22)23)17-4-5-30-31-9-17)14-25(36)34-12-19(28)8-24(34)26(37)32-20-7-18(27)10-29-11-20/h2-7,9-11,13,19,24H,8,12,14H2,1H3,(H,32,37)/t19-,24+/m1/s1	RWERKAKVTXGVNX-DVECYGJZSA-N	354162	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- chloropyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 66::US10822352, Comp No. 66::US9796741, cmp No. 66	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354162&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323598	386047894							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976318	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20ClFN8O3/c25-15-6-17(10-28-9-15)31-24(37)20-7-16(26)11-33(20)21(35)12-34-19-2-1-13(14-3-4-29-30-8-14)5-18(19)22(32-34)23(27)36/h1-6,8-10,16,20H,7,11-12H2,(H2,27,36)(H,31,37)/t16-,20+/m1/s1	WJWLVPUZJKKGAH-UZLBHIALSA-N	354163	1-(2-((2S,4R)-2-(5- chloropyridin-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 67::US10822352, Comp No. 67::US9796741, cmp No. 67	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354163&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323752	386047895							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976319	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22BrFN6O3/c1-15(35)22-13-33(23-3-2-16(6-21(22)23)17-4-5-30-31-9-17)14-25(36)34-12-19(28)8-24(34)26(37)32-20-7-18(27)10-29-11-20/h2-7,9-11,13,19,24H,8,12,14H2,1H3,(H,32,37)/t19-,24+/m1/s1	KBQQNSNKXFHXDY-DVECYGJZSA-N	354164	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- bromopyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 68::US10822352, Comp No. 68::US9796741, cmp No. 68	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354164&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323357	386047896							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976320	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccc(Cl)c(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H20Cl2FN9O3S/c28-18-3-1-14(8-19(18)29)26-35-36-27(43-26)34-25(42)21-9-16(30)11-38(21)22(40)12-39-20-4-2-13(15-5-6-32-33-10-15)7-17(20)23(37-39)24(31)41/h1-8,10,16,21H,9,11-12H2,(H2,31,41)(H,34,36,42)/t16-,21+/m1/s1	IEUBMOVRRHRDSO-IERDGZPVSA-N	354165	1-(2-((2S,4R)-2-(5-(3,4- dichlorophenyl)-1,3,4- thiadiazol-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 69::US10822352, Comp No. 69::US9796741, cmp No. 69	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354165&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323656	386047897							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976321	NCc1ccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)cc1	InChI=1S/C26H25FN8O3/c27-18-10-22(26(38)32-19-4-1-15(11-28)2-5-19)34(13-18)23(36)14-35-21-6-3-16(17-7-8-30-31-12-17)9-20(21)24(33-35)25(29)37/h1-9,12,18,22H,10-11,13-14,28H2,(H2,29,37)(H,32,38)/t18-,22+/m1/s1	LUAIUZSIJQWRGK-GCJKJVERSA-N	354166	1-(2-((2S,4R)-2-(4- (aminomethyl) phenylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 70::US10822352, Comp No. 70::US9796741, cmp No. 70	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354166&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323753	386047898							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976322	Cc1ccnn1-c1ccccc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C29H26FN9O3/c1-17-8-11-34-39(17)24-5-3-2-4-22(24)35-29(42)25-13-20(30)15-37(25)26(40)16-38-23-7-6-18(19-9-10-32-33-14-19)12-21(23)27(36-38)28(31)41/h2-12,14,20,25H,13,15-16H2,1H3,(H2,31,41)(H,35,42)/t20-,25+/m1/s1	LORLHRLRYFPEEE-NLFFAJNJSA-N	354167	1-(2-((2S,4R)-4-fluoro- 2-(2-(5-methyl-1H- pyrazol-1- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 71::US10822352, Comp No. 71::US9796741, cmp No. 71	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354167&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323709	386047899							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976323	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-n2nccc2C)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H28FN7O3/c1-19-9-12-35-39(19)28-6-4-3-5-26(28)36-31(42)29-14-23(32)16-38(29)30(41)18-37-17-25(20(2)40)24-13-21(7-8-27(24)37)22-10-11-33-34-15-22/h3-13,15,17,23,29H,14,16,18H2,1-2H3,(H,36,42)/t23-,29+/m1/s1	XYIFZSRMWUSPIC-BTYSJIOQSA-N	354168	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(5-methyl- 1H-pyrazol-1- yl)phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 72::US10822352, Comp No. 72::US9796741, cmp No. 72	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354168&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323579	386047900							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976324	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OCc3ccccc3)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H27FN8O4/c32-22-14-25(31(43)37-26-7-4-8-27(36-26)44-18-19-5-2-1-3-6-19)39(16-22)28(41)17-40-24-10-9-20(21-11-12-34-35-15-21)13-23(24)29(38-40)30(33)42/h1-13,15,22,25H,14,16-18H2,(H2,33,42)(H,36,37,43)/t22-,25+/m1/s1	HXYKQUZDRVMGIK-RDGATRHJSA-N	354169	1-(2-((2S,4R)-2-(6- (benzyloxy)pyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 73::US10822352, Comp No. 73::US9796741, cmp No. 73	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354169&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323654	386047901							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976325	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H36FN5O4/c1-22(41)28-19-39(30-12-11-24(15-27(28)30)25-13-14-36-37-17-25)20-33(42)40-18-26(35)16-31(40)34(43)38-29-9-5-6-10-32(29)44-21-23-7-3-2-4-8-23/h2-4,7-8,11-15,17,19,26,29,31-32H,5-6,9-10,16,18,20-21H2,1H3,(H,38,43)/t26-,29+,31+,32+/m1/s1	VDKAWHFQBJIXRL-PVKGFQCZSA-N	354170	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- ((1S,2S)-2- (benzyloxy)cyclohexyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 74::US10822352, Comp No. 74::US9796741, cmp No. 74	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354170&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323734	386047902							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976326	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3CC(C)(C)Oc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H30FN5O4/c1-18(38)25-16-36(26-7-5-19(10-24(25)26)21-8-9-33-34-14-21)17-29(39)37-15-22(32)11-27(37)30(40)35-23-6-4-20-13-31(2,3)41-28(20)12-23/h4-10,12,14,16,22,27H,11,13,15,17H2,1-3H3,(H,35,40)/t22-,27+/m1/s1	OHBNTBGQKUZLAO-AMGIVPHBSA-N	354171	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (2,2-dimethyl-2,3- dihydrobenzofuran-6- yl)-4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 75::US10822352, Comp No. 75::US9796741, cmp No. 75	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354171&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323609	386047903							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976327	CC1(C)Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)cc2O1	InChI=1S/C29H28FN7O4/c1-29(2)12-17-3-5-20(11-24(17)41-29)34-28(40)23-10-19(30)14-36(23)25(38)15-37-22-6-4-16(18-7-8-32-33-13-18)9-21(22)26(35-37)27(31)39/h3-9,11,13,19,23H,10,12,14-15H2,1-2H3,(H2,31,39)(H,34,40)/t19-,23+/m1/s1	HAWCJNPNNNWXOI-XXBNENTESA-N	354172	1-(2-((2S,4R)-2-(2,2- dimethyl-2,3- dihydrobenzofuran-6- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 76::US10822352, Comp No. 76::US9796741, cmp No. 76	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354172&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323625	386047904							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976328	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCC[C@@H]2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H34FN5O4/c1-21(40)27-18-38(29-11-10-23(14-26(27)29)24-12-13-35-36-16-24)19-32(41)39-17-25(34)15-30(39)33(42)37-28-8-5-9-31(28)43-20-22-6-3-2-4-7-22/h2-4,6-7,10-14,16,18,25,28,30-31H,5,8-9,15,17,19-20H2,1H3,(H,37,42)/t25-,28+,30+,31+/m1/s1	TVMIJUQREUIDRN-PEAQOHSKSA-N	354173	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- ((1S,2S)-2- (benzyloxy)cyclopentyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 77::US10822352, Comp No. 77::US9796741, cmp No. 77	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354173&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323687	386047905							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976329	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H34FN7O4/c33-23-15-27(32(43)37-25-8-4-5-9-28(25)44-19-20-6-2-1-3-7-20)39(17-23)29(41)18-40-26-11-10-21(22-12-13-35-36-16-22)14-24(26)30(38-40)31(34)42/h1-3,6-7,10-14,16,23,25,27-28H,4-5,8-9,15,17-19H2,(H2,34,42)(H,37,43)/t23-,25+,27+,28+/m1/s1	FTRCCOQGAJYPMT-DEKSYSNASA-N	354174	1-(2-((2S,4R)-2- ((1S),2S)-2-(benzyloxy) cyclohexylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 78::US10822352, Comp No. 78::US9796741, cmp No. 78	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354174&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334313	386047906							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976330	CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C20H20FN7O3/c1-23-20(31)16-7-13(21)9-27(16)17(29)10-28-15-3-2-11(12-4-5-24-25-8-12)6-14(15)18(26-28)19(22)30/h2-6,8,13,16H,7,9-10H2,1H3,(H2,22,30)(H,23,31)/t13-,16+/m1/s1	NPAMWFHESCJZMB-CJNGLKHVSA-N	354175	1-(2-((2S,4R)-4-fluoro- 2-(methylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 79::US10822352, Comp No. 79::US9796741, cmp No. 79	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354175&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323556	386047907							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976331	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H29ClFN5O4/c1-19(43)26-17-41(29-11-10-20(12-25(26)29)22-15-38-35(46-2)39-16-22)18-32(44)42-30-13-21(30)14-31(42)34(45)40-28-9-5-7-24(33(28)37)23-6-3-4-8-27(23)36/h3-12,15-17,21,30-31H,13-14,18H2,1-2H3,(H,40,45)/t21-,30-,31+/m1/s1	LXBXOMDOYZSHFZ-TUJMVGRMSA-N	354176	(1R,3S,5R)-2-(2-(3-  acetyl-5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 2-azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 80::US10822352, Comp No. 80::US9796741, cmp No. 80	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354176&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323539	386047908							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976332	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C28H25BrN6O4/c1-15(36)20-13-34(21-7-6-16(8-19(20)21)18-11-30-28(39-2)31-12-18)14-26(37)35-22-9-17(22)10-23(35)27(38)33-25-5-3-4-24(29)32-25/h3-8,11-13,17,22-23H,9-10,14H2,1-2H3,(H,32,33,38)/t17-,22-,23+/m1/s1	LBKYMXLWZMGZGL-ZQMYSKGWSA-N	354177	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 81::US10822352, Comp No. 81::US9796741, cmp No. 81	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354177&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323673	386047909							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976333	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C#N	InChI=1S/C27H21BrFN7O3/c1-15(37)20-13-35(21-6-5-16(7-19(20)21)17-10-31-25(9-30)32-11-17)14-26(38)36-12-18(29)8-22(36)27(39)34-24-4-2-3-23(28)33-24/h2-7,10-11,13,18,22H,8,12,14H2,1H3,(H,33,34,39)/t18-,22+/m1/s1	BZDCGIOHHRKHLK-GCJKJVERSA-N	354178	(2S,4R)-1-(2-(3-acetyl- 5-(2-cyanopyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 82::US10822352, Comp No. 82::US9796741, cmp No. 82	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354178&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323708	386047910							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976334	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(F)nc1	InChI=1S/C26H21BrF2N6O3/c1-14(36)19-12-34(20-6-5-15(7-18(19)20)16-9-30-26(29)31-10-16)13-24(37)35-11-17(28)8-21(35)25(38)33-23-4-2-3-22(27)32-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H,32,33,38)/t17-,21+/m1/s1	ODUZXFLSXMMLEF-UTKZUKDTSA-N	354180	(2S,4R)-1-(2-(3-acetyl- 5-(2-fluoropyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 83::US10822352, Comp No. 83::US9796741, cmp No. 83	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354180&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323597	386047912							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976335	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)18-10-30-16(2)31-11-18)14-26(37)35-12-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,32,33,38)/t19-,23+/m1/s1	HJOQHGVZGIOBFX-XXBNENTESA-N	354181	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 84::US10822352, Comp No. 84::US9796741, cmp No. 84	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354181&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323714	386047913							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976336	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(CN)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H27FN6O3/c1-17(36)24-15-34(25-7-4-19(10-23(24)25)20-8-9-31-32-13-20)16-27(37)35-14-21(29)11-26(35)28(38)33-22-5-2-18(12-30)3-6-22/h2-10,13,15,21,26H,11-12,14,16,30H2,1H3,(H,33,38)/t21-,26+/m1/s1	IQZCRKZSXCYGON-RLWLMLJZSA-N	354182	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(4- (aminomethyl)phenyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 85::US10822352, Comp No. 85::US9796741, cmp No. 85	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354182&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323692	386047914							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976337	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3cn[nH]c3c2)c2ccc(cc12)-c1ccnnc1			354183	1-(2-((2S,4R)-2-(1H- indazol-6- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 86::US10822352, Comp No. 86::US9796741, cmp No. 86	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354183&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208185	386047915							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976338	CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C22H22FN5O3/c1-13(29)18-11-27(12-21(30)28-10-16(23)8-20(28)22(31)24-2)19-4-3-14(7-17(18)19)15-5-6-25-26-9-15/h3-7,9,11,16,20H,8,10,12H2,1-2H3,(H,24,31)/t16-,20+/m1/s1	KAWNASMRXRUOPO-UZLBHIALSA-N	354184	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N- methylpyrrolidine-2- carboxamide::US10287301, Compound 87::US10822352, Comp No. 87::US9796741, cmp No. 87	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354184&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323456	386047916							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976339	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21ClFN7O3/c1-14(35)19-12-33(20-3-2-15(6-18(19)20)16-4-5-29-30-8-16)13-24(36)34-11-17(27)7-21(34)25(37)32-23-10-28-9-22(26)31-23/h2-6,8-10,12,17,21H,7,11,13H2,1H3,(H,31,32,37)/t17-,21+/m1/s1	HPLFDPFYFFETIZ-UTKZUKDTSA-N	354185	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- chloropyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 88::US10822352, Comp No. 88::US9796741, cmp No. 88	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354185&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323570	386047917							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976340	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20ClFN8O3/c25-20-8-28-9-21(31-20)32-24(37)19-6-15(26)10-34(19)22(35)12-33-11-17(23(27)36)16-5-13(1-2-18(16)33)14-3-4-29-30-7-14/h1-5,7-9,11,15,19H,6,10,12H2,(H2,27,36)(H,31,32,37)/t15-,19+/m1/s1	RLCBNKWBRASWJI-BEFAXECRSA-N	471804	1-(2-((2S,4R)-2-(6- chloropyrazin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 89	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471804&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313988	441610805							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976341	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21BrFN7O3/c26-16-6-18(10-29-9-16)32-25(37)22-7-17(27)11-34(22)23(35)13-33-12-20(24(28)36)19-5-14(1-2-21(19)33)15-3-4-30-31-8-15/h1-6,8-10,12,17,22H,7,11,13H2,(H2,28,36)(H,32,37)/t17-,22+/m1/s1	UANQLDJUJJEKFW-VGSWGCGISA-N	471805	1-(2-((2S,4R)-2-(5- bromopyridin-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 90	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471805&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314343	441610806							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976342	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H31F2N9O3/c34-21-13-28(33(47)39-22-6-7-26(35)24(14-22)32-41-40-29-4-2-1-3-11-43(29)32)44(16-21)30(45)18-42-17-25(31(36)46)23-12-19(5-8-27(23)42)20-9-10-37-38-15-20/h5-10,12,14-15,17,21,28H,1-4,11,13,16,18H2,(H2,36,46)(H,39,47)/t21-,28+/m1/s1	ZIKJKVNURGSPNI-PIKZIKFNSA-N	471806	1-(2-((2S,4R)-4- fluoro-2-(4-fluoro- 3-(6,7,8,9- tetrahydro-5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 91	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471806&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314114	441610807							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976343	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H32F2N8O3/c1-20(45)27-18-42(29-9-6-21(13-25(27)29)22-10-11-37-38-16-22)19-32(46)44-17-23(35)14-30(44)34(47)39-24-7-8-28(36)26(15-24)33-41-40-31-5-3-2-4-12-43(31)33/h6-11,13,15-16,18,23,30H,2-5,12,14,17,19H2,1H3,(H,39,47)/t23-,30+/m1/s1	OJSCJYOQHSYERH-DJUQAAIZSA-N	386161	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(4-fluoro-3- (6,7,8,9-tetrahydro- 5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenyl) pyrrolidine- 2-carboxamide::US10287301, Compound 92::US10822352, Comp No. 92	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386161&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323601	404855318							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976344	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClF4N6O3/c28-19-2-1-3-20(24(19)27(30,31)32)36-26(41)22-9-16(29)11-38(22)23(39)13-37-12-18(25(33)40)17-8-14(4-5-21(17)37)15-6-7-34-35-10-15/h1-8,10,12,16,22H,9,11,13H2,(H2,33,40)(H,36,41)/t16-,22+/m1/s1	JMHBYGNTWMXMBY-ZHRRBRCNSA-N	471808	1-(2-((2S,4R)-2-(3- chloro-2- (trifluoromethyl) phenylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 93	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471808&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314321	441610809							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976345	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]nc2-c2ccc(Cl)cc2Cl)c2ccc(cc12)-c1ccnnc1			354191	1-(2-((2S,4R)-2-(3-(2,4- dichlorophenyl)-1H- pyrazol-4- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 94::US10822352, Comp No. 94::US9796741, cmp No. 94	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354191&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208186	386047923							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976346	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2-n2cncn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H24ClFN8O3/c1-17(40)22-13-37(25-6-5-18(9-21(22)25)19-7-8-33-34-11-19)14-27(41)38-12-20(31)10-26(38)29(42)36-24-4-2-3-23(30)28(24)39-16-32-15-35-39/h2-9,11,13,15-16,20,26H,10,12,14H2,1H3,(H,36,42)/t20-,26+/m1/s1	SJLOEAHYJLTXLE-IBVKSMDESA-N	354192	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chloro-2-(1H-1,2,4- triazol-1-yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 95::US10822352, Comp No. 95::US9796741, cmp No. 95	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354192&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323507	386047924							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976347	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2-n2cncn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H22ClFN10O3/c28-19-2-1-3-20(25(19)39-14-31-13-34-39)35-27(42)22-9-17(29)11-37(22)23(40)12-38-21-5-4-15(16-6-7-32-33-10-16)8-18(21)24(36-38)26(30)41/h1-8,10,13-14,17,22H,9,11-12H2,(H2,30,41)(H,35,42)/t17-,22+/m1/s1	LEGRAROFLIPOMP-VGSWGCGISA-N	354193	1-(2-((2S,4R)-2-(3- chloro-2-(1H-1,2,4- triazol-1- yl)phenylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 96::US10822352, Comp No. 96::US9796741, cmp No. 96	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354193&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323565	386047925							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976348	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nc3nc(nn23)C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H23F4N9O3/c1-14-7-23(41-27(35-14)37-26(38-41)28(30,31)32)36-25(44)22-9-18(29)11-40(22)24(43)13-39-12-20(15(2)42)19-8-16(3-4-21(19)39)17-5-6-33-34-10-17/h3-8,10,12,18,22H,9,11,13H2,1-2H3,(H,36,44)/t18-,22+/m1/s1	MADDTEKZBMTHBB-GCJKJVERSA-N	354194	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(5-methyl-2- (trifluoromethyl)- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)pyrrolidine-2- carboxamide::US10287301, Compound 97::US10822352, Comp No. 97::US9796741, cmp No. 97	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354194&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323641	386047926							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976349	Cn1cnnc1-c1ccccc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C28H25FN10O3/c1-37-15-33-35-27(37)19-4-2-3-5-21(19)34-28(42)23-11-18(29)13-38(23)24(40)14-39-22-7-6-16(17-8-9-31-32-12-17)10-20(22)25(36-39)26(30)41/h2-10,12,15,18,23H,11,13-14H2,1H3,(H2,30,41)(H,34,42)/t18-,23+/m1/s1	NGTXTTHQTOTJAH-JPYJTQIMSA-N	386167	1-(2-((2S,4R)-4- fluoro-2-(2-(4- methyl-4H-1,2,4- triazol-3- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 98::US10822352, Comp No. 98	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386167&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323680	404855324							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976350	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O3S/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)28(41)35-29-34-27(36-42-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,35,36,41)/t19-,25+/m1/s1	YTVVKXFKGQTQKH-CLOONOSVSA-N	354196	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- (2-chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 99::US10822352, Comp No. 99::US9796741, cmp No. 99	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354196&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323715	386047928							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976351	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccccc1Cl	InChI=1S/C28H23BrClFN4O3/c1-16(36)21-14-34(23-10-9-17(11-20(21)23)19-5-2-3-6-22(19)30)15-27(37)35-13-18(31)12-24(35)28(38)33-26-8-4-7-25(29)32-26/h2-11,14,18,24H,12-13,15H2,1H3,(H,32,33,38)/t18-,24+/m1/s1	ZRAHPETXANGXSZ-KOSHJBKYSA-N	354197	(2S,4R)-1-(2-(3-acetyl- 5-(2-chlorophenyl)-1H- indol-1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 100::US10822352, Comp No. 100::US9796741, cmp No. 100	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354197&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323742	386047929							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976352	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(N)=O)c2c1	InChI=1S/C26H23BrFN7O3/c1-14-30-9-16(10-31-14)15-5-6-20-18(7-15)19(25(29)37)12-34(20)13-24(36)35-11-17(28)8-21(35)26(38)33-23-4-2-3-22(27)32-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H2,29,37)(H,32,33,38)/t17-,21+/m1/s1	ASQSBPRLPDMTIU-UTKZUKDTSA-N	386378	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5-(2- methylpyrimidin-5- yl)-1H-indole-3- carboxamide::US10287301, Compound 307::US10822352, Comp No. 307	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386378&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654069	404855535							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976353	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClF2N5O3/c1-19(43)27-17-41(30-11-10-21(12-26(27)30)22-14-38-20(2)39-15-22)18-32(44)42-16-23(36)13-31(42)34(45)40-29-9-5-7-25(33(29)37)24-6-3-4-8-28(24)35/h3-12,14-15,17,23,31H,13,16,18H2,1-2H3,(H,40,45)/t23-,31+/m1/s1	RCYMDCKZXLSTRB-IPBJYNAHSA-N	354199	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 163::US10822352, Comp No. 102::US9796741, cmp No. 102	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354199&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323574	386047931							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976354	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)nc(C(N)=O)c2c1	InChI=1S/C32H26ClF2N7O3/c1-17-37-13-19(14-38-17)18-9-10-26-23(11-18)30(31(36)44)40-42(26)16-28(43)41-15-20(34)12-27(41)32(45)39-25-8-4-6-22(29(25)35)21-5-2-3-7-24(21)33/h2-11,13-14,20,27H,12,15-16H2,1H3,(H2,36,44)(H,39,45)/t20-,27+/m1/s1	BNMJGBHJVHZWSP-HRFSGMKKSA-N	354200	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methylpyrimidin-5-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 103::US10822352, Comp No. 103::US9796741, cmp No. 103	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354200&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323759	386047932							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976355	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CN(Cc23)c2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H28FN9O3/c33-22-13-27(32(45)38-25-5-3-4-21-15-40(17-24(21)25)28-6-1-2-10-35-28)41(16-22)29(43)18-42-26-8-7-19(20-9-11-36-37-14-20)12-23(26)30(39-42)31(34)44/h1-12,14,22,27H,13,15-18H2,(H2,34,44)(H,38,45)/t22-,27+/m1/s1	SBEBZZCZYKGUPC-AMGIVPHBSA-N	354201	1-(2-((2S,4R)-4-fluoro- 2-(2-(pyridin-2- yl)isoindolin-4- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 104::US10822352, Comp No. 104::US9796741, cmp No. 104	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354201&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323648	386047933							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976356	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CN(Cc23)c2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H30FN7O3/c1-21(43)27-18-40(30-9-8-22(13-26(27)30)23-10-12-37-38-15-23)20-33(44)42-17-25(35)14-31(42)34(45)39-29-6-4-5-24-16-41(19-28(24)29)32-7-2-3-11-36-32/h2-13,15,18,25,31H,14,16-17,19-20H2,1H3,(H,39,45)/t25-,31+/m1/s1	RKUCOGVAXNDWRC-NJHZRGNWSA-N	354202	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(pyridin-2- yl)isoindolin-4- yl)pyrrolidine-2- carboxamide::US10287301, Compound 105::US10822352, Comp No. 105::US9796741, cmp No. 105	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354202&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323526	386047934							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976357	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCc3nc(sc23)-c2ccc(F)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H30F2N6O3S/c1-19(43)26-17-41(29-10-7-21(13-25(26)29)22-11-12-37-38-15-22)18-31(44)42-16-24(36)14-30(42)33(45)39-27-3-2-4-28-32(27)46-34(40-28)20-5-8-23(35)9-6-20/h5-13,15,17,24,27,30H,2-4,14,16,18H2,1H3,(H,39,45)/t24-,27?,30+/m1/s1	FEROJIGCHZJALH-JVVZTMHVSA-N	354203	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(4- fluorophenyl)-4,5,6,7- tetrahydrobenzo[d] thiazol-7-yl) pyrrolidine-2- carboxamide::US10287301, Compound 106::US10822352, Comp No. 106::US9796741, cmp No. 106	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354203&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323679	386047935							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976358	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCc3nc(sc23)-c2ccc(F)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H28F2N8O3S/c33-20-7-4-17(5-8-20)32-39-24-3-1-2-23(29(24)46-32)38-31(45)26-13-21(34)15-41(26)27(43)16-42-25-9-6-18(19-10-11-36-37-14-19)12-22(25)28(40-42)30(35)44/h4-12,14,21,23,26H,1-3,13,15-16H2,(H2,35,44)(H,38,45)/t21-,23?,26+/m1/s1	XGFKZXWWKPCNIT-HEEQAANPSA-N	354204	1-(2-((2S,4R)-4-fluoro- 2-(2-(4-fluorophenyl)- 4,5,6,7- tetrahydrobenzo[d] thiazol-7- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 107::US10822352, Comp No. 107::US9796741, cmp No. 107	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354204&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323784	386047936							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976359	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(Br)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21BrFN7O3/c1-14(35)20-12-33(21-3-2-15(6-19(20)21)16-4-5-30-31-8-16)13-23(36)34-11-18(27)7-22(34)24(37)32-25-28-9-17(26)10-29-25/h2-6,8-10,12,18,22H,7,11,13H2,1H3,(H,28,29,32,37)/t18-,22+/m1/s1	LFALWBRMCSKFCW-GCJKJVERSA-N	354205	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- bromopyrimidin-2-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 108::US10822352, Comp No. 108::US9796741, cmp No. 108	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354205&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323693	386047937							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976360	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(Br)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19BrFN9O3/c24-14-8-27-23(28-9-14)31-22(37)18-6-15(25)10-33(18)19(35)11-34-17-2-1-12(13-3-4-29-30-7-13)5-16(17)20(32-34)21(26)36/h1-5,7-9,15,18H,6,10-11H2,(H2,26,36)(H,27,28,31,37)/t15-,18+/m1/s1	IJUQRHNVXVLJCD-QAPCUYQASA-N	354207	1-(2-((2S,4R)-2-(5- bromopyrimidin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 109::US10822352, Comp No. 109::US9796741, cmp No. 109	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354207&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323593	386047939							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976361	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ccccc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H26FN5O3/c1-19(38)27-17-36(28-9-7-22(13-26(27)28)23-10-11-33-34-15-23)18-30(39)37-16-24(32)14-29(37)31(40)35-25-8-6-20-4-2-3-5-21(20)12-25/h2-13,15,17,24,29H,14,16,18H2,1H3,(H,35,40)/t24-,29+/m1/s1	MKKSPXFVUCKSBN-GIGWZHCTSA-N	354208	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(naphthalen-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 110::US10822352, Comp No. 110::US9796741, cmp No. 110	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354208&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323653	386047940							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976362	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H30FN5O4/c1-16(34)21-14-32(23-7-6-17(10-20(21)23)18-8-9-29-30-12-18)15-26(36)33-13-19(28)11-24(33)27(37)31-22-4-2-3-5-25(22)35/h6-10,12,14,19,22,24-25,35H,2-5,11,13,15H2,1H3,(H,31,37)/t19-,22+,24+,25+/m1/s1	BYUPNBICXSMYJH-FISOAXRRSA-N	354209	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-((1S,2S)-2- hydroxycyclohexyl) pyrrolidine-2- carboxamide::US10287301, Compound 111::US10822352, Comp No. 111::US9796741, cmp No. 111	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354209&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323606	386047941							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976363	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc3cc(ccc23)C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H20F4N8O4/c28-16-9-20(26(42)35-25-17-3-2-15(27(29,30)31)8-21(17)43-37-25)38(11-16)22(40)12-39-19-4-1-13(14-5-6-33-34-10-14)7-18(19)23(36-39)24(32)41/h1-8,10,16,20H,9,11-12H2,(H2,32,41)(H,35,37,42)/t16-,20+/m1/s1	CGKIVYROXKFNRV-UZLBHIALSA-N	354213	1-(2-((2S,4R)-4-fluoro- 2-(6-(trifluoromethyl) benzo[d]isoxazol-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10822352, Comp No. 112::US9796741, cmp No. 112	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354213&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323766	386047945							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976364	Cc1cc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)n2nc(nc2n1)C(F)(F)F	InChI=1S/C26H21F4N11O3/c1-12-6-19(41-25(34-12)36-24(38-41)26(28,29)30)35-23(44)18-8-15(27)10-39(18)20(42)11-40-17-3-2-13(14-4-5-32-33-9-14)7-16(17)21(37-40)22(31)43/h2-7,9,15,18H,8,10-11H2,1H3,(H2,31,43)(H,35,44)/t15-,18+/m1/s1	GTZJFYJAQQYUNL-QAPCUYQASA-N	354214	1-(2-((2S,4R)-4-fluoro- 2-(5-methyl-2- (trifluoromethyl)- [1,2,4]triazolo[1,5- a]pyrimidin-7- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10822352, Comp No. 113::US9796741, cmp No. 113	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354214&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323546	386047946							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976365	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClFN9O3S/c28-19-4-2-1-3-17(19)25-33-27(42-36-25)34-26(41)21-10-16(29)12-37(21)22(39)13-38-20-6-5-14(15-7-8-31-32-11-15)9-18(20)23(35-38)24(30)40/h1-9,11,16,21H,10,12-13H2,(H2,30,40)(H,33,34,36,41)/t16-,21+/m1/s1	ZAIOBGNYNNPPIX-IERDGZPVSA-N	354215	1-(2-((2S,4R)-2-(3-(2- chlorophenyl)-1,2,4- thiadiazol-5- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 114::US10822352, Comp No. 114::US9796741, cmp No. 114	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354215&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323787	386047947							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976366	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClFN9O3S/c28-19-4-2-1-3-17(19)26-34-35-27(42-26)33-25(41)21-10-16(29)12-37(21)22(39)13-38-20-6-5-14(15-7-8-31-32-11-15)9-18(20)23(36-38)24(30)40/h1-9,11,16,21H,10,12-13H2,(H2,30,40)(H,33,35,41)/t16-,21+/m1/s1	DLGOXSVFDGRFJW-IERDGZPVSA-N	354216	1-(2-((2S,4R)-2-(5-(2- chlorophenyl)-1,3,4- thiadiazol-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 115::US10822352, Comp No. 115::US9796741, cmp No. 115	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354216&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323602	386047948							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976367	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O3S/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)27(41)34-29-36-35-28(42-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,36,41)/t19-,25+/m1/s1	PVBVNNFWKNJHMU-CLOONOSVSA-N	354218	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- (2-chlorophenyl)-1,3,4- thiadiazol-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 116::US10822352, Comp No. 116::US9796741, cmp No. 116	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354218&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323563	386047950							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976368	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccc(Cl)c(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H22Cl2FN7O3S/c1-15(40)21-13-38(24-5-3-16(8-20(21)24)18-6-7-33-34-11-18)14-26(41)39-12-19(32)10-25(39)27(42)35-29-37-36-28(43-29)17-2-4-22(30)23(31)9-17/h2-9,11,13,19,25H,10,12,14H2,1H3,(H,35,37,42)/t19-,25+/m1/s1	FJFJPQGBNXXRNF-CLOONOSVSA-N	354219	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- (3,4-dichlorophenyl)- 1,3,4-thiadiazol-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 117::US10822352, Comp No. 117::US9796741, cmp No. 117	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354219&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323741	386047951							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976369	CC(=O)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C28H25BrFN7O4/c1-15(38)21-13-36(22-7-6-17(8-20(21)22)18-10-31-28(32-11-18)33-16(2)39)14-26(40)37-12-19(30)9-23(37)27(41)35-25-5-3-4-24(29)34-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,34,35,41)(H,31,32,33,39)/t19-,23+/m1/s1	UWJAWFUXNVXXEN-XXBNENTESA-N	354220	(2S,4R)-1-(2-(5-(2- acetamidopyrimidin-5- yl)-3-acetyl-1H-indol- 1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 118::US10822352, Comp No. 118::US9796741, cmp No. 118	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354220&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323697	386047952							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976370	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cccc(Cl)c1	InChI=1S/C28H23BrClFN4O3/c1-16(36)22-14-34(23-9-8-18(11-21(22)23)17-4-2-5-19(30)10-17)15-27(37)35-13-20(31)12-24(35)28(38)33-26-7-3-6-25(29)32-26/h2-11,14,20,24H,12-13,15H2,1H3,(H,32,33,38)/t20-,24+/m1/s1	WIQMCFLUSFKWBO-YKSBVNFPSA-N	354221	(2S,4R)-1-(2-(3-acetyl- 5-(3-chlorophenyl)-1H- indol-1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 119::US10822352, Comp No. 119::US9796741, cmp No. 119	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354221&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323719	386047953							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976371	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc(C)nc1	InChI=1S/C28H25BrFN5O3/c1-16-6-7-19(12-31-16)18-8-9-23-21(10-18)22(17(2)36)14-34(23)15-27(37)35-13-20(30)11-24(35)28(38)33-26-5-3-4-25(29)32-26/h3-10,12,14,20,24H,11,13,15H2,1-2H3,(H,32,33,38)/t20-,24+/m1/s1	VCUANRJPEFLMNS-YKSBVNFPSA-N	354222	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridin-3- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 120::US10822352, Comp No. 120::US9796741, cmp No. 120	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354222&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323689	386047954							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976372	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnnc(C)c1	InChI=1S/C34H28ClF2N5O3/c1-19-12-22(15-38-40-19)21-10-11-30-26(13-21)27(20(2)43)17-41(30)18-32(44)42-16-23(36)14-31(42)34(45)39-29-9-5-7-25(33(29)37)24-6-3-4-8-28(24)35/h3-13,15,17,23,31H,14,16,18H2,1-2H3,(H,39,45)/t23-,31+/m1/s1	OIMMHIXXLWLHLX-IPBJYNAHSA-N	354223	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridazin-4- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 121::US10822352, Comp No. 121::US9796741, cmp No. 121	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354223&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323765	386047955							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976373	COc1cc(C)cc2C(CCOc12)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C30H30FN7O5/c1-16-9-20-22(6-8-43-28(20)25(10-16)42-2)35-30(41)24-12-19(31)14-37(24)26(39)15-38-23-4-3-17(18-5-7-33-34-13-18)11-21(23)27(36-38)29(32)40/h3-5,7,9-11,13,19,22,24H,6,8,12,14-15H2,1-2H3,(H2,32,40)(H,35,41)/t19-,22?,24+/m1/s1	LJLICBSZMAKTAW-UFGRQMGQSA-N	354224	1-(2-((2S,4R)-4-fluoro- 2-(8-methoxy-6- methylchroman-4- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 122::US10822352, Comp No. 122::US9796741, cmp No. 122	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354224&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323773	386047956							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976374	COc1cc(C)cc2C(CCOc12)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C32H32FN5O5/c1-18-10-24-26(7-9-43-31(24)29(11-18)42-3)36-32(41)28-13-22(33)15-38(28)30(40)17-37-16-25(19(2)39)23-12-20(4-5-27(23)37)21-6-8-34-35-14-21/h4-6,8,10-12,14,16,22,26,28H,7,9,13,15,17H2,1-3H3,(H,36,41)/t22-,26?,28+/m1/s1	FZHIZZJQDAZUJY-KKTWTCTJSA-N	354225	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(8-methoxy-6- methylchroman-4- yl)pyrrolidine-2- carboxamide::US10287301, Compound 123::US10822352, Comp No. 123::US9796741, cmp No. 123	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354225&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323412	386047957							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976375	Cc1ccc(F)c(c1)N1CCCC(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)C1=O	InChI=1S/C31H30F2N8O4/c1-17-4-6-22(33)25(11-17)39-10-2-3-23(31(39)45)37-30(44)26-13-20(32)15-40(26)27(42)16-41-24-7-5-18(19-8-9-35-36-14-19)12-21(24)28(38-41)29(34)43/h4-9,11-12,14,20,23,26H,2-3,10,13,15-16H2,1H3,(H2,34,43)(H,37,44)/t20-,23?,26+/m1/s1	OLXGTJSMTVWTFK-MBPASQAPSA-N	354226	1-(2-((2S,4R)-4-fluoro- 2-(1-(2-fluoro-5- methylphenyl)-2- oxopiperidin-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 124::US10822352, Comp No. 124::US9796741, cmp No. 124	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354226&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323728	386047958							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976376	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2cc(C)ccc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H32F2N6O4/c1-19-5-7-26(35)29(12-19)40-11-3-4-27(33(40)45)38-32(44)30-14-23(34)16-41(30)31(43)18-39-17-25(20(2)42)24-13-21(6-8-28(24)39)22-9-10-36-37-15-22/h5-10,12-13,15,17,23,27,30H,3-4,11,14,16,18H2,1-2H3,(H,38,44)/t23-,27?,30+/m1/s1	FXDUTDMEBFWTCZ-DGGRJXBFSA-N	354227	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(2-fluoro- 5-methylphenyl)-2- oxopiperidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 125::US10822352, Comp No. 125::US9796741, cmp No. 125	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354227&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323713	386047959							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976377	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Cc2cccc(Cl)c2C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClF4N4O3/c1-16(39)22-14-37(24-6-5-17(9-21(22)24)19-7-8-35-36-12-19)15-27(41)38-13-20(31)11-25(38)26(40)10-18-3-2-4-23(30)28(18)29(32,33)34/h2-9,12,14,20,25H,10-11,13,15H2,1H3/t20-,25+/m1/s1	XXHQISCNIDCXNU-NLFFAJNJSA-N	471842	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-N-(3- chloro-2- (trifluoro- methyl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 126	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471842&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313993	441610842							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976378	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21BrFN7O3/c1-14(35)19-12-33(20-3-2-15(6-18(19)20)16-4-5-29-30-8-16)13-24(36)34-11-17(27)7-21(34)25(37)32-23-10-28-9-22(26)31-23/h2-6,8-10,12,17,21H,7,11,13H2,1H3,(H,31,32,37)/t17-,21+/m1/s1	QMNPPWZYTRGISQ-UTKZUKDTSA-N	354229	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- bromopyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 127::US10822352, Comp No. 127::US9796741, cmp No. 127	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354229&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323634	386047961							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976379	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20BrFN8O3/c25-20-8-28-9-21(31-20)32-24(37)19-6-15(26)10-34(19)22(35)12-33-11-17(23(27)36)16-5-13(1-2-18(16)33)14-3-4-29-30-7-14/h1-5,7-9,11,15,19H,6,10,12H2,(H2,27,36)(H,31,32,37)/t15-,19+/m1/s1	COHUJOBIFNHQRZ-BEFAXECRSA-N	471844	1-(2-((2S,4R)-2-(6- bromopyrazin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 128	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471844&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314119	441610844							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976380	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc3OC(F)(F)Oc3cc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H21F4N5O5/c1-14(38)19-12-36(22-3-2-15(6-18(19)22)16-4-5-33-34-10-16)13-26(39)37-11-17(29)7-23(37)27(40)35-21-9-25-24(8-20(21)30)41-28(31,32)42-25/h2-6,8-10,12,17,23H,7,11,13H2,1H3,(H,35,40)/t17-,23+/m1/s1	LVSKWPPYMYQIBU-HXOBKFHXSA-N	354231	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2,2,6- trifluorobenzo[d][1,3] dioxol-5-yl)pyrrolidine- 2-carboxamide::US10822352, Comp No. 129::US9796741, cmp No. 129	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354231&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323548	386047962							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976381	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc3OC(F)(F)Oc3cc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H19F4N7O5/c27-14-6-19(25(40)34-17-8-21-20(7-16(17)28)41-26(29,30)42-21)36(10-14)22(38)11-37-18-2-1-12(13-3-4-32-33-9-13)5-15(18)23(35-37)24(31)39/h1-5,7-9,14,19H,6,10-11H2,(H2,31,39)(H,34,40)/t14-,19+/m1/s1	LOAHZBPECSIMPS-KUHUBIRLSA-N	354232	1-(2-((2S,4R)-4-fluoro- 2-(2,2,6- trifluorobenzo[d][1,3] dioxol-5- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10822352, Comp No. 130::US9796741, cmp No. 130	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354232&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323756	386047963							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976382	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ccccc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H24FN7O3/c30-21-13-25(29(40)34-22-7-5-17-3-1-2-4-18(17)11-22)36(15-21)26(38)16-37-24-8-6-19(20-9-10-32-33-14-20)12-23(24)27(35-37)28(31)39/h1-12,14,21,25H,13,15-16H2,(H2,31,39)(H,34,40)/t21-,25+/m1/s1	PJCNYXBQSWMAOG-BWKNWUBXSA-N	354233	1-(2-((2S,4R)-4-fluoro- 2-(naphthalen-2- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 131::US10822352, Comp No. 131::US9796741, cmp No. 131	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354233&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323774	386047964							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976383	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25BrN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)19-11-30-16(2)31-12-19)14-27(37)35-23-9-18(23)10-24(35)28(38)33-26-5-3-4-25(29)32-26/h3-8,11-13,18,23-24H,9-10,14H2,1-2H3,(H,32,33,38)/t18-,23-,24+/m1/s1	VDORKYXTVASCJK-QFWMQHCXSA-N	354234	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-yl)- 1H-indol-1-yl)acetyl)- N-(6-bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 132::US10822352, Comp No. 132::US9796741, cmp No. 132	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354234&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323588	386047965							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976384	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H29ClFN5O3/c1-19(43)27-17-41(30-11-10-21(12-26(27)30)23-15-38-20(2)39-16-23)18-33(44)42-31-13-22(31)14-32(42)35(45)40-29-9-5-7-25(34(29)37)24-6-3-4-8-28(24)36/h3-12,15-17,22,31-32H,13-14,18H2,1-2H3,(H,40,45)/t22-,31-,32+/m1/s1	BRAAMOHBRUGSOM-MMFLPWJGSA-N	354236	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-yl)- 1H-indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 133::US10822352, Comp No. 133::US9796741, cmp No. 133	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354236&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323660	386047967							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976385	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H27ClFN5O3/c1-16(38)23-14-36(25-7-6-18(8-22(23)25)21-12-33-17(2)34-13-21)15-28(39)37-26-9-20(26)10-27(37)30(40)35-11-19-4-3-5-24(31)29(19)32/h3-8,12-14,20,26-27H,9-11,15H2,1-2H3,(H,35,40)/t20-,26-,27+/m1/s1	KJFCNCXMENHIRF-UIFDUCBYSA-N	354237	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-yl)- 1H-indol-1-yl)acetyl)- N-(3-chloro-2- fluorobenzyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 134::US10822352, Comp No. 134::US9796741, cmp No. 134	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354237&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323643	386047968							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976386	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26ClF2N5O3/c1-16(38)23-14-36(25-7-6-18(8-22(23)25)20-11-33-17(2)34-12-20)15-27(39)37-13-21(31)9-26(37)29(40)35-10-19-4-3-5-24(30)28(19)32/h3-8,11-12,14,21,26H,9-10,13,15H2,1-2H3,(H,35,40)/t21-,26+/m1/s1	JHHLIMNNIQOCGJ-RLWLMLJZSA-N	354238	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(3-chloro- 2-fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 135::US10822352, Comp No. 135::US9796741, cmp No. 135	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354238&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323543	386047969							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976387	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)NCc3cccc(Cl)c3F)cc(C(C)=O)c2c1	InChI=1S/C29H26ClF2N5O4/c1-16(38)22-14-36(24-7-6-17(8-21(22)24)19-11-34-29(41-2)35-12-19)15-26(39)37-13-20(31)9-25(37)28(40)33-10-18-4-3-5-23(30)27(18)32/h3-8,11-12,14,20,25H,9-10,13,15H2,1-2H3,(H,33,40)/t20-,25+/m1/s1	AMLVMZDJOUXHNX-NLFFAJNJSA-N	354239	(2S,4R)-1-(2-(3-acetyl- 5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(3-chloro- 2-fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 136::US10822352, Comp No. 136::US9796741, cmp No. 136	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354239&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323573	386047970							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976388	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24ClFN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)18-10-30-16(2)31-11-18)14-26(37)35-12-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,32,33,38)/t19-,23+/m1/s1	BZKVXKLDHVUFKO-XXBNENTESA-N	354240	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- chloropyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 137::US10822352, Comp No. 137::US9796741, cmp No. 137	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354240&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323536	386047971							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976389	CC(=O)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H29ClF2N6O4/c1-19(45)27-17-43(30-11-10-21(12-26(27)30)22-14-39-35(40-15-22)41-20(2)46)18-32(47)44-16-23(37)13-31(44)34(48)42-29-9-5-7-25(33(29)38)24-6-3-4-8-28(24)36/h3-12,14-15,17,23,31H,13,16,18H2,1-2H3,(H,42,48)(H,39,40,41,46)/t23-,31+/m1/s1	ZUEHMKHQIJZEEW-IPBJYNAHSA-N	354241	(2S,4R)-1-(2-(5-(2- acetamidopyrimidin-5- yl)-3-acetyl-1H-indol- 1-yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 138::US10822352, Comp No. 138::US9796741, cmp No. 138	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354241&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323661	386047972							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976390	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H23FN8O3/c26-17-10-21(25(37)29-12-18-3-1-2-7-28-18)33(13-17)22(35)14-34-20-5-4-15(16-6-8-30-31-11-16)9-19(20)23(32-34)24(27)36/h1-9,11,17,21H,10,12-14H2,(H2,27,36)(H,29,37)/t17-,21+/m1/s1	ZMOUVYBPXIBHNS-UTKZUKDTSA-N	354242	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-2- ylmethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 139::US10822352, Comp No. 139::US9796741, cmp No. 139	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354242&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323737	386047973							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976391	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2)c2cnn(C)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H33FN8O3/c1-19(40)26-17-38(27-6-5-20(10-25(26)27)21-7-8-32-33-12-21)18-29(41)39-14-22(31)11-28(39)30(42)35-23-4-3-9-37(15-23)24-13-34-36(2)16-24/h5-8,10,12-13,16-17,22-23,28H,3-4,9,11,14-15,18H2,1-2H3,(H,35,42)/t22-,23?,28+/m1/s1	PTTPIJSBFUGWMI-XFILVABKSA-N	354243	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(1-methyl- 1H-pyrazol-4- yl)piperidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 140::US10822352, Comp No. 140::US9796741, cmp No. 140	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354243&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323600	386047974							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976392	Cn1cc(cn1)N1CCCC(C1)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C28H31FN10O3/c1-36-15-21(12-33-36)37-8-2-3-20(14-37)34-28(42)24-10-19(29)13-38(24)25(40)16-39-23-5-4-17(18-6-7-31-32-11-18)9-22(23)26(35-39)27(30)41/h4-7,9,11-12,15,19-20,24H,2-3,8,10,13-14,16H2,1H3,(H2,30,41)(H,34,42)/t19-,20?,24+/m1/s1	MCBXXXNHKNEFJF-JATBYWIBSA-N	354244	1-(2-((2S,4R)-4-fluoro- 2-(1-(1-methyl-1H- pyrazol-4-yl)piperidin- 3-ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 141::US10822352, Comp No. 141::US9796741, cmp No. 141	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354244&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323529	386047975							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976393	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3cn[nH]c3c2)c2ccc(cc12)-c1ccnnc1			354245	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1H-indazol- 6-yl)pyrrolidine-2- carboxamide::US10287301, Compound 142::US10822352, Comp No. 142::US9796741, cmp No. 142	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354245&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208187	386047976							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976394	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCC[C@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H28FN5O4/c1-15(33)20-13-31(22-6-5-16(9-19(20)22)17-7-8-28-29-11-17)14-25(35)32-12-18(27)10-23(32)26(36)30-21-3-2-4-24(21)34/h5-9,11,13,18,21,23-24,34H,2-4,10,12,14H2,1H3,(H,30,36)/t18-,21-,23+,24-/m1/s1	JDFXREZXKVJIOX-OLOOCYQZSA-N	354246	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-((1R,2R)-2- hydroxycyclopentyl) pyrrolidine-2- carboxamide::US10287301, Compound 143::US10822352, Comp No. 143::US9796741, cmp No. 143	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354246&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323550	386047977							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976395	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(O)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O4/c1-15(34)20-13-32(21-6-5-16(9-19(20)21)17-7-8-28-29-11-17)14-25(36)33-12-18(27)10-22(33)26(37)31-23-3-2-4-24(35)30-23/h2-9,11,13,18,22H,10,12,14H2,1H3,(H2,30,31,35,37)/t18-,22+/m1/s1	HURUMVQSEGPJGQ-GCJKJVERSA-N	354247	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(6- hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 144::US10822352, Comp No. 144::US9796741, cmp No. 144	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354247&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323591	386047978							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976396	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCC[C@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H26FN7O4/c25-15-9-19(24(36)29-17-2-1-3-20(17)33)31(11-15)21(34)12-32-18-5-4-13(14-6-7-27-28-10-14)8-16(18)22(30-32)23(26)35/h4-8,10,15,17,19-20,33H,1-3,9,11-12H2,(H2,26,35)(H,29,36)/t15-,17-,19+,20-/m1/s1	NTKMUBWYJKVCJW-WSTLGDPDSA-N	354248	1-(2-((2S,4R)-4-fluoro- 2-((1R,2R)-2- hydroxycyclopentyl- carbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 145::US10822352, Comp No. 145::US9796741, cmp No. 145	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354248&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323605	386047979							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976397	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClFN9O3S/c28-17-3-1-2-15(8-17)25-33-27(42-36-25)34-26(41)21-10-18(29)12-37(21)22(39)13-38-20-5-4-14(16-6-7-31-32-11-16)9-19(20)23(35-38)24(30)40/h1-9,11,18,21H,10,12-13H2,(H2,30,40)(H,33,34,36,41)/t18-,21+/m1/s1	PBMTXPKHSJNECA-NQIIRXRSSA-N	354249	1-(2-((2S,4R)-2-(3-(3- chlorophenyl)-1,2,4- thiadiazol-5- ylcarbamoyl)-4- fluoropyrrolidin-l-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 146::US10822352, Comp No. 146::US9796741, cmp No. 146	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354249&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323678	386047980							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976398	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O3S/c1-16(39)23-14-37(24-6-5-17(10-22(23)24)19-7-8-32-33-12-19)15-26(40)38-13-21(31)11-25(38)28(41)35-29-34-27(36-42-29)18-3-2-4-20(30)9-18/h2-10,12,14,21,25H,11,13,15H2,1H3,(H,34,35,36,41)/t21-,25+/m1/s1	YYWGWXVFYLDSKE-BWKNWUBXSA-N	354250	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- (3-chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 147::US10822352, Comp No. 147::US9796741, cmp No. 147	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354250&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323637	386047981							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976399	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc(C)nn1	InChI=1S/C27H24BrFN6O3/c1-15-6-8-21(33-32-15)17-7-9-22-19(10-17)20(16(2)36)13-34(22)14-26(37)35-12-18(29)11-23(35)27(38)31-25-5-3-4-24(28)30-25/h3-10,13,18,23H,11-12,14H2,1-2H3,(H,30,31,38)/t18-,23+/m1/s1	XINDJMGEVZSWEF-JPYJTQIMSA-N	354251	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridazin-3- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 148::US10822352, Comp No. 148::US9796741, cmp No. 148	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354251&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323672	386047982							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976400	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2Cl)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)cn1	InChI=1S/C34H28Cl2FN5O3/c1-19-14-39-29(15-38-19)21-10-11-30-25(12-21)26(20(2)43)17-41(30)18-32(44)42-16-22(37)13-31(42)34(45)40-28-9-5-7-24(33(28)36)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,31H,13,16,18H2,1-2H3,(H,40,45)/t22-,31+/m1/s1	FTAIKCRSJDQGCO-UVDDSOTQSA-N	471865	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2,2'- dichlorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 149	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471865&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314121	441610865							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976401	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(F)c(F)cc2Cl)c2ccc(cc12)-c1cnc(C)cn1	InChI=1S/C34H26ClF4N5O3/c1-17-12-41-29(13-40-17)19-6-7-30-23(8-19)24(18(2)45)15-43(30)16-32(46)44-14-20(36)9-31(44)34(47)42-28-5-3-4-21(33(28)39)22-10-26(37)27(38)11-25(22)35/h3-8,10-13,15,20,31H,9,14,16H2,1-2H3,(H,42,47)/t20-,31+/m1/s1	YEYLIQFKDSWXHD-QJWGWKRISA-N	471866	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2,4',5'- trifluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 150	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471866&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313957	441610866							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976402	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(C)nc1	InChI=1S/C35H29ClF2N4O3/c1-20-10-11-23(16-39-20)22-12-13-31-27(14-22)28(21(2)43)18-41(31)19-33(44)42-17-24(37)15-32(42)35(45)40-30-9-5-7-26(34(30)38)25-6-3-4-8-29(25)36/h3-14,16,18,24,32H,15,17,19H2,1-2H3,(H,40,45)/t24-,32+/m1/s1	KEUSTPZVQDYRHT-QNLPTKCRSA-N	354254	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridin-3- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 151::US10822352, Comp No. 151::US9796741, cmp No. 151	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354254&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323544	386047985							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976403	CC1Oc2cccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)c2NC1=O	InChI=1S/C28H25FN8O5/c1-14-27(40)34-25-19(3-2-4-22(25)42-14)33-28(41)21-10-17(29)12-36(21)23(38)13-37-20-6-5-15(16-7-8-31-32-11-16)9-18(20)24(35-37)26(30)39/h2-9,11,14,17,21H,10,12-13H2,1H3,(H2,30,39)(H,33,41)(H,34,40)/t14?,17-,21+/m1/s1	VBIMXRCJVBIUJR-ZFXWJCKASA-N	354255	1-(2-((2S,4R)-4-fluoro- 2-(2-methyl-3-oxo-3,4- dihydro-2H- benzo[b][1,4]oxazin-5- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 152::US10822352, Comp No. 152::US9796741, cmp No. 152	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354255&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323619	386047986							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976404	CC1Oc2cccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(ccc34)-c3ccnnc3)c2NC1=O	InChI=1S/C30H27FN6O5/c1-16(38)22-14-36(24-7-6-18(10-21(22)24)19-8-9-32-33-12-19)15-27(39)37-13-20(31)11-25(37)30(41)34-23-4-3-5-26-28(23)35-29(40)17(2)42-26/h3-10,12,14,17,20,25H,11,13,15H2,1-2H3,(H,34,41)(H,35,40)/t17?,20-,25+/m1/s1	DNWBYAOOZUCOPM-SPGLARIMSA-N	354256	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-methyl-3- oxo-3,4-dihydro-2H- benzo[b][1,4]oxazin-5- yl)pyrrolidine-2- carboxamide::US10287301, Compound 153::US10822352, Comp No. 153::US9796741, cmp No. 153	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354256&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323614	386047987							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976405	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(O)ccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H21FN8O4/c25-15-8-19(24(37)30-20-9-16(34)4-5-27-20)32(11-15)21(35)12-33-18-2-1-13(14-3-6-28-29-10-14)7-17(18)22(31-33)23(26)36/h1-7,9-10,15,19H,8,11-12H2,(H2,26,36)(H2,27,30,34,37)/t15-,19+/m1/s1	NALNFESPHXYTFN-BEFAXECRSA-N	354257	1-(2-((2S,4R)-4-fluoro- 2-(4-hydroxypyridin-2- ylcarbamoyl)pyrrolidin- l-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 154::US10822352, Comp No. 154::US9796741, cmp No. 154	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354257&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323487	386047988							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976406	Cn1ccc(n1)N1CCC(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)C1=O	InChI=1S/C27H27FN10O4/c1-35-8-6-22(33-35)36-9-5-19(27(36)42)32-26(41)21-11-17(28)13-37(21)23(39)14-38-20-3-2-15(16-4-7-30-31-12-16)10-18(20)24(34-38)25(29)40/h2-4,6-8,10,12,17,19,21H,5,9,11,13-14H2,1H3,(H2,29,40)(H,32,41)/t17-,19?,21+/m1/s1	BFENFBFUUOJGHY-INMVSHNGSA-N	354258	1-(2-((2S,4R)-4-fluoro- 2-(1-(1-methyl-1H- pyrazol-3-yl)-2- oxopyrrolidin-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 155::US10822352, Comp No. 155::US9796741, cmp No. 155	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354258&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323720	386047989							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976407	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]nc2-c2ccc(Cl)cc2Cl)c2ccc(cc12)-c1ccnnc1			354259	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- (2,4-dichlorophenyl)- 1H-pyrazol-4-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 156::US10822352, Comp No. 156::US9796741, cmp No. 156	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354259&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208188	386047990							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976408	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccncc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H23FN8O3/c26-18-10-21(25(37)29-11-15-3-6-28-7-4-15)33(13-18)22(35)14-34-20-2-1-16(17-5-8-30-31-12-17)9-19(20)23(32-34)24(27)36/h1-9,12,18,21H,10-11,13-14H2,(H2,27,36)(H,29,37)/t18-,21+/m1/s1	GJCXNCCSWFAZFH-NQIIRXRSSA-N	354260	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-4- ylmethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 157::US10822352, Comp No. 157::US9796741, cmp No. 157	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354260&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323732	386047991							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976409	Cc1cc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)n(n1)-c1ccccc1F	InChI=1S/C29H25F2N9O3/c1-16-10-25(40(36-16)23-5-3-2-4-21(23)31)35-29(43)24-12-19(30)14-38(24)26(41)15-39-22-7-6-17(18-8-9-33-34-13-18)11-20(22)27(37-39)28(32)42/h2-11,13,19,24H,12,14-15H2,1H3,(H2,32,42)(H,35,43)/t19-,24+/m1/s1	AZNXFDFEWRKYIZ-DVECYGJZSA-N	354261	1-(2-((2S,4R)-4-fluoro- 2-(1-(2-fluorophenyl)- 3-methyl-1H-pyrazol-5- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 158::US10822352, Comp No. 158::US9796741, cmp No. 158	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354261&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323586	386047992							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976410	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H28ClFN8O4/c31-21-4-1-2-6-24(21)38-11-3-5-22(30(38)44)36-29(43)25-13-19(32)15-39(25)26(41)16-40-23-8-7-17(18-9-10-34-35-14-18)12-20(23)27(37-40)28(33)42/h1-2,4,6-10,12,14,19,22,25H,3,5,11,13,15-16H2,(H2,33,42)(H,36,43)/t19-,22?,25+/m1/s1	HMCWLTLTHIKDHQ-CGPDNSSVSA-N	354262	1-(2-((2S,4R)-2-(1-(2- chlorophenyl)-2- oxopiperidin-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 159::US10822352, Comp No. 159::US9796741, cmp No. 159	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354262&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323628	386047993							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976411	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nn2-c2ccccc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H27F2N7O3/c1-18-11-29(40(37-18)27-6-4-3-5-25(27)33)36-31(43)28-13-22(32)15-39(28)30(42)17-38-16-24(19(2)41)23-12-20(7-8-26(23)38)21-9-10-34-35-14-21/h3-12,14,16,22,28H,13,15,17H2,1-2H3,(H,36,43)/t22-,28+/m1/s1	IKLKWPUZKVAMQE-DFHRPNOPSA-N	386230	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(1-(2- fluorophenyl)-3- methyl-1H-pyrazol- 5-yl)pyrrolidine-2- carboxamide::US10287301, Compound 160::US10822352, Comp No. 160	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386230&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323649	404855387							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976412	CC(=O)c1cn(CC(=O)N2C[C@@H](F)C[C@@H]2C(=O)NC2CCCN(C2=O)c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H30ClFN6O4/c1-19(41)24-17-38(27-9-8-20(13-23(24)27)21-10-11-35-36-15-21)18-30(42)40-16-22(34)14-29(40)31(43)37-26-6-4-12-39(32(26)44)28-7-3-2-5-25(28)33/h2-3,5,7-11,13,15,17,22,26,29H,4,6,12,14,16,18H2,1H3,(H,37,43)/t22-,26?,29+/m0/s1	MVUMCWSPWBWAED-PWMFPERWSA-N	354264	(2R,4S)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(1- (2-chlorophenyl)-2- oxopiperidin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 161::US10822352, Comp No. 161::US9796741, cmp No. 161	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354264&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323523	386047995							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976413	CC(NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1ccnnc1)c1oc2ccc(F)cc2c1C	InChI=1S/C32H29F2N5O4/c1-17-24-11-22(33)5-7-29(24)43-31(17)18(2)37-32(42)28-12-23(34)14-39(28)30(41)16-38-15-26(19(3)40)25-10-20(4-6-27(25)38)21-8-9-35-36-13-21/h4-11,13,15,18,23,28H,12,14,16H2,1-3H3,(H,37,42)/t18?,23-,28+/m1/s1	PVDFVXKXFOCKJE-APRMAWDYSA-N	354265	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(5-fluoro- 3-methylbenzofuran-2- yl)ethyl)pyrrolidine-2- carboxamide::US10287301, Compound 162::US10822352, Comp No. 162::US9796741, cmp No. 162	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354265&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323533	386047996							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976414	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H27ClF2N6O3/c1-18(43)32-25-12-20(21-14-37-19(2)38-15-21)10-11-28(25)42(40-32)17-30(44)41-16-22(35)13-29(41)33(45)39-27-9-5-7-24(31(27)36)23-6-3-4-8-26(23)34/h3-12,14-15,22,29H,13,16-17H2,1-2H3,(H,39,45)/t22-,29+/m1/s1	IBAALFJDCTWVJH-MNNSJKJDSA-N	354266	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 163::US9796741, cmp No. 163	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354266&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323500	386047997							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976415	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ncccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H27ClF2N6O3/c1-18(43)25-16-41(28-9-8-20(11-24(25)28)21-13-38-19(2)39-14-21)17-30(44)42-15-22(35)12-29(42)33(45)40-27-7-3-5-23(31(27)36)32-26(34)6-4-10-37-32/h3-11,13-14,16,22,29H,12,15,17H2,1-2H3,(H,40,45)/t22-,29+/m1/s1	NDFKWKHKSOGTII-MNNSJKJDSA-N	354267	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(3-(3- chloropyridin-2-yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 164::US10822352, Comp No. 164::US9796741, cmp No. 164	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354267&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323701	386047998							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976416	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	PIBARDGJJAGJAJ-NQIIRXRSSA-N	354268	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 165::US10822352, Comp No. 165::US9796741, cmp No. 165	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354268&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323590	386047999							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976417	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClFN6O3/c1-15(35)20-13-33(22-5-4-16(9-19(20)22)17-6-8-30-31-11-17)14-24(36)34-12-18(28)10-23(34)26(37)32-21-3-2-7-29-25(21)27/h2-9,11,13,18,23H,10,12,14H2,1H3,(H,32,37)/t18-,23+/m1/s1	UURCFXLKBDDRAG-JPYJTQIMSA-N	386236	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-N-(2- chloropyridin-3-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 166::US10822352, Comp No. 166	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386236&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323786	404855393							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976418	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(C2=O)c2ccn(C)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H29FN8O4/c1-17(39)22-15-36(24-4-3-18(11-21(22)24)19-5-8-31-32-13-19)16-27(40)38-14-20(30)12-25(38)28(41)33-23-6-10-37(29(23)42)26-7-9-35(2)34-26/h3-5,7-9,11,13,15,20,23,25H,6,10,12,14,16H2,1-2H3,(H,33,41)/t20-,23?,25+/m1/s1	RLLJEQAWCCTGQK-PCXNKIBISA-N	386237	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(1-(1-methyl-1H- pyrazol-3-yl)-2- oxopyrrolidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 167::US10822352, Comp No. 167	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386237&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323599	404855394							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976419	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(=O)[nH]n2C2CCCCC2)c2ccc(cc12)-c1ccnnc1			386238	1-(2-((2S,4R)-2-(2- cyclohexyl-5-oxo- 2,5-dihydro-1H- pyrazol-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 168::US10822352, Comp No. 168	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386238&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323776	404855395							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976420	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]c(C)c2-c2ccccc2)c2ccc(cc12)-c1ccnnc1			471887	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(5-methyl-4- phenyl-1H-pyrazol- 3-yl)pyrrolidine-2- carboxamide::US10822352, Comp No. 169	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471887&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314115	441610887							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976421	Cc1[nH]nc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)c1-c1ccccc1			386240	1-(2-((2S,4R)-4- fluoro-2-(5-methyl- 4-phenyl-1H- pyrazol-3- ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 170::US10822352, Comp No. 170	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386240&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			145996358	404855397							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976422	CC1Cc2c(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(ccc34)-c3ccnnc3)nn(C)c2NC1=O	InChI=1S/C29H29FN8O4/c1-15-8-21-26(35-36(3)27(21)34-28(15)41)33-29(42)24-10-19(30)12-38(24)25(40)14-37-13-22(16(2)39)20-9-17(4-5-23(20)37)18-6-7-31-32-11-18/h4-7,9,11,13,15,19,24H,8,10,12,14H2,1-3H3,(H,34,41)(H,33,35,42)/t15?,19-,24+/m1/s1	WRELRJAPVRRMNW-NOLHBAOHSA-N	386241	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-N-(1,5- dimethyl-6-oxo- 4,5,6,7-tetrahydro- 1H-pyrazolo[3,4- b]pyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 171::US10822352, Comp No. 171	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386241&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137150265	404855398							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976423	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H28FN7O4/c26-16-10-20(25(37)30-18-3-1-2-4-21(18)34)32(12-16)22(35)13-33-19-6-5-14(15-7-8-28-29-11-15)9-17(19)23(31-33)24(27)36/h5-9,11,16,18,20-21,34H,1-4,10,12-13H2,(H2,27,36)(H,30,37)/t16-,18+,20+,21+/m1/s1	HSUKJCCUVJOQFW-LGYWMIHWSA-N	386242	1-(2-((2S,4R)-4- fluoro-2-((1S,2S)- 2- hydroxycyclohexyl carbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 172::US10822352, Comp No. 172	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386242&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323727	404855399							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976424	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccnc(=O)n2C)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H24FN7O4/c1-15(35)20-13-33(21-4-3-16(9-19(20)21)17-5-8-29-30-11-17)14-24(36)34-12-18(27)10-22(34)25(37)31-23-6-7-28-26(38)32(23)2/h3-9,11,13,18,22H,10,12,14H2,1-2H3,(H,31,37)/t18-,22+/m1/s1	FUWVHRYIUDLBBN-GCJKJVERSA-N	386243	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(3-methyl-2-oxo- 2,3- dihydropyrimidin- 4-yl)pyrrolidine-2- carboxamide::US10287301, Compound 173::US10822352, Comp No. 173	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386243&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323443	404855400							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976425	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(O)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H21FN8O4/c25-15-9-18(24(37)30-19-2-1-3-20(34)29-19)32(11-15)21(35)12-33-17-5-4-13(14-6-7-27-28-10-14)8-16(17)22(31-33)23(26)36/h1-8,10,15,18H,9,11-12H2,(H2,26,36)(H2,29,30,34,37)/t15-,18+/m1/s1	JMZBNEOUXAFMJG-QAPCUYQASA-N	386244	1-(2-((2S,4R)-4- fluoro-2-(6- hydroxypyridin-2- ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 174::US10822352, Comp No. 174	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386244&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323704	404855401							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976426	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(O)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O4/c1-15(34)21-13-32(22-4-2-16(8-20(21)22)17-6-7-29-30-10-17)14-25(36)33-12-18(27)9-23(33)26(37)31-24-5-3-19(35)11-28-24/h2-8,10-11,13,18,23,35H,9,12,14H2,1H3,(H,28,31,37)/t18-,23+/m1/s1	WPCKAMOPMLONTJ-JPYJTQIMSA-N	386245	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(5- hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 175::US10822352, Comp No. 175	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386245&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323733	404855402							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976427	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(O)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H21FN8O4/c25-15-8-19(24(37)30-20-4-2-16(34)10-27-20)32(11-15)21(35)12-33-18-3-1-13(14-5-6-28-29-9-14)7-17(18)22(31-33)23(26)36/h1-7,9-10,15,19,34H,8,11-12H2,(H2,26,36)(H,27,30,37)/t15-,19+/m1/s1	RYWTZSJYIUWIHH-BEFAXECRSA-N	386246	1-(2-((2S,4R)-4- fluoro-2-(5- hydroxypyridin-2- ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 176::US10822352, Comp No. 176	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386246&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323635	404855403							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976428	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(O)ccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O4/c1-15(34)21-13-32(22-3-2-16(8-20(21)22)17-4-7-29-30-11-17)14-25(36)33-12-18(27)9-23(33)26(37)31-24-10-19(35)5-6-28-24/h2-8,10-11,13,18,23H,9,12,14H2,1H3,(H2,28,31,35,37)/t18-,23+/m1/s1	MHVKVAPACRFZBZ-JPYJTQIMSA-N	386247	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(4- hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 177::US10822352, Comp No. 177	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386247&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323664	404855404							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976429	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nccc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19ClFN9O3/c24-18-4-5-27-23(30-18)31-22(37)17-8-14(25)10-33(17)19(35)11-34-16-2-1-12(13-3-6-28-29-9-13)7-15(16)20(32-34)21(26)36/h1-7,9,14,17H,8,10-11H2,(H2,26,36)(H,27,30,31,37)/t14-,17+/m1/s1	CYVGBPPYZDRYGW-PBHICJAKSA-N	386248	1-(2-((2S,4R)-2-(4- chloropyrimidin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 178::US10822352, Comp No. 178	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386248&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323580	404855405							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976430	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(F)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19F2N9O3/c24-14-6-18(22(37)31-23-27-8-15(25)9-28-23)33(10-14)19(35)11-34-17-2-1-12(13-3-4-29-30-7-13)5-16(17)20(32-34)21(26)36/h1-5,7-9,14,18H,6,10-11H2,(H2,26,36)(H,27,28,31,37)/t14-,18+/m1/s1	KAIOSWULGTTZOR-KDOFPFPSSA-N	471897	1-(2-((2S,4R)-4- fluoro-2-(5- iodopyrimidin-2- ylcarbamoyl)pyrroli- din-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 179	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471897&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137434849	441610897							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976431	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nccc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21ClFN7O3/c1-14(35)19-12-33(20-3-2-15(8-18(19)20)16-4-7-29-30-10-16)13-23(36)34-11-17(27)9-21(34)24(37)32-25-28-6-5-22(26)31-25/h2-8,10,12,17,21H,9,11,13H2,1H3,(H,28,31,32,37)/t17-,21+/m1/s1	NCPSQOOIKCVQLR-UTKZUKDTSA-N	386250	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-N-(4- chloropyrimidin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 180::US10822352, Comp No. 180	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386250&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323760	404855407							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976432	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nncn2C)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H27FN8O3/c1-18(40)24-15-38(26-8-7-19(11-23(24)26)20-9-10-32-33-13-20)16-28(41)39-14-21(31)12-27(39)30(42)35-25-6-4-3-5-22(25)29-36-34-17-37(29)2/h3-11,13,15,17,21,27H,12,14,16H2,1-2H3,(H,35,42)/t21-,27+/m1/s1	UJHOQDXFCSKBDI-ZBLYBZFDSA-N	386251	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(2-(4-methyl-4H- 1,2,4-triazol-3- yl)phenyl) pyrrolidine- 2-carboxamide::US10287301, Compound 181::US10822352, Comp No. 181	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386251&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323754	404855408							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976433	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc(n2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O4/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)27(41)34-29-35-28(42-36-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,36,41)/t19-,25+/m1/s1	QZJGDLXBYUTUBH-CLOONOSVSA-N	354269	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- (2-chlorophenyl)-1,2,4- oxadiazol-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 182::US10822352, Comp No. 182::US9796741, cmp No. 182	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354269&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323711	386048000							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976434	C[C@@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1)c1oc2ccc(F)cc2c1C	InChI=1S/C30H27F2N7O4/c1-15-21-10-19(31)4-6-25(21)43-28(15)16(2)36-30(42)24-11-20(32)13-38(24)26(40)14-39-23-5-3-17(18-7-8-34-35-12-18)9-22(23)27(37-39)29(33)41/h3-10,12,16,20,24H,11,13-14H2,1-2H3,(H2,33,41)(H,36,42)/t16-,20-,24+/m1/s1	QVPCYLQGYTWJBK-MYRUOYEDSA-N	386253	1-(2-((2S,4R)-4- fluoro-2-((R)-1-(5- fluoro-3- methylbenzofuran- 2- yl)ethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 183::US10822352, Comp No. 183	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386253&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323530	404855410							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976435	C[C@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1)c1oc2ccc(F)cc2c1C	InChI=1S/C30H27F2N7O4/c1-15-21-10-19(31)4-6-25(21)43-28(15)16(2)36-30(42)24-11-20(32)13-38(24)26(40)14-39-23-5-3-17(18-7-8-34-35-12-18)9-22(23)27(37-39)29(33)41/h3-10,12,16,20,24H,11,13-14H2,1-2H3,(H2,33,41)(H,36,42)/t16-,20+,24-/m0/s1	QVPCYLQGYTWJBK-GANZUKCXSA-N	386254	1-(2-((2S,4R)-4- fluoro-2-((S)-1-(5- fluoro-3- methylbenzofuran- 2- yl)ethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 184::US10822352, Comp No. 184	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386254&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323431	404855411							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976436	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20ClFN8O3/c25-22-17(2-1-6-28-22)31-24(37)19-9-15(26)11-33(19)20(35)12-34-18-4-3-13(14-5-7-29-30-10-14)8-16(18)21(32-34)23(27)36/h1-8,10,15,19H,9,11-12H2,(H2,27,36)(H,31,37)/t15-,19+/m1/s1	CTUFXBNQMOFNGZ-BEFAXECRSA-N	386255	1-(2-((2S,4R)-2-(2- chloropyridin-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 185::US10822352, Comp No. 185	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386255&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323780	404855412							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976437	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(O)nc1	InChI=1S/C33H26ClF2N5O4/c1-18(42)25-16-40(28-10-9-19(11-24(25)28)20-13-37-33(45)38-14-20)17-30(43)41-15-21(35)12-29(41)32(44)39-27-8-4-6-23(31(27)36)22-5-2-3-7-26(22)34/h2-11,13-14,16,21,29H,12,15,17H2,1H3,(H,39,44)(H,37,38,45)/t21-,29+/m1/s1	RWJNYEKDPREUGN-PBBNMVCDSA-N	354270	(2S,4R)-1-(2-(3-acetyl- 5-(2-hydroxypyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 186::US10822352, Comp No. 186::US9796741, cmp No. 186	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354270&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323433	386048001							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976438	COCCNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C36H33ClF2N6O4/c1-21(46)28-19-44(31-11-10-22(14-27(28)31)23-16-41-36(42-17-23)40-12-13-49-2)20-33(47)45-18-24(38)15-32(45)35(48)43-30-9-5-7-26(34(30)39)25-6-3-4-8-29(25)37/h3-11,14,16-17,19,24,32H,12-13,15,18,20H2,1-2H3,(H,43,48)(H,40,41,42)/t24-,32+/m1/s1	RGRXXQWTHFRHCF-QNLPTKCRSA-N	354271	(2S,4R)-1-(2-(3-acetyl- 5-(2-(2- methoxyethylamino) pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 187::US10822352, Comp No. 187::US9796741, cmp No. 187	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354271&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323428	386048002							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976439	CNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C34H29ClF2N6O3/c1-19(44)26-17-42(29-11-10-20(12-25(26)29)21-14-39-34(38-2)40-15-21)18-31(45)43-16-22(36)13-30(43)33(46)41-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,41,46)(H,38,39,40)/t22-,30+/m1/s1	UHTFHXXYAAMHRH-RCRUUEGKSA-N	354272	(2S,4R)-1-(2-(3-acetyl- 5-(2-(methylamino) pyrimidin-5-yl)-1H- indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 188::US10822352, Comp No. 188::US9796741, cmp No. 188	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354272&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323520	386048003							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976440	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClFN6O3/c1-18(43)33-25-12-20(22-15-37-19(2)38-16-22)10-11-28(25)41(40-33)17-31(44)42-29-13-21(29)14-30(42)34(45)39-27-9-5-7-24(32(27)36)23-6-3-4-8-26(23)35/h3-12,15-16,21,29-30H,13-14,17H2,1-2H3,(H,39,45)/t21-,29-,30+/m1/s1	OYAAIULROIAODN-KSMSDSDGSA-N	386259	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 189::US10822352, Comp No. 189	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386259&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323561	404855416							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976441	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-14(36)26-19-8-16(18-11-29-15(2)30-12-18)6-7-20(19)34(33-26)13-25(37)35-21-9-17(21)10-22(35)27(38)32-24-5-3-4-23(28)31-24/h3-8,11-12,17,21-22H,9-10,13H2,1-2H3,(H,31,32,38)/t17-,21-,22+/m1/s1	JLRVDNFYMDBUJT-YHYVQYDKSA-N	386260	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 190::US10822352, Comp No. 190	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386260&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323545	404855417							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976442	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)C(F)(F)F	InChI=1S/C34H25ClF5N5O3/c1-18(46)25-16-44(28-10-9-19(11-24(25)28)20-13-41-33(42-14-20)34(38,39)40)17-30(47)45-15-21(36)12-29(45)32(48)43-27-8-4-6-23(31(27)37)22-5-2-3-7-26(22)35/h2-11,13-14,16,21,29H,12,15,17H2,1H3,(H,43,48)/t21-,29+/m1/s1	CFRZMITVGSLXSG-PBBNMVCDSA-N	386261	(2S,4R)-1-(2-(3- acetyl-5-(2- (trifluoromethyl) pyrimidin-5-yl)-1H- indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 191::US10822352, Comp No. 191	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386261&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323587	404855418							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976443	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)C(C)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H29ClF2N6O4/c1-18(45)21-7-9-28(36)26(11-21)25-5-4-6-29(33(25)38)41-35(48)31-13-24(37)16-43(31)32(47)17-44-30-10-8-22(23-14-39-20(3)40-15-23)12-27(30)34(42-44)19(2)46/h4-12,14-15,24,31H,13,16-17H2,1-3H3,(H,41,48)/t24-,31+/m1/s1	ADZYZOYLENRZDN-XJFCNFDWSA-N	386262	(2S,4R)-N-(5'- acetyl-2'-chloro-2- fluorobiphenyl-3- yl)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 192::US10822352, Comp No. 192	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386262&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643065	404855419							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976444	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(NCC(F)(F)F)nc1	InChI=1S/C35H28ClF5N6O3/c1-19(48)26-16-46(29-10-9-20(11-25(26)29)21-13-42-34(43-14-21)44-18-35(39,40)41)17-31(49)47-15-22(37)12-30(47)33(50)45-28-8-4-6-24(32(28)38)23-5-2-3-7-27(23)36/h2-11,13-14,16,22,30H,12,15,17-18H2,1H3,(H,45,50)(H,42,43,44)/t22-,30+/m1/s1	SSTMRZRUQVVEGC-RCRUUEGKSA-N	386263	(2S,4R)-1-(2-(3- acetyl-5-(2-(2,2,2- trifluoroethylamino) pyrimidin-5-yl)- 1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 193::US10822352, Comp No. 193	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386263&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643115	404855420							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976445	CCOc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H30ClF2N5O4/c1-3-47-35-39-15-22(16-40-35)21-11-12-30-26(13-21)27(20(2)44)18-42(30)19-32(45)43-17-23(37)14-31(43)34(46)41-29-10-6-8-25(33(29)38)24-7-4-5-9-28(24)36/h4-13,15-16,18,23,31H,3,14,17,19H2,1-2H3,(H,41,46)/t23-,31+/m1/s1	KRXDOBOJIROXQJ-IPBJYNAHSA-N	386264	(2S,4R)-1-(2-(3- acetyl-5-(2- ethoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 194::US10822352, Comp No. 194	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386264&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643422	404855421							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976446	CC(C)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C29H29BrN8O3/c1-15(2)33-29-31-12-19(13-32-29)17-7-8-21-20(9-17)27(16(3)39)36-37(21)14-26(40)38-22-10-18(22)11-23(38)28(41)35-25-6-4-5-24(30)34-25/h4-9,12-13,15,18,22-23H,10-11,14H2,1-3H3,(H,31,32,33)(H,34,35,41)/t18-,22-,23+/m1/s1	VNHRXGQOPSSSGZ-YSZBQJHXSA-N	386265	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- (isopropylamino) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 195::US10822352, Comp No. 195	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386265&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654048	404855422							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976447	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H21FN8O4/c25-15-9-19(24(37)30-17-2-1-6-27-23(17)36)32(11-15)20(34)12-33-18-4-3-13(14-5-7-28-29-10-14)8-16(18)21(31-33)22(26)35/h1-8,10,15,19H,9,11-12H2,(H2,26,35)(H,27,36)(H,30,37)/t15-,19+/m1/s1	JRLHRYSCYBFYSG-BEFAXECRSA-N	386266	1-(2-((2S,4R)-4- fluoro-2-(2- hydroxypyridin-3- ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5- (pyridazin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 196::US10822352, Comp No. 196	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386266&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643410	404855423							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976448	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O4/c1-15(34)20-13-32(22-5-4-16(9-19(20)22)17-6-8-29-30-11-17)14-24(35)33-12-18(27)10-23(33)26(37)31-21-3-2-7-28-25(21)36/h2-9,11,13,18,23H,10,12,14H2,1H3,(H,28,36)(H,31,37)/t18-,23+/m1/s1	UTYYPVYYUADUIF-JPYJTQIMSA-N	386267	(2S,4R)-1-(2-(3- acetyl-5-(pyridazin- 4-yl)-1H-indol-1- yl)acetyl)-4-fluoro- N-(2- hydroxypyridin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 197::US10822352, Comp No. 197	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386267&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643116	404855424							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976449	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)C(N)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClF2N7O4/c1-17(45)32-25-10-19(21-13-39-18(2)40-14-21)7-9-28(25)44(42-32)16-30(46)43-15-22(36)12-29(43)34(48)41-27-5-3-4-23(31(27)37)24-11-20(33(38)47)6-8-26(24)35/h3-11,13-14,22,29H,12,15-16H2,1-2H3,(H2,38,47)(H,41,48)/t22-,29+/m1/s1	IWUDKCYUYOEAKQ-MNNSJKJDSA-N	386268	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(5'- carbamoyl-2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 198::US10822352, Comp No. 198	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386268&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623141	404855425							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976450	COCCNc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C30H30BrN7O4/c1-17(39)22-15-37(23-7-6-18(10-21(22)23)20-13-33-30(34-14-20)32-8-9-42-2)16-28(40)38-24-11-19(24)12-25(38)29(41)36-27-5-3-4-26(31)35-27/h3-7,10,13-15,19,24-25H,8-9,11-12,16H2,1-2H3,(H,32,33,34)(H,35,36,41)/t19-,24-,25+/m1/s1	GBTZJWFHAFCOSH-WVQWTBLQSA-N	386269	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-(2- methoxyethylamino) pyrimidin-5-yl)- 1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 199::US10822352, Comp No. 199	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386269&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654050	404855426							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976451	COCCNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C29H29BrFN7O4/c1-17(39)22-15-37(23-7-6-18(10-21(22)23)19-12-33-29(34-13-19)32-8-9-42-2)16-27(40)38-14-20(31)11-24(38)28(41)36-26-5-3-4-25(30)35-26/h3-7,10,12-13,15,20,24H,8-9,11,14,16H2,1-2H3,(H,32,33,34)(H,35,36,41)/t20-,24+/m1/s1	FMDLBBXWLKSHQD-YKSBVNFPSA-N	386270	(2S,4R)-1-(2-(3- acetyl-5-(2-(2- methoxyethylamino) pyrimidin-5-yl)- 1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 200::US10822352, Comp No. 200	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386270&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643256	404855427							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976452	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnnc(C)c1	InChI=1S/C26H23BrFN7O3/c1-14-8-17(11-29-32-14)16-6-7-20-19(9-16)25(15(2)36)33-35(20)13-24(37)34-12-18(28)10-21(34)26(38)31-23-5-3-4-22(27)30-23/h3-9,11,18,21H,10,12-13H2,1-2H3,(H,30,31,38)/t18-,21+/m1/s1	JXPSBHCELVTMQV-NQIIRXRSSA-N	386271	(2S,4R)-1-(2-(3- acetyl-5-(6- methylpyridazin-4- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 201::US10822352, Comp No. 201	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386271&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642911	404855428							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976453	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=O)c2c1	InChI=1S/C26H23BrN8O3/c1-13-29-10-16(11-30-13)14-5-6-18-17(7-14)24(25(28)37)33-34(18)12-23(36)35-19-8-15(19)9-20(35)26(38)32-22-4-2-3-21(27)31-22/h2-7,10-11,15,19-20H,8-9,12H2,1H3,(H2,28,37)(H,31,32,38)/t15-,19-,20+/m1/s1	KMAVKGFPOJFEIJ-YSGRDPCXSA-N	386272	1-(2-((1R,3S,5R)-3- (6-bromopyridin-2- ylcarbamoyl)-2- azabicyclo[3.1.0] hexan-2-yl)-2- oxoethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US10287301, Compound 202::US10822352, Comp No. 202	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386272&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654049	404855429							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976454	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](Cl)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C34H28Cl2FN5O4/c1-19(43)26-17-41(29-11-10-20(12-25(26)29)21-14-38-34(46-2)39-15-21)18-31(44)42-16-22(35)13-30(42)33(45)40-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)36/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,40,45)/t22-,30+/m1/s1	YXCRCLAXHKYUQP-RCRUUEGKSA-N	386273	(2S,4R)-1-(2-(3- acetyl-5-(2- methoxypyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-4-chloro- N-(2'-chloro-2- fluorobiphenyl-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 203::US10822352, Comp No. 203	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386273&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642857	404855430							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976455	COC(=O)c1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H28ClF2N5O5/c1-19(44)26-17-42(29-11-10-20(12-25(26)29)21-14-39-33(40-15-21)35(47)48-2)18-31(45)43-16-22(37)13-30(43)34(46)41-28-9-5-7-24(32(28)38)23-6-3-4-8-27(23)36/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,41,46)/t22-,30+/m1/s1	OHYZNTJBTXAPCG-RCRUUEGKSA-N	386274	US10287301, Compound 204::US10822352, Comp No. 204::methyl 5-(3-acetyl- 1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indol-5- yl)pyrimidine-2- carboxylate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386274&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654051	404855431							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976456	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)C(O)=O	InChI=1S/C34H26ClF2N5O5/c1-18(43)25-16-41(28-10-9-19(11-24(25)28)20-13-38-32(34(46)47)39-14-20)17-30(44)42-15-21(36)12-29(42)33(45)40-27-8-4-6-23(31(27)37)22-5-2-3-7-26(22)35/h2-11,13-14,16,21,29H,12,15,17H2,1H3,(H,40,45)(H,46,47)/t21-,29+/m1/s1	DYEJHTDHOOWGLH-PBBNMVCDSA-N	386275	5-(3-acetyl-1-(2- ((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indol-5- yl)pyrimidine-2- carboxylic acid::US10287301, Compound 205::US10822352, Comp No. 205	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386275&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642956	404855432							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976457	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccncc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H27ClF2N6O3/c1-18(43)26-16-41(29-7-6-20(10-25(26)29)21-12-38-19(2)39-13-21)17-31(44)42-15-22(35)11-30(42)33(45)40-28-5-3-4-24(32(28)36)23-8-9-37-14-27(23)34/h3-10,12-14,16,22,30H,11,15,17H2,1-2H3,(H,40,45)/t22-,30+/m1/s1	QUXKFVYPXQPKND-RCRUUEGKSA-N	386276	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(3-(3- chloropyridin-4-yl)- 2-fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 206::US10822352, Comp No. 206	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386276&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643193	404855433							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976458	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)c(Cl)c1	InChI=1S/C35H28Cl2F2N4O3/c1-19-29(37)13-22(15-40-19)21-10-11-31-26(12-21)27(20(2)44)17-42(31)18-33(45)43-16-23(38)14-32(43)35(46)41-30-9-5-7-25(34(30)39)24-6-3-4-8-28(24)36/h3-13,15,17,23,32H,14,16,18H2,1-2H3,(H,41,46)/t23-,32+/m1/s1	LGSBPKFPOPPHTK-HEIROHQZSA-N	386277	(2S,4R)-1-(2-(3- acetyl-5-(5-chloro- 6-methylpyridin-3- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 207::US10822352, Comp No. 207	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386277&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643370	404855434							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976459	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)cc1-c1ccsc1	InChI=1S/C27H22ClF2N5O3S/c28-20-6-2-1-4-17(20)18-5-3-7-21(24(18)30)32-27(38)22-10-16(29)11-35(22)23(36)13-34-12-19(15-8-9-39-14-15)25(33-34)26(31)37/h1-9,12,14,16,22H,10-11,13H2,(H2,31,37)(H,32,38)/t16-,22+/m1/s1	TYQXRZPYVWNMDU-ZHRRBRCNSA-N	386278	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-4- (thiophen-3-yl)-1H- pyrazole-3- carboxamide::US10287301, Compound 208::US10822352, Comp No. 208	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386278&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126618545	404855435							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976460	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)C(N)=O	InChI=1S/C34H27ClF2N6O4/c1-18(44)25-16-42(28-10-9-19(11-24(25)28)20-13-39-33(32(38)46)40-14-20)17-30(45)43-15-21(36)12-29(43)34(47)41-27-8-4-6-23(31(27)37)22-5-2-3-7-26(22)35/h2-11,13-14,16,21,29H,12,15,17H2,1H3,(H2,38,46)(H,41,47)/t21-,29+/m1/s1	QWTPYQCJJPWHDH-PBBNMVCDSA-N	386279	5-(3-acetyl-1-(2- ((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indol-5- yl)pyrimidine-2- carboxamide::US10287301, Compound 209::US10822352, Comp No. 209	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386279&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643072	404855436							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976461	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)S(C)(=O)=O	InChI=1S/C34H28ClF2N5O5S/c1-19(43)26-17-41(29-11-10-20(12-25(26)29)21-14-38-34(39-15-21)48(2,46)47)18-31(44)42-16-22(36)13-30(42)33(45)40-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,40,45)/t22-,30+/m1/s1	IMPLKHGBLXVOGE-RCRUUEGKSA-N	386280	(2S,4R)-1-(2-(3- acetyl-5-(2- (methylsulfonyl) pyrimidin-5-yl)-1H- indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 210::US10822352, Comp No. 210	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386280&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642947	404855437							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976462	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)C(=O)NC1CC1	InChI=1S/C37H31ClF2N6O4/c1-20(47)28-18-45(31-12-9-21(13-27(28)31)22-15-41-35(42-16-22)37(50)43-24-10-11-24)19-33(48)46-17-23(39)14-32(46)36(49)44-30-8-4-6-26(34(30)40)25-5-2-3-7-29(25)38/h2-9,12-13,15-16,18,23-24,32H,10-11,14,17,19H2,1H3,(H,43,50)(H,44,49)/t23-,32+/m1/s1	NEOKDEUVDIQQMF-HEIROHQZSA-N	386281	5-(3-acetyl-1-(2- ((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indol-5-yl)-N- cyclopropylpyrimidine- 2-carboxamide::US10287301, Compound 211::US10822352, Comp No. 211	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386281&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642867	404855438							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976463	COCCOCCNC(=O)c1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C39H37ClF2N6O6/c1-23(49)30-21-47(33-11-10-24(16-29(30)33)25-18-44-37(45-19-25)39(52)43-12-13-54-15-14-53-2)22-35(50)48-20-26(41)17-34(48)38(51)46-32-9-5-7-28(36(32)42)27-6-3-4-8-31(27)40/h3-11,16,18-19,21,26,34H,12-15,17,20,22H2,1-2H3,(H,43,52)(H,46,51)/t26-,34+/m1/s1	MUAANODNPSQJIO-SFRLIIPVSA-N	386282	5-(3-acetyl-1-(2- ((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indol-5-yl)-N-(2-(2- methoxyethoxy) ethyl)pyrimidine-2- carboxamide::US10287301, Compound 212::US10822352, Comp No. 212	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386282&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643208	404855439							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976464	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C(N)=O	InChI=1S/C27H23BrFN7O4/c1-14(37)19-12-35(20-6-5-15(7-18(19)20)16-9-31-26(25(30)39)32-10-16)13-24(38)36-11-17(29)8-21(36)27(40)34-23-4-2-3-22(28)33-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H2,30,39)(H,33,34,40)/t17-,21+/m1/s1	BNLJFAVTIGEAIQ-UTKZUKDTSA-N	386283	5-(3-acetyl-1-(2- ((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indol-5- yl)pyrimidine-2- carboxamide::US10287301, Compound 213::US10822352, Comp No. 213	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386283&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643165	404855440							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976465	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccc3[nH]ccc3c2Cl)c2ccc(cc12)-c1cnc(C)nc1			471932	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3-(4- chloro-1H- benzo[d]imidazol- 5-yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 214	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471932&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314007	441610930							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976466	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C33H27ClF2N6O3/c1-18(43)25-16-41(28-10-9-19(11-24(25)28)20-13-38-33(37)39-14-20)17-30(44)42-15-21(35)12-29(42)32(45)40-27-8-4-6-23(31(27)36)22-5-2-3-7-26(22)34/h2-11,13-14,16,21,29H,12,15,17H2,1H3,(H,40,45)(H2,37,38,39)/t21-,29+/m1/s1	YXMVUCOFWNIOJO-PBBNMVCDSA-N	386285	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 215::US10822352, Comp No. 215	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386285&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642799	404855442							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976467	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C1CC1	InChI=1S/C29H26BrFN6O3/c1-16(38)22-14-36(23-8-7-18(9-21(22)23)19-11-32-28(33-12-19)17-5-6-17)15-27(39)37-13-20(31)10-24(37)29(40)35-26-4-2-3-25(30)34-26/h2-4,7-9,11-12,14,17,20,24H,5-6,10,13,15H2,1H3,(H,34,35,40)/t20-,24+/m1/s1	JWXHDSSHWYEWAL-YKSBVNFPSA-N	386286	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrimidin- 5-yl)-1H-indol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 216::US10822352, Comp No. 216	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386286&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643203	404855443							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976468	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C28H23BrFN7O3/c1-16(38)21-14-35(22-6-5-17(9-20(21)22)18-11-31-26-7-8-32-37(26)12-18)15-27(39)36-13-19(30)10-23(36)28(40)34-25-4-2-3-24(29)33-25/h2-9,11-12,14,19,23H,10,13,15H2,1H3,(H,33,34,40)/t19-,23+/m1/s1	WLCHAEVJQMYWHV-XXBNENTESA-N	386287	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 217::US10822352, Comp No. 217	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386287&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643570	404855444							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976469	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C(C)=O	InChI=1S/C28H24BrFN6O4/c1-15(37)21-13-35(22-7-6-17(8-20(21)22)18-10-31-27(16(2)38)32-11-18)14-26(39)36-12-19(30)9-23(36)28(40)34-25-5-3-4-24(29)33-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,33,34,40)/t19-,23+/m1/s1	TWOLYKGCOORAFV-XXBNENTESA-N	386288	(2S,4R)-1-(2-(3- acetyl-5-(2- acetylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 218::US10822352, Comp No. 218	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386288&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643025	404855445							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976470	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)19-12-34(20-6-5-15(7-18(19)20)16-9-30-26(29)31-10-16)13-24(37)35-11-17(28)8-21(35)25(38)33-23-4-2-3-22(27)32-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H2,29,30,31)(H,32,33,38)/t17-,21+/m1/s1	RTXKWSBXICDRRR-UTKZUKDTSA-N	386289	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 219::US10822352, Comp No. 219	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386289&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643483	404855446							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976471	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H23F5N6O4/c1-14(40)26-19-8-16(17-10-34-15(2)35-11-17)6-7-21(19)39(37-26)13-24(41)38-12-18(29)9-22(38)27(42)36-20-4-3-5-23(25(20)30)43-28(31,32)33/h3-8,10-11,18,22H,9,12-13H2,1-2H3,(H,36,42)/t18-,22+/m1/s1	QIKWENOCCHLXSS-GCJKJVERSA-N	386290	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 220::US10822352, Comp No. 220	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386290&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642866	404855447							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976472	CC(=O)c1cn(CC(=O)N2N=CCC2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H26ClFN6O3/c1-19(42)26-17-40(29-11-10-21(14-25(26)29)22-15-36-20(2)37-16-22)18-31(43)41-30(12-13-38-41)33(44)39-28-9-5-7-24(32(28)35)23-6-3-4-8-27(23)34/h3-11,13-17,30H,12,18H2,1-2H3,(H,39,44)	JGHZDUHCGKVDCA-UHFFFAOYSA-N	471939	1-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4,5-dihydro-1H- pyrazole-5- carboxamide::US10822352, Comp No. 221	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471939&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642825	441610937							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976473	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2nccn2c1	InChI=1S/C28H23BrFN7O3/c1-16(38)21-14-36(22-6-5-17(9-20(21)22)18-11-32-28-31-7-8-35(28)12-18)15-26(39)37-13-19(30)10-23(37)27(40)34-25-4-2-3-24(29)33-25/h2-9,11-12,14,19,23H,10,13,15H2,1H3,(H,33,34,40)/t19-,23+/m1/s1	VVXMPACWPOTXSI-XXBNENTESA-N	386292	(2S,4R)-1-(2-(3- acetyl-5- (imidazo[1,2- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 222::US10822352, Comp No. 222	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386292&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643463	404855449							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976474	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C28H23ClFN7O3/c1-16(38)21-14-35(22-6-5-17(9-20(21)22)18-11-31-26-7-8-32-37(26)12-18)15-27(39)36-13-19(30)10-23(36)28(40)34-25-4-2-3-24(29)33-25/h2-9,11-12,14,19,23H,10,13,15H2,1H3,(H,33,34,40)/t19-,23+/m1/s1	CEZLHTIRRSLHBT-XXBNENTESA-N	386294	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-N-(6- chloropyridin-2-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 223::US10822352, Comp No. 223	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386294&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654053	404855451							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976475	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C30H23F5N6O4/c1-16(42)21-14-39(23-6-5-17(9-20(21)23)18-11-36-26-7-8-37-41(26)12-18)15-27(43)40-13-19(31)10-24(40)29(44)38-22-3-2-4-25(28(22)32)45-30(33,34)35/h2-9,11-12,14,19,24H,10,13,15H2,1H3,(H,38,44)/t19-,24+/m1/s1	YIHDKQTXMRVMMS-DVECYGJZSA-N	386295	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 224::US10822352, Comp No. 224	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386295&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643360	404855452							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976476	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23ClFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	QQZPZYOTTJGOIP-NQIIRXRSSA-N	386296	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- chloropyridin-2-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 225::US10822352, Comp No. 225	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386296&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643199	404855453							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976477	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25ClF2N6O3/c1-15(38)27-21-8-17(19-11-32-16(2)33-12-19)6-7-23(21)37(35-27)14-25(39)36-13-20(30)9-24(36)28(40)34-10-18-4-3-5-22(29)26(18)31/h3-8,11-12,20,24H,9-10,13-14H2,1-2H3,(H,34,40)/t20-,24+/m1/s1	ZEYXECMDIGKVJJ-YKSBVNFPSA-N	386297	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 226::US10822352, Comp No. 226	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386297&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643507	404855454							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976478	CC(=O)c1cn(CC(=O)N2NCCC2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H28ClFN6O3/c1-19(42)26-17-40(29-11-10-21(14-25(26)29)22-15-36-20(2)37-16-22)18-31(43)41-30(12-13-38-41)33(44)39-28-9-5-7-24(32(28)35)23-6-3-4-8-27(23)34/h3-11,14-17,30,38H,12-13,18H2,1-2H3,(H,39,44)	SYADTBRLEZKNRC-UHFFFAOYSA-N	471946	2-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)pyrazolidine-3- carboxamide::US10822352, Comp No. 227	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471946&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643131	441610944							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976479	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nccc(n2)-c2sccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H24ClFN8O3S/c1-15(40)26-20-9-17(18-11-33-16(2)34-12-18)3-4-23(20)39(37-26)14-25(41)38-13-19(31)10-24(38)28(42)36-29-32-7-5-22(35-29)27-21(30)6-8-43-27/h3-9,11-12,19,24H,10,13-14H2,1-2H3,(H,32,35,36,42)/t19-,24+/m1/s1	NCXISHUXKKOYJS-DVECYGJZSA-N	386299	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4-(3- chlorothiophen-2- yl)pyrimidin-2-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 228::US10822352, Comp No. 228	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386299&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642991	404855456							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976480	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(Cl)sc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24ClFN6O3S/c1-13(35)25-19-6-16(17-9-29-15(3)30-10-17)4-5-21(19)34(32-25)12-24(36)33-11-18(28)7-22(33)26(37)31-20-8-23(27)38-14(20)2/h4-6,8-10,18,22H,7,11-12H2,1-3H3,(H,31,37)/t18-,22+/m1/s1	CRCIIXDAVGJDJY-GCJKJVERSA-N	386300	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(5- chloro-2- methylthiophen-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 229::US10822352, Comp No. 229	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386300&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643211	404855457							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976481	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN7O3/c1-15(35)25-19-11-17(18-12-28-16(2)29-13-18)8-9-20(19)34(32-25)14-24(36)33-10-4-5-21(33)26(37)31-23-7-3-6-22(27)30-23/h3,6-9,11-13,21H,4-5,10,14H2,1-2H3,(H,30,31,37)/t21-/m0/s1	OVADICMOHRFEIM-NRFANRHFSA-N	386301	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 230::US10822352, Comp No. 230	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386301&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643061	404855458							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976482	CC(=O)c1nn(CC(=O)N2C[C@H](O)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN7O4/c1-14(35)25-19-8-16(17-10-28-15(2)29-11-17)6-7-20(19)34(32-25)13-24(37)33-12-18(36)9-21(33)26(38)31-23-5-3-4-22(27)30-23/h3-8,10-11,18,21,36H,9,12-13H2,1-2H3,(H,30,31,38)/t18-,21+/m1/s1	AZUQUXTVBQYWLC-NQIIRXRSSA-N	386302	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- hydroxypyrrolidine- 2-carboxamide::US10287301, Compound 231::US10822352, Comp No. 231	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386302&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623201	404855459					C04398		1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976483	CC(=O)c1nn(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NC2CCN(CC2)C(=O)c2cc(Cl)c[nH]2)c2ccc(cc12)-c1cnc(C)nc1			471951	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(1-(4- chloro-1H-pyrrole- 2- carbonyl)piperidin- 4-yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 232	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471951&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313772	441610949					C04398		1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976484	CCCCCC(=O)NC1CCC(CC1)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C33H42FN7O4/c1-4-5-6-7-30(43)37-25-9-11-26(12-10-25)38-33(45)29-15-24(34)18-40(29)31(44)19-41-28-13-8-22(23-16-35-21(3)36-17-23)14-27(28)32(39-41)20(2)42/h8,13-14,16-17,24-26,29H,4-7,9-12,15,18-19H2,1-3H3,(H,37,43)(H,38,45)/t24-,25?,26?,29+/m1/s1	XVHSPHIZBMDOCG-PUMVMFQNSA-N	386304	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(4- hexanamidocyclohexyl) pyrrolidine-2- carboxamide::US10287301, Compound 233::US10822352, Comp No. 233	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386304&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654054	404855461							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976485	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C27H22BrFN8O3/c1-15(38)26-19-9-16(17-11-30-24-7-8-31-37(24)12-17)5-6-20(19)36(34-26)14-25(39)35-13-18(29)10-21(35)27(40)33-23-4-2-3-22(28)32-23/h2-9,11-12,18,21H,10,13-14H2,1H3,(H,32,33,40)/t18-,21+/m1/s1	LFNHROMJLVPXNS-NQIIRXRSSA-N	386305	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 234::US10822352, Comp No. 234	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386305&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643186	404855462							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976486	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C29H22F5N7O4/c1-15(42)27-19-9-16(17-11-35-24-7-8-36-41(24)12-17)5-6-21(19)40(38-27)14-25(43)39-13-18(30)10-22(39)28(44)37-20-3-2-4-23(26(20)31)45-29(32,33)34/h2-9,11-12,18,22H,10,13-14H2,1H3,(H,37,44)/t18-,22+/m1/s1	LKCFSMLWSNQVKG-GCJKJVERSA-N	386306	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 235::US10822352, Comp No. 235	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386306&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643447	404855463							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976487	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C29H24ClF2N7O3/c1-16(40)28-21-9-17(19-12-33-25-7-8-35-39(25)13-19)5-6-23(21)38(36-28)15-26(41)37-14-20(31)10-24(37)29(42)34-11-18-3-2-4-22(30)27(18)32/h2-9,12-13,20,24H,10-11,14-15H2,1H3,(H,34,42)/t20-,24+/m1/s1	UVELADTVWVFRSB-YKSBVNFPSA-N	386307	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 236::US10822352, Comp No. 236	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386307&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643503	404855464							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976488	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C34H26ClF2N7O3/c1-19(45)33-25-13-20(21-15-38-30-11-12-39-44(30)16-21)9-10-28(25)43(41-33)18-31(46)42-17-22(36)14-29(42)34(47)40-27-8-4-6-24(32(27)37)23-5-2-3-7-26(23)35/h2-13,15-16,22,29H,14,17-18H2,1H3,(H,40,47)/t22-,29+/m1/s1	JJXZUCHTQZDFRP-MNNSJKJDSA-N	386308	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 237::US10822352, Comp No. 237	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386308&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643133	404855465							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976489	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C28H23BrN8O3/c1-15(38)27-19-9-16(18-12-30-25-7-8-31-36(25)13-18)5-6-20(19)35(34-27)14-26(39)37-21-10-17(21)11-22(37)28(40)33-24-4-2-3-23(29)32-24/h2-9,12-13,17,21-22H,10-11,14H2,1H3,(H,32,33,40)/t17-,21-,22+/m1/s1	XWTCKZWYPJICCE-YHYVQYDKSA-N	386309	(1R,3S,5R)-2-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 238::US10822352, Comp No. 238	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386309&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654056	404855466							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976490	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C30H23F4N7O4/c1-15(42)28-19-9-16(18-12-35-25-7-8-36-40(25)13-18)5-6-21(19)39(38-28)14-26(43)41-22-10-17(22)11-23(41)29(44)37-20-3-2-4-24(27(20)31)45-30(32,33)34/h2-9,12-13,17,22-23H,10-11,14H2,1H3,(H,37,44)/t17-,22-,23+/m1/s1	UTLUOLJAHZKYMS-ZQMYSKGWSA-N	386310	(1R,3S,5R)-2-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(2- fluoro-3- (trifluoromethoxy) phenyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 239::US10822352, Comp No. 239	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386310&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654055	404855467							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976491	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C30H25ClFN7O3/c1-16(40)29-21-9-17(20-13-33-26-7-8-35-38(26)14-20)5-6-23(21)37(36-29)15-27(41)39-24-10-19(24)11-25(39)30(42)34-12-18-3-2-4-22(31)28(18)32/h2-9,13-14,19,24-25H,10-12,15H2,1H3,(H,34,42)/t19-,24-,25+/m1/s1	YJVICRPSJPZQOU-WVQWTBLQSA-N	386311	(1R,3S,5R)-2-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 240::US10822352, Comp No. 240	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386311&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654057	404855468							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976492	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2n(C)cnc2c1	InChI=1S/C28H24BrFN8O3/c1-15(39)26-19-8-16(17-9-20-27(31-11-17)36(2)14-32-20)6-7-21(19)38(35-26)13-25(40)37-12-18(30)10-22(37)28(41)34-24-5-3-4-23(29)33-24/h3-9,11,14,18,22H,10,12-13H2,1-2H3,(H,33,34,41)/t18-,22+/m1/s1	XRFJXPLYROXRQV-GCJKJVERSA-N	386312	(2S,4R)-1-(2-(3- acetyl-5-(3-methyl- 3H-imidazo[4,5- b]pyridin-6-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 241::US10822352, Comp No. 241	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386312&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623246	404855469							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976493	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccn2nccc2n1	InChI=1S/C27H22BrFN8O3/c1-15(38)26-18-11-16(19-8-10-36-24(31-19)7-9-30-36)5-6-20(18)37(34-26)14-25(39)35-13-17(29)12-21(35)27(40)33-23-4-2-3-22(28)32-23/h2-11,17,21H,12-14H2,1H3,(H,32,33,40)/t17-,21+/m1/s1	DZSLLPJQAAWYGI-UTKZUKDTSA-N	386313	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 242::US10822352, Comp No. 242	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386313	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386313&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642876	404855470							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976494	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H24BrFN8O3/c1-15-8-25-31-11-18(12-38(25)34-15)17-6-7-21-20(9-17)27(16(2)39)35-37(21)14-26(40)36-13-19(30)10-22(36)28(41)33-24-5-3-4-23(29)32-24/h3-9,11-12,19,22H,10,13-14H2,1-2H3,(H,32,33,41)/t19-,22+/m1/s1	MXMAIQFRXPJBDP-KNQAVFIVSA-N	386314	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 243::US10822352, Comp No. 277	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386314	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386314&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643248	404855471							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976495	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C27H24BrF4N9O3/c1-14(42)24-17-10-16(38-7-8-39-22(12-38)35-36-26(39)27(30,31)32)5-6-18(17)41(37-24)13-23(43)40-11-15(29)9-19(40)25(44)34-21-4-2-3-20(28)33-21/h2-6,10,15,19H,7-9,11-13H2,1H3,(H,33,34,44)/t15-,19+/m1/s1	XCOCBUFCLOAILW-BEFAXECRSA-N	386315	(2S,4R)-1-(2-(3- acetyl-5-(3- (trifluoromethyl)- 5,6-dihydro- [1,2,4]triazolo[4,3- a]pyrazin-7(8H)- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 244::US10822352, Comp No. 244::US11407738, Example 00407	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386315	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386315&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643027	404855472							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976496	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2ncccn12	InChI=1S/C27H22BrFN8O3/c1-15(38)25-18-10-16(21-12-31-27-30-8-3-9-35(21)27)6-7-19(18)37(34-25)14-24(39)36-13-17(29)11-20(36)26(40)33-23-5-2-4-22(28)32-23/h2-10,12,17,20H,11,13-14H2,1H3,(H,32,33,40)/t17-,20+/m1/s1	ALQPWTUFISFGQB-XLIONFOSSA-N	386316	(2S,4R)-1-(2-(3- acetyl-5- (imidazo[1,2- a]pyrimidin-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 245::US10822352, Comp No. 245	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386316	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386316&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623474	404855473							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976497	CSc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C27H26FN7O3S/c1-15(36)26-20-9-17(18-11-29-16(2)30-12-18)7-8-21(20)35(33-26)14-25(37)34-13-19(28)10-22(34)27(38)32-23-5-4-6-24(31-23)39-3/h4-9,11-12,19,22H,10,13-14H2,1-3H3,(H,31,32,38)/t19-,22+/m1/s1	FLNHGRVDSITPDB-KNQAVFIVSA-N	386317	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(6- (methylthio)pyridin- 2-yl)pyrrolidine-2- carboxamide::US10287301, Compound 246::US10822352, Comp No. 246	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386317	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386317&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643093	404855474							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976498	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23F2N7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(27)9-21(34)26(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	WYXCFIWMTRZQBM-NQIIRXRSSA-N	386318	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(6-fluoropyridin- 2-yl)pyrrolidine-2- carboxamide::US10287301, Compound 247::US10822352, Comp No. 247	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386318	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386318&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642878	404855475							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976499	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc2ncnn2c1	InChI=1S/C27H22BrFN8O3/c1-15(38)26-19-9-16(17-6-8-24-30-14-31-37(24)11-17)5-7-20(19)36(34-26)13-25(39)35-12-18(29)10-21(35)27(40)33-23-4-2-3-22(28)32-23/h2-9,11,14,18,21H,10,12-13H2,1H3,(H,32,33,40)/t18-,21+/m1/s1	VIASWALEKBCYLT-NQIIRXRSSA-N	386319	(2S,4R)-1-(2-(5- ([1,2,4]triazolo[1,5- a]pyridin-6-yl)-3- acetyl-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 248::US10822352, Comp No. 248	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386319	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386319&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643540	404855476							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976500	CC(=O)c1nn(CC(=O)N2C[C@@H](O)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN7O4/c1-14(35)25-19-8-16(17-10-28-15(2)29-11-17)6-7-20(19)34(32-25)13-24(37)33-12-18(36)9-21(33)26(38)31-23-5-3-4-22(27)30-23/h3-8,10-11,18,21,36H,9,12-13H2,1-2H3,(H,30,31,38)/t18-,21-/m0/s1	AZUQUXTVBQYWLC-RXVVDRJESA-N	386320	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- hydroxypyrrolidine- 2-carboxamide::US10287301, Compound 249::US10822352, Comp No. 249	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386320&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623556	404855477							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976501	CC(=O)c1nn(CC(=O)N2CC(=O)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrN7O4/c1-14(35)25-19-8-16(17-10-28-15(2)29-11-17)6-7-20(19)34(32-25)13-24(37)33-12-18(36)9-21(33)26(38)31-23-5-3-4-22(27)30-23/h3-8,10-11,21H,9,12-13H2,1-2H3,(H,30,31,38)/t21-/m0/s1	ULNOEUNTAXFTTJ-NRFANRHFSA-N	386321	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- oxopyrrolidine-2- carboxamide::US10287301, Compound 250::US10822352, Comp No. 250	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386321	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386321&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623232	404855478							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976502	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1[nH]nnc1-c1cncnc1			386322	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (4-(pyrimidin-5-yl)- 1H-1,2,3-triazol-5- yl)-1H-indazole-3- carboxamide::US10287301, Compound 251::US10822352, Comp No. 251	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386322&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			145996359	404855479							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976503	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1[nH]nnc1-c1ncccn1			386323	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (4-(pyrimidin-2-yl)- 1H-1,2,3-triazol-5- yl)-1H-indazole-3- carboxamide::US10287301, Compound 252::US10822352, Comp No. 252	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386323&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			145996360	404855480							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976504	CC(=O)c1nn(CC(=O)N2C[C@@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21-/m0/s1	PIBARDGJJAGJAJ-RXVVDRJESA-N	386324	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 253::US10822352, Comp No. 253	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386324	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386324&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642978	404855481							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976505	COCCN(C)CCN1CC(CC1=O)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H39FN8O5/c1-19(41)30-25-11-21(22-14-33-20(2)34-15-22)5-6-26(25)40(36-30)18-29(43)39-16-23(32)12-27(39)31(44)35-24-13-28(42)38(17-24)8-7-37(3)9-10-45-4/h5-6,11,14-15,23-24,27H,7-10,12-13,16-18H2,1-4H3,(H,35,44)/t23-,24?,27+/m1/s1	IXOSDSLTMAYVDU-WRNLUVMSSA-N	386325	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(1-(2-((2- methoxyethyl)(methyl) amino)ethyl)-5- oxopyrrolidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 254::US10822352, Comp No. 254::US11407738, Example 00329	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386325	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386325&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643275	404855482							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976506	CC(=O)c1nn(CC(=O)N2CC(F)(F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrF2N7O3/c1-14(37)24-18-8-16(17-10-30-15(2)31-11-17)6-7-19(18)36(34-24)12-23(38)35-13-26(28,29)9-20(35)25(39)33-22-5-3-4-21(27)32-22/h3-8,10-11,20H,9,12-13H2,1-2H3,(H,32,33,39)/t20-/m0/s1	FWOWQPHCWNCKDQ-FQEVSTJZSA-N	386326	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4,4- difluoropyrrolidine- 2-carboxamide::US10287301, Compound 255::US10822352, Comp No. 255	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386326	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386326&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622902	404855483							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976507	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H24F5N7O4/c1-15-8-25-36-11-18(12-42(25)38-15)17-6-7-22-20(9-17)28(16(2)43)39-41(22)14-26(44)40-13-19(31)10-23(40)29(45)37-21-4-3-5-24(27(21)32)46-30(33,34)35/h3-9,11-12,19,23H,10,13-14H2,1-2H3,(H,37,45)/t19-,23+/m1/s1	XTAAFYFDZKVYCN-XXBNENTESA-N	386327	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 256::US10822352, Comp No. 276	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386327	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386327&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643344	404855484							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976508	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H25BrN8O3/c1-15-8-26-31-12-19(13-37(26)34-15)17-6-7-21-20(9-17)28(16(2)39)35-36(21)14-27(40)38-22-10-18(22)11-23(38)29(41)33-25-5-3-4-24(30)32-25/h3-9,12-13,18,22-23H,10-11,14H2,1-2H3,(H,32,33,41)/t18-,22-,23+/m1/s1	XHTIVISDMHWJOA-YSZBQJHXSA-N	386328	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 257::US10822352, Comp No. 298	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386328	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386328&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653932	404855485							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976509	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Cl)cs2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C24H21ClFN7O3S/c1-12(34)22-17-5-14(15-7-27-13(2)28-8-15)3-4-18(17)33(31-22)10-21(35)32-9-16(26)6-19(32)23(36)30-24-29-20(25)11-37-24/h3-5,7-8,11,16,19H,6,9-10H2,1-2H3,(H,29,30,36)/t16-,19+/m1/s1	KPJCSHWGJJSBFO-APWZRJJASA-N	386329	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4- chlorothiazol-2-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 258::US10822352, Comp No. 258	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386329	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386329&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643242	404855486							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976510	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C1CC1	InChI=1S/C28H25BrFN7O3/c1-15(38)26-20-9-17(18-11-31-27(32-12-18)16-5-6-16)7-8-21(20)37(35-26)14-25(39)36-13-19(30)10-22(36)28(40)34-24-4-2-3-23(29)33-24/h2-4,7-9,11-12,16,19,22H,5-6,10,13-14H2,1H3,(H,33,34,40)/t19-,22+/m1/s1	ZEWIURDEMYWNLS-KNQAVFIVSA-N	386330	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 259::US10822352, Comp No. 259	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386330	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386330&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643201	404855487							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976511	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C25H22BrFN8O3/c1-13(36)23-17-7-14(15-9-29-25(28)30-10-15)5-6-18(17)35(33-23)12-22(37)34-11-16(27)8-19(34)24(38)32-21-4-2-3-20(26)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,28,29,30)(H,31,32,38)/t16-,19+/m1/s1	XSODZDKXBFADNJ-APWZRJJASA-N	386331	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 260::US10822352, Comp No. 260	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386331	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386331&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643009	404855488							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976512	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(CC2)C(=O)c2cn[nH]c2)c2ccc(cc12)-c1cnc(C)nc1			386332	(2S,4R)-N-(1-(1H- pyrazole-4- carbonyl)piperidin- 4-yl)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 261::US10822352, Comp No. 261::US11407738, Example 00330	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386332&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643502	404855489							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976513	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2c(C#N)c(C)nn2c1	InChI=1S/C29H23BrFN9O3/c1-15-21(10-32)28-33-11-18(12-40(28)36-15)17-6-7-22-20(8-17)27(16(2)41)37-39(22)14-26(42)38-13-19(31)9-23(38)29(43)35-25-5-3-4-24(30)34-25/h3-8,11-12,19,23H,9,13-14H2,1-2H3,(H,34,35,43)/t19-,23+/m1/s1	UHOGEBPTYCBDDL-XXBNENTESA-N	386333	(2S,4R)-1-(2-(3- acetyl-5-(3-cyano-2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 262::US10822352, Comp No. 262	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386333&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643005	404855490							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976514	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2c(cnn2c1)C#N	InChI=1S/C28H21BrFN9O3/c1-15(40)26-20-7-16(18-10-32-27-17(9-31)11-33-39(27)12-18)5-6-21(20)38(36-26)14-25(41)37-13-19(30)8-22(37)28(42)35-24-4-2-3-23(29)34-24/h2-7,10-12,19,22H,8,13-14H2,1H3,(H,34,35,42)/t19-,22+/m1/s1	GBPATNDXYTVERV-KNQAVFIVSA-N	386334	(2S,4R)-1-(2-(3- acetyl-5-(3- cyanopyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 263::US10822352, Comp No. 263	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386334	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386334&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643416	404855491							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976515	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H24F4N8O3/c1-15-8-25-34-11-18(12-41(25)37-15)17-6-7-21-20(9-17)27(16(2)42)38-40(21)14-26(43)39-13-19(30)10-22(39)28(44)36-24-5-3-4-23(35-24)29(31,32)33/h3-9,11-12,19,22H,10,13-14H2,1-2H3,(H,35,36,44)/t19-,22+/m1/s1	DAQZHLUSIJDRSW-KNQAVFIVSA-N	386335	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(6- (trifluoromethyl) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 264::US10822352, Comp No. 264	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386335	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386335&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643335	404855492							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976516	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C#N)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H24FN9O3/c1-16-8-26-32-12-19(13-39(26)35-16)18-6-7-23-22(9-18)28(17(2)40)36-38(23)15-27(41)37-14-20(30)10-24(37)29(42)34-25-5-3-4-21(11-31)33-25/h3-9,12-13,20,24H,10,14-15H2,1-2H3,(H,33,34,42)/t20-,24+/m1/s1	VDNRBGKCFJXKDD-YKSBVNFPSA-N	386336	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- cyanopyridin-2-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 265::US10822352, Comp No. 265	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386336	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386336&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643261	404855493							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976517	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1C	InChI=1S/C27H25BrFN7O3/c1-14-20(11-30-16(3)31-14)17-7-8-21-19(9-17)26(15(2)37)34-36(21)13-25(38)35-12-18(29)10-22(35)27(39)33-24-6-4-5-23(28)32-24/h4-9,11,18,22H,10,12-13H2,1-3H3,(H,32,33,39)/t18-,22+/m1/s1	CKNCYPTYKJRKRT-GCJKJVERSA-N	386337	(2S,4R)-1-(2-(3- acetyl-5-(2,4- dimethylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 266::US10822352, Comp No. 266	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386337	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386337&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642976	404855494							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976518	CCc1cn(CC(=O)N2NCCC2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H30ClFN6O2/c1-3-21-18-40(29-12-11-22(15-26(21)29)23-16-36-20(2)37-17-23)19-31(42)41-30(13-14-38-41)33(43)39-28-10-6-8-25(32(28)35)24-7-4-5-9-27(24)34/h4-12,15-18,30,38H,3,13-14,19H2,1-2H3,(H,39,43)	POKGFLXJXNNMEQ-UHFFFAOYSA-N	471987	N-(2'-chloro-2- fluorobiphenyl-3- yl)-2-(2-(3-ethyl-5- (2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)pyrazolidine- 3-carboxamide::US10822352, Comp No. 267	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471987&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643257	441610983							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976519	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2c(C)cnn2c1	InChI=1S/C28H24BrFN8O3/c1-15-10-32-38-12-18(11-31-27(15)38)17-6-7-21-20(8-17)26(16(2)39)35-37(21)14-25(40)36-13-19(30)9-22(36)28(41)34-24-5-3-4-23(29)33-24/h3-8,10-12,19,22H,9,13-14H2,1-2H3,(H,33,34,41)/t19-,22+/m1/s1	LIHBDMFMDRJFGL-KNQAVFIVSA-N	386339	(2S,4R)-1-(2-(3- acetyl-5-(3- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 268::US10822352, Comp No. 268	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386339	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386339&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643535	404855496							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976520	COCCNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C28H28BrFN8O4/c1-16(39)26-20-10-17(18-12-32-28(33-13-18)31-8-9-42-2)6-7-21(20)38(36-26)15-25(40)37-14-19(30)11-22(37)27(41)35-24-5-3-4-23(29)34-24/h3-7,10,12-13,19,22H,8-9,11,14-15H2,1-2H3,(H,31,32,33)(H,34,35,41)/t19-,22+/m1/s1	RETHWTWAVCDCAA-KNQAVFIVSA-N	386340	(2S,4R)-1-(2-(3- acetyl-5-(2-(2- methoxyethylamino) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 269::US10822352, Comp No. 269	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386340	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386340&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643401	404855497							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976521	CC(=O)c1nn(CC(=O)N2CC[C@@H](N)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrN8O3/c1-14(36)24-18-10-16(17-11-29-15(2)30-12-17)6-7-20(18)35(33-24)13-23(37)34-9-8-19(28)25(34)26(38)32-22-5-3-4-21(27)31-22/h3-7,10-12,19,25H,8-9,13,28H2,1-2H3,(H,31,32,38)/t19-,25+/m1/s1	BDQRDHKJZCIJHT-CLOONOSVSA-N	386341	(2S,3R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-amino- N-(6-bromopyridin- 2-yl)pyrrolidine-2- carboxamide::US10287301, Compound 270::US10822352, Comp No. 270	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386341	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386341&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622944	404855498							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976522	CC(=O)c1nn(CC(=O)N2[C@@H](CCC2=O)C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrN7O4/c1-14(35)25-18-10-16(17-11-28-15(2)29-12-17)6-7-19(18)33(32-25)13-24(37)34-20(8-9-23(34)36)26(38)31-22-5-3-4-21(27)30-22/h3-7,10-12,20H,8-9,13H2,1-2H3,(H,30,31,38)/t20-/m0/s1	LTONUBLXSMWGRA-FQEVSTJZSA-N	386342	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-5- oxopyrrolidine-2- carboxamide::US10287301, Compound 271::US10822352, Comp No. 271	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386342&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623196	404855499							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976523	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2c(F)c(F)c(F)c(F)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H23F7N6O3/c1-14(47)32-20-8-16(17-10-41-15(2)42-11-17)6-7-22(20)46(44-32)13-24(48)45-12-18(34)9-23(45)33(49)43-21-5-3-4-19(26(21)35)25-27(36)29(38)31(40)30(39)28(25)37/h3-8,10-11,18,23H,9,12-13H2,1-2H3,(H,43,49)/t18-,23+/m1/s1	CNTQURVLSKPGFV-JPYJTQIMSA-N	386343	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(2,2',3',4',5',6'- hexafluorobiphenyl- 3-yl)pyrrolidine-2- carboxamide::US10287301, Compound 272::US10822352, Comp No. 272	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386343	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386343&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643500	404855500							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976524	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23BrF2N6O3/c1-14(37)26-19-8-16(17-10-31-15(2)32-11-17)6-7-22(19)36(34-26)13-24(38)35-12-18(29)9-23(35)27(39)33-21-5-3-4-20(28)25(21)30/h3-8,10-11,18,23H,9,12-13H2,1-2H3,(H,33,39)/t18-,23+/m1/s1	UENPAFKISDTQLB-JPYJTQIMSA-N	386344	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- bromo-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 273::US10822352, Comp No. 273	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386344&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623898	404855501							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976525	CC(C)c1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)c3)nc(C(C)=O)c2c1	InChI=1S/C31H29BrFN7O3/c1-17(2)25-12-28-34-13-20(14-40(28)36-25)19-7-8-26-24(9-19)30(18(3)41)37-39(26)16-29(42)38-15-22(33)11-27(38)31(43)35-23-6-4-5-21(32)10-23/h4-10,12-14,17,22,27H,11,15-16H2,1-3H3,(H,35,43)/t22-,27+/m1/s1	PHXCSCXYGJNRBI-AMGIVPHBSA-N	471994	(2S,4R)-1-(2-(3- acetyl-5-(2- isopropylpyrazolo [1,5-a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 274	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=471994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=471994&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314362	441610990							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976526	COc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc3cc(C)nn3c2)c1F	InChI=1S/C30H27F2N7O4/c1-16-9-26-33-12-19(13-39(26)35-16)18-7-8-23-21(10-18)29(17(2)40)36-38(23)15-27(41)37-14-20(31)11-24(37)30(42)34-22-5-4-6-25(43-3)28(22)32/h4-10,12-13,20,24H,11,14-15H2,1-3H3,(H,34,42)/t20-,24+/m1/s1	HVQCCZYHXBEZAN-YKSBVNFPSA-N	386346	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3- methoxyphenyl) pyrrolidine-2- carboxamide::US10287301, Compound 275::US10822352, Comp No. 275	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386346	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386346&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643330	404855503							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976527	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H24F5N7O4/c1-15-8-25-36-11-18(12-42(25)38-15)17-6-7-22-20(9-17)28(16(2)43)39-41(22)14-26(44)40-13-19(31)10-23(40)29(45)37-21-4-3-5-24(27(21)32)46-30(33,34)35/h3-9,11-12,19,23H,10,13-14H2,1-2H3,(H,37,45)/t19-,23+/m1/s1	XTAAFYFDZKVYCN-XXBNENTESA-N	386327	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 256::US10822352, Comp No. 276	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386327	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386327&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643344	404855484							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976528	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H24BrFN8O3/c1-15-8-25-31-11-18(12-38(25)34-15)17-6-7-21-20(9-17)27(16(2)39)35-37(21)14-26(40)36-13-19(30)10-22(36)28(41)33-24-5-3-4-23(29)32-24/h3-9,11-12,19,22H,10,13-14H2,1-2H3,(H,32,33,41)/t19-,22+/m1/s1	MXMAIQFRXPJBDP-KNQAVFIVSA-N	386314	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 243::US10822352, Comp No. 277	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386314	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386314&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643248	404855471							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976529	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=O)c2c1	InChI=1S/C25H22BrFN8O3/c1-13-29-9-15(10-30-13)14-5-6-18-17(7-14)23(24(28)37)33-35(18)12-22(36)34-11-16(27)8-19(34)25(38)32-21-4-2-3-20(26)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,28,37)(H,31,32,38)/t16-,19+/m1/s1	QIFSWMBIFIBWOP-APWZRJJASA-N	354198	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methylpyrimidin-5-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 101::US10822352, Comp No. 278::US9796741, cmp No. 101	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354198&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323747	386047930							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976530	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(C=C)cc(Cl)c2F)c2ccc(cc12)-c1cnc(NCCCCCCCCCC=C)nc1	InChI=1S/C40H46ClF2N7O3/c1-4-6-7-8-9-10-11-12-13-16-44-40-46-22-30(23-47-40)28-14-15-34-32(19-28)38(26(3)51)48-50(34)25-36(52)49-24-31(42)20-35(49)39(53)45-21-29-17-27(5-2)18-33(41)37(29)43/h4-5,14-15,17-19,22-23,31,35H,1-2,6-13,16,20-21,24-25H2,3H3,(H,45,53)(H,44,46,47)/t31-,35+/m1/s1	IWLWMPVQURLHMX-NQVJXQQZSA-N	386350	(2S,4R)-1-(2-(3- acetyl-5-(2-(undec- 10- enylamino)pyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- chloro-2-fluoro-5- vinylbenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 279::US10822352, Comp No. 279	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386350&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623691	404855507							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976531	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)c2C#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H23BrFN7O3/c1-15(38)27-20-8-17(18-11-32-16(2)33-12-18)6-7-24(20)37(35-27)14-26(39)36-13-19(30)9-25(36)28(40)34-23-5-3-4-22(29)21(23)10-31/h3-8,11-12,19,25H,9,13-14H2,1-2H3,(H,34,40)/t19-,25+/m1/s1	QSWFJBWFWKBSPZ-CLOONOSVSA-N	386351	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- bromo-2- cyanophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 280::US10822352, Comp No. 280	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386351&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643100	404855508							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976532	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)F)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H25F4N7O4/c1-15-8-25-35-11-18(12-41(25)37-15)17-6-7-22-20(9-17)28(16(2)42)38-40(22)14-26(43)39-13-19(31)10-23(39)29(44)36-21-4-3-5-24(27(21)32)45-30(33)34/h3-9,11-12,19,23,30H,10,13-14H2,1-2H3,(H,36,44)/t19-,23+/m1/s1	SJBCDPZJXCCJCF-XXBNENTESA-N	386352	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(3- (difluoromethoxy)- 2-fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 281::US10822352, Comp No. 281	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386352&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643187	404855509							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976533	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)F)c2F)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C29H23F4N7O4/c1-15(41)27-19-9-16(17-11-34-24-7-8-35-40(24)12-17)5-6-21(19)39(37-27)14-25(42)38-13-18(30)10-22(38)28(43)36-20-3-2-4-23(26(20)31)44-29(32)33/h2-9,11-12,18,22,29H,10,13-14H2,1H3,(H,36,43)/t18-,22+/m1/s1	NUOWQTQIQBFPQZ-GCJKJVERSA-N	386353	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(3- (difluoromethoxy)- 2-fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 282::US10822352, Comp No. 282	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386353&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643106	404855510							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976534	Cc1cc2ncc(cn2n1)-c1cc2c(nn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(OC(F)(F)F)c3F)c2cn1)C(N)=O	InChI=1S/C28H22F5N9O4/c1-13-5-22-36-8-14(10-42(22)38-13)18-7-16-20(9-35-18)41(39-25(16)26(34)44)12-23(43)40-11-15(29)6-19(40)27(45)37-17-3-2-4-21(24(17)30)46-28(31,32)33/h2-5,7-10,15,19H,6,11-12H2,1H3,(H2,34,44)(H,37,45)/t15-,19+/m1/s1	DAKTYDZWJVRZFS-BEFAXECRSA-N	386354	1-(2-((2S,4R)-4- fluoro-2-(2-fluoro-3- (trifluoromethoxy) phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-pyrazolo[3,4- c]pyridine-3- carboxamide::US10287301, Compound 283::US10822352, Comp No. 283	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386354&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643310	404855511							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976535	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)c3)nc(C(N)=O)c2c1	InChI=1S/C28H24BrFN8O3/c1-15-7-24-32-11-17(12-38(24)34-15)16-5-6-22-21(8-16)26(27(31)40)35-37(22)14-25(39)36-13-19(30)10-23(36)28(41)33-20-4-2-3-18(29)9-20/h2-9,11-12,19,23H,10,13-14H2,1H3,(H2,31,40)(H,33,41)/t19-,23+/m1/s1	DCNCEVAFSPRSOR-XXBNENTESA-N	472005	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazole-3- carboxamide::US10822352, Comp No. 284	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472005&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313776	441611001							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976536	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(OC(F)(F)F)c3F)nc(C(N)=O)c2c1	InChI=1S/C29H23F5N8O4/c1-14-7-23-36-10-16(11-42(23)38-14)15-5-6-20-18(8-15)26(27(35)44)39-41(20)13-24(43)40-12-17(30)9-21(40)28(45)37-19-3-2-4-22(25(19)31)46-29(32,33)34/h2-8,10-11,17,21H,9,12-13H2,1H3,(H2,35,44)(H,37,45)/t17-,21+/m1/s1	LJXURCISAOOUHE-UTKZUKDTSA-N	386356	1-(2-((2S,4R)-4- fluoro-2-(2-fluoro-3- (trifluoromethoxy) phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 285::US10822352, Comp No. 285	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386356&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643296	404855513							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976537	CC(=O)c1nn(CC(=O)N2CC=C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H26ClFN6O3/c1-19(42)32-25-15-21(22-16-36-20(2)37-17-22)12-13-28(25)41(39-32)18-30(43)40-14-6-11-29(40)33(44)38-27-10-5-8-24(31(27)35)23-7-3-4-9-26(23)34/h3-13,15-17,29H,14,18H2,1-2H3,(H,38,44)/t29-/m0/s1	OSRLJYOXYUIALQ-LJAQVGFWSA-N	386357	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-2,5-dihydro-1H- pyrrole-2- carboxamide::US10287301, Compound 286::US10822352, Comp No. 286	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386357&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643018	404855514							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976538	CCOC(=O)c1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C30H26BrFN8O5/c1-3-45-30(44)21-11-26-33-12-18(13-40(26)36-21)17-7-8-22-20(9-17)28(16(2)41)37-39(22)15-27(42)38-14-19(32)10-23(38)29(43)35-25-6-4-5-24(31)34-25/h4-9,11-13,19,23H,3,10,14-15H2,1-2H3,(H,34,35,43)/t19-,23+/m1/s1	UPMSBRCMNCNZHX-XXBNENTESA-N	386358	US10287301, Compound 287::US10822352, Comp No. 287::ethyl 6-(3-acetyl-1- (2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indazol-5- yl)pyrazolo[1,5- a]pyrimidine-2- carboxylate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386358&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623527	404855515							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976539	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C(N)=O	InChI=1S/C28H23BrFN9O4/c1-14(40)26-18-7-15(16-10-32-24-9-19(27(31)42)35-39(24)11-16)5-6-20(18)38(36-26)13-25(41)37-12-17(30)8-21(37)28(43)34-23-4-2-3-22(29)33-23/h2-7,9-11,17,21H,8,12-13H2,1H3,(H2,31,42)(H,33,34,43)/t17-,21+/m1/s1	DMXSENAFRNXUTC-UTKZUKDTSA-N	386359	6-(3-acetyl-1-(2- ((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indazol-5- yl)pyrazolo[1,5- a]pyrimidine-2- carboxamide::US10287301, Compound 288::US10822352, Comp No. 288	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386359&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623395	404855516							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976540	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C(O)=O	InChI=1S/C28H22BrFN8O5/c1-14(39)26-18-7-15(16-10-31-24-9-19(28(42)43)34-38(24)11-16)5-6-20(18)37(35-26)13-25(40)36-12-17(30)8-21(36)27(41)33-23-4-2-3-22(29)32-23/h2-7,9-11,17,21H,8,12-13H2,1H3,(H,42,43)(H,32,33,41)/t17-,21+/m1/s1	STINAHYALAKXNU-UTKZUKDTSA-N	386360	6-(3-acetyl-1-(2- ((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indazol-5- yl)pyrazolo[1,5- a]pyrimidine-2- carboxylic acid::US10287301, Compound 289::US10822352, Comp No. 289	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386360&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622942	404855517							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976541	COCCOCCNC(=O)c1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C33H33BrFN9O6/c1-19(45)31-23-12-20(21-15-37-29-14-24(40-44(29)16-21)32(47)36-8-9-50-11-10-49-2)6-7-25(23)43(41-31)18-30(46)42-17-22(35)13-26(42)33(48)39-28-5-3-4-27(34)38-28/h3-7,12,14-16,22,26H,8-11,13,17-18H2,1-2H3,(H,36,47)(H,38,39,48)/t22-,26+/m1/s1	UGGYEOMXDQCEDU-GJZUVCINSA-N	386361	6-(3-acetyl-1-(2- ((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-1H- indazol-5-yl)-N-(2- (2-methoxyethoxy) ethyl)pyrazolo[1,5- a]pyrimidine-2- carboxamide::US10287301, Compound 290::US10822352, Comp No. 290	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386361&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654068	404855518							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976542	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1n[nH]c2ccsc12			386362	(2S,4R)-1-(2-(3- acetyl-5-(1H- thieno[3,2- c]pyrazol-3-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 291::US10822352, Comp No. 291	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386362&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623451	404855519							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976543	CC(=O)n1cc(NC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14-29-10-17(11-30-14)16-6-7-19-20(13-34(15(2)36)21(19)8-16)31-26(38)35-12-18(28)9-22(35)25(37)33-24-5-3-4-23(27)32-24/h3-8,10-11,13,18,22H,9,12H2,1-2H3,(H,31,38)(H,32,33,37)/t18-,22+/m1/s1	ABFGQDANIXECRA-GCJKJVERSA-N	386363	(2S,4R)-N1-(1- acetyl-6-(2- methylpyrimidin-5- yl)-1H-indol-3-yl)- N2-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 1,2-dicarboxamide::US10287301, Compound 292::US10822352, Comp No. 292	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386363&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643167	404855520							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976544	CC(=O)n1cc(NC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H27ClF2N6O3/c1-18-37-14-21(15-38-18)20-10-11-25-28(17-41(19(2)43)29(25)12-20)40-33(45)42-16-22(35)13-30(42)32(44)39-27-9-5-7-24(31(27)36)23-6-3-4-8-26(23)34/h3-12,14-15,17,22,30H,13,16H2,1-2H3,(H,39,44)(H,40,45)/t22-,30+/m1/s1	AAYDDKMGZYLNBX-RCRUUEGKSA-N	386364	(2S,4R)-N1-(1- acetyl-6-(2- methylpyrimidin-5- yl)-1H-indol-3-yl)- N2-(2'-chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine- 1,2-dicarboxamide::US10287301, Compound 293::US10822352, Comp No. 293	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386364&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643505	404855521							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976545	CC(=O)c1nn(CC(=O)N2CC=C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrN7O3/c1-15(35)25-19-11-17(18-12-28-16(2)29-13-18)8-9-20(19)34(32-25)14-24(36)33-10-4-5-21(33)26(37)31-23-7-3-6-22(27)30-23/h3-9,11-13,21H,10,14H2,1-2H3,(H,30,31,37)/t21-/m0/s1	HOFNRZYNDAYFGV-NRFANRHFSA-N	386365	(S)-1-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2,5-dihydro-1H- pyrrole-2- carboxamide::US10287301, Compound 294::US10822352, Comp No. 294	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386365&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643148	404855522							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976546	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(-c3cccc(c3)S(C)(=O)=O)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H30F2N6O5S/c1-19(43)33-27-13-21(23-15-37-20(2)38-16-23)10-11-29(27)42(40-33)18-31(44)41-17-24(35)14-30(41)34(45)39-28-9-5-8-26(32(28)36)22-6-4-7-25(12-22)48(3,46)47/h4-13,15-16,24,30H,14,17-18H2,1-3H3,(H,39,45)/t24-,30+/m1/s1	DYOXIJKDGYEHKN-HLADLETHSA-N	386366	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro- N-(2-fluoro-3'- (methylsulfonyl) biphenyl-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 295::US10822352, Comp No. 295	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386366&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623345	404855523							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976547	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C35H28ClF2N7O3/c1-19-12-31-39-15-22(16-45(31)41-19)21-10-11-29-26(13-21)34(20(2)46)42-44(29)18-32(47)43-17-23(37)14-30(43)35(48)40-28-9-5-7-25(33(28)38)24-6-3-4-8-27(24)36/h3-13,15-16,23,30H,14,17-18H2,1-2H3,(H,40,48)/t23-,30+/m1/s1	IVNCOXFOPIRABF-DJUQAAIZSA-N	386367	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 296::US10822352, Comp No. 296	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386367&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643259	404855524							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976548	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1nc2CCCCc2s1	InChI=1S/C28H26BrFN6O3S/c1-15(37)26-18-11-16(28-31-19-5-2-3-6-22(19)40-28)9-10-20(18)36(34-26)14-25(38)35-13-17(30)12-21(35)27(39)33-24-8-4-7-23(29)32-24/h4,7-11,17,21H,2-3,5-6,12-14H2,1H3,(H,32,33,39)/t17-,21+/m1/s1	IIEPFMDGZMXQAC-UTKZUKDTSA-N	386368	(2S,4R)-1-(2-(3- acetyl-5-(4,5,6,7- tetrahydrobenzo[d] thiazol-2-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 297::US10822352, Comp No. 297	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386368&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643198	404855525							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976549	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H25BrN8O3/c1-15-8-26-31-12-19(13-37(26)34-15)17-6-7-21-20(9-17)28(16(2)39)35-36(21)14-27(40)38-22-10-18(22)11-23(38)29(41)33-25-5-3-4-24(30)32-25/h3-9,12-13,18,22-23H,10-11,14H2,1-2H3,(H,32,33,41)/t18-,22-,23+/m1/s1	XHTIVISDMHWJOA-YSZBQJHXSA-N	386328	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 257::US10822352, Comp No. 298	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386328	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386328&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653932	404855485							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976550	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C31H27ClF2N6O3/c1-17-8-28-35-12-21(13-40(28)37-17)19-6-7-26-23(9-19)24(18(2)41)15-38(26)16-29(42)39-14-22(33)10-27(39)31(43)36-11-20-4-3-5-25(32)30(20)34/h3-9,12-13,15,22,27H,10-11,14,16H2,1-2H3,(H,36,43)/t22-,27+/m1/s1	LFZKKSRZBOAYLM-AMGIVPHBSA-N	386370	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 299::US10822352, Comp No. 299	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386370&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643380	404855527							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976551	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C36H29ClF2N6O3/c1-20-12-33-40-15-23(16-45(33)42-20)22-10-11-31-27(13-22)28(21(2)46)18-43(31)19-34(47)44-17-24(38)14-32(44)36(48)41-30-9-5-7-26(35(30)39)25-6-3-4-8-29(25)37/h3-13,15-16,18,24,32H,14,17,19H2,1-2H3,(H,41,48)/t24-,32+/m1/s1	PBDGQQTUJRNMKJ-QNLPTKCRSA-N	386371	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 300::US10822352, Comp No. 300	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386371&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643442	404855528							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976552	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H25F4N7O3/c1-16-8-27-35-11-19(12-41(27)38-16)18-6-7-23-21(9-18)22(17(2)42)14-39(23)15-28(43)40-13-20(31)10-24(40)29(44)37-26-5-3-4-25(36-26)30(32,33)34/h3-9,11-12,14,20,24H,10,13,15H2,1-2H3,(H,36,37,44)/t20-,24+/m1/s1	LKQZGVAFWWWDFG-YKSBVNFPSA-N	386372	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-4-fluoro- N-(6- (trifluoromethyl) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 301::US10822352, Comp No. 301	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386372&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643227	404855529							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976553	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cccnn12	InChI=1S/C28H23BrFN7O3/c1-16(38)20-14-35(21-8-7-17(10-19(20)21)23-12-31-26-6-3-9-32-37(23)26)15-27(39)36-13-18(30)11-22(36)28(40)34-25-5-2-4-24(29)33-25/h2-10,12,14,18,22H,11,13,15H2,1H3,(H,33,34,40)/t18-,22+/m1/s1	RAMDHCKEFOSVRD-GCJKJVERSA-N	472023	(2S,4R)-1-(2-(3- acetyl-5- (imidazo[1,2- b]pyridazin-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 302	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472023&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314363	441611019							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976554	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc2nccn2n1	InChI=1S/C27H22BrFN8O3/c1-15(38)26-18-11-16(19-6-8-24-30-9-10-36(24)33-19)5-7-20(18)37(34-26)14-25(39)35-13-17(29)12-21(35)27(40)32-23-4-2-3-22(28)31-23/h2-11,17,21H,12-14H2,1H3,(H,31,32,40)/t17-,21+/m1/s1	MKWPHRGFQURYSC-UTKZUKDTSA-N	386374	(2S,4R)-1-(2-(3- acetyl-5- (imidazo[1,2- b]pyridazin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 303::US10822352, Comp No. 303	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386374&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643013	404855531							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976555	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)C1=CC2N=CC=[N]2N=C1	InChI=1S/C27H23BrFN8O3/c1-15(38)26-19-9-16(17-10-24-30-7-8-36(24)31-12-17)5-6-20(19)37(34-26)14-25(39)35-13-18(29)11-21(35)27(40)33-23-4-2-3-22(28)32-23/h2-10,12,18,21,24H,11,13-14H2,1H3,(H,32,33,40)/t18-,21+,24?/m1/s1	OHGWAGRMIYGUEH-BGNYOVEWSA-N	472025	(2S,4R)-1-(2-(3- acetyl-5- (imidazo[1,2- b]pyridazin-7-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 304	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472025&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698570	441611021							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976556	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(F)ccc2S(C)(=O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H29F3N6O5S/c1-18(44)33-26-11-20(21-14-38-19(2)39-15-21)7-9-28(26)43(41-33)17-31(45)42-16-23(36)13-29(42)34(46)40-27-6-4-5-24(32(27)37)25-12-22(35)8-10-30(25)49(3,47)48/h4-12,14-15,23,29H,13,16-17H2,1-3H3,(H,40,46)/t23-,29+/m1/s1	YUNBZWYDNPTXJJ-BTYSJIOQSA-N	386376	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2,5'- difluoro-2'- (methylsulfonyl) biphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 305::US10822352, Comp No. 305::US11407738, Example 00335	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386376&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642967	404855533							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976557	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C27H23BrFN9O3/c1-14-5-24-31-8-17(11-38(24)34-14)16-3-4-20-19(6-16)26(15(2)39)35-37(20)13-25(40)36-12-18(29)7-21(36)27(41)33-23-10-30-9-22(28)32-23/h3-6,8-11,18,21H,7,12-13H2,1-2H3,(H,32,33,41)/t18-,21+/m1/s1	XIEUTALUDOZCEY-NQIIRXRSSA-N	386377	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 306::US10822352, Comp No. 310	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386377&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643166	404855534							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976558	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(N)=O)c2c1	InChI=1S/C26H23BrFN7O3/c1-14-30-9-16(10-31-14)15-5-6-20-18(7-15)19(25(29)37)12-34(20)13-24(36)35-11-17(28)8-21(35)26(38)33-23-4-2-3-22(27)32-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H2,29,37)(H,32,33,38)/t17-,21+/m1/s1	ASQSBPRLPDMTIU-UTKZUKDTSA-N	386378	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5-(2- methylpyrimidin-5- yl)-1H-indole-3- carboxamide::US10287301, Compound 307::US10822352, Comp No. 307	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386378&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654069	404855535							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976559	CC(=O)c1nn(CC(=O)N2CCS[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H22BrN7O3S/c1-14(34)23-18-10-16(17-11-27-15(2)28-12-17)6-7-19(18)33(31-23)13-22(35)32-8-9-37-25(32)24(36)30-21-5-3-4-20(26)29-21/h3-7,10-12,25H,8-9,13H2,1-2H3,(H,29,30,36)/t25-/m0/s1	AHLPLZWCOYIMBY-VWLOTQADSA-N	386379	(S)-3-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)thiazolidine-2- carboxamide::US10287301, Compound 308::US10822352, Comp No. 308	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386379&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643251	404855536							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976560	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2CCCCn12	InChI=1S/C28H27BrFN7O3/c1-16(38)27-19-11-17(22-13-31-25-7-2-3-10-35(22)25)8-9-20(19)37(34-27)15-26(39)36-14-18(30)12-21(36)28(40)33-24-6-4-5-23(29)32-24/h4-6,8-9,11,13,18,21H,2-3,7,10,12,14-15H2,1H3,(H,32,33,40)/t18-,21+/m1/s1	SCGFNYCIEBGTDG-NQIIRXRSSA-N	386380	(2S,4R)-1-(2-(3- acetyl-5-(5,6,7,8- tetrahydroimidazo [1,2-a]pyridin-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 309::US10822352, Comp No. 309	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386380&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654070	404855537							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976561	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C27H23BrFN9O3/c1-14-5-24-31-8-17(11-38(24)34-14)16-3-4-20-19(6-16)26(15(2)39)35-37(20)13-25(40)36-12-18(29)7-21(36)27(41)33-23-10-30-9-22(28)32-23/h3-6,8-11,18,21H,7,12-13H2,1-2H3,(H,32,33,41)/t18-,21+/m1/s1	XIEUTALUDOZCEY-NQIIRXRSSA-N	386377	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 306::US10822352, Comp No. 310	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386377&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643166	404855534							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976562	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc2nc(C)nn2c1	InChI=1S/C28H24BrFN8O3/c1-15(39)27-20-10-17(18-7-9-25-31-16(2)34-38(25)12-18)6-8-21(20)37(35-27)14-26(40)36-13-19(30)11-22(36)28(41)33-24-5-3-4-23(29)32-24/h3-10,12,19,22H,11,13-14H2,1-2H3,(H,32,33,41)/t19-,22+/m1/s1	ZBMOINZOPNVADI-KNQAVFIVSA-N	386382	(2S,4R)-1-(2-(3- acetyl-5-(2-methyl- [1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 311::US10822352, Comp No. 311	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386382&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642958	404855539							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976563	CC(=O)c1nn(CC(=O)N2CSC[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H22BrN7O3S/c1-14(34)24-18-8-16(17-9-27-15(2)28-10-17)6-7-19(18)33(31-24)11-23(35)32-13-37-12-20(32)25(36)30-22-5-3-4-21(26)29-22/h3-10,20H,11-13H2,1-2H3,(H,29,30,36)/t20-/m0/s1	ZMOPQZXDPIBLHN-FQEVSTJZSA-N	386383	(R)-3-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)thiazolidine-4- carboxamide::US10287301, Compound 312::US10822352, Comp No. 312	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386383&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643129	404855540							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976564	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H23F4N9O3/c1-14-5-24-34-8-17(11-41(24)37-14)16-3-4-20-19(6-16)26(15(2)42)38-40(20)13-25(43)39-12-18(29)7-21(39)27(44)36-23-10-33-9-22(35-23)28(30,31)32/h3-6,8-11,18,21H,7,12-13H2,1-2H3,(H,35,36,44)/t18-,21+/m1/s1	QXYANYHAQFHLDG-NQIIRXRSSA-N	386384	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(6- (trifluoromethyl) pyrazin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 313::US10822352, Comp No. 313	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386384&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643128	404855541							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976565	Cc1ncc(cn1)-c1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)nc(C(N)=O)c2s1	InChI=1S/C30H24ClF2N7O3S/c1-15-35-11-16(12-36-15)24-10-22-28(44-24)27(29(34)42)38-40(22)14-25(41)39-13-17(32)9-23(39)30(43)37-21-8-4-6-19(26(21)33)18-5-2-3-7-20(18)31/h2-8,10-12,17,23H,9,13-14H2,1H3,(H2,34,42)(H,37,43)/t17-,23+/m1/s1	KKLKWJWFZAAXLZ-HXOBKFHXSA-N	386385	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (2- methylpyrimidin-5- yl)-1H-thieno[3,2- c]pyrazole-3- carboxamide::US10287301, Compound 314::US10822352, Comp No. 314	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386385&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643321	404855542							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976566	CC(=O)c1nn(CC(=O)N2CC[C@@H](O)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN7O4/c1-14(35)24-18-10-16(17-11-28-15(2)29-12-17)6-7-19(18)34(32-24)13-23(37)33-9-8-20(36)25(33)26(38)31-22-5-3-4-21(27)30-22/h3-7,10-12,20,25,36H,8-9,13H2,1-2H3,(H,30,31,38)/t20-,25+/m1/s1	BKPJCZKXLZKRMW-NLFFAJNJSA-N	386386	(2S,3R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-3- hydroxypyrrolidine- 2-carboxamide::US10287301, Compound 315::US10822352, Comp No. 315	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386386&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643394	404855543							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976567	COCCOCCOCCOCCOCCOc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C36H43BrFN7O9/c1-24(46)34-28-18-25(26-20-39-36(40-21-26)54-17-16-53-15-14-52-13-12-51-11-10-50-9-8-49-2)6-7-29(28)45(43-34)23-33(47)44-22-27(38)19-30(44)35(48)42-32-5-3-4-31(37)41-32/h3-7,18,20-21,27,30H,8-17,19,22-23H2,1-2H3,(H,41,42,48)/t27-,30+/m1/s1	UQTIBKXODYGOBO-OFSOJUDTSA-N	386387	(2S,4R)-1-(2-(5-(2- (2,5,8,11,14- pentaoxahexadecan-16- yloxy)pyrimidin-5- yl)-3-acetyl-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 316::US10822352, Comp No. 316	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386387&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643081	404855544							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976568	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H22BrFN8O3/c1-13(36)24-18-5-15(16-7-29-14(2)30-8-16)3-4-19(18)35(33-24)12-23(37)34-11-17(27)6-20(34)25(38)32-22-10-28-9-21(26)31-22/h3-5,7-10,17,20H,6,11-12H2,1-2H3,(H,31,32,38)/t17-,20+/m1/s1	PYJPZMJEECTLDX-XLIONFOSSA-N	386388	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 317::US10822352, Comp No. 317	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386388&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643517	404855545							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976569	COc1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C35H30ClF2N5O4/c1-19(44)27-17-42(30-13-32(47-3)25(12-26(27)30)21-14-39-20(2)40-15-21)18-33(45)43-16-22(37)11-31(43)35(46)41-29-10-6-8-24(34(29)38)23-7-4-5-9-28(23)36/h4-10,12-15,17,22,31H,11,16,18H2,1-3H3,(H,41,46)/t22-,31+/m1/s1	GEAXTDUJUVQNIS-UVDDSOTQSA-N	386389	(2S,4R)-1-(2-(3- acetyl-6-methoxy- 5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 318::US10822352, Comp No. 318	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386389&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643136	404855546							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976570	COc1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C28H26BrFN6O4/c1-15(37)21-13-35(22-9-24(40-3)19(8-20(21)22)17-10-31-16(2)32-11-17)14-27(38)36-12-18(30)7-23(36)28(39)34-26-6-4-5-25(29)33-26/h4-6,8-11,13,18,23H,7,12,14H2,1-3H3,(H,33,34,39)/t18-,23+/m1/s1	YTWIZQSABORDIJ-JPYJTQIMSA-N	386390	(2S,4R)-1-(2-(3- acetyl-6-methoxy- 5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 319::US10822352, Comp No. 319	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386390&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623040	404855547							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976571	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2cc(O)c(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClF2N5O4/c1-18(43)26-16-41(29-12-31(44)24(11-25(26)29)20-13-38-19(2)39-14-20)17-32(45)42-15-21(36)10-30(42)34(46)40-28-9-5-7-23(33(28)37)22-6-3-4-8-27(22)35/h3-9,11-14,16,21,30,44H,10,15,17H2,1-2H3,(H,40,46)/t21-,30+/m1/s1	UHWNMIINZRNRFP-DFXYEROKSA-N	386391	(2S,4R)-1-(2-(3- acetyl-6-hydroxy-5- (2-methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 320::US10822352, Comp No. 320	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386391&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643058	404855548							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976572	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2nc(C)ccn12	InChI=1S/C28H24BrFN8O3/c1-15-8-9-36-22(12-31-28(36)32-15)17-6-7-20-19(10-17)26(16(2)39)35-38(20)14-25(40)37-13-18(30)11-21(37)27(41)34-24-5-3-4-23(29)33-24/h3-10,12,18,21H,11,13-14H2,1-2H3,(H,33,34,41)/t18-,21+/m1/s1	FEBGSIRRGXQSLN-NQIIRXRSSA-N	386392	(2S,4R)-1-(2-(3- acetyl-5-(7- methylimidazo[1,2- a]pyrimidin-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 321::US10822352, Comp No. 321	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386392&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643241	404855549							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976573	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C26H21BrFN9O3/c1-14(38)25-18-6-15(16-8-30-23-4-5-31-37(23)11-16)2-3-19(18)36(34-25)13-24(39)35-12-17(28)7-20(35)26(40)33-22-10-29-9-21(27)32-22/h2-6,8-11,17,20H,7,12-13H2,1H3,(H,32,33,40)/t17-,20+/m1/s1	OPKPBMDTMFGERA-XLIONFOSSA-N	386393	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 322::US10822352, Comp No. 323	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386393&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642791	404855550							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976574	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C26H21BrFN9O3/c1-14(38)25-18-6-15(16-8-30-23-4-5-31-37(23)11-16)2-3-19(18)36(34-25)13-24(39)35-12-17(28)7-20(35)26(40)33-22-10-29-9-21(27)32-22/h2-6,8-11,17,20H,7,12-13H2,1H3,(H,32,33,40)/t17-,20+/m1/s1	OPKPBMDTMFGERA-XLIONFOSSA-N	386393	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 322::US10822352, Comp No. 323	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386393&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642791	404855550							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976575	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H24BrN9O3/c1-14-5-25-31-9-18(12-37(25)34-14)16-3-4-20-19(6-16)27(15(2)39)35-36(20)13-26(40)38-21-7-17(21)8-22(38)28(41)33-24-11-30-10-23(29)32-24/h3-6,9-12,17,21-22H,7-8,13H2,1-2H3,(H,32,33,41)/t17-,21-,22+/m1/s1	ISMZXGDZFYVTFH-YHYVQYDKSA-N	386395	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 324::US10822352, Comp No. 324	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386395&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654071	404855552							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976576	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccc2nc(C)nn2c1	InChI=1S/C27H23BrFN9O3/c1-14(39)26-19-7-16(17-4-6-24-31-15(2)34-38(24)11-17)3-5-20(19)37(35-26)13-25(40)36-12-18(29)8-21(36)27(41)33-23-10-30-9-22(28)32-23/h3-7,9-11,18,21H,8,12-13H2,1-2H3,(H,32,33,41)/t18-,21+/m1/s1	MFNAIRRAUQRRKR-NQIIRXRSSA-N	386396	(2S,4R)-1-(2-(3- acetyl-5-(2-methyl- [1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 325::US10287301, Compound 659::US10822352, Comp No. 325	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386396&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643392	404855553							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976577	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(-c3sccc3Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H25ClF2N6O3S/c1-16(41)29-22-10-18(19-12-35-17(2)36-13-19)6-7-25(22)40(38-29)15-27(42)39-14-20(33)11-26(39)31(43)37-24-5-3-4-21(28(24)34)30-23(32)8-9-44-30/h3-10,12-13,20,26H,11,14-15H2,1-2H3,(H,37,43)/t20-,26+/m1/s1	VIUAYEKEHADXGZ-IBVKSMDESA-N	386397	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3-(3- chlorothiophen-2- yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 327::US10822352, Comp No. 327	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386397&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642920	404855554							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976578	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2cc(O)c(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O4/c1-14(36)20-12-34(21-8-23(37)18(7-19(20)21)16-9-30-15(2)31-10-16)13-26(38)35-11-17(29)6-22(35)27(39)33-25-5-3-4-24(28)32-25/h3-5,7-10,12,17,22,37H,6,11,13H2,1-2H3,(H,32,33,39)/t17-,22+/m1/s1	PJPPLXDHQWEKJR-VGSWGCGISA-N	386398	(2S,4R)-1-(2-(3- acetyl-6-hydroxy-5- (2-methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 328::US10822352, Comp No. 328	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386398&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622868	404855555							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976579	CC(=O)c1nn(CC(=O)N2CSC(C)(C)[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28ClFN6O3S/c1-16(38)26-21-10-18(20-12-32-17(2)33-13-20)8-9-23(21)37(35-26)14-24(39)36-15-41-29(3,4)27(36)28(40)34-11-19-6-5-7-22(30)25(19)31/h5-10,12-13,27H,11,14-15H2,1-4H3,(H,34,40)/t27-/m1/s1	MDNFBHGRCLNODZ-HHHXNRCGSA-N	386399	(R)-3-(2-(3-acetyl- 5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-5,5- dimethylthiazolidine- 4-carboxamide::US10287301, Compound 329::US10822352, Comp No. 329	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386399&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643364	404855556							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976580	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H24F4N8O4/c1-15-8-24-34-11-18(12-41(24)37-15)17-6-7-21-20(9-17)27(16(2)42)38-40(21)14-26(43)39-13-19(30)10-22(39)28(44)36-23-4-3-5-25(35-23)45-29(31,32)33/h3-9,11-12,19,22H,10,13-14H2,1-2H3,(H,35,36,44)/t19-,22+/m1/s1	LPTLBAOFUQISKD-KNQAVFIVSA-N	386400	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4-fluoro- N-(6- (trifluoromethoxy) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 330::US10287301, Compound 656::US10822352, Comp No. 330	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386400&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643217	404855557							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976581	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H25BrN8O3/c1-15-5-27-32-9-19(12-37(27)35-15)17-3-4-22-20(6-17)21(16(2)39)13-36(22)14-28(40)38-23-7-18(23)8-24(38)29(41)34-26-11-31-10-25(30)33-26/h3-6,9-13,18,23-24H,7-8,14H2,1-2H3,(H,33,34,41)/t18-,23-,24+/m1/s1	KTCMNQZYOVQXNK-QFWMQHCXSA-N	386401	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 331::US10822352, Comp No. 331	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386401&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654072	404855558							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976582	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H26BrFN8O3/c1-15-6-24(30)33-25(7-15)34-29(42)23-10-20(31)13-37(23)27(41)14-38-22-5-4-18(9-21(22)28(36-38)17(3)40)19-11-32-26-8-16(2)35-39(26)12-19/h4-9,11-12,20,23H,10,13-14H2,1-3H3,(H,33,34,42)/t20-,23+/m1/s1	CRUCUPJRLYPVLT-OFNKIYASSA-N	386402	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromo-4- methylpyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 332::US10287301, Compound 657::US10822352, Comp No. 332	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386402&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643427	404855559							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976583	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(O[C@@H]2CO[C@@H]3[C@H](O)CO[C@H]23)nc1	InChI=1S/C39H34ClF2N5O7/c1-20(48)27-16-46(30-10-9-21(11-26(27)30)22-13-43-39(44-14-22)54-33-19-53-36-32(49)18-52-37(33)36)17-34(50)47-15-23(41)12-31(47)38(51)45-29-8-4-6-25(35(29)42)24-5-2-3-7-28(24)40/h2-11,13-14,16,23,31-33,36-37,49H,12,15,17-19H2,1H3,(H,45,51)/t23-,31+,32-,33-,36-,37-/m1/s1	YTEMJPGCGGZQBW-NUSUXSJVSA-N	386403	(2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6- hydroxyhexahydrofuro [3,2-b]furan-3- yl)oxy)pyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 333::US10822352, Comp No. 333::US11407738, Cmpd No. 501	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386403&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623797	404855560							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976584	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(O[C@@H]2CO[C@@H]3[C@H](O)CO[C@H]23)nc1	InChI=1S/C32H30BrFN6O7/c1-16(41)21-12-39(13-28(43)40-11-19(34)8-23(40)31(44)38-27-4-2-3-26(33)37-27)22-6-5-17(7-20(21)22)18-9-35-32(36-10-18)47-25-15-46-29-24(42)14-45-30(25)29/h2-7,9-10,12,19,23-25,29-30,42H,8,11,13-15H2,1H3,(H,37,38,44)/t19-,23+,24-,25-,29-,30-/m1/s1	XNEOEGQFBKMSBQ-QBRLCXGLSA-N	386404	(2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6- hydroxyhexahydrofuro [3,2-b]furan-3- yl)oxy)pyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 334::US10287301, Compound 337::US10822352, Comp No. 334::US11407738, Cmpd No. 502	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386404&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623765	404855561							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976585	CO[C@@H]1CO[C@@H]2[C@@H](CO[C@H]12)Oc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C40H36ClF2N5O7/c1-21(49)28-17-47(31-11-10-22(12-27(28)31)23-14-44-40(45-15-23)55-34-20-54-37-33(52-2)19-53-38(34)37)18-35(50)48-16-24(42)13-32(48)39(51)46-30-9-5-7-26(36(30)43)25-6-3-4-8-29(25)41/h3-12,14-15,17,24,32-34,37-38H,13,16,18-20H2,1-2H3,(H,46,51)/t24-,32+,33-,34-,37-,38-/m1/s1	XDEIEXBZTNVABE-FEAIFORNSA-N	386405	(2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6- methoxyhexahydrofuro [3,2-b]furan-3- yl)oxy)pyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2-fluoro- [1,1'-biphenyl]-3- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 335::US10822352, Comp No. 335	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386405&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623814	404855562							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976586	CO[C@@H]1CO[C@@H]2[C@@H](CO[C@H]12)Oc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C33H32BrFN6O7/c1-17(42)22-13-40(14-29(43)41-12-20(35)9-24(41)32(44)39-28-5-3-4-27(34)38-28)23-7-6-18(8-21(22)23)19-10-36-33(37-11-19)48-26-16-47-30-25(45-2)15-46-31(26)30/h3-8,10-11,13,20,24-26,30-31H,9,12,14-16H2,1-2H3,(H,38,39,44)/t20-,24+,25-,26-,30-,31-/m1/s1	CGAPZQCWVTTXAD-HDLSZUIBSA-N	472056	(2S,4R)-1-(2-(3- acetyl-5-(2- (((3R,3aR,6R,6aR)-6- methoxyhexahydrofuro [3,2-b]furan-3- yl)oxy)pyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 337	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472056&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623843	441611052							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976587	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(CC(N)=O)c2c1	InChI=1S/C26H24BrFN8O3/c1-14-30-10-16(11-31-14)15-5-6-20-18(7-15)19(9-23(29)37)34-36(20)13-25(38)35-12-17(28)8-21(35)26(39)33-24-4-2-3-22(27)32-24/h2-7,10-11,17,21H,8-9,12-13H2,1H3,(H2,29,37)(H,32,33,39)/t17-,21+/m1/s1	JDUXBLPCGOLKOA-UTKZUKDTSA-N	386407	(2S,4R)-1-(2-(3- (2-amino-2- oxoethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 340::US10822352, Comp No. 340::US11407738, Cmpd No. 523	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386407&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623799	404855563							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976588	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)S(N)(=O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H28ClF2N7O5S/c1-17(44)32-25-10-19(20-13-38-18(2)39-14-20)6-9-28(25)43(41-32)16-30(45)42-15-21(35)11-29(42)33(46)40-27-5-3-4-23(31(27)36)24-12-22(49(37,47)48)7-8-26(24)34/h3-10,12-14,21,29H,11,15-16H2,1-2H3,(H,40,46)(H2,37,47,48)/t21-,29+/m1/s1	GGOIOOYAFPJIFL-PBBNMVCDSA-N	386408	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-2- fluoro-5'- sulfamoyl-[1,1'- biphenyl]-3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 341::US10822352, Comp No. 341::US11407738, Cmpd No. 525	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386408&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642908	404855564							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976589	CNS(=O)(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1F	InChI=1S/C34H30ClF2N7O5S/c1-18(45)33-26-11-20(21-14-39-19(2)40-15-21)7-10-29(26)44(42-33)17-31(46)43-16-22(36)12-30(43)34(47)41-28-6-4-5-24(32(28)37)25-13-23(8-9-27(25)35)50(48,49)38-3/h4-11,13-15,22,30,38H,12,16-17H2,1-3H3,(H,41,47)/t22-,30+/m1/s1	ZLAJFNIIBSQNMV-RCRUUEGKSA-N	386409	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-2- fluoro-5'-(N- methylsulfamoyl)- [1,1'-biphenyl]- 3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 342::US10822352, Comp No. 342::US11407738, Cmpd No. 529	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386409&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643097	404855565							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976590	CN(C)S(=O)(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1F	InChI=1S/C35H32ClF2N7O5S/c1-19(46)34-27-12-21(22-15-39-20(2)40-16-22)8-11-30(27)45(42-34)18-32(47)44-17-23(37)13-31(44)35(48)41-29-7-5-6-25(33(29)38)26-14-24(9-10-28(26)36)51(49,50)43(3)4/h5-12,14-16,23,31H,13,17-18H2,1-4H3,(H,41,48)/t23-,31+/m1/s1	ZEJAWACPRFOOES-IPBJYNAHSA-N	386410	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-5'- (N,N- dimethylsulfamoyl)- 2-fluoro-[1,1'- biphenyl]-3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 343::US10822352, Comp No. 343	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386410&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643209	404855566							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976591	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23F4N7O4/c1-14(39)25-19-8-16(17-10-32-15(2)33-11-17)6-7-20(19)38(36-25)13-24(40)37-12-18(28)9-21(37)26(41)35-22-4-3-5-23(34-22)42-27(29,30)31/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,34,35,41)/t18-,21+/m1/s1	LVIIZBCFJCXZLJ-NQIIRXRSSA-N	386411	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethoxy) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 344::US10287301, Compound 582::US10822352, Comp No. 344	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386411&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642821	404855567							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976592	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-14-6-23(28)32-24(7-14)33-27(39)22-9-19(29)12-35(22)25(38)13-36-21-5-4-17(18-10-30-16(3)31-11-18)8-20(21)26(34-36)15(2)37/h4-8,10-11,19,22H,9,12-13H2,1-3H3,(H,32,33,39)/t19-,22+/m1/s1	ZQBBRGWASYSFHM-KNQAVFIVSA-N	386412	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 345::US10822352, Comp No. 345	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386412&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623108	404855568							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976593	CC(=O)c1nn(CC(=O)N2C[C@H](F)[C@@H](O)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O4/c1-13(36)23-17-8-15(16-9-29-14(2)30-10-16)6-7-19(17)35(33-23)12-22(37)34-11-18(28)25(38)24(34)26(39)32-21-5-3-4-20(27)31-21/h3-10,18,24-25,38H,11-12H2,1-2H3,(H,31,32,39)/t18-,24-,25+/m0/s1	NHJXMWVWNIXMJZ-RIEVBORMSA-N	386413	(2S,3S,4S)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoro-3- hydroxypyrrolidine- 2-carboxamide::US10287301, Compound 346::US10822352, Comp No. 346	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386413&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643262	404855569							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976594	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2[nH]c(C)nc2c1			472064	(2S,4R)-1-(2-(3-acetyl- 5-(2-methyl-3H- imidazo[4,5-b]pyridin- 6-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 347	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472064&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643155	441611060							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976595	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN8O3/c1-13-25(27)32-22(10-29-13)33-26(39)21-7-18(28)11-35(21)23(38)12-36-20-5-4-16(17-8-30-15(3)31-9-17)6-19(20)24(34-36)14(2)37/h4-6,8-10,18,21H,7,11-12H2,1-3H3,(H,32,33,39)/t18-,21+/m1/s1	IGSOZSFGZCNXOP-NQIIRXRSSA-N	386414	(2S,4R)-1-(2-(3- acetyl-5-(2- methyl-3H- imidazo[4,5- b]pyridin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 347::US10287301, Compound 349::US10822352, Comp No. 349	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386414&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642982	404855570							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976596	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrN8O3/c1-13(36)25-18-5-15(17-8-29-14(2)30-9-17)3-4-19(18)34(33-25)12-24(37)35-20-6-16(20)7-21(35)26(38)32-23-11-28-10-22(27)31-23/h3-5,8-11,16,20-21H,6-7,12H2,1-2H3,(H,31,32,38)/t16-,20-,21+/m1/s1	DMVCPCVSEWJDLJ-HBGVWJBISA-N	386416	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 350::US10822352, Comp No. 350	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386416&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643291	404855571							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976597	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C27H25BrFN7O4/c1-14(37)26-20-6-16(17-10-30-15(2)31-11-17)4-5-21(20)36(34-26)13-25(38)35-12-18(29)7-22(35)27(39)33-24-9-19(40-3)8-23(28)32-24/h4-6,8-11,18,22H,7,12-13H2,1-3H3,(H,32,33,39)/t18-,22+/m1/s1	SALLBFIXJGPYQS-GCJKJVERSA-N	386417	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- methoxypyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 351::US10822352, Comp No. 351	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386417&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642995	404855572							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976598	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C25H22BrN9O3/c1-12(36)23-16-4-13(15-7-29-25(27)30-8-15)2-3-17(16)34(33-23)11-22(37)35-18-5-14(18)6-19(35)24(38)32-21-10-28-9-20(26)31-21/h2-4,7-10,14,18-19H,5-6,11H2,1H3,(H2,27,29,30)(H,31,32,38)/t14-,18-,19+/m1/s1	VLTXKJZFXYGBNC-ZMYBRWDISA-N	386418	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 352::US10822352, Comp No. 352	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386418&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642786	404855573							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976599	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C24H21BrFN9O3/c1-12(36)22-16-4-13(14-6-29-24(27)30-7-14)2-3-17(16)35(33-22)11-21(37)34-10-15(26)5-18(34)23(38)32-20-9-28-8-19(25)31-20/h2-4,6-9,15,18H,5,10-11H2,1H3,(H2,27,29,30)(H,31,32,38)/t15-,18+/m1/s1	GVCUVYJNKBCEDI-QAPCUYQASA-N	386419	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 353::US10822352, Comp No. 353	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386419&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643114	404855574							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976600	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C1CC1	InChI=1S/C27H24BrFN8O3/c1-14(38)25-19-6-16(17-8-31-26(32-9-17)15-2-3-15)4-5-20(19)37(35-25)13-24(39)36-12-18(29)7-21(36)27(40)34-23-11-30-10-22(28)33-23/h4-6,8-11,15,18,21H,2-3,7,12-13H2,1H3,(H,33,34,40)/t18-,21+/m1/s1	SYZGULNXNMCRLO-NQIIRXRSSA-N	386420	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 354::US10287301, Compound 356::US10822352, Comp No. 354	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386420&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642918	404855575							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976601	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(CC(F)(F)F)cs2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23F4N7O3S/c1-13(38)23-19-5-15(16-8-31-14(2)32-9-16)3-4-20(19)37(35-23)11-22(39)36-10-17(27)6-21(36)24(40)34-25-33-18(12-41-25)7-26(28,29)30/h3-5,8-9,12,17,21H,6-7,10-11H2,1-2H3,(H,33,34,40)/t17-,21+/m1/s1	CJNLXZUFRFSLPX-UTKZUKDTSA-N	386421	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(4- (2,2,2- trifluoroethyl) thiazol-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 355::US10822352, Comp No. 355	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386421&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623410	404855576							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976602	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C1CC1	InChI=1S/C28H25BrN8O3/c1-14(38)26-19-6-16(18-9-31-27(32-10-18)15-2-3-15)4-5-20(19)36(35-26)13-25(39)37-21-7-17(21)8-22(37)28(40)34-24-12-30-11-23(29)33-24/h4-6,9-12,15,17,21-22H,2-3,7-8,13H2,1H3,(H,33,34,40)/t17-,21-,22+/m1/s1	APQVKDPNOBAMDT-YHYVQYDKSA-N	472072	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- cyclopropylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 356	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472072&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642910	441611068							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976603	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24F4N8O3/c1-14(39)24-19-7-16(17-9-31-15(2)32-10-17)3-4-20(19)38(35-24)12-23(40)37-11-18(27)8-21(37)25(41)33-22-5-6-36(34-22)13-26(28,29)30/h3-7,9-10,18,21H,8,11-13H2,1-2H3,(H,33,34,41)/t18-,21+/m1/s1	XDRUGXQNQBDNGB-NQIIRXRSSA-N	386423	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 357::US10822352, Comp No. 401	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386423&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623078	404855577							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976604	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)c2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23BrClFN6O3/c1-14(37)26-19-8-16(17-10-31-15(2)32-11-17)6-7-22(19)36(34-26)13-24(38)35-12-18(30)9-23(35)27(39)33-21-5-3-4-20(28)25(21)29/h3-8,10-11,18,23H,9,12-13H2,1-2H3,(H,33,39)/t18-,23+/m1/s1	NADCDLRUULSKQZ-JPYJTQIMSA-N	386424	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- bromo-2- chlorophenyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 358::US10822352, Comp No. 358	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386424&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623136	404855578							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976605	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(Cl)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrClFN7O3/c1-13(37)25-19-5-15(16-9-30-14(2)31-10-16)3-4-20(19)36(34-25)12-24(38)35-11-18(29)8-21(35)26(39)33-23-7-17(28)6-22(27)32-23/h3-7,9-10,18,21H,8,11-12H2,1-2H3,(H,32,33,39)/t18-,21+/m1/s1	MPYLMWIIBCECSO-NQIIRXRSSA-N	386425	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- chloropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 359::US10822352, Comp No. 359	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386425&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623286	404855579							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976606	CC(O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,14,18,21,36H,9,12-13H2,1-2H3,(H,31,32,38)/t14?,18-,21+/m1/s1	AQGKBCYKVYEJRB-VXOHXDMYSA-N	386426	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-(1- hydroxyethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US10287301, Compound 360::US10287301, Compound 361::US10287301, Compound 376::US10822352, Comp No. 376	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386426&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623322	404855580							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976607	CC(O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,14,18,21,36H,9,12-13H2,1-2H3,(H,31,32,38)/t14?,18-,21+/m1/s1	AQGKBCYKVYEJRB-VXOHXDMYSA-N	386426	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-(1- hydroxyethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US10287301, Compound 360::US10287301, Compound 361::US10287301, Compound 376::US10822352, Comp No. 376	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386426&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623322	404855580							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976608	CN(C)C(=O)c1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C29H28BrFN8O4/c1-15(40)27-21-9-19(17-11-32-16(2)33-12-17)20(29(43)37(3)4)10-22(21)39(36-27)14-26(41)38-13-18(31)8-23(38)28(42)35-25-7-5-6-24(30)34-25/h5-7,9-12,18,23H,8,13-14H2,1-4H3,(H,34,35,42)/t18-,23+/m1/s1	DWNZCKJEWMHTPF-JPYJTQIMSA-N	386428	3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- N,N-dimethyl-5-(2- methylpyrimidin- 5-yl)-1H- indazole-6- carboxamide::US10287301, Compound 362::US10287301, Compound 722::US10822352, Comp No. 722	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386428&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623428	404855581							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976609	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25F3N8O3/c1-14(39)25-19-7-16(18-10-31-15(2)32-11-18)3-4-20(19)37(35-25)12-24(40)38-21-8-17(21)9-22(38)26(41)33-23-5-6-36(34-23)13-27(28,29)30/h3-7,10-11,17,21-22H,8-9,12-13H2,1-2H3,(H,33,34,41)/t17-,21-,22+/m1/s1	FVNALDFWKXAKSL-YHYVQYDKSA-N	386429	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 363::US10822352, Comp No. 363	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386429&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642897	404855582							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976610	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H23BrN8O3/c1-13(36)24-17-7-14(16-10-29-26(28)30-11-16)5-6-18(17)34(33-24)12-23(37)35-19-8-15(19)9-20(35)25(38)32-22-4-2-3-21(27)31-22/h2-7,10-11,15,19-20H,8-9,12H2,1H3,(H2,28,29,30)(H,31,32,38)/t15-,19-,20+/m1/s1	DAFWXLDQDOYJNP-YSGRDPCXSA-N	386430	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 364::US10822352, Comp No. 364	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386430&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643067	404855583							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976611	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrN8O3/c1-13-26(28)32-23(11-29-13)33-27(39)22-8-17-7-21(17)36(22)24(38)12-35-20-5-4-16(18-9-30-15(3)31-10-18)6-19(20)25(34-35)14(2)37/h4-6,9-11,17,21-22H,7-8,12H2,1-3H3,(H,32,33,39)/t17-,21-,22+/m1/s1	GIYNXULKIOTBBI-YHYVQYDKSA-N	386431	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 365::US10822352, Comp No. 365	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386431&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642998	404855584							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976612	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C28H26BrN7O4/c1-14(37)27-20-6-16(18-11-30-15(2)31-12-18)4-5-21(20)35(34-27)13-26(38)36-22-7-17(22)8-23(36)28(39)33-25-10-19(40-3)9-24(29)32-25/h4-6,9-12,17,22-23H,7-8,13H2,1-3H3,(H,32,33,39)/t17-,22-,23+/m1/s1	BTPJCWBZYWEALP-ZQMYSKGWSA-N	386432	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- methoxypyridin- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 366::US10822352, Comp No. 366	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386432&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643210	404855585							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976613	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(NC2CC2)nc1	InChI=1S/C28H26BrFN8O3/c1-15(39)26-20-9-16(17-11-31-28(32-12-17)33-19-6-7-19)5-8-21(20)38(36-26)14-25(40)37-13-18(30)10-22(37)27(41)35-24-4-2-3-23(29)34-24/h2-5,8-9,11-12,18-19,22H,6-7,10,13-14H2,1H3,(H,31,32,33)(H,34,35,41)/t18-,22+/m1/s1	DHSFVQZKOIYOOI-GCJKJVERSA-N	386433	(2S,4R)-1-(2-(3- acetyl-5-(2- (cyclopropylamino) pyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 367::US10822352, Comp No. 367	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386433&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623505	404855586							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976614	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H22ClFN8O3/c1-13(36)24-18-5-15(16-7-29-14(2)30-8-16)3-4-19(18)35(33-24)12-23(37)34-11-17(27)6-20(34)25(38)32-22-10-28-9-21(26)31-22/h3-5,7-10,17,20H,6,11-12H2,1-2H3,(H,31,32,38)/t17-,20+/m1/s1	JVVBFESEDAGYIM-XLIONFOSSA-N	386434	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- chloropyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 368::US10822352, Comp No. 368	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386434&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622916	404855587							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976615	CC(=O)c1nn(CC(=O)N2CC3CC3C2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-14(36)25-20-8-16(18-10-29-15(2)30-11-18)6-7-21(20)35(33-25)13-24(37)34-12-17-9-19(17)26(34)27(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,17,19,26H,9,12-13H2,1-2H3,(H,31,32,38)	IQUYAWMKSVZUAC-UHFFFAOYSA-N	386435	3-(2-(3-acetyl-5- (2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 369::US10822352, Comp No. 369	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386435&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643053	404855588							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976616	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H22BrF4N7O3/c1-13(40)25-19-5-15(16-9-33-14(2)34-10-16)3-4-20(19)39(37-25)12-24(41)38-11-18(29)8-21(38)26(42)36-23-7-17(27(30,31)32)6-22(28)35-23/h3-7,9-10,18,21H,8,11-12H2,1-2H3,(H,35,36,42)/t18-,21+/m1/s1	VMTVDPXCDJACQD-NQIIRXRSSA-N	386436	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- (trifluoromethyl) pyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 370::US10822352, Comp No. 370	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386436&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623524	404855589							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976617	CC(=O)c1nn(CC(=O)N2C[C@@H]3C[C@@H]3[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-14(36)25-20-8-16(18-10-29-15(2)30-11-18)6-7-21(20)35(33-25)13-24(37)34-12-17-9-19(17)26(34)27(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,17,19,26H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,19-,26-/m0/s1	IQUYAWMKSVZUAC-IAKTWSEQSA-N	386437	(1S,2S,5R)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 371::US10822352, Comp No. 371	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386437&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643020	404855590							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976618	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-15(37)26-19-9-17(18-12-30-16(2)31-13-18)7-8-20(19)35(34-26)14-25(38)36-21(10-28(3)11-22(28)36)27(39)33-24-6-4-5-23(29)32-24/h4-9,12-13,21-22H,10-11,14H2,1-3H3,(H,32,33,39)/t21-,22+,28-/m0/s1	WDGDIZRREOUISQ-TYPXCFOJSA-N	386438	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 372::US10822352, Comp No. 372	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386438&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643139	404855591							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976619	COc1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O4/c1-14(37)26-19-8-18(16-10-30-15(2)31-11-16)22(40-3)9-20(19)36(34-26)13-25(38)35-12-17(29)7-21(35)27(39)33-24-6-4-5-23(28)32-24/h4-6,8-11,17,21H,7,12-13H2,1-3H3,(H,32,33,39)/t17-,21+/m1/s1	VCNZMICBFBVRBF-UTKZUKDTSA-N	386439	(2S,4R)-1-(2-(3- acetyl-6- methoxy-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 373::US10822352, Comp No. 373	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386439&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643267	404855592							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976620	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CO)nc1	InChI=1S/C26H23BrFN7O4/c1-14(37)25-18-7-15(16-9-29-23(13-36)30-10-16)5-6-19(18)35(33-25)12-24(38)34-11-17(28)8-20(34)26(39)32-22-4-2-3-21(27)31-22/h2-7,9-10,17,20,36H,8,11-13H2,1H3,(H,31,32,39)/t17-,20+/m1/s1	JWIAHEWNRCNDOY-XLIONFOSSA-N	386440	(2S,4R)-1-(2-(3- acetyl-5-(2- (hydroxymethyl) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 374::US10822352, Comp No. 374	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386440&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623269	404855593							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976621	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23ClN8O3/c1-13(36)25-18-5-15(17-8-29-14(2)30-9-17)3-4-19(18)34(33-25)12-24(37)35-20-6-16(20)7-21(35)26(38)32-23-11-28-10-22(27)31-23/h3-5,8-11,16,20-21H,6-7,12H2,1-2H3,(H,31,32,38)/t16-,20-,21+/m1/s1	GDKSYPMCCIDAKX-HBGVWJBISA-N	386441	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- chloropyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 375::US10822352, Comp No. 375	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386441&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642763	404855594							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976622	CC(O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,14,18,21,36H,9,12-13H2,1-2H3,(H,31,32,38)/t14?,18-,21+/m1/s1	AQGKBCYKVYEJRB-VXOHXDMYSA-N	386426	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-(1- hydroxyethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US10287301, Compound 360::US10287301, Compound 361::US10287301, Compound 376::US10822352, Comp No. 376	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386426&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623322	404855580							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976623	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccnc(OCC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24F4N8O4/c1-14(40)24-19-7-16(17-9-33-15(2)34-10-17)3-4-20(19)39(37-24)12-23(41)38-11-18(28)8-21(38)25(42)35-22-5-6-32-26(36-22)43-13-27(29,30)31/h3-7,9-10,18,21H,8,11-13H2,1-2H3,(H,32,35,36,42)/t18-,21+/m1/s1	BIWHWYQWDWGGMY-NQIIRXRSSA-N	386443	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(2- (2,2,2- trifluoroethoxy) pyrimidin-4- yl)pyrrolidine-2- carboxamide::US10287301, Compound 377::US10822352, Comp No. 377	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386443&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643019	404855595							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976624	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H23F4N9O3/c1-13(39)22-18-5-15(16-7-30-14(2)31-8-16)3-4-19(18)38(34-22)10-21(40)37-9-17(26)6-20(37)23(41)33-24-32-12-36(35-24)11-25(27,28)29/h3-5,7-8,12,17,20H,6,9-11H2,1-2H3,(H,33,35,41)/t17-,20+/m1/s1	YVVIQBMTTRGFBW-XLIONFOSSA-N	386444	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- (2,2,2- trifluoroethyl)- 1H-1,2,4-triazol- 3-yl)pyrrolidine- 2-carboxamide::US10287301, Compound 378::US10822352, Comp No. 378	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386444&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622950	404855596							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976625	CNc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cncc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H24BrN9O3/c1-13(37)24-17-5-14(16-8-30-26(28-2)31-9-16)3-4-18(17)35(34-24)12-23(38)36-19-6-15(19)7-20(36)25(39)33-22-11-29-10-21(27)32-22/h3-5,8-11,15,19-20H,6-7,12H2,1-2H3,(H,28,30,31)(H,32,33,39)/t15-,19-,20+/m1/s1	PVFIQKINVBVJRX-YSGRDPCXSA-N	386445	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- (methylamino) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 379::US10822352, Comp No. 379	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386445&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642854	404855597							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976626	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(NC2CC2)nc1	InChI=1S/C28H26BrN9O3/c1-14(39)26-19-6-15(17-9-31-28(32-10-17)33-18-3-4-18)2-5-20(19)37(36-26)13-25(40)38-21-7-16(21)8-22(38)27(41)35-24-12-30-11-23(29)34-24/h2,5-6,9-12,16,18,21-22H,3-4,7-8,13H2,1H3,(H,31,32,33)(H,34,35,41)/t16-,21-,22+/m1/s1	ZMMDKIDNUHJXCI-HVETUWLQSA-N	386446	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- (cyclopropylamino) pyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 380::US10822352, Comp No. 380	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386446&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643390	404855598							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976627	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(Br)n(C)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H24BrFN8O3/c1-13(36)24-18-6-15(16-9-28-14(2)29-10-16)4-5-19(18)35(32-24)12-23(37)34-11-17(27)7-20(34)25(38)30-22-8-21(26)33(3)31-22/h4-6,8-10,17,20H,7,11-12H2,1-3H3,(H,30,31,38)/t17-,20+/m1/s1	AMLXUMRZLCFQQL-XLIONFOSSA-N	386447	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(5- bromo-1-methyl- 1H-pyrazol-3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 381::US10822352, Comp No. 381	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386447&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623500	404855599							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976628	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-15(37)26-19-9-17(18-12-30-16(2)31-13-18)7-8-20(19)35(34-26)14-25(38)36-21(10-28(3)11-22(28)36)27(39)33-24-6-4-5-23(29)32-24/h4-9,12-13,21-22H,10-11,14H2,1-3H3,(H,32,33,39)/t21-,22-,28+/m0/s1	WDGDIZRREOUISQ-RXYILKCJSA-N	386448	(1S,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 382::US10822352, Comp No. 382	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386448&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643403	404855600							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976629	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CO)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O4/c1-15(38)26-19-8-17(18-11-30-16(2)31-12-18)6-7-20(19)35(34-26)13-25(39)36-21(9-28(14-37)10-22(28)36)27(40)33-24-5-3-4-23(29)32-24/h3-8,11-12,21-22,37H,9-10,13-14H2,1-2H3,(H,32,33,40)/t21-,22-,28+/m0/s1	UJHUOTGSMLMBFX-RXYILKCJSA-N	386449	(1S,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5- (hydroxymethyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 383::US10822352, Comp No. 383	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386449&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643350	404855601							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976630	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H23BrFN7O4/c1-14(36)24-18-8-15(16-10-29-26(39-2)30-11-16)6-7-19(18)35(33-24)13-23(37)34-12-17(28)9-20(34)25(38)32-22-5-3-4-21(27)31-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,20+/m1/s1	KNTISZBRSSRMIE-XLIONFOSSA-N	386450	(2S,4R)-1-(2-(3- acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 384::US10822352, Comp No. 384	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386450&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622983	404855602							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976631	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cncc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H23BrN8O4/c1-13(36)24-17-5-14(16-8-29-26(39-2)30-9-16)3-4-18(17)34(33-24)12-23(37)35-19-6-15(19)7-20(35)25(38)32-22-11-28-10-21(27)31-22/h3-5,8-11,15,19-20H,6-7,12H2,1-2H3,(H,31,32,38)/t15-,19-,20+/m1/s1	VNCHFZIVOLJFPL-YSGRDPCXSA-N	386451	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 385::US10822352, Comp No. 385	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386451&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643070	404855603							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976632	COc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O4/c1-14(37)25-19-8-16(17-10-30-15(2)31-11-17)4-5-20(19)36(34-25)13-24(38)35-12-18(29)9-21(35)27(39)33-26-22(40-3)6-7-23(28)32-26/h4-8,10-11,18,21H,9,12-13H2,1-3H3,(H,32,33,39)/t18-,21+/m1/s1	JSNRYZQZCLDHKY-NQIIRXRSSA-N	386452	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methoxypyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 386::US10822352, Comp No. 386	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386452&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623355	404855604							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976633	CN(C)Cc1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C29H30BrFN8O3/c1-16(40)28-22-10-21(19-11-32-17(2)33-12-19)18(13-37(3)4)8-23(22)39(36-28)15-27(41)38-14-20(31)9-24(38)29(42)35-26-7-5-6-25(30)34-26/h5-8,10-12,20,24H,9,13-15H2,1-4H3,(H,34,35,42)/t20-,24+/m1/s1	QBUJTIWVMYDQHI-YKSBVNFPSA-N	386453	(2S,4R)-1-(2-(3- acetyl-6- ((dimethylamino) methyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 387::US10822352, Comp No. 387	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386453&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642940	404855605							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976634	CCc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cncc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H24BrFN8O3/c1-3-22-30-8-16(9-31-22)15-4-5-19-18(6-15)25(14(2)37)34-36(19)13-24(38)35-12-17(28)7-20(35)26(39)33-23-11-29-10-21(27)32-23/h4-6,8-11,17,20H,3,7,12-13H2,1-2H3,(H,32,33,39)/t17-,20+/m1/s1	BVHITBYIZORSBO-XLIONFOSSA-N	386454	(2S,4R)-1-(2-(3- acetyl-5-(2- ethylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 388::US10822352, Comp No. 388	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386454&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623439	404855606							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976635	CC(C)c1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cncc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C27H26BrFN8O3/c1-14(2)26-31-8-17(9-32-26)16-4-5-20-19(6-16)25(15(3)38)35-37(20)13-24(39)36-12-18(29)7-21(36)27(40)34-23-11-30-10-22(28)33-23/h4-6,8-11,14,18,21H,7,12-13H2,1-3H3,(H,33,34,40)/t18-,21+/m1/s1	YSYUDXDXUHTRPL-NQIIRXRSSA-N	386455	(2S,4R)-1-(2-(3- acetyl-5-(2- isopropylpyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 389::US10822352, Comp No. 389	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386455&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643428	404855607							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976636	CNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H24BrFN8O3/c1-14(37)24-18-8-15(16-10-30-26(29-2)31-11-16)6-7-19(18)36(34-24)13-23(38)35-12-17(28)9-20(35)25(39)33-22-5-3-4-21(27)32-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,29,30,31)(H,32,33,39)/t17-,20+/m1/s1	OMZZFWLPJBWOEK-XLIONFOSSA-N	386456	(2S,4R)-1-(2-(3- acetyl-5-(2- (methylamino) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 390::US10822352, Comp No. 390	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386456&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643219	404855608							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976637	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CC#N)nc1	InChI=1S/C27H22BrFN8O3/c1-15(38)26-19-9-16(17-11-31-23(7-8-30)32-12-17)5-6-20(19)37(35-26)14-25(39)36-13-18(29)10-21(36)27(40)34-24-4-2-3-22(28)33-24/h2-6,9,11-12,18,21H,7,10,13-14H2,1H3,(H,33,34,40)/t18-,21+/m1/s1	RMLRZUMDNNVOEB-NQIIRXRSSA-N	386457	(2S,4R)-1-(2-(3- acetyl-5-(2- (cyanomethyl) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 391::US10822352, Comp No. 391	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386457&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623120	404855609							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976638	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CO)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O4/c1-15(38)26-19-8-17(18-11-30-16(2)31-12-18)6-7-20(19)35(34-26)13-25(39)36-21(9-28(14-37)10-22(28)36)27(40)33-24-5-3-4-23(29)32-24/h3-8,11-12,21-22,37H,9-10,13-14H2,1-2H3,(H,32,33,40)/t21-,22+,28-/m0/s1	UJHUOTGSMLMBFX-TYPXCFOJSA-N	386458	(1R,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5- (hydroxymethyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 392::US10822352, Comp No. 392	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386458&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643023	404855610							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976639	CO[C@@H]1[C@@H](F)CN([C@@H]1C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O4/c1-14(37)24-18-9-16(17-10-30-15(2)31-11-17)7-8-20(18)36(34-24)13-23(38)35-12-19(29)26(40-3)25(35)27(39)33-22-6-4-5-21(28)32-22/h4-11,19,25-26H,12-13H2,1-3H3,(H,32,33,39)/t19-,25-,26+/m0/s1	STOJYCIOVRVIIP-RRWZXMNXSA-N	386459	(2S,3S,4S)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoro-3- methoxypyrrolidine- 2-carboxamide::US10287301, Compound 393::US10822352, Comp No. 393	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386459&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623326	404855611							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976640	COc1ccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)nc1Br	InChI=1S/C27H25BrFN7O4/c1-14(37)25-19-8-16(17-10-30-15(2)31-11-17)4-5-20(19)36(34-25)13-24(38)35-12-18(29)9-21(35)27(39)33-23-7-6-22(40-3)26(28)32-23/h4-8,10-11,18,21H,9,12-13H2,1-3H3,(H,32,33,39)/t18-,21+/m1/s1	SWCSYKRDPSWGSF-NQIIRXRSSA-N	386460	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- methoxypyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 394::US10822352, Comp No. 394	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386460&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623129	404855612							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976641	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CN)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrFN8O3/c1-15(38)25-19-8-17(18-10-31-16(2)32-11-18)6-7-20(19)37(35-25)12-24(39)36-14-27(29,13-30)9-21(36)26(40)34-23-5-3-4-22(28)33-23/h3-8,10-11,21H,9,12-14,30H2,1-2H3,(H,33,34,40)/t21-,27-/m0/s1	CHGQWMNQJHOKGI-IDISGSTGSA-N	386461	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- (aminomethyl)-N- (6-bromopyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 395::US10822352, Comp No. 395	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386461&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643104	404855613							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976642	COC(=O)c1cc(Cl)nc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C28H25ClFN7O5/c1-14(38)26-20-6-16(18-10-31-15(2)32-11-18)4-5-21(20)37(35-26)13-25(39)36-12-19(30)9-22(36)27(40)34-24-8-17(28(41)42-3)7-23(29)33-24/h4-8,10-11,19,22H,9,12-13H2,1-3H3,(H,33,34,40)/t19-,22+/m1/s1	MKNHVWHCRBPRRB-KNQAVFIVSA-N	386462	US10287301, Compound 396::US10822352, Comp No. 396::methyl 2- ((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)-6- chloroisonicotinate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386462&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623191	404855614							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976643	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrF2N7O3/c1-13(37)24-18-7-15(16-9-30-14(2)31-10-16)3-5-20(18)36(34-24)12-23(38)35-11-17(28)8-21(35)26(39)33-22-6-4-19(29)25(27)32-22/h3-7,9-10,17,21H,8,11-12H2,1-2H3,(H,32,33,39)/t17-,21+/m1/s1	SSMGBAIYGVCQFT-UTKZUKDTSA-N	472118	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-4-fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 397	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472118&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623354	441611113							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976644	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc(CO)nc1	InChI=1S/C25H22BrFN8O4/c1-13(37)24-17-4-14(15-6-29-22(12-36)30-7-15)2-3-18(17)35(33-24)11-23(38)34-10-16(27)5-19(34)25(39)32-21-9-28-8-20(26)31-21/h2-4,6-9,16,19,36H,5,10-12H2,1H3,(H,31,32,39)/t16-,19+/m1/s1	MGVDPTDPEHEECJ-APWZRJJASA-N	386464	(2S,4R)-1-(2-(3- acetyl-5-(2- (hydroxymethyl) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 398::US10822352, Comp No. 398	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386464&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643014	404855616							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976645	CC(=O)c1nn(CC(=O)N2CC(F)(CN)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrFN8O3/c1-15(38)25-19-8-17(18-10-31-16(2)32-11-18)6-7-20(19)37(35-25)12-24(39)36-14-27(29,13-30)9-21(36)26(40)34-23-5-3-4-22(28)33-23/h3-8,10-11,21H,9,12-14,30H2,1-2H3,(H,33,34,40)/t21-,27?/m0/s1	CHGQWMNQJHOKGI-LWAJAQLZSA-N	386465	(2S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- (aminomethyl)-N- (6-bromopyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 399::US10822352, Comp No. 399	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386465&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643216	404855617							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976646	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CO)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O4/c1-15(38)25-19-8-17(18-10-30-16(2)31-11-18)6-7-20(19)36(34-25)12-24(39)35-13-27(29,14-37)9-21(35)26(40)33-23-5-3-4-22(28)32-23/h3-8,10-11,21,37H,9,12-14H2,1-2H3,(H,32,33,40)/t21-,27+/m0/s1	JQCRGKIFIDNXNV-KDYSTLNUSA-N	386466	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoro-4- (hydroxymethyl) pyrrolidine-2- carboxamide::US10287301, Compound 400::US10822352, Comp No. 400	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386466&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623361	404855618							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976647	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24F4N8O3/c1-14(39)24-19-7-16(17-9-31-15(2)32-10-17)3-4-20(19)38(35-24)12-23(40)37-11-18(27)8-21(37)25(41)33-22-5-6-36(34-22)13-26(28,29)30/h3-7,9-10,18,21H,8,11-13H2,1-2H3,(H,33,34,41)/t18-,21+/m1/s1	XDRUGXQNQBDNGB-NQIIRXRSSA-N	386423	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 357::US10822352, Comp No. 401	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386423&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623078	404855577							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976648	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(C)c(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-14-4-7-23(32-26(14)28)33-27(39)22-9-19(29)12-35(22)24(38)13-36-21-6-5-17(18-10-30-16(3)31-11-18)8-20(21)25(34-36)15(2)37/h4-8,10-11,19,22H,9,12-13H2,1-3H3,(H,32,33,39)/t19-,22+/m1/s1	PTCNXCBJJDSWAD-KNQAVFIVSA-N	386463	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 397::US10287301, Compound 402::US10822352, Comp No. 402	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386463&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623043	404855615							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976649	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CNC(=O)OC(C)(C)C)nc1	InChI=1S/C31H32BrFN8O5/c1-17(42)28-21-10-18(19-12-34-26(35-13-19)14-36-30(45)46-31(2,3)4)8-9-22(21)41(39-28)16-27(43)40-15-20(33)11-23(40)29(44)38-25-7-5-6-24(32)37-25/h5-10,12-13,20,23H,11,14-16H2,1-4H3,(H,36,45)(H,37,38,44)/t20-,23+/m1/s1	AATCREDNTNMGEZ-OFNKIYASSA-N	386469	US10287301, Compound 403::US10822352, Comp No. 403::tert-butyl ((5-(3- acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)methyl)carbamate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386469&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653947	404855620							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976650	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CN)nc1	InChI=1S/C26H24BrFN8O3/c1-14(37)25-18-7-15(16-10-30-23(9-29)31-11-16)5-6-19(18)36(34-25)13-24(38)35-12-17(28)8-20(35)26(39)33-22-4-2-3-21(27)32-22/h2-7,10-11,17,20H,8-9,12-13,29H2,1H3,(H,32,33,39)/t17-,20+/m1/s1	ZTKORAZDNKQYGB-XLIONFOSSA-N	386470	(2S,4R)-1-(2-(3- acetyl-5-(2- (aminomethyl) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 404::US10822352, Comp No. 404	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386470&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623497	404855621							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976651	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-14-4-7-23(28)32-26(14)33-27(39)22-9-19(29)12-35(22)24(38)13-36-21-6-5-17(18-10-30-16(3)31-11-18)8-20(21)25(34-36)15(2)37/h4-8,10-11,19,22H,9,12-13H2,1-3H3,(H,32,33,39)/t19-,22+/m1/s1	SDVHIEZNTOWOHH-KNQAVFIVSA-N	386471	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 405::US10822352, Comp No. 405	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386471&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642902	404855622							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976652	CC(=O)NCc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C28H26BrFN8O4/c1-15(39)27-20-8-17(18-10-32-25(33-11-18)12-31-16(2)40)6-7-21(20)38(36-27)14-26(41)37-13-19(30)9-22(37)28(42)35-24-5-3-4-23(29)34-24/h3-8,10-11,19,22H,9,12-14H2,1-2H3,(H,31,40)(H,34,35,42)/t19-,22+/m1/s1	DMIJMEYVWNORBX-KNQAVFIVSA-N	386472	(2S,4R)-1-(2-(5- (2-(acetamidomethyl) pyrimidin-5-yl)- 3-acetyl-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 406::US10822352, Comp No. 406	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386472&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623568	404855623							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976653	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)cn2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23F2N7O3/c1-14(36)25-20-7-16(17-9-29-15(2)30-10-17)3-5-21(20)35(33-25)13-24(37)34-12-19(28)8-22(34)26(38)32-23-6-4-18(27)11-31-23/h3-7,9-11,19,22H,8,12-13H2,1-2H3,(H,31,32,38)/t19-,22+/m1/s1	FULYIYKNTIPEDI-KNQAVFIVSA-N	386473	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(5- fluoropyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 407::US10822352, Comp No. 407	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386473&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643046	404855624							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976654	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(F)cc2Br)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrF2N7O3/c1-13(37)24-19-5-15(16-8-30-14(2)31-9-16)3-4-21(19)36(34-24)12-23(38)35-11-18(29)7-22(35)26(39)33-25-20(27)6-17(28)10-32-25/h3-6,8-10,18,22H,7,11-12H2,1-2H3,(H,32,33,39)/t18-,22+/m1/s1	SGDKRYNUUUEBMQ-GCJKJVERSA-N	386474	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- bromo-5- fluoropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 408::US10822352, Comp No. 408	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386474&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623373	404855625							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976655	CC(O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrN7O3/c1-14(36)26-19-8-16(18-11-29-15(2)30-12-18)6-7-20(19)34(33-26)13-25(37)35-21-9-17(21)10-22(35)27(38)32-24-5-3-4-23(28)31-24/h3-8,11-12,14,17,21-22,36H,9-10,13H2,1-2H3,(H,31,32,38)/t14?,17-,21-,22+/m1/s1	BWEGSZOAFGVPCZ-BXKOGVBLSA-N	472134	(1R,3S,5R)-N-(6- bromopyridin-2- yl)-2-(2-(3-(1- hydroxyethyl)-5- (2-methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 409	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472134&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643179	441611127							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976656	CC(=O)c1nn([C@H](F)C(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrF2N7O3/c1-13(37)23-18-8-15(16-10-30-14(2)31-11-16)6-7-19(18)36(34-23)24(29)26(39)35-12-17(28)9-20(35)25(38)33-22-5-3-4-21(27)32-22/h3-8,10-11,17,20,24H,9,12H2,1-2H3,(H,32,33,38)/t17-,20+,24+/m1/s1	WDGDGHAQRFLGEO-YQOVMPOYSA-N	386476	(2S,4R)-1-((R)-2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)-2- fluoroacetyl)-N- (6-bromopyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 411::US10822352, Comp No. 411	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386476&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642912	404855627							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976657	CC(=O)c1nn([C@@H](F)C(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrF2N7O3/c1-13(37)23-18-8-15(16-10-30-14(2)31-11-16)6-7-19(18)36(34-23)24(29)26(39)35-12-17(28)9-20(35)25(38)33-22-5-3-4-21(27)32-22/h3-8,10-11,17,20,24H,9,12H2,1-2H3,(H,32,33,38)/t17-,20+,24-/m1/s1	WDGDGHAQRFLGEO-VWQFJMCTSA-N	386477	(2S,4R)-1-((S)-2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)-2- fluoroacetyl)-N- (6-bromopyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 412::US10822352, Comp No. 412	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386477&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643059	404855628							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976658	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-14(36)25-20-8-16(18-10-29-15(2)30-11-18)6-7-21(20)35(33-25)13-24(37)34-12-17-9-19(17)26(34)27(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,17,19,26H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,19-,26+/m1/s1	IQUYAWMKSVZUAC-AZZGJVAJSA-N	386478	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 413::US10822352, Comp No. 413	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386478&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643074	404855629							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976659	CC(=O)c1nn(CC(=O)N2C[C@@H]3C[C@@H]3[C@@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-14(36)25-20-8-16(18-10-29-15(2)30-11-18)6-7-21(20)35(33-25)13-24(37)34-12-17-9-19(17)26(34)27(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,17,19,26H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,19-,26+/m0/s1	IQUYAWMKSVZUAC-CMPWMSKVSA-N	386479	(1S,2R,5R)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 414::US10822352, Comp No. 414	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386479&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642816	404855630							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976660	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrF2N7O3/c1-15(38)25-19-8-17(18-10-31-16(2)32-11-18)6-7-20(19)37(35-25)12-24(39)36-14-27(30,13-29)9-21(36)26(40)34-23-5-3-4-22(28)33-23/h3-8,10-11,21H,9,12-14H2,1-2H3,(H,33,34,40)/t21-,27-/m0/s1	TUOPYVQKKXQYJS-IDISGSTGSA-N	386480	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoro-4- (fluoromethyl) pyrrolidine-2- carboxamide::US10287301, Compound 415::US10822352, Comp No. 415	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386480&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643234	404855631							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976661	COC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O4/c1-16(38)27-20-9-18(19-12-31-17(2)32-13-19)7-8-21(20)36(35-27)14-26(39)37-22(10-29(15-41-3)11-23(29)37)28(40)34-25-6-4-5-24(30)33-25/h4-9,12-13,22-23H,10-11,14-15H2,1-3H3,(H,33,34,40)/t22-,23+,29-/m0/s1	TVJJBTODNONXCG-CTWZREHQSA-N	386481	(1R,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5- (methoxymethyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 416::US10822352, Comp No. 416	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386481&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643163	404855632							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976662	COC[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O4/c1-16(38)27-20-9-18(19-12-31-17(2)32-13-19)7-8-21(20)36(35-27)14-26(39)37-22(10-29(15-41-3)11-23(29)37)28(40)34-25-6-4-5-24(30)33-25/h4-9,12-13,22-23H,10-11,14-15H2,1-3H3,(H,33,34,40)/t22-,23-,29+/m0/s1	TVJJBTODNONXCG-SBZVUBOMSA-N	386482	(1S,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5- (methoxymethyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 417::US10822352, Comp No. 417	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386482&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643222	404855633							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976663	CC(=O)c1nn(CC(=O)N2C[C@](C)(F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-15(37)25-19-9-17(18-11-30-16(2)31-12-18)7-8-20(19)36(34-25)13-24(38)35-14-27(3,29)10-21(35)26(39)33-23-6-4-5-22(28)32-23/h4-9,11-12,21H,10,13-14H2,1-3H3,(H,32,33,39)/t21-,27+/m0/s1	VJUVJSOISNLSLZ-KDYSTLNUSA-N	472142	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-fluoro-4- methylpyrrolidine- 2-carboxamide::US10822352, Comp No. 418	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472142&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623297	441611135							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976664	COC[C@@]1(F)C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C28H27BrFN7O4/c1-16(38)26-20-9-18(19-11-31-17(2)32-12-19)7-8-21(20)37(35-26)13-25(39)36-14-28(30,15-41-3)10-22(36)27(40)34-24-6-4-5-23(29)33-24/h4-9,11-12,22H,10,13-15H2,1-3H3,(H,33,34,40)/t22-,28+/m0/s1	ZWASDVZIUVHKKO-RBISFHTESA-N	386484	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoro-4- (methoxymethyl) pyrrolidine-2- carboxamide::US10287301, Compound 419::US10822352, Comp No. 419	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386484&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622905	404855635							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976665	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nn(CC(F)(F)F)cc2Br)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrF4N8O3/c1-13(40)23-18-5-15(16-7-32-14(2)33-8-16)3-4-20(18)39(35-23)11-22(41)38-9-17(28)6-21(38)25(42)34-24-19(27)10-37(36-24)12-26(29,30)31/h3-5,7-8,10,17,21H,6,9,11-12H2,1-2H3,(H,34,36,42)/t17-,21+/m1/s1	HJRVVGONDYTKGG-UTKZUKDTSA-N	386485	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(4- bromo-1-(2,2,2- trifluoroethyl)- 1H-pyrazol-3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 420::US10822352, Comp No. 420	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386485&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623498	404855636							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976666	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-14-4-7-24(29)32-27(14)33-28(39)23-10-18-9-22(18)36(23)25(38)13-35-21-6-5-17(19-11-30-16(3)31-12-19)8-20(21)26(34-35)15(2)37/h4-8,11-12,18,22-23H,9-10,13H2,1-3H3,(H,32,33,39)/t18-,22-,23+/m1/s1	YTXAKBLMVGVLGM-YSZBQJHXSA-N	386486	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 421::US10822352, Comp No. 421	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386486&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643152	404855637							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976667	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nn(CC(F)(F)F)cc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26F4N8O3/c1-14-10-37(13-27(29,30)31)36-25(14)34-26(42)22-7-19(28)11-38(22)23(41)12-39-21-5-4-17(18-8-32-16(3)33-9-18)6-20(21)24(35-39)15(2)40/h4-6,8-10,19,22H,7,11-13H2,1-3H3,(H,34,36,42)/t19-,22+/m1/s1	RPTXGVUPWGFDAS-KNQAVFIVSA-N	386487	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(4- methyl-1-(2,2,2- trifluoroethyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 422::US10822352, Comp No. 422	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386487&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623029	404855638							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976668	CNC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN8O3/c1-14-30-10-16(11-31-14)15-6-7-19-18(8-15)24(26(39)29-2)34-36(19)13-23(37)35-12-17(28)9-20(35)25(38)33-22-5-3-4-21(27)32-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,29,39)(H,32,33,38)/t17-,20+/m1/s1	OPVIUMBDCCYXNF-XLIONFOSSA-N	386488	1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- N-methyl-5-(2- methylpyrimidin- 5-yl)-1H- indazole-3- carboxamide::US10287301, Compound 424::US10822352, Comp No. 424	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386488&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643008	404855639							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976669	C[C@H](O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,14,18,21,36H,9,12-13H2,1-2H3,(H,31,32,38)/t14-,18+,21-/m0/s1	AQGKBCYKVYEJRB-HLLQZAQXSA-N	386489	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-((S)-1- hydroxyethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US10287301, Compound 425::US10822352, Comp No. 425	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386489&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623306	404855640							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976670	C[C@@H](O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,14,18,21,36H,9,12-13H2,1-2H3,(H,31,32,38)/t14-,18-,21+/m1/s1	AQGKBCYKVYEJRB-IQVOZAENSA-N	386490	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-((R)-1- hydroxyethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US10287301, Compound 426::US10822352, Comp No. 426	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386490&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623418	404855641							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976671	CC(=O)c1nn(CC(=O)N2C[C@H](F)[C@@H](N)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN8O3/c1-13(37)24-17-8-15(16-9-30-14(2)31-10-16)6-7-19(17)36(34-24)12-22(38)35-11-18(28)23(29)25(35)26(39)33-21-5-3-4-20(27)32-21/h3-10,18,23,25H,11-12,29H2,1-2H3,(H,32,33,39)/t18-,23+,25-/m0/s1	LUUVBLWJMDXOST-UODBTFMRSA-N	386491	(2S,3S,4S)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-3- amino-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 427::US10822352, Comp No. 427	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386491&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643237	404855642							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976672	CC(=O)c1nn(CC(=O)N2C[C@@H](N)[C@H](F)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrFN8O3/c1-13(37)24-17-8-15(16-9-30-14(2)31-10-16)6-7-19(17)36(34-24)12-22(38)35-11-18(29)23(28)25(35)26(39)33-21-5-3-4-20(27)32-21/h3-10,18,23,25H,11-12,29H2,1-2H3,(H,32,33,39)/t18-,23+,25+/m1/s1	KCZKWPFVRRPESF-DPQOWFAMSA-N	386492	(2R,3S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- amino-N-(6- bromopyridin-2- yl)-3- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 428::US10822352, Comp No. 428	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386492&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643141	404855643							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976673	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)n(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26F4N8O3/c1-14-6-23(35-39(14)13-27(29,30)31)34-26(42)22-8-19(28)11-37(22)24(41)12-38-21-5-4-17(18-9-32-16(3)33-10-18)7-20(21)25(36-38)15(2)40/h4-7,9-10,19,22H,8,11-13H2,1-3H3,(H,34,35,42)/t19-,22+/m1/s1	MFCHVUWQBVDMHW-KNQAVFIVSA-N	386493	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(5- methyl-1-(2,2,2- trifluoroethyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 429::US10822352, Comp No. 429	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386493&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623364	404855644							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976674	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nn(CC(F)(F)F)cc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23ClF4N8O3/c1-13(40)23-18-5-15(16-7-32-14(2)33-8-16)3-4-20(18)39(35-23)11-22(41)38-9-17(28)6-21(38)25(42)34-24-19(27)10-37(36-24)12-26(29,30)31/h3-5,7-8,10,17,21H,6,9,11-12H2,1-2H3,(H,34,36,42)/t17-,21+/m1/s1	JVLZVAYDVFMONK-UTKZUKDTSA-N	386494	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(4- chloro-1-(2,2,2- trifluoroethyl)- 1H-pyrazol-3-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 430::US10822352, Comp No. 430	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386494&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623162	404855645							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976675	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(OC)nc2)c1	InChI=1S/C27H25BrFN7O5/c1-14(37)25-19-6-15(16-10-30-27(41-3)31-11-16)4-5-20(19)36(34-25)13-24(38)35-12-17(29)7-21(35)26(39)33-23-9-18(40-2)8-22(28)32-23/h4-6,8-11,17,21H,7,12-13H2,1-3H3,(H,32,33,39)/t17-,21+/m1/s1	NPVQAMPHNHTVJT-UTKZUKDTSA-N	386495	(2S,4R)-1-(2-(3- acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-4- methoxypyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 431::US10822352, Comp No. 431	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386495&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623034	404855646							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976676	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(N)nc2)c1	InChI=1S/C26H24BrFN8O4/c1-13(37)24-18-5-14(15-9-30-26(29)31-10-15)3-4-19(18)36(34-24)12-23(38)35-11-16(28)6-20(35)25(39)33-22-8-17(40-2)7-21(27)32-22/h3-5,7-10,16,20H,6,11-12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t16-,20+/m1/s1	IIYFYFZXYCEGJH-UZLBHIALSA-N	386496	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- methoxypyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 432::US10822352, Comp No. 432	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386496&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643164	404855647							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976677	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(OC)nc2)c1	InChI=1S/C28H26BrN7O5/c1-14(37)26-19-6-15(17-11-30-28(41-3)31-12-17)4-5-20(19)35(34-26)13-25(38)36-21-7-16(21)8-22(36)27(39)33-24-10-18(40-2)9-23(29)32-24/h4-6,9-12,16,21-22H,7-8,13H2,1-3H3,(H,32,33,39)/t16-,21-,22+/m1/s1	LGJSEJUZURQABA-HVETUWLQSA-N	386497	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-4- methoxypyridin- 2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 433::US10822352, Comp No. 433	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386497&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642796	404855648							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976678	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(N)nc2)c1	InChI=1S/C27H25BrN8O4/c1-13(37)25-18-5-14(16-10-30-27(29)31-11-16)3-4-19(18)35(34-25)12-24(38)36-20-6-15(20)7-21(36)26(39)33-23-9-17(40-2)8-22(28)32-23/h3-5,8-11,15,20-21H,6-7,12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t15-,20-,21+/m1/s1	CWGTXTPGFTUIGQ-LPTQZCDUSA-N	386498	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- methoxypyridin- 2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 434::US10822352, Comp No. 434	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386498&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642831	404855649							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976679	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H24BrFN8O3/c1-13-3-6-21(27)32-24(13)33-25(39)20-8-17(28)11-35(20)22(38)12-36-19-5-4-15(16-9-30-26(29)31-10-16)7-18(19)23(34-36)14(2)37/h3-7,9-10,17,20H,8,11-12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t17-,20+/m1/s1	XCWPZWHOWUREMG-XLIONFOSSA-N	386499	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 435::US10822352, Comp No. 435::US11407738, Example 00349	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386499&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642917	404855650							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976680	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccn(CCC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26F4N8O3/c1-15(40)25-20-9-17(18-11-32-16(2)33-12-18)3-4-21(20)39(36-25)14-24(41)38-13-19(28)10-22(38)26(42)34-23-5-7-37(35-23)8-6-27(29,30)31/h3-5,7,9,11-12,19,22H,6,8,10,13-14H2,1-2H3,(H,34,35,42)/t19-,22+/m1/s1	JOKOGWUYYDXNND-KNQAVFIVSA-N	386501	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- (3,3,3- trifluoropropyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 437::US10822352, Comp No. 437	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386501&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623146	404855652							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976681	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(F)ncc2Br)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrF2N7O3/c1-13(37)25-18-5-15(16-8-30-14(2)31-9-16)3-4-21(18)36(34-25)12-24(38)35-11-17(28)6-22(35)26(39)33-20-7-23(29)32-10-19(20)27/h3-5,7-10,17,22H,6,11-12H2,1-2H3,(H,32,33,39)/t17-,22+/m1/s1	YCQWWQWCJGTEFO-VGSWGCGISA-N	386502	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(5- bromo-2- fluoropyridin-4- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 438::US10822352, Comp No. 438	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386502&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623009	404855653							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976682	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nn(C)c3ncccc23)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26FN9O3/c1-15(39)25-21-9-17(18-11-31-16(2)32-12-18)6-7-22(21)38(34-25)14-24(40)37-13-19(29)10-23(37)28(41)33-26-20-5-4-8-30-27(20)36(3)35-26/h4-9,11-12,19,23H,10,13-14H2,1-3H3,(H,33,35,41)/t19-,23+/m1/s1	NXKKBEOWKZZMIA-XXBNENTESA-N	386503	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- methyl-1H- pyrazolo[3,4- b]pyridin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 439::US10822352, Comp No. 439	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386503&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622866	404855654							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976683	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(=O)CO)c2c1	InChI=1S/C26H23BrFN7O4/c1-14-29-9-16(10-30-14)15-5-6-19-18(7-15)25(21(37)13-36)33-35(19)12-24(38)34-11-17(28)8-20(34)26(39)32-23-4-2-3-22(27)31-23/h2-7,9-10,17,20,36H,8,11-13H2,1H3,(H,31,32,39)/t17-,20+/m1/s1	MHJCCRWGRPCGCO-XLIONFOSSA-N	386504	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-(2- hydroxyacetyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US10287301, Compound 440::US10822352, Comp No. 440	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386504&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623438	404855655							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976684	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28FN5O3/c1-18(36)25-16-34(26-9-8-21(10-24(25)26)22-13-31-19(2)32-14-22)17-28(37)35-15-23(30)11-27(35)29(38)33-12-20-6-4-3-5-7-20/h3-10,13-14,16,23,27H,11-12,15,17H2,1-2H3,(H,33,38)/t23-,27+/m1/s1	QLCRXBFRGQSWPR-KCWPFWIISA-N	386505	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N- benzyl-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 442::US10822352, Comp No. 442	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386505&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623133	404855656							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976685	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCc2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30FN5O3/c1-19(37)26-17-35(27-9-8-22(12-25(26)27)23-14-33-20(2)34-15-23)18-29(38)36-16-24(31)13-28(36)30(39)32-11-10-21-6-4-3-5-7-21/h3-9,12,14-15,17,24,28H,10-11,13,16,18H2,1-2H3,(H,32,39)/t24-,28+/m1/s1	JANKFGFOAWVPLY-YWEHKCAJSA-N	386506	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-4- fluoro-N- phenethylpyrrolidine- 2-carboxamide::US10287301, Compound 443::US10822352, Comp No. 443	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386506&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642937	404855657							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976686	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCc2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H32FN5O3/c1-20(38)27-18-36(28-11-10-23(13-26(27)28)24-15-34-21(2)35-16-24)19-30(39)37-17-25(32)14-29(37)31(40)33-12-6-9-22-7-4-3-5-8-22/h3-5,7-8,10-11,13,15-16,18,25,29H,6,9,12,14,17,19H2,1-2H3,(H,33,40)/t25-,29+/m1/s1	VEURRMODINSUPY-IRPSRAIASA-N	386507	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-4- fluoro-N-(3- phenylpropyl) pyrrolidine-2- carboxamide::US10287301, Compound 444::US10822352, Comp No. 444	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386507&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643143	404855658							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976687	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C28H26BrN7O4/c1-14-4-7-23(29)32-26(14)33-27(39)22-10-17-9-21(17)36(22)24(38)13-35-20-6-5-16(8-19(20)25(34-35)15(2)37)18-11-30-28(40-3)31-12-18/h4-8,11-12,17,21-22H,9-10,13H2,1-3H3,(H,32,33,39)/t17-,21-,22+/m1/s1	RVQNQALYGPOMSB-YHYVQYDKSA-N	386508	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 445::US10822352, Comp No. 445	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386508&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642870	404855659							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976688	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C27H25BrN8O3/c1-13-3-6-22(28)32-25(13)33-26(39)21-9-16-8-20(16)36(21)23(38)12-35-19-5-4-15(17-10-30-27(29)31-11-17)7-18(19)24(34-35)14(2)37/h3-7,10-11,16,20-21H,8-9,12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t16-,20-,21+/m1/s1	VQNCNQHEUTXULZ-HBGVWJBISA-N	386509	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 446::US10822352, Comp No. 446	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386509&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643313	404855660							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976689	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2ccc(F)c(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23BrFN7O3/c1-13(37)25-18-7-15(17-10-30-14(2)31-11-17)3-5-20(18)35(34-25)12-24(38)36-21-8-16(21)9-22(36)27(39)33-23-6-4-19(29)26(28)32-23/h3-7,10-11,16,21-22H,8-9,12H2,1-2H3,(H,32,33,39)/t16-,21-,22+/m1/s1	FTMVESFQOXZSMC-HVETUWLQSA-N	386510	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 447::US10822352, Comp No. 447	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386510&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643002	404855661							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976690	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)cs2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C24H21BrFN7O3S/c1-12(34)22-17-5-14(15-7-27-13(2)28-8-15)3-4-18(17)33(31-22)10-21(35)32-9-16(26)6-19(32)23(36)30-24-29-20(25)11-37-24/h3-5,7-8,11,16,19H,6,9-10H2,1-2H3,(H,29,30,36)/t16-,19+/m1/s1	JJDPJDAXTKFPBQ-APWZRJJASA-N	386511	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(4- bromothiazol-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 448::US10822352, Comp No. 448	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386511&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623678	404855662							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976691	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)c(C)s2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H23BrFN7O3S/c1-12(35)22-18-6-15(16-8-28-14(3)29-9-16)4-5-19(18)34(32-22)11-21(36)33-10-17(27)7-20(33)24(37)31-25-30-23(26)13(2)38-25/h4-6,8-9,17,20H,7,10-11H2,1-3H3,(H,30,31,37)/t17-,20+/m1/s1	QEPRHLRLELDENR-XLIONFOSSA-N	386512	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(4- bromo-5- methylthiazol-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 449::US10822352, Comp No. 449	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386512&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622982	404855663							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976692	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3ccc(F)c(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H22BrF2N7O4/c1-13(37)23-17-7-14(15-9-30-26(40-2)31-10-15)3-5-19(17)36(34-23)12-22(38)35-11-16(28)8-20(35)25(39)33-21-6-4-18(29)24(27)32-21/h3-7,9-10,16,20H,8,11-12H2,1-2H3,(H,32,33,39)/t16-,20+/m1/s1	MRKQCMRHFCTQFY-UZLBHIALSA-N	386513	(2S,4R)-1-(2-(3- acetyl-5-(2- methoxypyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 450::US10822352, Comp No. 450	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386513&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643135	404855664							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976693	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C25H21BrF2N8O3/c1-12(37)22-16-6-13(14-8-30-25(29)31-9-14)2-4-18(16)36(34-22)11-21(38)35-10-15(27)7-19(35)24(39)33-20-5-3-17(28)23(26)32-20/h2-6,8-9,15,19H,7,10-11H2,1H3,(H2,29,30,31)(H,32,33,39)/t15-,19+/m1/s1	CCWBSBYDKLZNGL-BEFAXECRSA-N	386514	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 451::US10822352, Comp No. 451	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386514&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642941	404855665							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976694	CC(=O)O[C@@H]1[C@@H](F)CN([C@@H]1C(=O)Nc1cccc(Br)n1)C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C29H26BrFN6O5/c1-15(38)21-12-36(23-8-7-18(9-20(21)23)19-10-32-16(2)33-11-19)14-26(40)37-13-22(31)28(42-17(3)39)27(37)29(41)35-25-6-4-5-24(30)34-25/h4-12,22,27-28H,13-14H2,1-3H3,(H,34,35,41)/t22-,27-,28+/m0/s1	JNOKUJUMTAUUOQ-QLCOJLISSA-N	472181	(2S,3S,4S)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 3-yl acetate::US10822352, Comp No. 452	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472181&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313778	441611171							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976695	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H25ClFN7O3S/c1-16(40)28-22-9-18(19-11-33-17(2)34-12-19)7-8-25(22)39(37-28)14-27(41)38-13-20(32)10-26(38)29(42)36-30-35-24(15-43-30)21-5-3-4-6-23(21)31/h3-9,11-12,15,20,26H,10,13-14H2,1-2H3,(H,35,36,42)/t20-,26+/m1/s1	SDNIACYBIOGSFL-IBVKSMDESA-N	472182	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(4- (2-chlorophenyl) thiazol-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 453	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472182&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643122	441611172							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976696	CC(=O)c1nn(CC(=O)N2C3CC3(CN)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27BrN8O3/c1-15(38)26-19-8-17(18-11-31-16(2)32-12-18)6-7-20(19)36(35-26)13-25(39)37-21(9-28(14-30)10-22(28)37)27(40)34-24-5-3-4-23(29)33-24/h3-8,11-12,21-22H,9-10,13-14,30H2,1-2H3,(H,33,34,40)/t21-,22?,28?/m0/s1	LIYPBHJKNHFRTR-MVHBVBLISA-N	386517	(3S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-5- (aminomethyl)-N- (6-bromopyridin- 2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 454::US10822352, Comp No. 454	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386517&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623424	404855668							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976697	Cc1cccc(NC(O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C26H27FN8O3/c1-14-4-3-5-22(31-14)32-26(38)21-9-18(27)12-34(21)23(36)13-35-20-7-6-16(17-10-29-15(2)30-11-17)8-19(20)24(33-35)25(28)37/h3-8,10-11,18,21,26,38H,9,12-13H2,1-2H3,(H2,28,37)(H,31,32)/t18-,21+,26?/m1/s1	AISWISPMVFFYMS-YIRICJMVSA-N	472184	1-(2-((2S,4R)-4- fluoro-2-((S)-1- hydroxy-2-(6- methylpyridin-2- yl)ethyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (2-methylpyrimidin- 5-yl)-1H-indole- 3-carboxamide::US10822352, Comp No. 455	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472184&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314015	441611174							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976698	CC(F)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrF2N7O2/c1-14(28)25-19-8-16(17-10-30-15(2)31-11-17)6-7-20(19)36(34-25)13-24(37)35-12-18(29)9-21(35)26(38)33-23-5-3-4-22(27)32-23/h3-8,10-11,14,18,21H,9,12-13H2,1-2H3,(H,32,33,38)/t14?,18-,21+/m1/s1	ZKYRXYKTRUPTJR-VXOHXDMYSA-N	386519	(2S,4R)-N-(6- bromopyridin-2- yl)-4-fluoro-1-(2- (3-(1- fluoroethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl) pyrrolidine- 2-carboxamide::US10287301, Compound 456::US10822352, Comp No. 456	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386519&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642894	404855670							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976699	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3ccc(F)c(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C27H23BrFN7O4/c1-13(37)24-17-7-14(16-10-30-27(40-2)31-11-16)3-5-19(17)35(34-24)12-23(38)36-20-8-15(20)9-21(36)26(39)33-22-6-4-18(29)25(28)32-22/h3-7,10-11,15,20-21H,8-9,12H2,1-2H3,(H,32,33,39)/t15-,20-,21+/m1/s1	YEYUUQTXGPTOIG-LPTQZCDUSA-N	386520	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 457::US10822352, Comp No. 457	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386520&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643258	404855671							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976700	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2ccc(F)c(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H22BrFN8O3/c1-12(37)23-16-6-13(15-9-30-26(29)31-10-15)2-4-18(16)35(34-23)11-22(38)36-19-7-14(19)8-20(36)25(39)33-21-5-3-17(28)24(27)32-21/h2-6,9-10,14,19-20H,7-8,11H2,1H3,(H2,29,30,31)(H,32,33,39)/t14-,19-,20+/m1/s1	BRZRWGUZXHWKKF-XMCHAPAWSA-N	386521	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5- fluoropyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 458::US10822352, Comp No. 458	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386521&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643200	404855672							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976701	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCC2CC2(Cl)Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H25Cl2FN6O3/c1-13(35)23-19-5-15(16-8-29-14(2)30-9-16)3-4-20(19)34(32-23)12-22(36)33-11-18(28)6-21(33)24(37)31-10-17-7-25(17,26)27/h3-5,8-9,17-18,21H,6-7,10-12H2,1-2H3,(H,31,37)/t17?,18-,21+/m1/s1	CQIRODLWZPPMDD-MBSQGRNLSA-N	386522	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((2,2- dichlorocyclopropyl) methyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 459::US10822352, Comp No. 459	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386522&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643458	404855673							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976702	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2C[C@H]2c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28ClFN6O3/c1-16(39)29-23-9-18(19-12-33-17(2)34-13-19)7-8-26(23)38(36-29)15-28(40)37-14-20(32)10-27(37)30(41)35-25-11-22(25)21-5-3-4-6-24(21)31/h3-9,12-13,20,22,25,27H,10-11,14-15H2,1-2H3,(H,35,41)/t20-,22+,25?,27+/m1/s1	RNWUHHQKMWBDQW-XDVZKYIHSA-N	386523	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((2S)-2-(2- chlorophenyl) cyclopropyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 460::US10822352, Comp No. 460	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386523&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642828	404855674							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976703	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCCc2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34FN5O3/c1-21(39)28-19-37(29-12-11-24(14-27(28)29)25-16-35-22(2)36-17-25)20-31(40)38-18-26(33)15-30(38)32(41)34-13-7-6-10-23-8-4-3-5-9-23/h3-5,8-9,11-12,14,16-17,19,26,30H,6-7,10,13,15,18,20H2,1-2H3,(H,34,41)/t26-,30+/m1/s1	FZRCTNHVQICDCI-VIZCGCQYSA-N	386524	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-4- fluoro-N-(4- phenylbutyl) pyrrolidine-2- carboxamide::US10287301, Compound 461::US10822352, Comp No. 461	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386524&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642782	404855675							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976704	CC(=O)c1nn(CC(=O)N2CC3CC2(C3)C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrN7O3/c1-15(36)25-20-8-18(19-11-29-16(2)30-12-19)6-7-21(20)35(33-25)14-24(37)34-13-17-9-27(34,10-17)26(38)32-23-5-3-4-22(28)31-23/h3-8,11-12,17H,9-10,13-14H2,1-2H3,(H,31,32,38)	PLLVXWABLZKMGJ-UHFFFAOYSA-N	386525	2-(2-(3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[2.1.1] hexane-1- carboxamide::US10287301, Compound 462::US10822352, Comp No. 462	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386525&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642839	404855676							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976705	CCn1ccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C26H27FN8O3/c1-4-33-8-7-23(31-33)30-26(38)22-10-19(27)13-34(22)24(37)14-35-21-6-5-17(18-11-28-16(3)29-12-18)9-20(21)25(32-35)15(2)36/h5-9,11-12,19,22H,4,10,13-14H2,1-3H3,(H,30,31,38)/t19-,22+/m1/s1	CLUBHSYXODFBAB-KNQAVFIVSA-N	386526	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(1- ethyl-1H-pyrazol- 3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 463::US10822352, Comp No. 463	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386526&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622857	404855677							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976706	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCC(C)(C)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H35FN6O3/c1-17(37)27-23-10-19(20-13-31-18(2)32-14-20)7-8-24(23)36(34-27)16-26(38)35-15-21(30)11-25(35)28(39)33-22-6-5-9-29(3,4)12-22/h7-8,10,13-14,21-22,25H,5-6,9,11-12,15-16H2,1-4H3,(H,33,39)/t21-,22?,25+/m1/s1	IGSCSZDWHSKWTB-IYRGYZHQSA-N	386527	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (3,3- dimethylcyclohexyl)- 4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 464::US10822352, Comp No. 464	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386527&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643530	404855678							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976707	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)cn1	InChI=1S/C26H23BrFN7O3/c1-14-10-30-19(11-29-14)16-6-7-20-18(8-16)25(15(2)36)33-35(20)13-24(37)34-12-17(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,17,21H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,21+/m1/s1	XASRGXDDJQPQPF-UTKZUKDTSA-N	386528	(2S,4R)-1-(2-(3- acetyl-5-(5- methylpyrazin-2- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 465::US10822352, Comp No. 465	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386528&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643231	404855679							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976708	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)cn1	InChI=1S/C27H25BrFN7O3/c1-14-4-7-23(28)32-26(14)33-27(39)22-9-18(29)12-35(22)24(38)13-36-21-6-5-17(20-11-30-15(2)10-31-20)8-19(21)25(34-36)16(3)37/h4-8,10-11,18,22H,9,12-13H2,1-3H3,(H,32,33,39)/t18-,22+/m1/s1	LWSZJAMDVLQHEL-GCJKJVERSA-N	386529	(2S,4R)-1-(2-(3- acetyl-5-(5- methylpyrazin-2- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 467::US10822352, Comp No. 467	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386529&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623382	404855680							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976709	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1ccnc(C)n1	InChI=1S/C27H25BrFN7O3/c1-14-4-7-23(28)32-26(14)33-27(39)22-11-18(29)12-35(22)24(38)13-36-21-6-5-17(20-8-9-30-16(3)31-20)10-19(21)25(34-36)15(2)37/h4-10,18,22H,11-13H2,1-3H3,(H,32,33,39)/t18-,22+/m1/s1	HUEQXBGIZIEFTB-GCJKJVERSA-N	386530	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 4-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 468::US10822352, Comp No. 468	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386530&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643445	404855681							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976710	CC(=O)n1cc(CC(=O)C2C[C@H](F)C[C@H]2c2nc(c[nH]2)-c2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1			472197	2-(3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)-1-((2S,4R)- 2-(4-(6- bromopyridin-2- yl)-1H-imidazol- 2-yl)-4- fluoropyrrolidin- 1-yl)ethan-1-one::US10822352, Comp No. 469	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472197&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314383	441611187							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976711	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22BrClFN7O3/c1-13(37)24-18-7-15(16-9-30-14(2)31-10-16)3-5-20(18)36(34-24)12-23(38)35-11-17(29)8-21(35)26(39)33-25-19(28)4-6-22(27)32-25/h3-7,9-10,17,21H,8,11-12H2,1-2H3,(H,32,33,39)/t17-,21+/m1/s1	BSFSLZYYPPTBJZ-UTKZUKDTSA-N	386532	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- chloropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 472::US10822352, Comp No. 472	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386532&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623229	404855683							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976712	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C29H29N7O3/c1-16-4-3-5-25(33-16)34-29(39)27-19-6-8-21(10-19)36(27)26(37)15-35-14-23(28(30)38)22-11-18(7-9-24(22)35)20-12-31-17(2)32-13-20/h3-5,7,9,11-14,19,21,27H,6,8,10,15H2,1-2H3,(H2,30,38)(H,33,34,39)/t19?,21?,27-/m0/s1	RPKPXWJIQAZXHD-GASOQUEOSA-N	386533	1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5-(2- methylpyrimidin- 5-yl)-1H-indole- 3-carboxamide::US10287301, Compound 473::US10822352, Comp No. 473	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386533&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653849	404855684							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976713	CC(C)=C(F)CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C26H28F2N6O3/c1-14(2)21(28)11-31-26(37)23-8-19(27)12-33(23)24(36)13-34-22-6-5-17(18-9-29-16(4)30-10-18)7-20(22)25(32-34)15(3)35/h5-7,9-10,19,23H,8,11-13H2,1-4H3,(H,31,37)/t19-,23+/m1/s1	QMXAYJXMGFTFFW-XXBNENTESA-N	386534	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(2- fluoro-3- methylbut-2-en-1- yl)pyrrolidine-2- carboxamide::US10287301, Compound 474::US10822352, Comp No. 474	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386534&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643176	404855685							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976714	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C4CCC(C4)[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(N)=O)c2c1	InChI=1S/C28H26BrN7O3/c1-15-31-11-18(12-32-15)16-6-8-22-20(10-16)21(27(30)38)13-35(22)14-25(37)36-19-7-5-17(9-19)26(36)28(39)34-24-4-2-3-23(29)33-24/h2-4,6,8,10-13,17,19,26H,5,7,9,14H2,1H3,(H2,30,38)(H,33,34,39)/t17?,19?,26-/m0/s1	JWVFIKFDHZDELF-QVTSAQFISA-N	472201	(35,45)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2-azabicyclo[2.2.1] heptane-3-carboxamide::US10822352, Comp No. 475	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472201&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698585	441611191							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976715	CC(=O)c1nn(CC(=O)N2C[C@H](F)CC2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21?/m1/s1	PIBARDGJJAGJAJ-ITUIMRKVSA-N	386536	(2R,4S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 1-carboxamide::US10287301, Compound 476::US10287301, Compound 477::US10822352, Comp No. 476	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386536&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			138626523	404855687							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976716	CC(=O)c1cn(CC(=O)N2C[C@H](F)CC2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)18-10-30-16(2)31-11-18)14-26(37)35-12-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,32,33,38)/t19-,23?/m1/s1	HJOQHGVZGIOBFX-HWYAHNCWSA-N	472203	(25,45)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoropyrrolidine- 1-carboxamide::US10822352, Comp No. 477	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472203&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			124130774	441611193							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976717	CC(=O)c1cn(CC(=O)N2C[C@H]3C[C@H]3C2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25BrN6O3/c1-15(36)22-13-34(23-7-6-17(8-21(22)23)19-10-30-16(2)31-11-19)14-26(37)35-12-18-9-20(18)27(35)28(38)33-25-5-3-4-24(29)32-25/h3-8,10-11,13,18,20,27H,9,12,14H2,1-2H3,(H,32,33,38)/t18-,20-,27?/m1/s1	UTIUFZRKFDNHGI-OHIRTLJUSA-N	472204	(1R,3S,5R)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2-azabicyclo[3.1.0] hexane-2-carboxamide::US10822352, Comp No. 478	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472204&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698577	441611194							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976718	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccn(n2)-c2ccc(F)cn2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H25F2N9O3/c1-16(41)28-22-9-18(19-11-32-17(2)33-12-19)3-5-23(22)40(37-28)15-27(42)38-14-21(31)10-24(38)29(43)35-25-7-8-39(36-25)26-6-4-20(30)13-34-26/h3-9,11-13,21,24H,10,14-15H2,1-2H3,(H,35,36,43)/t21-,24+/m1/s1	WVDBOQMRFMAEFM-QPPBQGQZSA-N	386539	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1-(5- fluoropyridin-2- yl)-1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 479::US10822352, Comp No. 479	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386539&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623134	404855689							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976719	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C28H26BrN7O3/c1-15(37)19-13-35(20-7-6-16(8-18(19)20)17-11-31-27(30)32-12-17)14-25(38)36-21(9-28(2)10-22(28)36)26(39)34-24-5-3-4-23(29)33-24/h3-8,11-13,21-22H,9-10,14H2,1-2H3,(H2,30,31,32)(H,33,34,39)/t21-,22+,28-/m0/s1	WNBWLLIYFHEIMA-TYPXCFOJSA-N	472206	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 480	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472206&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314169	441611196							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976720	CC(=O)c1cn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26N6O3/c1-16-5-4-6-25(30-16)31-27(36)24-9-10-33(24)26(35)15-32-14-22(17(2)34)21-11-19(7-8-23(21)32)20-12-28-18(3)29-13-20/h4-8,11-14,24H,9-10,15H2,1-3H3,(H,30,31,36)/t24-/m0/s1	MKBLSXFVANNAFC-DEOSSOPVSA-N	386541	(S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 481::US10822352, Comp No. 481	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386541&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643276	404855691							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976721	CC(C)=C(F)CNC(=O)[C@@H]1C[C@H]2C[C@H]2N1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H30FN5O3/c1-15(2)23(29)12-32-28(37)26-9-19-8-25(19)34(26)27(36)14-33-13-22(16(3)35)21-7-18(5-6-24(21)33)20-10-30-17(4)31-11-20/h5-7,10-11,13,19,25-26H,8-9,12,14H2,1-4H3,(H,32,37)/t19-,25-,26+/m1/s1	PKPUFFUEXZGROQ-BAEUJYSMSA-N	472208	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(2- fluoro-3- methylbut-2-en-1- yl)-2-azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 482	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472208&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139310386	441611198							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976722	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-15(37)26-21-8-17(18-10-30-16(2)31-11-18)6-7-22(21)36(34-26)14-25(38)35-13-19(29)9-23(35)27(39)32-12-20-4-3-5-24(28)33-20/h3-8,10-11,19,23H,9,12-14H2,1-2H3,(H,32,39)/t19-,23+/m1/s1	GTLOMXKAYMVTJN-XXBNENTESA-N	472209	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((6-bromopyridin- 2-yl)methyl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 483	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472209&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623332	441611199							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976723	COc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2cc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C30H29BrN6O4/c1-16(38)22-14-36(23-6-5-18(7-21(22)23)19-12-32-17(2)33-13-19)15-28(39)37-24(10-30(3)11-25(30)37)29(40)35-27-9-20(41-4)8-26(31)34-27/h5-9,12-14,24-25H,10-11,15H2,1-4H3,(H,34,35,40)/t24-,25+,30-/m0/s1	DLMKAUPECOTQEJ-FVXXUCQHSA-N	472210	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-4- methoxypyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 484	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472210&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126670854	441611200							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976724	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23+,29-/m0/s1	OCXAGXCMZACNEC-CTWZREHQSA-N	386545	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 485::US10822352, Comp No. 485::US11084800, Cpd No. 279	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386545&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642840	404855695							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976725	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3cncc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C27H25BrN8O4/c1-14(37)24-17-6-15(16-9-30-26(40-3)31-10-16)4-5-18(17)35(34-24)13-23(38)36-19(7-27(2)8-20(27)36)25(39)33-22-12-29-11-21(28)32-22/h4-6,9-12,19-20H,7-8,13H2,1-3H3,(H,32,33,39)/t19-,20+,27-/m0/s1	XHJKGOUUDRKKOE-VKIDHGPPSA-N	386546	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 486::US10822352, Comp No. 486	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386546&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642846	404855696							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976726	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-14-4-7-23(29)32-27(14)33-28(39)26-20-9-18(20)12-35(26)24(38)13-36-22-6-5-17(19-10-30-16(3)31-11-19)8-21(22)25(34-36)15(2)37/h4-8,10-11,18,20,26H,9,12-13H2,1-3H3,(H,32,33,39)/t18-,20-,26+/m1/s1	XWMKYPOTZXCMAH-DZTNWFRXSA-N	386547	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 488::US10287301, Compound 652::US10822352, Comp No. 488	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386547&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643297	404855697							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976727	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3ccccc3c2)n1	InChI=1S/C34H31N5O3/c1-20-5-4-8-30(36-20)37-34(42)32-25-11-13-26(16-25)39(32)31(40)19-38-18-28(33(35)41)27-17-24(12-14-29(27)38)23-10-9-21-6-2-3-7-22(21)15-23/h2-10,12,14-15,17-18,25-26,32H,11,13,16,19H2,1H3,(H2,35,41)(H,36,37,42)/t25?,26?,32-/m0/s1	LGKCAYFZEQMHIJ-FFJARJNZSA-N	386548	1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5- (naphthalen-2-yl)- 1H-indole-3- carboxamide::US10287301, Compound 489::US10822352, Comp No. 489	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386548&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654078	404855698							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976728	Cc1ccc(cn1)-c1ccc2n(CC(=O)N3C4CCC(C4)[C@H]3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H30N6O3/c1-17-6-7-21(14-32-17)19-9-11-25-23(13-19)24(29(31)38)15-35(25)16-27(37)36-22-10-8-20(12-22)28(36)30(39)34-26-5-3-4-18(2)33-26/h3-7,9,11,13-15,20,22,28H,8,10,12,16H2,1-2H3,(H2,31,38)(H,33,34,39)/t20?,22?,28-/m0/s1	RZJNWQXKMBADPW-FEPYILBSSA-N	386549	1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5-(6- methylpyridin-3- yl)-1H-indole-3- carboxamide::US10287301, Compound 490::US10287301, Compound 500::US10822352, Comp No. 490	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386549&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653854	404855699							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976729	CC(=O)c1nn(CC(=O)N2C3CCC(C3)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-15(37)26-21-11-17(19-12-30-16(2)31-13-19)7-9-22(21)35(34-26)14-25(38)36-20-8-6-18(10-20)27(36)28(39)33-24-5-3-4-23(29)32-24/h3-5,7,9,11-13,18,20,27H,6,8,10,14H2,1-2H3,(H,32,33,39)/t18?,20?,27-/m0/s1	WMAUWVANJOKKMS-KBVTYMBASA-N	386535	(3S,4S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[2.2.1] heptane-3- carboxamide::US10287301, Compound 475::US10822352, Comp No. 734	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386535&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654077	404855686							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976730	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC[C@H]2CC2(Cl)Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H25Cl2FN6O3/c1-13(35)23-19-5-15(16-8-29-14(2)30-9-16)3-4-20(19)34(32-23)12-22(36)33-11-18(28)6-21(33)24(37)31-10-17-7-25(17,26)27/h3-5,8-9,17-18,21H,6-7,10-12H2,1-2H3,(H,31,37)/t17-,18-,21+/m1/s1	CQIRODLWZPPMDD-OPYAIIAOSA-N	386551	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (((R)-2,2- dichlorocyclopropyl) methyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 494::US10822352, Comp No. 494	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386551&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643223	404855701							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976731	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC[C@@H]2CC2(Cl)Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H25Cl2FN6O3/c1-13(35)23-19-5-15(16-8-29-14(2)30-9-16)3-4-20(19)34(32-23)12-22(36)33-11-18(28)6-21(33)24(37)31-10-17-7-25(17,26)27/h3-5,8-9,17-18,21H,6-7,10-12H2,1-2H3,(H,31,37)/t17-,18+,21-/m0/s1	CQIRODLWZPPMDD-UEXGIBASSA-N	386552	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (((S)-2,2- dichlorocyclopropyl) methyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 495::US10822352, Comp No. 495	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386552&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642800	404855702							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976732	COc1ccc(cn1)-c1ccc2n(CC(=O)N3C4CCC(C4)[C@H]3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C30H30N6O4/c1-17-4-3-5-25(33-17)34-30(39)28-19-6-9-21(12-19)36(28)27(37)16-35-15-23(29(31)38)22-13-18(7-10-24(22)35)20-8-11-26(40-2)32-14-20/h3-5,7-8,10-11,13-15,19,21,28H,6,9,12,16H2,1-2H3,(H2,31,38)(H,33,34,39)/t19?,21?,28-/m0/s1	SEBJQBAUBQUNBD-BNMCDZCRSA-N	386553	5-(6- methoxypyridin- 3-yl)-1-(2- ((1R,3S,4S)-3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 496::US10822352, Comp No. 496	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386553&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653857	404855703							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976733	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cccc(c2)C#N)n1	InChI=1S/C31H28N6O3/c1-18-4-2-7-27(34-18)35-31(40)29-22-8-10-23(13-22)37(29)28(38)17-36-16-25(30(33)39)24-14-21(9-11-26(24)36)20-6-3-5-19(12-20)15-32/h2-7,9,11-12,14,16,22-23,29H,8,10,13,17H2,1H3,(H2,33,39)(H,34,35,40)/t22?,23?,29-/m0/s1	CVURLGUUXJBTFL-AOEXMQEJSA-N	386554	5-(3- cyanophenyl)-1- (2-((1R,3S,4S)-3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 497::US10822352, Comp No. 497	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386554&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654081	404855704							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976734	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc(N)nc2)n1	InChI=1S/C29H29N7O3/c1-16-3-2-4-25(33-16)34-29(39)27-18-5-8-20(11-18)36(27)26(37)15-35-14-22(28(31)38)21-12-17(6-9-23(21)35)19-7-10-24(30)32-13-19/h2-4,6-7,9-10,12-14,18,20,27H,5,8,11,15H2,1H3,(H2,30,32)(H2,31,38)(H,33,34,39)/t18?,20?,27-/m0/s1	DGOGFUGMCGJJMW-KBVTYMBASA-N	386555	5-(6- aminopyridin-3- yl)-1-(2- ((1R,3S,4S)-3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 498::US10822352, Comp No. 498	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386555&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653860	404855705							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976735	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3cccnc3c2)n1	InChI=1S/C33H30N6O3/c1-19-4-2-6-29(36-19)37-33(42)31-23-9-11-24(14-23)39(31)30(40)18-38-17-26(32(34)41)25-15-21(10-12-28(25)38)22-8-7-20-5-3-13-35-27(20)16-22/h2-8,10,12-13,15-17,23-24,31H,9,11,14,18H2,1H3,(H2,34,41)(H,36,37,42)/t23?,24?,31-/m0/s1	APXJYARLJWWEDP-HIKYDRHYSA-N	386556	1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5- (quinolin-7-yl)- 1H-indole-3- carboxamide::US10287301, Compound 499::US10822352, Comp No. 499	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386556&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653866	404855706							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976736	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc(F)nc2)n1	InChI=1S/C29H27FN6O3/c1-16-3-2-4-25(33-16)34-29(39)27-18-5-8-20(11-18)36(27)26(37)15-35-14-22(28(31)38)21-12-17(6-9-23(21)35)19-7-10-24(30)32-13-19/h2-4,6-7,9-10,12-14,18,20,27H,5,8,11,15H2,1H3,(H2,31,38)(H,33,34,39)/t18?,20?,27-/m0/s1	ZAJLUQHTQVCQIX-KBVTYMBASA-N	472223	5-(6-fluoropyridin-3- yl)-1-(2-((1R,3S,4S)-3- ((6-methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3-carboxamide::US10822352, Comp No. 500	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472223&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653861	441611213							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976737	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cccnc2)n1	InChI=1S/C29H28N6O3/c1-17-4-2-6-25(32-17)33-29(38)27-19-7-9-21(12-19)35(27)26(36)16-34-15-23(28(30)37)22-13-18(8-10-24(22)34)20-5-3-11-31-14-20/h2-6,8,10-11,13-15,19,21,27H,7,9,12,16H2,1H3,(H2,30,37)(H,32,33,38)/t19?,21?,27-/m0/s1	QRMDPPMOMZPVAR-GASOQUEOSA-N	386558	1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5- (pyridin-3-yl)- 1H-indole-3- carboxamide::US10287301, Compound 501::US10822352, Comp No. 501	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386558&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653851	404855707							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976738	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC\C(F)=C(\C)c2cccc(Cl)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29ClF2N6O3/c1-17(20-5-4-6-23(32)9-20)26(34)14-37-31(43)28-11-24(33)15-39(28)29(42)16-40-27-8-7-21(22-12-35-19(3)36-13-22)10-25(27)30(38-40)18(2)41/h4-10,12-13,24,28H,11,14-16H2,1-3H3,(H,37,43)/b26-17+/t24-,28+/m1/s1	WHXGFLQYIFPFPD-OJVJINHCSA-N	386559	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((E)-3-(3- chlorophenyl)-2- fluorobut-2-en-1- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 503::US10822352, Comp No. 503	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386559&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642964	404855708							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976739	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc2ncncc2c1	InChI=1S/C29H23BrFN7O3/c1-16(39)28-21-10-18(17-5-7-22-19(9-17)12-32-15-33-22)6-8-23(21)38(36-28)14-27(40)37-13-20(31)11-24(37)29(41)35-26-4-2-3-25(30)34-26/h2-10,12,15,20,24H,11,13-14H2,1H3,(H,34,35,41)/t20-,24+/m1/s1	MZSBNMRTRXFHAI-YKSBVNFPSA-N	386560	(2S,4R)-1-(2-(3- acetyl-5- (quinazolin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 504::US10822352, Comp No. 504	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386560&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642864	404855709							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976740	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(OCC(F)(F)F)nc1	InChI=1S/C27H22BrF4N7O4/c1-14(40)24-18-7-15(16-9-33-26(34-10-16)43-13-27(30,31)32)5-6-19(18)39(37-24)12-23(41)38-11-17(29)8-20(38)25(42)36-22-4-2-3-21(28)35-22/h2-7,9-10,17,20H,8,11-13H2,1H3,(H,35,36,42)/t17-,20+/m1/s1	UEJFYYMGLJNAAW-XLIONFOSSA-N	386561	(2S,4R)-1-(2-(3- acetyl-5-(2- (2,2,2- trifluoroethoxy) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 505::US10822352, Comp No. 505	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386561&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642953	404855710							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976741	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C(\C)c2cccc(Cl)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30ClFN6O3/c1-17(20-5-4-6-24(33)9-20)26(34)15-37-32(43)29-12-22-11-28(22)40(29)30(42)16-39-27-8-7-21(23-13-35-19(3)36-14-23)10-25(27)31(38-39)18(2)41/h4-10,13-14,22,28-29H,11-12,15-16H2,1-3H3,(H,37,43)/b26-17+/t22-,28-,29+/m1/s1	WAKKEPUJBUOHSC-QKEIRCIHSA-N	386562	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((E)-3-(3- chlorophenyl)-2- fluorobut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 506::US10822352, Comp No. 506	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386562&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642981	404855711							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976742	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15(36)26-22-8-17(18-11-30-16(2)31-12-18)6-7-23(22)35(33-26)14-25(37)34-13-20(29)10-24(34)27(38)32-21-5-3-4-19(28)9-21/h3-9,11-12,20,24H,10,13-14H2,1-2H3,(H,32,38)/t20-,24+/m1/s1	TYDFFZYQNDIEMC-YKSBVNFPSA-N	386563	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- bromophenyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 507::US10822352, Comp No. 507	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386563&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623042	404855712							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976743	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24ClFN6O3/c1-15(36)26-22-8-17(18-11-30-16(2)31-12-18)6-7-23(22)35(33-26)14-25(37)34-13-20(29)10-24(34)27(38)32-21-5-3-4-19(28)9-21/h3-9,11-12,20,24H,10,13-14H2,1-2H3,(H,32,38)/t20-,24+/m1/s1	IIGWGZXGWWDDIS-YKSBVNFPSA-N	386564	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- chlorophenyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 508::US10822352, Comp No. 508	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386564&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623442	404855713							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976744	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(Br)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23BrF2N6O3/c1-14(37)26-20-7-16(17-10-31-15(2)32-11-17)3-6-23(20)36(34-26)13-25(38)35-12-18(29)8-24(35)27(39)33-19-4-5-22(30)21(28)9-19/h3-7,9-11,18,24H,8,12-13H2,1-2H3,(H,33,39)/t18-,24+/m1/s1	VPPHANCIKXNZRW-KOSHJBKYSA-N	386565	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- bromo-4- fluorophenyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 509::US10822352, Comp No. 509	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386565&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642966	404855714							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976745	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)CNS(=O)(=O)c2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27FN6O5S/c1-17(36)28-23-10-19(20-12-30-18(2)31-13-20)8-9-24(23)35(33-28)16-27(38)34-15-21(29)11-25(34)26(37)14-32-41(39,40)22-6-4-3-5-7-22/h3-10,12-13,21,25,32H,11,14-16H2,1-2H3/t21-,25+/m1/s1	NJDOWTPMZWMTAR-BWKNWUBXSA-N	472232	N-(2-((2R,4R)-1- (2-(3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-4- fluoropyrrolidin-2- yl)ethyl) benzenesulfonamide::US10822352, Comp No. 510	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472232&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314386	441611222							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976746	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrF2N7O3/c1-15-4-7-23(29)34-26(15)35-27(41)22-9-28(31,13-30)14-37(22)24(40)12-38-21-6-5-18(19-10-32-17(3)33-11-19)8-20(21)25(36-38)16(2)39/h4-8,10-11,22H,9,12-14H2,1-3H3,(H,34,35,41)/t22-,28-/m0/s1	NSJDTCLMYOVWIE-DWACAAAGSA-N	386567	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4-fluoro-4- (fluoromethyl) pyrrolidine-2- carboxamide::US10287301, Compound 511::US10822352, Comp No. 511	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386567&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643228	404855716							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976747	CC(=O)N[C@@H]1[C@@H](F)CN([C@@H]1C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O4/c1-14(39)25-19-9-17(18-10-31-15(2)32-11-18)7-8-21(19)38(36-25)13-24(41)37-12-20(30)26(33-16(3)40)27(37)28(42)35-23-6-4-5-22(29)34-23/h4-11,20,26-27H,12-13H2,1-3H3,(H,33,40)(H,34,35,42)/t20-,26+,27-/m0/s1	QRANZELULCVTBU-BAURHKQJSA-N	386568	(2S,3S,4S)-3- acetamido-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 512::US10822352, Comp No. 512	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386568&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623175	404855717							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976748	CC(=O)N[C@@H]1CN([C@@H]([C@H]1F)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O4/c1-14(39)26-19-9-17(18-10-31-15(2)32-11-18)7-8-21(19)38(36-26)13-24(41)37-12-20(33-16(3)40)25(30)27(37)28(42)35-23-6-4-5-22(29)34-23/h4-11,20,25,27H,12-13H2,1-3H3,(H,33,40)(H,34,35,42)/t20-,25+,27+/m1/s1	IABBZARCJJGQCQ-RAHIQWLESA-N	386569	(2R,3S,4R)-4- acetamido-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-3- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 513::US10822352, Comp No. 513	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386569&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643153	404855718							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976749	CC(=O)c1nn(CC(=O)N2C[Si](C)(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H28BrN7O3Si/c1-16(36)26-20-10-18(19-11-29-17(2)30-12-19)8-9-21(20)35(33-26)13-25(37)34-15-39(3,4)14-22(34)27(38)32-24-7-5-6-23(28)31-24/h5-12,22H,13-15H2,1-4H3,(H,31,32,38)/t22-/m0/s1	PQFINMKKCRBSLQ-QFIPXVFZSA-N	386570	(R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-3,3-dimethyl- 1,3-azasilolidine- 5-carboxamide::US10287301, Compound 514::US10822352, Comp No. 514	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386570&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			140776886	404855719							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976750	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3CCCCc3c2)n1	InChI=1S/C34H35N5O3/c1-20-5-4-8-30(36-20)37-34(42)32-25-11-13-26(16-25)39(32)31(40)19-38-18-28(33(35)41)27-17-24(12-14-29(27)38)23-10-9-21-6-2-3-7-22(21)15-23/h4-5,8-10,12,14-15,17-18,25-26,32H,2-3,6-7,11,13,16,19H2,1H3,(H2,35,41)(H,36,37,42)/t25?,26?,32-/m0/s1	UMKIKBMPJZULGR-FFJARJNZSA-N	386571	1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5- (5,6,7,8- tetrahydronaphthalen- 2-yl)-1H- indole-3- carboxamide::US10287301, Compound 515::US10822352, Comp No. 515	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386571&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653891	404855720							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976751	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C(/C)c2cccc(Cl)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30ClFN6O3/c1-17(20-5-4-6-24(33)9-20)26(34)15-37-32(43)29-12-22-11-28(22)40(29)30(42)16-39-27-8-7-21(23-13-35-19(3)36-14-23)10-25(27)31(38-39)18(2)41/h4-10,13-14,22,28-29H,11-12,15-16H2,1-3H3,(H,37,43)/b26-17-/t22-,28-,29+/m1/s1	WAKKEPUJBUOHSC-YSUSKYDRSA-N	386572	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((Z)-3-(3- chlorophenyl)-2- fluorobut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 516::US10822352, Comp No. 516	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386572&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642954	404855721							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976752	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21-/m1/s1	PIBARDGJJAGJAJ-WIYYLYMNSA-N	386573	(2R,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 517::US10822352, Comp No. 517	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386573&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643324	404855722							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976753	CC(=O)c1nn(CC(=O)N2C[C@@H](F)C[C@@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m0/s1	PIBARDGJJAGJAJ-GHTZIAJQSA-N	386574	(2R,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 518::US10822352, Comp No. 518	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386574&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642975	404855723							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976754	CCCCCOc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C31H34FN7O4/c1-4-5-6-12-43-28-9-7-8-27(35-28)36-31(42)26-14-23(32)17-38(26)29(41)18-39-25-11-10-21(22-15-33-20(3)34-16-22)13-24(25)30(37-39)19(2)40/h7-11,13,15-16,23,26H,4-6,12,14,17-18H2,1-3H3,(H,35,36,42)/t23-,26+/m1/s1	DANJMFOCNWICRL-BVAGGSTKSA-N	472241	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (pentyloxy)pyridin- 2-yl)pyrrolidine-2- carboxamide::US10822352, Comp No. 519	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472241&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623448	441611231							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976755	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrF2N7O3/c1-13-6-20(30)25(28)33-26(13)34-27(40)22-8-18(29)11-36(22)23(39)12-37-21-5-4-16(17-9-31-15(3)32-10-17)7-19(21)24(35-37)14(2)38/h4-7,9-10,18,22H,8,11-12H2,1-3H3,(H,33,34,40)/t18-,22+/m1/s1	CWMZXJUXAIHNEK-GCJKJVERSA-N	386576	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-5-fluoro- 3-methylpyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 520::US10822352, Comp No. 520	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386576&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622999	404855725							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976756	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)S(C)(=O)=O	InChI=1S/C26H23BrFN7O5S/c1-14(36)24-18-8-15(16-10-29-26(30-11-16)41(2,39)40)6-7-19(18)35(33-24)13-23(37)34-12-17(28)9-20(34)25(38)32-22-5-3-4-21(27)31-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,20+/m1/s1	DHPQOMUQTZVDIG-XLIONFOSSA-N	386577	(2S,4R)-1-(2-(3- acetyl-5-(2- (methylsulfonyl) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 521::US10822352, Comp No. 521	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386577&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643183	404855726							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976757	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)-n1cccn1	InChI=1S/C28H23BrFN9O3/c1-16(40)26-20-10-17(18-12-31-28(32-13-18)38-9-3-8-33-38)6-7-21(20)39(36-26)15-25(41)37-14-19(30)11-22(37)27(42)35-24-5-2-4-23(29)34-24/h2-10,12-13,19,22H,11,14-15H2,1H3,(H,34,35,42)/t19-,22+/m1/s1	NKTQZZXIAQXWBX-KNQAVFIVSA-N	386578	(2S,4R)-1-(2-(5- (2-(1H-pyrazol-1- yl)pyrimidin-5- yl)-3-acetyl-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 522::US10822352, Comp No. 522	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386578&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623140	404855727							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976758	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C(\C)c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30ClFN6O3/c1-17(23-6-4-5-7-25(23)33)26(34)15-37-32(43)29-12-21-11-28(21)40(29)30(42)16-39-27-9-8-20(22-13-35-19(3)36-14-22)10-24(27)31(38-39)18(2)41/h4-10,13-14,21,28-29H,11-12,15-16H2,1-3H3,(H,37,43)/b26-17+/t21-,28-,29+/m1/s1	NYIFSGFMVXEABK-UJCUCBGGSA-N	386579	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((E)-3-(2- chlorophenyl)-2- fluorobut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 523::US10822352, Comp No. 523	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386579&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643083	404855728							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976759	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(Br)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H22BrF3N6O3/c1-13(38)26-18-7-15(16-9-32-14(2)33-10-16)3-6-21(18)37(35-26)12-23(39)36-11-17(29)8-22(36)27(40)34-20-5-4-19(30)24(28)25(20)31/h3-7,9-10,17,22H,8,11-12H2,1-2H3,(H,34,40)/t17-,22+/m1/s1	UTBWTQVEKZEREE-VGSWGCGISA-N	386580	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- bromo-2,4- difluorophenyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 524::US10822352, Comp No. 524	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386580&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643202	404855729							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976760	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cccnc1	InChI=1S/C27H26N6O3/c1-17-6-3-9-24(29-17)30-27(36)23-8-5-13-32(23)25(35)16-33-22-11-10-19(20-7-4-12-28-15-20)14-21(22)26(31-33)18(2)34/h3-4,6-7,9-12,14-15,23H,5,8,13,16H2,1-2H3,(H,29,30,36)/t23-/m0/s1	ZDYJAEURBASAEE-QHCPKHFHSA-N	386581	(S)-1-(2-(3- acetyl-5-(pyridin- 3-yl)-1H-indazol- 1-yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 525::US10822352, Comp No. 525	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386581&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622886	404855730							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976761	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28ClFN6O3/c1-16(39)29-23-9-18(19-12-33-17(2)34-13-19)7-8-26(23)38(36-29)15-28(40)37-14-20(32)10-27(37)30(41)35-25-11-22(25)21-5-3-4-6-24(21)31/h3-9,12-13,20,22,25,27H,10-11,14-15H2,1-2H3,(H,35,41)/t20-,22-,25+,27+/m1/s1	RNWUHHQKMWBDQW-RYFPDZNGSA-N	386582	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((1S,2R)-2-(2- chlorophenyl) cyclopropyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 526::US10822352, Comp No. 526	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386582&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642755	404855731							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976762	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28ClFN6O3/c1-16(39)29-23-9-18(19-12-33-17(2)34-13-19)7-8-26(23)38(36-29)15-28(40)37-14-20(32)10-27(37)30(41)35-25-11-22(25)21-5-3-4-6-24(21)31/h3-9,12-13,20,22,25,27H,10-11,14-15H2,1-2H3,(H,35,41)/t20-,22+,25-,27+/m1/s1	RNWUHHQKMWBDQW-YQLJFJGKSA-N	386583	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((1R,2S)-2-(2- chlorophenyl) cyclopropyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 527::US10822352, Comp No. 527	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386583&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642970	404855732							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976763	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C(/C)c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30ClFN6O3/c1-17(23-6-4-5-7-25(23)33)26(34)15-37-32(43)29-12-21-11-28(21)40(29)30(42)16-39-27-9-8-20(22-13-35-19(3)36-14-22)10-24(27)31(38-39)18(2)41/h4-10,13-14,21,28-29H,11-12,15-16H2,1-3H3,(H,37,43)/b26-17-/t21-,28-,29+/m1/s1	NYIFSGFMVXEABK-BZRIVGMCSA-N	386584	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((Z)-3-(2- chlorophenyl)-2- fluorobut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 528::US10822352, Comp No. 528	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386584&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643084	404855733							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976764	COC(=O)Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C28H25BrFN7O5/c1-15(38)27-19-8-16(17-11-31-24(32-12-17)10-26(40)42-2)6-7-20(19)37(35-27)14-25(39)36-13-18(30)9-21(36)28(41)34-23-5-3-4-22(29)33-23/h3-8,11-12,18,21H,9-10,13-14H2,1-2H3,(H,33,34,41)/t18-,21+/m1/s1	AMUOXZZHQFGGGE-NQIIRXRSSA-N	386585	US10287301, Compound 529::US10822352, Comp No. 529::methyl 2-(5-(3- acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)acetate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386585&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623195	404855734							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976765	C[C@H]1CC[C@H](C1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C28H27BrN6O3/c1-15-7-9-20(28(38)33-25-6-4-5-24(29)32-25)26(15)23(37)14-35-22-10-8-18(19-12-30-17(3)31-13-19)11-21(22)27(34-35)16(2)36/h4-6,8,10-13,15,20,26H,7,9,14H2,1-3H3,(H,32,33,38)/t15-,20+,26?/m0/s1	NEMZGWIYCSSGAM-YCZZGTQISA-N	472252	(2S,5S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2-yl)-5- methylpyrrolidine- 2-carboxamide::US10822352, Comp No. 530	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472252&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314173	441611242							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976766	CSc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C26H23BrFN7O3S/c1-14(36)24-18-8-15(16-10-29-26(39-2)30-11-16)6-7-19(18)35(33-24)13-23(37)34-12-17(28)9-20(34)25(38)32-22-5-3-4-21(27)31-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,20+/m1/s1	HHEMTRHYNPDLPR-XLIONFOSSA-N	386587	(2S,4R)-1-(2-(3- acetyl-5-(2- (methylthio) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 531::US10822352, Comp No. 531	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386587&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642783	404855736							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976767	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CC(N)=O)nc1	InChI=1S/C27H24BrFN8O4/c1-14(38)26-18-7-15(16-10-31-24(32-11-16)9-22(30)39)5-6-19(18)37(35-26)13-25(40)36-12-17(29)8-20(36)27(41)34-23-4-2-3-21(28)33-23/h2-7,10-11,17,20H,8-9,12-13H2,1H3,(H2,30,39)(H,33,34,41)/t17-,20+/m1/s1	LNAIYAQQHRKCMY-XLIONFOSSA-N	386588	(2S,4R)-1-(2-(3- acetyl-5-(2-(2- amino-2- oxoethyl) pyrimidin-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 532::US10822352, Comp No. 532	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386588&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623358	404855737							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976768	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(CC(O)=O)nc1	InChI=1S/C27H23BrFN7O5/c1-14(37)26-18-7-15(16-10-30-23(31-11-16)9-25(39)40)5-6-19(18)36(34-26)13-24(38)35-12-17(29)8-20(35)27(41)33-22-4-2-3-21(28)32-22/h2-7,10-11,17,20H,8-9,12-13H2,1H3,(H,39,40)(H,32,33,41)/t17-,20+/m1/s1	FXOQNEKZXTWWFR-XLIONFOSSA-N	386589	2-(5-(3-acetyl-1- (2-((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)acetic acid::US10287301, Compound 533::US10822352, Comp No. 533	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386589&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642882	404855738							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976769	CCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H27BrFN7O3/c1-4-17-6-8-24(29)33-27(17)34-28(40)23-10-20(30)13-36(23)25(39)14-37-22-7-5-18(19-11-31-16(3)32-12-19)9-21(22)26(35-37)15(2)38/h5-9,11-12,20,23H,4,10,13-14H2,1-3H3,(H,33,34,40)/t20-,23+/m1/s1	BVUPDYTVLYWVQY-OFNKIYASSA-N	386590	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- ethylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 534::US10822352, Comp No. 534	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386590&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623485	404855739							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976770	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc3CCCc3c2)n1	InChI=1S/C32H32N6O3/c1-18-4-2-7-28(35-18)36-32(41)30-21-8-10-23(13-21)38(30)29(39)17-37-16-25(31(33)40)24-14-19(9-11-27(24)37)22-12-20-5-3-6-26(20)34-15-22/h2,4,7,9,11-12,14-16,21,23,30H,3,5-6,8,10,13,17H2,1H3,(H2,33,40)(H,35,36,41)/t21?,23?,30-/m0/s1	RMJMPAYIUNJASN-WADZGEJMSA-N	386591	5-(6,7-dihydro-5H- cyclopenta[b] pyridin-3-yl)-1-(2- ((1R,3S,4S)-3- ((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 535::US10822352, Comp No. 535	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386591&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653868	404855740							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976771	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2ccc3CCc3c2)n1	InChI=1S/C32H31N5O3/c1-18-3-2-4-28(34-18)35-32(40)30-23-9-11-24(14-23)37(30)29(38)17-36-16-26(31(33)39)25-15-22(10-12-27(25)36)21-8-6-19-5-7-20(19)13-21/h2-4,6,8,10,12-13,15-16,23-24,30H,5,7,9,11,14,17H2,1H3,(H2,33,39)(H,34,35,40)/t23?,24?,30-/m0/s1	MRDJWOLRIHAOFK-YFIBMDDPSA-N	386592	5-(bicyclo[4.2.0] octa-1,3,5-trien-3- yl)-1-(2- ((1R,3S,4S)-3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 536::US10822352, Comp No. 536	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386592&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653890	404855741							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976772	CCOC(=O)Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C29H27BrFN7O5/c1-3-43-27(41)11-25-32-12-18(13-33-25)17-7-8-21-20(9-17)28(16(2)39)36-38(21)15-26(40)37-14-19(31)10-22(37)29(42)35-24-6-4-5-23(30)34-24/h4-9,12-13,19,22H,3,10-11,14-15H2,1-2H3,(H,34,35,42)/t19-,22+/m1/s1	GTMAOYCCKBSBKT-KNQAVFIVSA-N	386593	US10287301, Compound 537::US10822352, Comp No. 537::ethyl 2-(5-(3- acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)acetate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386593&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623032	404855742							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976773	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O3/c1-15(39)27-22-9-18(19-11-32-16(2)33-12-19)5-7-23(22)38(36-27)14-26(40)37-13-20(31)10-24(37)29(41)35-28-21(17-3-4-17)6-8-25(30)34-28/h5-9,11-12,17,20,24H,3-4,10,13-14H2,1-2H3,(H,34,35,41)/t20-,24+/m1/s1	HSTUTLCDRTYIFX-YKSBVNFPSA-N	386594	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- cyclopropylpyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 538::US10822352, Comp No. 538	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386594&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623179	404855743							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976774	CCOC(=O)Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3ccc(F)c(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C29H26BrF2N7O5/c1-3-44-26(42)10-24-33-11-17(12-34-24)16-4-6-21-19(8-16)27(15(2)40)37-39(21)14-25(41)38-13-18(31)9-22(38)29(43)36-23-7-5-20(32)28(30)35-23/h4-8,11-12,18,22H,3,9-10,13-14H2,1-2H3,(H,35,36,43)/t18-,22+/m1/s1	BPYZKRGITGBHSB-GCJKJVERSA-N	386595	US10287301, Compound 539::US10822352, Comp No. 539::ethyl 2-(5-(3- acetyl-1-(2- ((2S,4R)-2-((6- bromo-5- fluoropyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)acetate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386595&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643247	404855744							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976775	CCOC(=O)Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C30H29BrFN7O5/c1-4-44-27(42)11-25-33-12-19(13-34-25)18-6-7-22-21(9-18)28(17(3)40)37-39(22)15-26(41)38-14-20(32)10-23(38)30(43)36-29-16(2)5-8-24(31)35-29/h5-9,12-13,20,23H,4,10-11,14-15H2,1-3H3,(H,35,36,43)/t20-,23+/m1/s1	JFFPOQZUYGGMBB-OFNKIYASSA-N	386596	US10287301, Compound 540::US10822352, Comp No. 540::ethyl 2-(5-(3- acetyl-1-(2- ((2S,4R)-2-((6- bromo-3- methylpyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)acetate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386596&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642891	404855745							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976776	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C(\C)c2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H31FN6O3/c1-18(21-7-5-4-6-8-21)26(33)16-36-32(42)29-13-23-12-28(23)39(29)30(41)17-38-27-10-9-22(24-14-34-20(3)35-15-24)11-25(27)31(37-38)19(2)40/h4-11,14-15,23,28-29H,12-13,16-17H2,1-3H3,(H,36,42)/b26-18+/t23-,28-,29+/m1/s1	HUDOLRITSCMJGH-TVWZIDNLSA-N	386597	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((E)-2-fluoro-3- phenylbut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 541::US10822352, Comp No. 541	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386597&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643194	404855746							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976777	CC(=O)c1cn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrN6O3/c1-15(34)20-13-32(21-7-6-17(10-19(20)21)18-11-28-16(2)29-12-18)14-25(35)33-9-8-22(33)26(36)31-24-5-3-4-23(27)30-24/h3-7,10-13,22H,8-9,14H2,1-2H3,(H,30,31,36)/t22-/m0/s1	PQSKSUWECBEFMH-QFIPXVFZSA-N	472264	(S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)azetidine-2- carboxamide::US10822352, Comp No. 542	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472264&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313963	441611254							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976778	COc1ccc(cn1)-c1ccc2n(CC(=O)N3CCC[C@H]3C(=O)Nc3cccc(C)n3)nc(C(C)=O)c2c1	InChI=1S/C28H28N6O4/c1-17-6-4-8-24(30-17)31-28(37)23-7-5-13-33(23)26(36)16-34-22-11-9-19(14-21(22)27(32-34)18(2)35)20-10-12-25(38-3)29-15-20/h4,6,8-12,14-15,23H,5,7,13,16H2,1-3H3,(H,30,31,37)/t23-/m0/s1	SDLWISJHNVVMGI-QHCPKHFHSA-N	386599	(S)-1-(2-(3- acetyl-5-(6- methoxypyridin- 3-yl)-1H-indazol- 1-yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 543::US10822352, Comp No. 543	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386599&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643302	404855748							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976779	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cccc(c1)C#N	InChI=1S/C29H26N6O3/c1-18-6-3-10-26(31-18)32-29(38)25-9-5-13-34(25)27(37)17-35-24-12-11-22(15-23(24)28(33-35)19(2)36)21-8-4-7-20(14-21)16-30/h3-4,6-8,10-12,14-15,25H,5,9,13,17H2,1-2H3,(H,31,32,38)/t25-/m0/s1	OKNIIUPXTSDQCS-VWLOTQADSA-N	386600	(S)-1-(2-(3- acetyl-5-(3- cyanophenyl)-1H- indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 544::US10822352, Comp No. 544	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386600&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642795	404855749							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976780	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc(F)nc1	InChI=1S/C27H25FN6O3/c1-16-5-3-7-24(30-16)31-27(37)22-6-4-12-33(22)25(36)15-34-21-10-8-18(19-9-11-23(28)29-14-19)13-20(21)26(32-34)17(2)35/h3,5,7-11,13-14,22H,4,6,12,15H2,1-2H3,(H,30,31,37)/t22-/m0/s1	NPFVTCXXGOFRJK-QFIPXVFZSA-N	386601	(S)-1-(2-(3- acetyl-5-(6- fluoropyridin-3- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 545::US10822352, Comp No. 545	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386601&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642871	404855750							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976781	COc1ccc(cn1)-c1ccc2n(CC(=O)N3CC[C@H]3C(=O)Nc3cccc(C)n3)nc(C(C)=O)c2c1	InChI=1S/C27H26N6O4/c1-16-5-4-6-23(29-16)30-27(36)22-11-12-32(22)25(35)15-33-21-9-7-18(13-20(21)26(31-33)17(2)34)19-8-10-24(37-3)28-14-19/h4-10,13-14,22H,11-12,15H2,1-3H3,(H,29,30,36)/t22-/m0/s1	KNQHZZBQVDWPIF-QFIPXVFZSA-N	386602	(S)-1-(2-(3- acetyl-5-(6- methoxypyridin- 3-yl)-1H-indazol- 1-yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 546::US10822352, Comp No. 546	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386602&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642955	404855751							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976782	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cccc(c1)C#N	InChI=1S/C28H24N6O3/c1-17-5-3-8-25(30-17)31-28(37)24-11-12-33(24)26(36)16-34-23-10-9-21(14-22(23)27(32-34)18(2)35)20-7-4-6-19(13-20)15-29/h3-10,13-14,24H,11-12,16H2,1-2H3,(H,30,31,37)/t24-/m0/s1	GYSCTNGZEJGTOF-DEOSSOPVSA-N	386603	(S)-1-(2-(3- acetyl-5-(3- cyanophenyl)-1H- indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 547::US10822352, Comp No. 547	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386603&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623509	404855752							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976783	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cccnc1	InChI=1S/C26H24N6O3/c1-16-5-3-7-23(28-16)29-26(35)22-10-12-31(22)24(34)15-32-21-9-8-18(19-6-4-11-27-14-19)13-20(21)25(30-32)17(2)33/h3-9,11,13-14,22H,10,12,15H2,1-2H3,(H,28,29,35)/t22-/m0/s1	FASLAXCKDMYYGM-QFIPXVFZSA-N	386604	(S)-1-(2-(3- acetyl-5-(pyridin- 3-yl)-1H-indazol- 1-yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 548::US10822352, Comp No. 548	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386604&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623123	404855753							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976784	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc(F)nc1	InChI=1S/C26H23FN6O3/c1-15-4-3-5-23(29-15)30-26(36)21-10-11-32(21)24(35)14-33-20-8-6-17(18-7-9-22(27)28-13-18)12-19(20)25(31-33)16(2)34/h3-9,12-13,21H,10-11,14H2,1-2H3,(H,29,30,36)/t21-/m0/s1	QAGJSEBSKFQVIF-NRFANRHFSA-N	386605	(S)-1-(2-(3- acetyl-5-(6- fluoropyridin-3- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 549::US10822352, Comp No. 549	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386605&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642806	404855754							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976785	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCC2CCN(CC(F)(F)F)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H31F4N7O3/c1-16(40)26-22-7-19(20-10-33-17(2)34-11-20)3-4-23(22)39(36-26)14-25(41)38-13-21(29)8-24(38)27(42)35-9-18-5-6-37(12-18)15-28(30,31)32/h3-4,7,10-11,18,21,24H,5-6,8-9,12-15H2,1-2H3,(H,35,42)/t18?,21-,24+/m1/s1	NKAXARHKZYMOHI-UJJNXARTSA-N	386606	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-((1- (2,2,2- trifluoroethyl) pyrrolidin-3- yl)methyl)pyrrolidine- 2-carboxamide::US10287301, Compound 550::US10822352, Comp No. 550	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386606&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623593	404855755							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976786	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NCC(F)=C(C)C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H31FN6O3/c1-15(18-4-5-18)23(30)13-33-29(39)26-10-20-9-25(20)36(26)27(38)14-35-24-7-6-19(21-11-31-17(3)32-12-21)8-22(24)28(34-35)16(2)37/h6-8,11-12,18,20,25-26H,4-5,9-10,13-14H2,1-3H3,(H,33,39)/t20-,25-,26+/m1/s1	MOUHZIOUKZLJIM-VANUSSGQSA-N	386607	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- cyclopropyl-2- fluorobut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 551::US10822352, Comp No. 551	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386607&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643132	404855756							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976787	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(Oc2ccncc2)nc1	InChI=1S/C30H24BrFN8O4/c1-17(41)28-22-11-18(19-13-34-30(35-14-19)44-21-7-9-33-10-8-21)5-6-23(22)40(38-28)16-27(42)39-15-20(32)12-24(39)29(43)37-26-4-2-3-25(31)36-26/h2-11,13-14,20,24H,12,15-16H2,1H3,(H,36,37,43)/t20-,24+/m1/s1	WUHWQUXTLVXABW-YKSBVNFPSA-N	386608	(2S,4R)-1-(2-(3- acetyl-5-(2- (pyridin-4- yloxy)pyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 554::US10822352, Comp No. 554	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386608&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643090	404855757							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976788	CN(C)C(=O)OCc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C29H28BrFN8O5/c1-16(40)27-20-9-17(18-11-32-25(33-12-18)15-44-29(43)37(2)3)7-8-21(20)39(36-27)14-26(41)38-13-19(31)10-22(38)28(42)35-24-6-4-5-23(30)34-24/h4-9,11-12,19,22H,10,13-15H2,1-3H3,(H,34,35,42)/t19-,22+/m1/s1	COIVRWGXWTXEME-KNQAVFIVSA-N	386609	(5-(3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidin-2- yl)methyl dimethylcarbamate::US10287301, Compound 555::US10822352, Comp No. 555	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386609&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642986	404855758							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976789	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(NS(C)(=O)=O)nc1	InChI=1S/C26H24BrFN8O5S/c1-14(37)24-18-8-15(16-10-29-26(30-11-16)34-42(2,40)41)6-7-19(18)36(33-24)13-23(38)35-12-17(28)9-20(35)25(39)32-22-5-3-4-21(27)31-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,29,30,34)(H,31,32,39)/t17-,20+/m1/s1	VWROMPKXDIGCBM-XLIONFOSSA-N	386610	(2S,4R)-1-(2-(3- acetyl-5-(2- (methylsulfonamido) pyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 556::US10822352, Comp No. 556	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386610&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642873	404855759							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976790	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C(/C)c2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H31FN6O3/c1-18(21-7-5-4-6-8-21)26(33)16-36-32(42)29-13-23-12-28(23)39(29)30(41)17-38-27-10-9-22(24-14-34-20(3)35-15-24)11-25(27)31(37-38)19(2)40/h4-11,14-15,23,28-29H,12-13,16-17H2,1-3H3,(H,36,42)/b26-18-/t23-,28-,29+/m1/s1	HUDOLRITSCMJGH-PUEJNYRNSA-N	386611	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((Z)-2-fluoro-3- phenylbut-2-en-1- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 557::US10822352, Comp No. 557	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386611&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643085	404855760							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976791	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C25H23F4N9O3/c1-13(39)22-17-6-14(15-8-31-24(30)32-9-15)2-3-18(17)38(35-22)11-21(40)37-10-16(26)7-19(37)23(41)33-20-4-5-36(34-20)12-25(27,28)29/h2-6,8-9,16,19H,7,10-12H2,1H3,(H2,30,31,32)(H,33,34,41)/t16-,19+/m1/s1	MANBTKHUBYLRDB-APWZRJJASA-N	386612	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 558::US10822352, Comp No. 558	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386612&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623090	404855761							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976792	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H22F4N8O4/c1-13(39)23-17-7-14(15-9-32-25(31)33-10-15)5-6-18(17)38(36-23)12-22(40)37-11-16(27)8-19(37)24(41)35-20-3-2-4-21(34-20)42-26(28,29)30/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,31,32,33)(H,34,35,41)/t16-,19+/m1/s1	SNGFDCNBMTWURE-APWZRJJASA-N	386613	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethoxy) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 559::US10822352, Comp No. 559	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386613&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622958	404855762							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976793	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C26H22F4N8O3/c1-13(39)23-17-7-14(15-9-32-25(31)33-10-15)5-6-18(17)38(36-23)12-22(40)37-11-16(27)8-19(37)24(41)35-21-4-2-3-20(34-21)26(28,29)30/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,31,32,33)(H,34,35,41)/t16-,19+/m1/s1	AIRYCNQMPATFKA-APWZRJJASA-N	386614	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethyl) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 560::US10822352, Comp No. 560	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386614&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642829	404855763							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976794	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26FN7O3/c1-15-5-4-6-24(31-15)32-27(38)23-10-20(28)13-34(23)25(37)14-35-22-8-7-18(19-11-29-17(3)30-12-19)9-21(22)26(33-35)16(2)36/h4-9,11-12,20,23H,10,13-14H2,1-3H3,(H,31,32,38)/t20-,23+/m1/s1	RTXDNTYYQVQOEE-OFNKIYASSA-N	386615	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 561::US10822352, Comp No. 561	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386615&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623333	404855764							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976795	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23F4N7O3/c1-14(39)25-19-8-16(17-10-32-15(2)33-11-17)6-7-20(19)38(36-25)13-24(40)37-12-18(28)9-21(37)26(41)35-23-5-3-4-22(34-23)27(29,30)31/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,34,35,41)/t18-,21+/m1/s1	ZJCIQPWHIMILCA-NQIIRXRSSA-N	386616	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethyl) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 562::US10822352, Comp No. 562	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386616&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623250	404855765							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976796	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C27H22F5N7O4/c1-13(40)24-17-7-14(15-9-34-26(33)35-10-15)5-6-19(17)39(37-24)12-22(41)38-11-16(28)8-20(38)25(42)36-18-3-2-4-21(23(18)29)43-27(30,31)32/h2-7,9-10,16,20H,8,11-12H2,1H3,(H,36,42)(H2,33,34,35)/t16-,20+/m1/s1	SJQSAYHRSDPAKM-UZLBHIALSA-N	386617	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(2- fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 563::US10822352, Comp No. 563	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386617&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642996	404855766							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976797	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccnc(C)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26FN7O3/c1-15-8-21(6-7-29-15)32-27(38)24-10-20(28)13-34(24)25(37)14-35-23-5-4-18(19-11-30-17(3)31-12-19)9-22(23)26(33-35)16(2)36/h4-9,11-12,20,24H,10,13-14H2,1-3H3,(H,29,32,38)/t20-,24+/m1/s1	OURUKMCUYAGNTJ-YKSBVNFPSA-N	386618	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(2- methylpyridin-4- yl)pyrrolidine-2- carboxamide::US10287301, Compound 565::US10822352, Comp No. 565	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386618&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642904	404855767							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976798	CCc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C27H25BrFN7O3/c1-3-23-30-11-17(12-31-23)16-7-8-20-19(9-16)26(15(2)37)34-36(20)14-25(38)35-13-18(29)10-21(35)27(39)33-24-6-4-5-22(28)32-24/h4-9,11-12,18,21H,3,10,13-14H2,1-2H3,(H,32,33,39)/t18-,21+/m1/s1	YYLLVASNGMAFBN-NQIIRXRSSA-N	386619	(2S,4R)-1-(2-(3- acetyl-5-(2- ethylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 566::US10822352, Comp No. 566	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386619&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643088	404855768							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976799	CC(C)c1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C28H27BrFN7O3/c1-15(2)27-31-11-18(12-32-27)17-7-8-21-20(9-17)26(16(3)38)35-37(21)14-25(39)36-13-19(30)10-22(36)28(40)34-24-6-4-5-23(29)33-24/h4-9,11-12,15,19,22H,10,13-14H2,1-3H3,(H,33,34,40)/t19-,22+/m1/s1	QDMAVYWWNDUKIC-KNQAVFIVSA-N	386620	(2S,4R)-1-(2-(3- acetyl-5-(2- isopropylpyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 567::US10822352, Comp No. 567	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386620&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623671	404855769							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976800	CN1CC[C@@H](CNC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)C1	InChI=1S/C27H32FN7O3/c1-16(36)26-22-8-19(20-11-29-17(2)30-12-20)4-5-23(22)35(32-26)15-25(37)34-14-21(28)9-24(34)27(38)31-10-18-6-7-33(3)13-18/h4-5,8,11-12,18,21,24H,6-7,9-10,13-15H2,1-3H3,(H,31,38)/t18-,21+,24-/m0/s1	GGCOSZCFSQSFDX-VNZMSGEBSA-N	386621	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(((S)-1- methylpyrrolidin- 3-yl)methyl) pyrrolidine-2- carboxamide::US10287301, Compound 568::US10822352, Comp No. 568	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386621&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623459	404855770							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976801	CN1CC[C@H](CNC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)C1	InChI=1S/C27H32FN7O3/c1-16(36)26-22-8-19(20-11-29-17(2)30-12-20)4-5-23(22)35(32-26)15-25(37)34-14-21(28)9-24(34)27(38)31-10-18-6-7-33(3)13-18/h4-5,8,11-12,18,21,24H,6-7,9-10,13-15H2,1-3H3,(H,31,38)/t18-,21-,24+/m1/s1	GGCOSZCFSQSFDX-JLGINSKQSA-N	386622	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(((R)-1- methylpyrrolidin- 3-yl)methyl) pyrrolidine-2- carboxamide::US10287301, Compound 569::US10822352, Comp No. 569	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386622&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642919	404855771							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976802	C[C@@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)[C@H]1CC1(Cl)Cl	InChI=1S/C26H27Cl2FN6O3/c1-13(20-8-26(20,27)28)32-25(38)22-7-18(29)11-34(22)23(37)12-35-21-5-4-16(17-9-30-15(3)31-10-17)6-19(21)24(33-35)14(2)36/h4-6,9-10,13,18,20,22H,7-8,11-12H2,1-3H3,(H,32,38)/t13-,18-,20-,22+/m1/s1	JYEXZFZNBRDEKX-FPZBQUANSA-N	386623	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((R)-1-((R)-2,2- dichlorocyclopropyl) ethyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 570::US10822352, Comp No. 570	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386623&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623007	404855772							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976803	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc2CCCc2c1	InChI=1S/C31H31N5O3/c1-19-6-3-10-28(32-19)33-31(39)27-9-5-15-35(27)29(38)18-36-26-14-13-24(17-25(26)30(34-36)20(2)37)23-12-11-21-7-4-8-22(21)16-23/h3,6,10-14,16-17,27H,4-5,7-9,15,18H2,1-2H3,(H,32,33,39)/t27-/m0/s1	MURBNEZIRYALIS-MHZLTWQESA-N	386624	(S)-1-(2-(3- acetyl-5-(2,3- dihydro-1H- inden-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 572::US10822352, Comp No. 572	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386624&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643119	404855773							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976804	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc2CCCc2c1	InChI=1S/C30H29N5O3/c1-18-5-3-8-27(31-18)32-30(38)26-13-14-34(26)28(37)17-35-25-12-11-23(16-24(25)29(33-35)19(2)36)22-10-9-20-6-4-7-21(20)15-22/h3,5,8-12,15-16,26H,4,6-7,13-14,17H2,1-2H3,(H,31,32,38)/t26-/m0/s1	WDZFMSHXUFBOJL-SANMLTNESA-N	386625	(S)-1-(2-(3- acetyl-5-(2,3- dihydro-1H- inden-5-yl)-1H- indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 573::US10822352, Comp No. 573	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386625&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642833	404855774							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976805	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2nc(Br)ccc2CO)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O4/c1-14(38)26-20-7-16(19-10-30-15(2)31-11-19)3-5-21(20)35(34-26)12-25(39)36-22-8-18(22)9-23(36)28(40)33-27-17(13-37)4-6-24(29)32-27/h3-7,10-11,18,22-23,37H,8-9,12-13H2,1-2H3,(H,32,33,40)/t18-,22-,23+/m1/s1	FFHMIFQHUQCEOZ-YSZBQJHXSA-N	386626	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- (hydroxymethyl) pyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 574::US10822352, Comp No. 574	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386626&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643147	404855775							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976806	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC\C(F)=C/c2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29FN6O3/c1-18(39)30-25-11-21(23-14-33-19(2)34-15-23)8-9-26(25)37(36-30)17-29(40)38-27-12-22(27)13-28(38)31(41)35-16-24(32)10-20-6-4-3-5-7-20/h3-11,14-15,22,27-28H,12-13,16-17H2,1-2H3,(H,35,41)/b24-10+/t22-,27-,28+/m1/s1	KHGNXIQEQOQDLY-FFTNJCJGSA-N	386627	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((E)-2-fluoro-3- phenylallyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 575::US10822352, Comp No. 575	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386627&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643381	404855776							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976807	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28FN7O3/c1-16(38)28-22-10-19(20-12-31-17(2)32-13-20)8-9-24(22)37(35-28)15-27(39)36-14-21(30)11-25(36)29(40)34-26-5-3-4-23(33-26)18-6-7-18/h3-5,8-10,12-13,18,21,25H,6-7,11,14-15H2,1-2H3,(H,33,34,40)/t21-,25+/m1/s1	AAKYTFAPLXOWKV-BWKNWUBXSA-N	386628	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- cyclopropylpyridin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 576::US10822352, Comp No. 576	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386628&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622925	404855777							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976808	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O3/c1-17(40)28-21-10-19(20-13-32-18(2)33-14-20)8-9-22(21)38(36-28)15-27(41)39-23(11-30(12-24(30)39)16-37(3)4)29(42)35-26-7-5-6-25(31)34-26/h5-10,13-14,23-24H,11-12,15-16H2,1-4H3,(H,34,35,42)/t23-,24+,30-/m0/s1	IAYHOEXPAPJRDM-BBANNHEPSA-N	472299	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5-((dimethylamino) methyl)-2-azabicyclo [3.1.0]hexane-3- carboxamide::US10822352, Comp No. 577	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472299&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643042	441611289							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976809	CN(C)C[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O3/c1-17(40)28-21-10-19(20-13-32-18(2)33-14-20)8-9-22(21)38(36-28)15-27(41)39-23(11-30(12-24(30)39)16-37(3)4)29(42)35-26-7-5-6-25(31)34-26/h5-10,13-14,23-24H,11-12,15-16H2,1-4H3,(H,34,35,42)/t23-,24-,30+/m0/s1	IAYHOEXPAPJRDM-FOUYOVOOSA-N	472300	(1S,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-5-((dimethylamino) methyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 578	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472300&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642843	441611290							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976810	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C27H25BrF2N8O3/c1-14-3-6-21(28)34-24(14)35-25(41)20-8-27(30,12-29)13-37(20)22(40)11-38-19-5-4-16(17-9-32-26(31)33-10-17)7-18(19)23(36-38)15(2)39/h3-7,9-10,20H,8,11-13H2,1-2H3,(H2,31,32,33)(H,34,35,41)/t20-,27-/m0/s1	FTTSFYKNXKBNBR-DCFHFQCYSA-N	472301	(2S,4R)-1-(2-(3- acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4-fluoro-4- (fluoromethyl) pyrrolidine-2- carboxamide::US10822352, Comp No. 579	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472301&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643102	441611291							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976811	COc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C27H26FN7O4/c1-15(36)26-20-9-17(18-11-29-16(2)30-12-18)7-8-21(20)35(33-26)14-25(37)34-13-19(28)10-22(34)27(38)32-23-5-4-6-24(31-23)39-3/h4-9,11-12,19,22H,10,13-14H2,1-3H3,(H,31,32,38)/t19-,22+/m1/s1	CCYYVSRRIDWNAW-KNQAVFIVSA-N	386632	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- methoxypyridin- 2-yl)pyrrolidine- 2-carboxamide::US10287301, Compound 580::US10822352, Comp No. 580	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386632&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623256	404855781							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976812	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H22F4N8O3/c1-13(39)24-18-5-15(16-7-32-14(2)33-8-16)3-4-19(18)38(36-24)12-23(40)37-11-17(27)6-20(37)25(41)35-22-10-31-9-21(34-22)26(28,29)30/h3-5,7-10,17,20H,6,11-12H2,1-2H3,(H,34,35,41)/t17-,20+/m1/s1	CDAMQDLPUGEZMT-XLIONFOSSA-N	386633	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethyl) pyrazin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 581::US10822352, Comp No. 581	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386633&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643379	404855782							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976813	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24F3N7O4/c1-14(38)25-19-8-16(17-10-31-15(2)32-11-17)6-7-20(19)37(35-25)13-24(39)36-12-18(28)9-21(36)26(40)34-22-4-3-5-23(33-22)41-27(29)30/h3-8,10-11,18,21,27H,9,12-13H2,1-2H3,(H,33,34,40)/t18-,21+/m1/s1	AEYMDYVTCBIEFP-NQIIRXRSSA-N	472304	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- (difluoromethoxy) pyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 582	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472304&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643026	441611294							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976814	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(F)nc1	InChI=1S/C25H20BrF2N7O3/c1-13(36)23-17-7-14(15-9-29-25(28)30-10-15)5-6-18(17)35(33-23)12-22(37)34-11-16(27)8-19(34)24(38)32-21-4-2-3-20(26)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H,31,32,38)/t16-,19+/m1/s1	NRDBJJGHJZOSMK-APWZRJJASA-N	386635	(2S,4R)-1-(2-(3- acetyl-5-(2- fluoropyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 583::US10822352, Comp No. 583	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386635&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642798	404855783							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976815	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)C(C)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26FN7O4/c1-15(37)22-5-4-6-25(32-22)33-28(40)24-10-20(29)13-35(24)26(39)14-36-23-8-7-18(19-11-30-17(3)31-12-19)9-21(23)27(34-36)16(2)38/h4-9,11-12,20,24H,10,13-14H2,1-3H3,(H,32,33,40)/t20-,24+/m1/s1	DNUJUMOWWIKKSB-YKSBVNFPSA-N	386636	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- acetylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 584::US10822352, Comp No. 584	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386636&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622937	404855784							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976816	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc2ccccc2c1	InChI=1S/C32H29N5O3/c1-20-7-5-11-29(33-20)34-32(40)28-10-6-16-36(28)30(39)19-37-27-15-14-25(18-26(27)31(35-37)21(2)38)24-13-12-22-8-3-4-9-23(22)17-24/h3-5,7-9,11-15,17-18,28H,6,10,16,19H2,1-2H3,(H,33,34,40)/t28-/m0/s1	NZMNYHVJKWLIOS-NDEPHWFRSA-N	386637	(S)-1-(2-(3- acetyl-5- (naphthalen-2-yl)- 1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 585::US10822352, Comp No. 585	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386637&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642835	404855785							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976817	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc(C)nc1	InChI=1S/C28H28N6O3/c1-17-9-10-21(15-29-17)20-11-12-23-22(14-20)27(19(3)35)32-34(23)16-26(36)33-13-5-7-24(33)28(37)31-25-8-4-6-18(2)30-25/h4,6,8-12,14-15,24H,5,7,13,16H2,1-3H3,(H,30,31,37)/t24-/m0/s1	PSMMURUJHLVMLR-DEOSSOPVSA-N	472309	(S)-1-(2-(3-acetyl-5- (6-methylpyridin-3- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10822352, Comp No. 586	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472309&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642860	441611299							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976818	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc2ccccc2c1	InChI=1S/C31H27N5O3/c1-19-6-5-9-28(32-19)33-31(39)27-14-15-35(27)29(38)18-36-26-13-12-24(17-25(26)30(34-36)20(2)37)23-11-10-21-7-3-4-8-22(21)16-23/h3-13,16-17,27H,14-15,18H2,1-2H3,(H,32,33,39)/t27-/m0/s1	UJRCVVGRWOPIDM-MHZLTWQESA-N	386639	(S)-1-(2-(3- acetyl-5- (naphthalen-2-yl)- 1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 587::US10822352, Comp No. 587	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386639&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622862	404855787							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976819	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc(C)nc1	InChI=1S/C27H26N6O3/c1-16-7-8-20(14-28-16)19-9-10-22-21(13-19)26(18(3)34)31-33(22)15-25(35)32-12-11-23(32)27(36)30-24-6-4-5-17(2)29-24/h4-10,13-14,23H,11-12,15H2,1-3H3,(H,29,30,36)/t23-/m0/s1	DUDVNQLWYANVHJ-QHCPKHFHSA-N	386640	(S)-1-(2-(3- acetyl-5-(6- methylpyridin-3- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 588::US10822352, Comp No. 588	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386640&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623366	404855788							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976820	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc2cccnc2c1	InChI=1S/C31H28N6O3/c1-19-6-3-9-28(33-19)34-31(40)27-8-5-15-36(27)29(39)18-37-26-13-12-22(16-24(26)30(35-37)20(2)38)23-11-10-21-7-4-14-32-25(21)17-23/h3-4,6-7,9-14,16-17,27H,5,8,15,18H2,1-2H3,(H,33,34,40)/t27-/m0/s1	UAGRJUWAWFQGEE-MHZLTWQESA-N	386641	(S)-1-(2-(3- acetyl-5- (quinolin-7-yl)- 1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 589::US10822352, Comp No. 589	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386641&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643060	404855789							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976821	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1ccc2cccnc2c1	InChI=1S/C30H26N6O3/c1-18-5-3-7-27(32-18)33-30(39)26-12-14-35(26)28(38)17-36-25-11-10-21(15-23(25)29(34-36)19(2)37)22-9-8-20-6-4-13-31-24(20)16-22/h3-11,13,15-16,26H,12,14,17H2,1-2H3,(H,32,33,39)/t26-/m0/s1	QKTGXQZCQCTLEO-SANMLTNESA-N	386642	(S)-1-(2-(3- acetyl-5- (quinolin-7-yl)- 1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 590::US10822352, Comp No. 590	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386642&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623334	404855790							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976822	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(OC2CS(=O)(=O)C2)nc1	InChI=1S/C28H25BrFN7O6S/c1-15(38)26-20-7-16(17-9-31-28(32-10-17)43-19-13-44(41,42)14-19)5-6-21(20)37(35-26)12-25(39)36-11-18(30)8-22(36)27(40)34-24-4-2-3-23(29)33-24/h2-7,9-10,18-19,22H,8,11-14H2,1H3,(H,33,34,40)/t18-,22+/m1/s1	RRTTYNPYKNJMKF-GCJKJVERSA-N	386643	(2S,4R)-1-(2-(3- acetyl-5-(2-((1,1- dioxidothietan-3- yl)oxy)pyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 591::US10822352, Comp No. 591	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386643&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622971	404855791							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976823	CC(=O)c1nn(CC(=O)N2CCCC[C@@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrN7O3/c1-16(36)26-20-12-18(19-13-29-17(2)30-14-19)9-10-21(20)35(33-26)15-25(37)34-11-4-3-6-22(34)27(38)32-24-8-5-7-23(28)31-24/h5,7-10,12-14,22H,3-4,6,11,15H2,1-2H3,(H,31,32,38)/t22-/m1/s1	QWQYBGAFNUUSGW-JOCHJYFZSA-N	386644	(R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)piperidine-2- carboxamide::US10287301, Compound 592::US10822352, Comp No. 592	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386644&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622891	404855792							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976824	CC(=O)c1nn(CC(=O)N2CCCC[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrN7O3/c1-16(36)26-20-12-18(19-13-29-17(2)30-14-19)9-10-21(20)35(33-26)15-25(37)34-11-4-3-6-22(34)27(38)32-24-8-5-7-23(28)31-24/h5,7-10,12-14,22H,3-4,6,11,15H2,1-2H3,(H,31,32,38)/t22-/m0/s1	QWQYBGAFNUUSGW-QFIPXVFZSA-N	386645	(S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)piperidine-2- carboxamide::US10287301, Compound 593::US10822352, Comp No. 593	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386645&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623011	404855793							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976825	CC(=O)c1cn(CCN2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26F5N5O3/c1-16(40)22-15-39(24-7-6-18(10-21(22)24)19-12-35-17(2)36-13-19)9-8-38-14-20(30)11-25(38)28(41)37-23-4-3-5-26(27(23)31)42-29(32,33)34/h3-7,10,12-13,15,20,25H,8-9,11,14H2,1-2H3,(H,37,41)/t20-,25+/m1/s1	UBSBUJQBCJDZGK-NLFFAJNJSA-N	386646	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indol-1- yl)ethyl)-4- fluoro-N-(2- fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 594::US10822352, Comp No. 594	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386646&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622947	404855794							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976826	COC(=O)c1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C27H23BrFN7O5/c1-14(37)24-18-8-15(16-10-30-25(31-11-16)27(40)41-2)6-7-19(18)36(34-24)13-23(38)35-12-17(29)9-20(35)26(39)33-22-5-3-4-21(28)32-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,32,33,39)/t17-,20+/m1/s1	NNVNBCMCGYSLOF-XLIONFOSSA-N	386647	US10287301, Compound 596::US10822352, Comp No. 596::methyl 5-(3- acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidine-2- carboxylate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386647&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623452	404855795							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976827	CC(=O)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C27H24BrFN8O4/c1-14(38)25-19-8-16(17-10-30-27(31-11-17)32-15(2)39)6-7-20(19)37(35-25)13-24(40)36-12-18(29)9-21(36)26(41)34-23-5-3-4-22(28)33-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,33,34,41)(H,30,31,32,39)/t18-,21+/m1/s1	JEVJRTNQOHXCQY-NQIIRXRSSA-N	386648	(2S,4R)-1-(2-(5-(2- acetamidopyrimidin- 5-yl)-3-acetyl- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 597::US10822352, Comp No. 597	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386648&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623314	404855796							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976828	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C(O)=O	InChI=1S/C26H21BrFN7O5/c1-13(36)23-17-7-14(15-9-29-24(26(39)40)30-10-15)5-6-18(17)35(33-23)12-22(37)34-11-16(28)8-19(34)25(38)32-21-4-2-3-20(27)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H,39,40)(H,31,32,38)/t16-,19+/m1/s1	XKIQQGXEQJYPPQ-APWZRJJASA-N	386649	5-(3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidine-2- carboxylic acid::US10287301, Compound 598::US10822352, Comp No. 598	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386649&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642983	404855797							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976829	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C(N)=O	InChI=1S/C26H22BrFN8O4/c1-13(37)23-17-7-14(15-9-30-25(24(29)39)31-10-15)5-6-18(17)36(34-23)12-22(38)35-11-16(28)8-19(35)26(40)33-21-4-2-3-20(27)32-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,29,39)(H,32,33,40)/t16-,19+/m1/s1	IGNUUMSEJHJASA-APWZRJJASA-N	386650	5-(3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5- yl)pyrimidine-2- carboxamide::US10287301, Compound 599::US10822352, Comp No. 599	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386650&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642922	404855798							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976830	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(n2)-c2ncco2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H25FN8O4/c1-16(39)27-21-10-18(19-12-32-17(2)33-13-19)6-7-23(21)38(36-27)15-26(40)37-14-20(30)11-24(37)28(41)35-25-5-3-4-22(34-25)29-31-8-9-42-29/h3-10,12-13,20,24H,11,14-15H2,1-2H3,(H,34,35,41)/t20-,24+/m1/s1	AANSXLDCALUQCV-YKSBVNFPSA-N	386651	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(6- (oxazol-2- yl)pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 600::US10822352, Comp No. 600	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386651&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623052	404855799							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976831	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(OCC(F)(F)F)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27F4N7O4/c1-15-4-7-24(44-14-29(31,32)33)36-27(15)37-28(43)23-9-20(30)12-39(23)25(42)13-40-22-6-5-18(19-10-34-17(3)35-11-19)8-21(22)26(38-40)16(2)41/h4-8,10-11,20,23H,9,12-14H2,1-3H3,(H,36,37,43)/t20-,23+/m1/s1	PQDKCODCXLRASG-OFNKIYASSA-N	386652	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(3- methyl-6-(2,2,2- trifluoroethoxy) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 601::US10822352, Comp No. 601	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386652&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623379	404855800							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976832	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ccc2C)C(C)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28F3N7O3/c1-15-5-8-24(29(4,31)32)35-27(15)36-28(42)23-10-20(30)13-38(23)25(41)14-39-22-7-6-18(19-11-33-17(3)34-12-19)9-21(22)26(37-39)16(2)40/h5-9,11-12,20,23H,10,13-14H2,1-4H3,(H,35,36,42)/t20-,23+/m1/s1	RNPKWZMEPDQQJV-OFNKIYASSA-N	386653	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- (1,1-difluoroethyl)- 3-methylpyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 602::US10822352, Comp No. 602	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386653&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642811	404855801							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976833	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2nc(Br)ccc2C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrN7O3/c1-15(39)28-22-9-18(20-12-32-16(2)33-13-20)5-7-23(22)37(36-28)14-27(40)38-24-10-19(24)11-25(38)30(41)35-29-21(17-3-4-17)6-8-26(31)34-29/h5-9,12-13,17,19,24-25H,3-4,10-11,14H2,1-2H3,(H,34,35,41)/t19-,24-,25+/m1/s1	ZEFPTHDJOZGCDY-WVQWTBLQSA-N	386654	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- cyclopropylpyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 603::US10822352, Comp No. 603	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386654&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643010	404855802							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976834	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(O)nc1	InChI=1S/C25H21BrFN7O4/c1-13(35)23-17-7-14(15-9-28-25(38)29-10-15)5-6-18(17)34(32-23)12-22(36)33-11-16(27)8-19(33)24(37)31-21-4-2-3-20(26)30-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H,28,29,38)(H,30,31,37)/t16-,19+/m1/s1	DGIQXCUOJYTGFI-APWZRJJASA-N	386655	(2S,4R)-1-(2-(3- acetyl-5-(2- hydroxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 604::US10822352, Comp No. 604	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386655&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643038	404855803							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976835	CC(=O)c1nn(CC(=O)N2C[C@@H]3C[C@@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-14-4-7-23(29)32-27(14)33-28(39)26-20-9-18(20)12-35(26)24(38)13-36-22-6-5-17(19-10-30-16(3)31-11-19)8-21(22)25(34-36)15(2)37/h4-8,10-11,18,20,26H,9,12-13H2,1-3H3,(H,32,33,39)/t18-,20-,26-/m0/s1	XWMKYPOTZXCMAH-GCOVDLRRSA-N	386656	(1S,2S,5R)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 605::US10822352, Comp No. 605	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386656&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642815	404855804							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976836	COCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H27BrFN7O4/c1-15(38)26-21-8-17(19-10-31-16(2)32-11-19)4-6-22(21)37(35-26)13-25(39)36-12-20(30)9-23(36)28(40)34-27-18(14-41-3)5-7-24(29)33-27/h4-8,10-11,20,23H,9,12-14H2,1-3H3,(H,33,34,40)/t20-,23+/m1/s1	ABCDNMOGVZJZNM-OFNKIYASSA-N	386657	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- (methoxymethyl) pyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 606::US10822352, Comp No. 606	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386657&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622964	404855805							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976837	COC(=O)c1ccc(Br)nc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H25BrFN7O5/c1-14(38)25-20-8-16(17-10-31-15(2)32-11-17)4-6-21(20)37(35-25)13-24(39)36-12-18(30)9-22(36)27(40)34-26-19(28(41)42-3)5-7-23(29)33-26/h4-8,10-11,18,22H,9,12-13H2,1-3H3,(H,33,34,40)/t18-,22+/m1/s1	NOGIRORHXYUCNF-GCJKJVERSA-N	386658	US10287301, Compound 607::US10822352, Comp No. 607::methyl 2- ((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)-6- bromonicotinate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386658&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643170	404855806							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976838	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-14-7-17(18-10-30-16(3)31-11-18)8-20-25(15(2)37)34-36(26(14)20)13-24(38)35-12-19(29)9-21(35)27(39)33-23-6-4-5-22(28)32-23/h4-8,10-11,19,21H,9,12-13H2,1-3H3,(H,32,33,39)/t19-,21+/m1/s1	MWQBMBNCCOPRPL-CTNGQTDRSA-N	386659	(2S,4R)-1-(2-(3- acetyl-7-methyl- 5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 608::US10822352, Comp No. 608	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386659&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622992	404855807							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976839	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2cc(C)c(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrFN7O3/c1-14-7-21-20(9-19(14)17-10-30-16(3)31-11-17)26(15(2)37)34-36(21)13-25(38)35-12-18(29)8-22(35)27(39)33-24-6-4-5-23(28)32-24/h4-7,9-11,18,22H,8,12-13H2,1-3H3,(H,32,33,39)/t18-,22+/m1/s1	XKNSDZMXAVEUBF-GCJKJVERSA-N	386660	(2S,4R)-1-(2-(3- acetyl-6-methyl- 5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 609::US10822352, Comp No. 609	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386660&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643326	404855808							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976840	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(CC(F)(F)F)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H29F4N7O3/c1-15(39)25-21-7-17(18-9-32-16(2)33-10-18)3-4-22(21)38(35-25)13-24(40)37-11-19(28)8-23(37)26(41)34-20-5-6-36(12-20)14-27(29,30)31/h3-4,7,9-10,19-20,23H,5-6,8,11-14H2,1-2H3,(H,34,41)/t19-,20?,23+/m1/s1	JJANSLSRFRFBIQ-HUJVSABWSA-N	386661	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-(1- (2,2,2- trifluoroethyl) pyrrolidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 610::US10822352, Comp No. 610	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386661&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643052	404855809							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976841	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCN(CC(F)(F)F)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H30F3N7O3/c1-15(39)26-21-7-17(19-10-32-16(2)33-11-19)3-4-22(21)37(35-26)13-25(40)38-23-8-18(23)9-24(38)27(41)34-20-5-6-36(12-20)14-28(29,30)31/h3-4,7,10-11,18,20,23-24H,5-6,8-9,12-14H2,1-2H3,(H,34,41)/t18-,20?,23-,24+/m1/s1	WUILUUWBESDBEL-DVTLIPQCSA-N	386662	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(1- (2,2,2- trifluoroethyl) pyrrolidin-3-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 611::US10822352, Comp No. 611	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386662&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643098	404855810							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976842	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCC23CC4CC(CC(C4)C2)C3)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H37FN6O3/c1-18(40)30-26-8-23(24-13-34-19(2)35-14-24)3-4-27(26)39(37-30)16-29(41)38-15-25(33)9-28(38)31(42)36-17-32-10-20-5-21(11-32)7-22(6-20)12-32/h3-4,8,13-14,20-22,25,28H,5-7,9-12,15-17H2,1-2H3,(H,36,42)/t20?,21?,22?,25-,28+,32?/m1/s1	VHPJPIDIGMENDK-PIRRZJPHSA-N	386663	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (((3S,5S,7S)- adamantan-1- yl)methyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 612::US10822352, Comp No. 612	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386663&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642827	404855811							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976843	C[C@@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(F)=C(C)C	InChI=1S/C27H30F2N6O3/c1-14(2)25(29)15(3)32-27(38)23-9-20(28)12-34(23)24(37)13-35-22-7-6-18(19-10-30-17(5)31-11-19)8-21(22)26(33-35)16(4)36/h6-8,10-11,15,20,23H,9,12-13H2,1-5H3,(H,32,38)/t15-,20-,23+/m1/s1	KFZRZBHPKIJHNU-OFSQETHSSA-N	386664	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-((R)-3- fluoro-4- methylpent-3-en- 2-yl)pyrrolidine- 2-carboxamide::US10287301, Compound 613::US10822352, Comp No. 613	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386664&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643056	404855812							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976844	C[C@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(F)=C(C)C	InChI=1S/C27H30F2N6O3/c1-14(2)25(29)15(3)32-27(38)23-9-20(28)12-34(23)24(37)13-35-22-7-6-18(19-10-30-17(5)31-11-19)8-21(22)26(33-35)16(4)36/h6-8,10-11,15,20,23H,9,12-13H2,1-5H3,(H,32,38)/t15-,20+,23-/m0/s1	KFZRZBHPKIJHNU-NQKDMWHGSA-N	386665	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoro-N-((S)-3- fluoro-4- methylpent-3-en- 2-yl)pyrrolidine- 2-carboxamide::US10287301, Compound 614::US10822352, Comp No. 614	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386665&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622846	404855813							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976845	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23BrFN7O5/c1-13(37)24-19-7-15(16-9-30-14(2)31-10-16)3-5-20(19)36(34-24)12-23(38)35-11-17(29)8-21(35)26(39)33-25-18(27(40)41)4-6-22(28)32-25/h3-7,9-10,17,21H,8,11-12H2,1-2H3,(H,40,41)(H,32,33,39)/t17-,21+/m1/s1	OJGZGNZZGSPAFP-UTKZUKDTSA-N	386666	2-((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)- 6-bromonicotinic acid::US10287301, Compound 615::US10822352, Comp No. 615	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386666&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643028	404855814							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976846	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H30BrN7O3/c1-16(40)28-22-10-19(20-13-33-17(2)34-14-20)6-8-23(22)38(37-28)15-27(41)39-24(11-31(3)12-25(31)39)30(42)36-29-21(18-4-5-18)7-9-26(32)35-29/h6-10,13-14,18,24-25H,4-5,11-12,15H2,1-3H3,(H,35,36,42)/t24-,25+,31-/m0/s1	OHJHBZAINWDICU-NTWBYJAHSA-N	386667	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- cyclopropylpyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 616::US10822352, Comp No. 616	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386667&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643096	404855815							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976847	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C4CCC(C4)[C@H]3C(=O)Nc3nc(Br)ccc3C)cc(C(N)=O)c2c1	InChI=1S/C29H28BrN7O3/c1-15-3-8-24(30)34-28(15)35-29(40)26-18-4-6-20(9-18)37(26)25(38)14-36-13-22(27(31)39)21-10-17(5-7-23(21)36)19-11-32-16(2)33-12-19/h3,5,7-8,10-13,18,20,26H,4,6,9,14H2,1-2H3,(H2,31,39)(H,34,35,40)/t18?,20?,26-/m0/s1	FKGBSJNDLJPPPN-OWRPTYIMSA-N	472342	(3R,4S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)- 2-azabicyclo[2.2.1] heptane-3- carboxamide::US10822352, Comp No. 617	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472342&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698566	441611331							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976848	CN(C)C(=O)c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C29H29FN8O4/c1-16(39)27-21-10-18(19-12-31-17(2)32-13-19)8-9-23(21)38(35-27)15-26(40)37-14-20(30)11-24(37)28(41)34-25-7-5-6-22(33-25)29(42)36(3)4/h5-10,12-13,20,24H,11,14-15H2,1-4H3,(H,33,34,41)/t20-,24+/m1/s1	WMJMCCQDOVNEFM-YKSBVNFPSA-N	472343	6-((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)-N,N- dimethylpicolinamide::US10822352, Comp No. 618	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472343	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472343&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643331	441611332							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976849	CNC(=O)c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C28H27FN8O4/c1-15(38)26-20-9-17(18-11-31-16(2)32-12-18)7-8-22(20)37(35-26)14-25(39)36-13-19(29)10-23(36)28(41)34-24-6-4-5-21(33-24)27(40)30-3/h4-9,11-12,19,23H,10,13-14H2,1-3H3,(H,30,40)(H,33,34,41)/t19-,23+/m1/s1	NQUUBGQCZAAXNM-XXBNENTESA-N	472344	6-((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)-N- methylpicolinamide::US10822352, Comp No. 619	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472344&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623590	441611333							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976850	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C28H27BrN8O3/c1-14-4-7-22(29)33-25(14)34-26(40)20-9-28(3)10-21(28)37(20)23(39)13-36-19-6-5-16(17-11-31-27(30)32-12-17)8-18(19)24(35-36)15(2)38/h4-8,11-12,20-21H,9-10,13H2,1-3H3,(H2,30,31,32)(H,33,34,40)/t20-,21+,28-/m0/s1	CQCRLHCHCYMQKD-GTNJKRJXSA-N	386671	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 620::US10822352, Comp No. 620	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386671&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643349	404855819							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976851	CC(C)=C(F)CNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H31FN6O3/c1-15(2)21(29)13-32-27(38)23-9-28(5)10-24(28)35(23)25(37)14-34-22-7-6-18(19-11-30-17(4)31-12-19)8-20(22)26(33-34)16(3)36/h6-8,11-12,23-24H,9-10,13-14H2,1-5H3,(H,32,38)/t23-,24+,28-/m0/s1	SFPALFHRFGNQMX-JPYHZWLXSA-N	386672	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(2- fluoro-3- methylbut-2-en-1- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 621::US10822352, Comp No. 621	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386672&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643177	404855820							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976852	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(F)=C(C)C	InChI=1S/C29H33FN6O3/c1-15(2)26(30)16(3)33-28(39)23-10-29(6)11-24(29)36(23)25(38)14-35-22-8-7-19(20-12-31-18(5)32-13-20)9-21(22)27(34-35)17(4)37/h7-9,12-13,16,23-24H,10-11,14H2,1-6H3,(H,33,39)/t16-,23-,24+,29-/m0/s1	HDEACIXBHXLZFY-HFHNTYOASA-N	386673	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((S)-3-fluoro-4- methylpent-3-en- 2-yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 622::US10822352, Comp No. 622	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386673&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643306	404855821							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976853	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(F)=C(C)C	InChI=1S/C29H33FN6O3/c1-15(2)26(30)16(3)33-28(39)23-10-29(6)11-24(29)36(23)25(38)14-35-22-8-7-19(20-12-31-18(5)32-13-20)9-21(22)27(34-35)17(4)37/h7-9,12-13,16,23-24H,10-11,14H2,1-6H3,(H,33,39)/t16-,23+,24-,29+/m1/s1	HDEACIXBHXLZFY-SFBRURGASA-N	386674	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((R)-3-fluoro-4- methylpent-3-en- 2-yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 623::US10822352, Comp No. 623	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386674&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643110	404855822							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976854	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26F3N7O4/c1-15(40)26-19-9-17(18-12-33-16(2)34-13-18)7-8-20(19)38(37-26)14-25(41)39-21(10-28(3)11-22(28)39)27(42)36-23-5-4-6-24(35-23)43-29(30,31)32/h4-9,12-13,21-22H,10-11,14H2,1-3H3,(H,35,36,42)/t21-,22+,28-/m0/s1	IZCHVCXCDOOGEO-TYPXCFOJSA-N	386675	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-5- methyl-N-(6- (trifluoromethoxy) pyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 624::US10822352, Comp No. 624	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386675&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643384	404855823							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976855	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27F3N8O3/c1-15(40)25-19-8-17(18-11-32-16(2)33-12-18)4-5-20(19)38(36-25)13-24(41)39-21(9-27(3)10-22(27)39)26(42)34-23-6-7-37(35-23)14-28(29,30)31/h4-8,11-12,21-22H,9-10,13-14H2,1-3H3,(H,34,35,42)/t21-,22+,27-/m0/s1	BZCSBICEIONGJV-XXAUWVGASA-N	386676	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-5- methyl-N-(1- (2,2,2- 1H-pyrazol-3-yl)- 2-azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 625::US10822352, Comp No. 625	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386676&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643032	404855824							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976856	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29ClN6O3/c1-17(38)28-23-10-20(21-14-32-18(2)33-15-21)7-8-24(23)36(35-28)16-27(39)37-25(11-30(3)12-26(30)37)29(40)34-13-19-5-4-6-22(31)9-19/h4-10,14-15,25-26H,11-13,16H2,1-3H3,(H,34,40)/t25-,26+,30-/m0/s1	JBQDRPIJODKZIP-MWSYKCOMSA-N	386677	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- chlorobenzyl)-5- methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 626::US10822352, Comp No. 626	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386677&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643239	404855825							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976857	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28ClFN6O3/c1-16(39)28-21-9-18(20-13-33-17(2)34-14-20)7-8-23(21)37(36-28)15-26(40)38-24(10-30(3)11-25(30)38)29(41)35-12-19-5-4-6-22(31)27(19)32/h4-9,13-14,24-25H,10-12,15H2,1-3H3,(H,35,41)/t24-,25+,30-/m0/s1	NLJDKFZAZYOEBX-FVXXUCQHSA-N	386678	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-5- methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 627::US10822352, Comp No. 627	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386678&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642849	404855826							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976858	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCC2CC2(Cl)Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H28Cl2N6O3/c1-14(36)24-19-6-16(17-10-30-15(2)31-11-17)4-5-20(19)34(33-24)13-23(37)35-21(8-26(3)9-22(26)35)25(38)32-12-18-7-27(18,28)29/h4-6,10-11,18,21-22H,7-9,12-13H2,1-3H3,(H,32,38)/t18?,21-,22+,26-/m0/s1	UFBGOQMYSOPGJO-CEUZLIPISA-N	386679	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-((2,2- dichlorocyclopropyl) methyl)-5- methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 628::US10822352, Comp No. 628	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386679&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643126	404855827							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976859	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)[C@H]1CC1(Cl)Cl	InChI=1S/C28H30Cl2N6O3/c1-14(20-8-28(20,29)30)33-26(39)22-9-27(4)10-23(27)36(22)24(38)13-35-21-6-5-17(18-11-31-16(3)32-12-18)7-19(21)25(34-35)15(2)37/h5-7,11-12,14,20,22-23H,8-10,13H2,1-4H3,(H,33,39)/t14-,20-,22+,23-,27+/m1/s1	VAKCXUNETKAZKN-LFJPSELNSA-N	472355	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- ((R)-1-((R)-2,2- dichlorocyclopropyl) ethyl)-5-methyl-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 629	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472355&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643000	441611344							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976860	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H26F4N6O4/c1-15(41)27-19-9-17(18-12-35-16(2)36-13-18)7-8-21(19)39(38-27)14-25(42)40-22(10-29(3)11-24(29)40)28(43)37-20-5-4-6-23(26(20)31)44-30(32,33)34/h4-9,12-13,22,24H,10-11,14H2,1-3H3,(H,37,43)/t22-,24+,29-/m0/s1	QCLOFESTXNFPOE-KNAJXNNHSA-N	386681	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(2- fluoro-3- (trifluoromethoxy) phenyl)-5- methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 630::US10822352, Comp No. 630	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386681&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643627	404855829							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976861	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26F3N7O3/c1-15(40)26-19-9-17(18-12-33-16(2)34-13-18)7-8-20(19)38(37-26)14-25(41)39-21(10-28(3)11-23(28)39)27(42)36-24-6-4-5-22(35-24)29(30,31)32/h4-9,12-13,21,23H,10-11,14H2,1-3H3,(H,35,36,42)/t21-,23+,28-/m0/s1	NTZOOUZZFHTRIS-ZCUZBQTDSA-N	386682	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-5- methyl-N-(6- (trifluoromethyl) pyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 631::US10822352, Comp No. 631	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386682&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643253	404855830							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976862	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C29H28BrN7O4/c1-15-5-8-23(30)33-26(15)34-27(40)21-10-29(3)11-22(29)37(21)24(39)14-36-20-7-6-17(9-19(20)25(35-36)16(2)38)18-12-31-28(41-4)32-13-18/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H,33,34,40)/t21-,22+,29-/m0/s1	QOVKPZZFGFXTOB-KERYWQKISA-N	386683	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 632::US10822352, Comp No. 632	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386683&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643417	404855831							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976863	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C25H22BrFN8O3/c1-13(36)24-17-7-18(15-8-28-14(2)29-9-15)30-10-20(17)35(33-24)12-23(37)34-11-16(27)6-19(34)25(38)32-22-5-3-4-21(26)31-22/h3-5,7-10,16,19H,6,11-12H2,1-2H3,(H,31,32,38)/t16-,19+/m1/s1	PWQVOQUPIQGUIO-APWZRJJASA-N	386684	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H- pyrazolo[3,4- c]pyridin-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 633::US10822352, Comp No. 633	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386684	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386684&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623385	404855832							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976864	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H]4C[C@H]4[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C28H26BrN7O4/c1-14-4-7-22(29)32-26(14)33-27(39)25-19-9-17(19)12-35(25)23(38)13-36-21-6-5-16(8-20(21)24(34-36)15(2)37)18-10-30-28(40-3)31-11-18/h4-8,10-11,17,19,25H,9,12-13H2,1-3H3,(H,32,33,39)/t17-,19-,25+/m1/s1	LWQNJELXGLDMSU-IZJXBPLLSA-N	386685	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 634::US10822352, Comp No. 634	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386685&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642817	404855833							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976865	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(N)nc1	InChI=1S/C27H25BrN8O3/c1-13-3-6-21(28)32-25(13)33-26(39)24-18-8-16(18)11-35(24)22(38)12-36-20-5-4-15(17-9-30-27(29)31-10-17)7-19(20)23(34-36)14(2)37/h3-7,9-10,16,18,24H,8,11-12H2,1-2H3,(H2,29,30,31)(H,32,33,39)/t16-,18-,24+/m1/s1	YZWNEXTYDUZIOJ-OSWMTFESSA-N	386686	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- aminopyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 635::US10822352, Comp No. 635	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386686&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643033	404855834							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976866	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O3/c1-15-6-7-24(31)34-28(15)35-29(41)22-10-30(5)11-23(30)38(22)25(40)14-37-27-16(2)8-19(20-12-32-18(4)33-13-20)9-21(27)26(36-37)17(3)39/h6-9,12-13,22-23H,10-11,14H2,1-5H3,(H,34,35,41)/t22-,23+,30-/m0/s1	JIHUPBGAEWTVSY-BURCIIJTSA-N	386687	(1R,3S,5R)-2-(2- (3-acetyl-7- methyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 636::US10822352, Comp No. 636	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386687&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642787	404855835							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976867	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrN7O3/c1-15(39)27-23-9-18(20-11-32-16(2)33-12-20)5-7-24(23)38(36-27)14-26(40)37-13-19-10-22(19)28(37)30(41)35-29-21(17-3-4-17)6-8-25(31)34-29/h5-9,11-12,17,19,22,28H,3-4,10,13-14H2,1-2H3,(H,34,35,41)/t19-,22-,28+/m1/s1	OHSMWQGTXOBARC-VVDSWQSDSA-N	386688	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- cyclopropylpyridin- 2-yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 637::US10287301, Compound 750::US10822352, Comp No. 750	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386688&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642903	404855836							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976868	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25F3N8O3/c1-14(39)24-20-7-16(18-9-31-15(2)32-10-18)3-4-21(20)38(35-24)12-23(40)37-11-17-8-19(17)25(37)26(41)33-22-5-6-36(34-22)13-27(28,29)30/h3-7,9-10,17,19,25H,8,11-13H2,1-2H3,(H,33,34,41)/t17-,19-,25+/m1/s1	UNQZSLWAOMKHKP-IZJXBPLLSA-N	386689	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3-yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 638::US10822352, Comp No. 638::US11407738, Example 00399	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386689&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642790	404855837							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976869	CN(C)C[C@@]1(F)C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1cccc(Br)n1	InChI=1S/C29H30BrFN8O3/c1-17(40)27-21-10-19(20-12-32-18(2)33-13-20)8-9-22(21)39(36-27)14-26(41)38-16-29(31,15-37(3)4)11-23(38)28(42)35-25-7-5-6-24(30)34-25/h5-10,12-13,23H,11,14-16H2,1-4H3,(H,34,35,42)/t23-,29-/m0/s1	DJGMXGBIBCDECW-IADCTJSHSA-N	386690	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- ((dimethylamino) methyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 639::US10822352, Comp No. 639	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386690&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643049	404855838							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976870	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cncc(n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25F3N8O3/c1-14(40)25-18-6-16(17-9-33-15(2)34-10-17)4-5-19(18)38(37-25)13-24(41)39-20(7-27(3)8-22(27)39)26(42)36-23-12-32-11-21(35-23)28(29,30)31/h4-6,9-12,20,22H,7-8,13H2,1-3H3,(H,35,36,42)/t20-,22+,27-/m0/s1	UDQWMIGWHVVPFA-ZIHSNCGMSA-N	472367	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-5- methyl-N-(6- (trifluoromethyl) pyrazin-2-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 640	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472367&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642807	441611356							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976871	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H]4C[C@H]4[C@H]3C(=O)Nc3nc(Br)ccc3C3CC3)nc(C(C)=O)c2c1	InChI=1S/C30H28BrN7O4/c1-15(39)26-22-9-17(19-11-32-30(42-2)33-12-19)5-7-23(22)38(36-26)14-25(40)37-13-18-10-21(18)27(37)29(41)35-28-20(16-3-4-16)6-8-24(31)34-28/h5-9,11-12,16,18,21,27H,3-4,10,13-14H2,1-2H3,(H,34,35,41)/t18-,21-,27+/m1/s1	RUOJQAYJUCRBER-WOSYXGESSA-N	386692	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methoxypyrimidin- 5-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromo-3- cyclopropylpyridin- 2-yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 641::US10822352, Comp No. 641	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386692&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643215	404855840							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976872	C[C@H]1CC(N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C28H28BrN7O3/c1-15-9-23(28(39)33-27-16(2)5-8-24(29)32-27)35(13-15)25(38)14-36-22-7-6-19(20-11-30-18(4)31-12-20)10-21(22)26(34-36)17(3)37/h5-8,10-12,15,23H,9,13-14H2,1-4H3,(H,32,33,39)/t15-,23?/m0/s1	FYFIVEPCHXDOHL-NGMICRHFSA-N	472369	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4-methylpyrrolidine- 2-carboxamide::US10822352, Comp No. 643	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472369&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698558	441611358							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976873	C[C@@H]1C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C28H28BrN7O3/c1-15-9-23(28(39)33-27-16(2)5-8-24(29)32-27)35(13-15)25(38)14-36-22-7-6-19(20-11-30-18(4)31-12-20)10-21(22)26(34-36)17(3)37/h5-8,10-12,15,23H,9,13-14H2,1-4H3,(H,32,33,39)/t15-,23+/m1/s1	FYFIVEPCHXDOHL-CMJOXMDJSA-N	386694	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- methylpyrrolidine- 2-carboxamide::US10287301, Compound 644::US10822352, Comp No. 644	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386694&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622913	404855842							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976874	CN(C)C[C@@]1(F)C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C30H32BrFN8O3/c1-17-6-9-25(31)35-28(17)36-29(43)24-11-30(32,15-38(4)5)16-39(24)26(42)14-40-23-8-7-20(21-12-33-19(3)34-13-21)10-22(23)27(37-40)18(2)41/h6-10,12-13,24H,11,14-16H2,1-5H3,(H,35,36,43)/t24-,30-/m0/s1	HFKYPZIYNQFXMI-NGQVCNFZSA-N	386695	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-4- ((dimethylamino) methyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 645::US10822352, Comp No. 645	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386695&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643293	404855843							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976875	C[C@H]1CC[C@H](N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C28H28BrN7O3/c1-15-5-10-24(29)32-27(15)33-28(39)23-8-6-16(2)36(23)25(38)14-35-22-9-7-19(20-12-30-18(4)31-13-20)11-21(22)26(34-35)17(3)37/h5,7,9-13,16,23H,6,8,14H2,1-4H3,(H,32,33,39)/t16-,23-/m0/s1	FQNSKPLTBZGEGG-HJPURHCSSA-N	386696	(2S,5S)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5- methylpyrrolidine- 2-carboxamide::US10287301, Compound 646::US10822352, Comp No. 646	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386696&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622997	404855844							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976876	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@H]3C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-14-4-7-24(29)32-27(14)33-28(39)23-10-18-9-22(18)36(23)25(38)13-35-21-6-5-17(19-11-30-16(3)31-12-19)8-20(21)26(34-35)15(2)37/h4-8,11-12,18,22-23H,9-10,13H2,1-3H3,(H,32,33,39)/t18-,22-,23-/m0/s1	YTXAKBLMVGVLGM-TZYHBYERSA-N	386697	(1S,3S,5S)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 647::US10822352, Comp No. 647	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386697&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642883	404855845							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976877	CC(=O)c1nn(CC(=O)N2C[C@H](F)CC2C(=O)Nc2nc(Br)ccc2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H23BrFN7O5/c1-13(37)24-19-7-15(16-9-30-14(2)31-10-16)3-5-20(19)36(34-24)12-23(38)35-11-17(29)8-21(35)26(39)33-25-18(27(40)41)4-6-22(28)32-25/h3-7,9-10,17,21H,8,11-12H2,1-2H3,(H,40,41)(H,32,33,39)/t17-,21?/m1/s1	OJGZGNZZGSPAFP-OQHSHRKDSA-N	386698	2-((2R,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)- 6-bromonicotinic acid::US10287301, Compound 648::US10822352, Comp No. 648	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386698&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126671459	404855846							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976878	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)S(C)=O	InChI=1S/C26H23BrFN7O4S/c1-14(36)24-18-8-15(16-10-29-26(30-11-16)40(2)39)6-7-19(18)35(33-24)13-23(37)34-12-17(28)9-20(34)25(38)32-22-5-3-4-21(27)31-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,31,32,38)/t17-,20+,40?/m1/s1	MLBZOBHASQNKKU-FVFIPPBDSA-N	386699	(2S,4R)-1-(2-(3- acetyl-5-(2- (methylsulfinyl) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 649::US10822352, Comp No. 649	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386699&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622276	404855847							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976879	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(Cl)nc1	InChI=1S/C25H20BrClFN7O3/c1-13(36)23-17-7-14(15-9-29-25(27)30-10-15)5-6-18(17)35(33-23)12-22(37)34-11-16(28)8-19(34)24(38)32-21-4-2-3-20(26)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H,31,32,38)/t16-,19+/m1/s1	KNBMAZHAANNWBF-APWZRJJASA-N	386700	(2S,4R)-1-(2-(3- acetyl-5-(2- chloropyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 651::US10822352, Comp No. 651	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386700&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623218	404855848							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976880	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-14-5-6-23(30)33-28(14)34-29(40)27-21-9-19(21)12-36(27)24(39)13-37-26-15(2)7-18(20-10-31-17(4)32-11-20)8-22(26)25(35-37)16(3)38/h5-8,10-11,19,21,27H,9,12-13H2,1-4H3,(H,33,34,40)/t19-,21-,27+/m1/s1	MMBZUPLBAKKQLI-ZOIIRCJOSA-N	472377	(1R,2S,5S)-3-(2- (3-acetyl-7-methyl-5- (2-methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-3- azabicyclo[3.1.0] hexane-2-carboxamide::US10822352, Comp No. 652	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472377&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642985	441611366							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976881	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccc2nc(C)cn2c1	InChI=1S/C28H24BrFN8O3/c1-15-11-36-12-18(4-6-25(36)32-15)17-3-5-21-20(7-17)27(16(2)39)35-38(21)14-26(40)37-13-19(30)8-22(37)28(41)34-24-10-31-9-23(29)33-24/h3-7,9-12,19,22H,8,13-14H2,1-2H3,(H,33,34,41)/t19-,22+/m1/s1	PHWCWGHZOLEJID-KNQAVFIVSA-N	386702	(2S,4R)-1-(2-(3- acetyl-5-(2- methylimidazo[1, 2-a]pyridin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 654::US10822352, Comp No. 654	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386702&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622874	404855849							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976882	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1	InChI=1S/C29H25BrFN9O3/c1-15(41)28-20-6-17(18-9-33-26-8-21(16-2-3-16)36-40(26)12-18)4-5-22(20)39(37-28)14-27(42)38-13-19(31)7-23(38)29(43)35-25-11-32-10-24(30)34-25/h4-6,8-12,16,19,23H,2-3,7,13-14H2,1H3,(H,34,35,43)/t19-,23+/m1/s1	BDTAJFWVXXOPRT-XXBNENTESA-N	472380	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrazolo [1,5-a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2-yl)- 4-fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 655	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472380&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623240	441611369							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976883	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H25F4N7O4/c1-16-8-26-35-11-19(12-41(26)38-16)18-6-7-23-21(9-18)22(17(2)42)14-39(23)15-28(43)40-13-20(31)10-24(40)29(44)37-25-4-3-5-27(36-25)45-30(32,33)34/h3-9,11-12,14,20,24H,10,13,15H2,1-2H3,(H,36,37,44)/t20-,24+/m1/s1	YBLZCECQPJHBBL-YKSBVNFPSA-N	472381	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5-a] pyrimidin-6-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethoxy) pyridin-2- yl)pyrrolidine-2- carboxamide::US10822352, Comp No. 656	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472381&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623187	441611370							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976884	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H27BrFN7O3/c1-16-6-26(31)34-27(7-16)35-30(42)25-10-21(32)13-38(25)29(41)15-37-14-23(18(3)40)22-9-19(4-5-24(22)37)20-11-33-28-8-17(2)36-39(28)12-20/h4-9,11-12,14,21,25H,10,13,15H2,1-3H3,(H,34,35,42)/t21-,25+/m1/s1	QHQHQPPANJKBBQ-BWKNWUBXSA-N	472382	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5-a] pyrimidin-6-yl)-1H- indol-1-yl)acetyl)-N- (6-bromo-4- methylpyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 657	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472382&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643263	441611371							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976885	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)F)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H25F3N8O4/c1-15-8-24-33-11-18(12-40(24)36-15)17-6-7-21-20(9-17)27(16(2)41)37-39(21)14-26(42)38-13-19(30)10-22(38)28(43)35-23-4-3-5-25(34-23)44-29(31)32/h3-9,11-12,19,22,29H,10,13-14H2,1-2H3,(H,34,35,43)/t19-,22+/m1/s1	DYJXGDDZBYHXQX-KNQAVFIVSA-N	386706	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- (difluoromethoxy) pyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 658::US10822352, Comp No. 658	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386706&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623153	404855851							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976886	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccc2nc(C)nn2c1	InChI=1S/C28H24BrN9O3/c1-14(39)27-19-7-16(17-4-6-25-31-15(2)34-37(25)12-17)3-5-20(19)36(35-27)13-26(40)38-21-8-18(21)9-22(38)28(41)33-24-11-30-10-23(29)32-24/h3-7,10-12,18,21-22H,8-9,13H2,1-2H3,(H,32,33,41)/t18-,21-,22+/m1/s1	HCZPXBQBNWELJL-QIJUGHKUSA-N	472384	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methyl-[1,2,4]triazolo [1,5-a]pyridin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2-yl)2- azabicyclo[3.1.0] hexane-3- carboxamide::US10822352, Comp No. 659	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472384&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642993	441611373							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976887	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc2nc(C)nn2c1	InChI=1S/C29H25BrN8O3/c1-15(39)28-20-10-17(18-7-9-26-31-16(2)34-37(26)13-18)6-8-21(20)36(35-28)14-27(40)38-22-11-19(22)12-23(38)29(41)33-25-5-3-4-24(30)32-25/h3-10,13,19,22-23H,11-12,14H2,1-2H3,(H,32,33,41)/t19-,22-,23+/m1/s1	LQIUJAYNXVHSJS-PTUXOGIPSA-N	386708	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methyl- [1,2,4]triazolo[1,5- a]pyridin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 660::US10822352, Comp No. 660	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386708&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642988	404855852							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976888	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccn2nc(C)nc2c1	InChI=1S/C28H24BrFN8O3/c1-15(39)27-20-10-17(18-8-9-37-25(11-18)31-16(2)34-37)6-7-21(20)38(35-27)14-26(40)36-13-19(30)12-22(36)28(41)33-24-5-3-4-23(29)32-24/h3-11,19,22H,12-14H2,1-2H3,(H,32,33,41)/t19-,22+/m1/s1	HHPKVWXIDJPFHR-KNQAVFIVSA-N	386709	(2S,4R)-1-(2-(3- acetyl-5-(2- methyl- [1,2,4]triazolo[1,5- a]pyridin-7-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 661::US10822352, Comp No. 661	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386709&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642924	404855853							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976889	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H25BrFN9O3/c1-14-6-24-32-9-18(11-39(24)35-14)17-4-5-21-20(7-17)26(16(3)40)36-38(21)13-25(41)37-12-19(30)8-22(37)28(42)34-23-10-31-15(2)27(29)33-23/h4-7,9-11,19,22H,8,12-13H2,1-3H3,(H,33,34,42)/t19-,22+/m1/s1	XPYLPQCPQBCTFV-KNQAVFIVSA-N	386710	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 662::US10822352, Comp No. 662	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386710&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643055	404855854							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976890	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1ccc2nc(C)nn2c1	InChI=1S/C28H25BrFN9O3/c1-14-27(29)33-23(10-31-14)34-28(42)22-9-19(30)12-37(22)25(41)13-38-21-6-4-17(8-20(21)26(36-38)15(2)40)18-5-7-24-32-16(3)35-39(24)11-18/h4-8,10-11,19,22H,9,12-13H2,1-3H3,(H,33,34,42)/t19-,22+/m1/s1	HVNUSNKPBABROZ-KNQAVFIVSA-N	386711	(2S,4R)-1-(2-(3- acetyl-5-(2- methyl- [1,2,4]triazolo[1,5- a]pyridin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 663::US10822352, Comp No. 663	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386711&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623144	404855855							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976891	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C27H22BrN9O3/c1-14(38)26-18-6-15(17-9-30-24-4-5-31-36(24)12-17)2-3-19(18)35(34-26)13-25(39)37-20-7-16(20)8-21(37)27(40)33-23-11-29-10-22(28)32-23/h2-6,9-12,16,20-21H,7-8,13H2,1H3,(H,32,33,40)/t16-,20-,21+/m1/s1	XVZXNCUPGGYQMV-HBGVWJBISA-N	386712	(1R,3S,5R)-2-(2- (3-acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 664::US10822352, Comp No. 664	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386712&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642951	404855856							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976892	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C27H23BrFN9O3/c1-14-26(28)33-22(10-30-14)34-27(41)21-8-18(29)12-36(21)24(40)13-37-20-4-3-16(7-19(20)25(35-37)15(2)39)17-9-31-23-5-6-32-38(23)11-17/h3-7,9-11,18,21H,8,12-13H2,1-2H3,(H,33,34,41)/t18-,21+/m1/s1	QZAIEFKCDHTHPO-NQIIRXRSSA-N	386713	(2S,4R)-1-(2-(3- acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 665::US10822352, Comp No. 665	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386713&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643087	404855857							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976893	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H26BrN9O3/c1-14-6-25-32-10-19(12-38(25)35-14)17-4-5-21-20(7-17)27(16(3)40)36-37(21)13-26(41)39-22-8-18(22)9-23(39)29(42)34-24-11-31-15(2)28(30)33-24/h4-7,10-12,18,22-23H,8-9,13H2,1-3H3,(H,33,34,42)/t18-,22-,23+/m1/s1	YKLFFNOSXPEQPS-YSZBQJHXSA-N	386714	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 666::US10822352, Comp No. 666	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386714&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643298	404855858							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976894	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C28H24BrN9O3/c1-14-27(29)33-23(11-30-14)34-28(41)22-9-17-8-21(17)38(22)25(40)13-36-20-4-3-16(7-19(20)26(35-36)15(2)39)18-10-31-24-5-6-32-37(24)12-18/h3-7,10-12,17,21-22H,8-9,13H2,1-2H3,(H,33,34,41)/t17-,21-,22+/m1/s1	OZJUETFWLMDKQZ-YHYVQYDKSA-N	386715	(1R,3S,5R)-2-(2- (3-acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 667::US10822352, Comp No. 667	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386715&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642971	404855859							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976895	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C28H22F4N8O4/c1-15(41)26-19-9-16(17-11-33-23-7-8-34-40(23)12-17)5-6-20(19)39(37-26)14-25(42)38-13-18(29)10-21(38)27(43)36-22-3-2-4-24(35-22)44-28(30,31)32/h2-9,11-12,18,21H,10,13-14H2,1H3,(H,35,36,43)/t18-,21+/m1/s1	JLQFSTITQHMLOF-NQIIRXRSSA-N	472394	(2S,4R)-1-(2-(3-acetyl- 5-(pyrazolo[1,5-a] pyrimidin-6-yl)-1H- indazol-1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethoxy) pyridin-2-yl) pyrrolidine-2- carboxamide::US10822352, Comp No. 668	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472394&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622930	441611383							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976896	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1	InChI=1S/C30H26BrN9O3/c1-15(41)29-20-6-17(19-10-33-27-9-21(16-2-3-16)36-39(27)13-19)4-5-22(20)38(37-29)14-28(42)40-23-7-18(23)8-24(40)30(43)35-26-12-32-11-25(31)34-26/h4-6,9-13,16,18,23-24H,2-3,7-8,14H2,1H3,(H,34,35,43)/t18-,23-,24+/m1/s1	HEVFPNJCYFVHPU-QFWMQHCXSA-N	386717	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- cyclopropylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 669::US10822352, Comp No. 669	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386717&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623453	404855861							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976897	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H25F3N8O4/c1-15-8-25-34-12-19(13-40(25)37-15)17-6-7-21-20(9-17)28(16(2)42)38-39(21)14-27(43)41-22-10-18(22)11-23(41)29(44)36-24-4-3-5-26(35-24)45-30(31,32)33/h3-9,12-13,18,22-23H,10-11,14H2,1-2H3,(H,35,36,44)/t18-,22-,23+/m1/s1	QVVDUTDTHFXOQS-YSZBQJHXSA-N	386718	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- (trifluoromethoxy) pyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 670::US10822352, Comp No. 670	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386718&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642916	404855862							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976898	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc2ccnn2c1	InChI=1S/C29H23F3N8O4/c1-15(41)27-19-9-16(18-12-33-24-7-8-34-39(24)13-18)5-6-20(19)38(37-27)14-26(42)40-21-10-17(21)11-22(40)28(43)36-23-3-2-4-25(35-23)44-29(30,31)32/h2-9,12-13,17,21-22H,10-11,14H2,1H3,(H,35,36,43)/t17-,21-,22+/m1/s1	AGDBGZMJQBSBNK-YHYVQYDKSA-N	386719	(1R,3S,5R)-2-(2- (3-acetyl-5- (pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- (trifluoromethoxy) pyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 671::US10822352, Comp No. 671	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386719&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643243	404855863							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976899	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1	InChI=1S/C31H26F4N8O4/c1-16(44)29-21-9-18(19-12-36-26-11-22(17-5-6-17)39-43(26)13-19)7-8-23(21)42(40-29)15-28(45)41-14-20(32)10-24(41)30(46)38-25-3-2-4-27(37-25)47-31(33,34)35/h2-4,7-9,11-13,17,20,24H,5-6,10,14-15H2,1H3,(H,37,38,46)/t20-,24+/m1/s1	TVZUJKBSWXOHFD-YKSBVNFPSA-N	386720	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-4- fluoro-N-(6- (trifluoromethoxy) pyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 672::US10822352, Comp No. 672	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386720&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623540	404855864							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976900	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1	InChI=1S/C31H27BrN8O3/c1-16(41)30-21-9-18(20-13-33-28-12-22(17-5-6-17)36-39(28)14-20)7-8-23(21)38(37-30)15-29(42)40-24-10-19(24)11-25(40)31(43)35-27-4-2-3-26(32)34-27/h2-4,7-9,12-14,17,19,24-25H,5-6,10-11,15H2,1H3,(H,34,35,43)/t19-,24-,25+/m1/s1	XRSSRQHKTRWOAZ-WVQWTBLQSA-N	386721	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- cyclopropylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 673::US10822352, Comp No. 673	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386721&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642943	404855865							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976901	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1	InChI=1S/C30H26BrFN8O3/c1-16(41)29-21-9-18(19-12-33-27-11-22(17-5-6-17)36-40(27)13-19)7-8-23(21)39(37-29)15-28(42)38-14-20(32)10-24(38)30(43)35-26-4-2-3-25(31)34-26/h2-4,7-9,11-13,17,20,24H,5-6,10,14-15H2,1H3,(H,34,35,43)/t20-,24+/m1/s1	UKNPEZWJMLVMAR-YKSBVNFPSA-N	386722	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 674::US10822352, Comp No. 674	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386722&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643075	404855866							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976902	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C1CC1	InChI=1S/C30H27BrFN9O3/c1-15-29(31)35-25(11-33-15)36-30(44)24-8-20(32)13-39(24)27(43)14-40-23-6-5-18(7-21(23)28(38-40)16(2)42)19-10-34-26-9-22(17-3-4-17)37-41(26)12-19/h5-7,9-12,17,20,24H,3-4,8,13-14H2,1-2H3,(H,35,36,44)/t20-,24+/m1/s1	BERLHTHNDDKSCG-YKSBVNFPSA-N	386723	(2S,4R)-1-(2-(3- acetyl-5-(2- cyclopropylpyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromo-5- methylpyrazin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 675::US10822352, Comp No. 675	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386723&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643011	404855867							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976903	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(Cl)cc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H23BrClFN8O3/c1-14-5-25-32-10-17(11-39(25)35-14)16-3-4-21-20(6-16)27(15(2)40)36-38(21)13-26(41)37-12-19(31)9-22(37)28(42)34-24-8-18(30)7-23(29)33-24/h3-8,10-11,19,22H,9,12-13H2,1-2H3,(H,33,34,42)/t19-,22+/m1/s1	NWTSQZFZCQYERA-KNQAVFIVSA-N	386724	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- chloropyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 676::US10822352, Comp No. 676	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386724&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642968	404855868							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976904	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnn2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C27H24FN9O3/c1-15-8-24-29-11-18(12-37(24)33-15)17-5-6-21-20(9-17)26(16(2)38)34-36(21)14-25(39)35-13-19(28)10-22(35)27(40)31-23-4-3-7-30-32-23/h3-9,11-12,19,22H,10,13-14H2,1-2H3,(H,31,32,40)/t19-,22+/m1/s1	VQAWCSQZYBJUGN-KNQAVFIVSA-N	386725	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-4- fluoro-N- (pyridazin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 677::US10822352, Comp No. 677	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386725&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642841	404855869							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976905	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C28H25F4N9O3/c1-15-7-24-33-10-18(11-41(24)35-15)17-3-4-21-20(8-17)26(16(2)42)37-40(21)13-25(43)39-12-19(29)9-22(39)27(44)34-23-5-6-38(36-23)14-28(30,31)32/h3-8,10-11,19,22H,9,12-14H2,1-2H3,(H,34,36,44)/t19-,22+/m1/s1	HVKPSKKXXNRJAT-KNQAVFIVSA-N	386726	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-4- fluoro-N-(1- (2,2,2- trifluoroethyl)- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 678::US10822352, Comp No. 678	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386726&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642906	404855870							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976906	COC(=O)Cc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc3cc(C)nn3c2)n1	InChI=1S/C31H29FN8O5/c1-17-9-27-33-13-20(14-40(27)36-17)19-7-8-24-23(10-19)30(18(2)41)37-39(24)16-28(42)38-15-21(32)11-25(38)31(44)35-26-6-4-5-22(34-26)12-29(43)45-3/h4-10,13-14,21,25H,11-12,15-16H2,1-3H3,(H,34,35,44)/t21-,25+/m1/s1	GKZHWMNYXBTBSA-BWKNWUBXSA-N	386727	US10287301, Compound 679::US10822352, Comp No. 679::methyl 2-(6- ((2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido) pyridin-2-yl)acetate	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386727&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643080	404855871							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976907	CC(C)c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc3cc(C)nn3c2)n1	InChI=1S/C31H31FN8O3/c1-17(2)24-6-5-7-27(34-24)35-31(43)26-12-22(32)15-38(26)29(42)16-39-25-9-8-20(11-23(25)30(37-39)19(4)41)21-13-33-28-10-18(3)36-40(28)14-21/h5-11,13-14,17,22,26H,12,15-16H2,1-4H3,(H,34,35,43)/t22-,26+/m1/s1	WKGUAARTWFDQAA-GJZUVCINSA-N	386728	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1.5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-4- fluoro-N-(6- isopropylpyridin- 2-yl)pyrrolidine- 2-carboxamide::US10287301, Compound 680::US10822352, Comp No. 680	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386728&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643232	404855872							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976908	CCc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C29H26BrFN8O3/c1-3-20-11-26-32-12-18(13-39(26)35-20)17-7-8-22-21(9-17)28(16(2)40)36-38(22)15-27(41)37-14-19(31)10-23(37)29(42)34-25-6-4-5-24(30)33-25/h4-9,11-13,19,23H,3,10,14-15H2,1-2H3,(H,33,34,42)/t19-,23+/m1/s1	YJHYGVRHJWKKQZ-XXBNENTESA-N	386729	(2S,4R)-1-(2-(3- acetyl-5-(2- ethylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 681::US10822352, Comp No. 681	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386729&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623457	404855873							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976909	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C(C)(C)C	InChI=1S/C31H30BrFN8O3/c1-17(42)29-21-10-18(19-13-34-27-12-24(31(2,3)4)37-41(27)14-19)8-9-22(21)40(38-29)16-28(43)39-15-20(33)11-23(39)30(44)36-26-7-5-6-25(32)35-26/h5-10,12-14,20,23H,11,15-16H2,1-4H3,(H,35,36,44)/t20-,23+/m1/s1	RKEWSTIDCRBRCT-OFNKIYASSA-N	386730	(2S,4R)-1-(2-(3- acetyl-5-(2-(tert- butyl)pyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 682::US10822352, Comp No. 682	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386730&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623401	404855874							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976910	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(F)nn2c1	InChI=1S/C27H21BrF2N8O3/c1-14(39)26-18-7-15(16-10-31-24-9-22(30)34-38(24)11-16)5-6-19(18)37(35-26)13-25(40)36-12-17(29)8-20(36)27(41)33-23-4-2-3-21(28)32-23/h2-7,9-11,17,20H,8,12-13H2,1H3,(H,32,33,41)/t17-,20+/m1/s1	ZQBGKHBAFXTAIY-XLIONFOSSA-N	386731	(2S,4R)-1-(2-(3- acetyl-5-(2- fluoropyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 683::US10822352, Comp No. 683	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386731&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643255	404855875							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976911	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(nn2c1)C(F)(F)F	InChI=1S/C28H21BrF4N8O3/c1-14(42)26-18-7-15(16-10-34-24-9-21(28(31,32)33)37-41(24)11-16)5-6-19(18)40(38-26)13-25(43)39-12-17(30)8-20(39)27(44)36-23-4-2-3-22(29)35-23/h2-7,9-11,17,20H,8,12-13H2,1H3,(H,35,36,44)/t17-,20+/m1/s1	UYYXWCJPXFBYFO-XLIONFOSSA-N	386732	(2S,4R)-1-(2-(3- acetyl-5-(2- (trifluoromethyl) pyrazolo[1,5- a]pyrimidin-6-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 684::US10822352, Comp No. 684	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386732&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643022	404855876							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976912	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccc2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C31H29FN6O3/c1-19-10-29-33-14-23(15-38(29)35-19)22-8-9-27-25(11-22)26(20(2)39)17-36(27)18-30(40)37-16-24(32)12-28(37)31(41)34-13-21-6-4-3-5-7-21/h3-11,14-15,17,24,28H,12-13,16,18H2,1-2H3,(H,34,41)/t24-,28+/m1/s1	PGRGUTBTABKMTG-YWEHKCAJSA-N	386733	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)acetyl)-N- benzyl-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 685::US10822352, Comp No. 685	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386733&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642863	404855877							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976913	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCc2ccccc2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C32H31FN6O3/c1-20-12-30-35-15-24(16-39(30)36-20)23-8-9-28-26(13-23)27(21(2)40)18-37(28)19-31(41)38-17-25(33)14-29(38)32(42)34-11-10-22-6-4-3-5-7-22/h3-9,12-13,15-16,18,25,29H,10-11,14,17,19H2,1-2H3,(H,34,42)/t25-,29+/m1/s1	XDHCQFXZOSNBJA-IRPSRAIASA-N	386734	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)acetyl)-4- fluoro-N- phenethylpyrrolidine- 2-carboxamide::US10287301, Compound 686::US10822352, Comp No. 686	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386734&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643432	404855878							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976914	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCc2ccccc2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C33H33FN6O3/c1-21-13-31-36-16-25(17-40(31)37-21)24-10-11-29-27(14-24)28(22(2)41)19-38(29)20-32(42)39-18-26(34)15-30(39)33(43)35-12-6-9-23-7-4-3-5-8-23/h3-5,7-8,10-11,13-14,16-17,19,26,30H,6,9,12,15,18,20H2,1-2H3,(H,35,43)/t26-,30+/m1/s1	OMAMYBFIZNGTFI-VIZCGCQYSA-N	386735	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)acetyl)-4- fluoro-N-(3- phenylpropyl) pyrrolidine-2- carboxamide::US10287301, Compound 687::US10822352, Comp No. 687	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386735&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643144	404855879							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976915	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCCc2ccccc2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C34H35FN6O3/c1-22-14-32-37-17-26(18-41(32)38-22)25-11-12-30-28(15-25)29(23(2)42)20-39(30)21-33(43)40-19-27(35)16-31(40)34(44)36-13-7-6-10-24-8-4-3-5-9-24/h3-5,8-9,11-12,14-15,17-18,20,27,31H,6-7,10,13,16,19,21H2,1-2H3,(H,36,44)/t27-,31+/m1/s1	WECWIVBDEQIDDP-JOMNFKBKSA-N	386736	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)acetyl)-4- fluoro-N-(4- phenylbutyl) pyrrolidine-2- carboxamide::US10287301, Compound 688::US10822352, Comp No. 688	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386736&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643012	404855880							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976916	CC(=O)c1nn(CC(=O)N2CC3CC2(C3)C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H25BrN8O3/c1-16-8-25-31-12-20(14-38(25)34-16)19-6-7-22-21(9-19)27(17(2)39)35-37(22)15-26(40)36-13-18-10-29(36,11-18)28(41)33-24-5-3-4-23(30)32-24/h3-9,12,14,18H,10-11,13,15H2,1-2H3,(H,32,33,41)	HINPHPBBHDNCLL-UHFFFAOYSA-N	472416	2-(2-(3-acetyl-5-(2- methylpyrazolo [1,5-a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-2-azabicyclo[2.1.1] hexane-1-carboxamide::US10822352, Comp No. 689	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472416&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642907	441611405							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976917	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C4CCC(C4)C3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C31H30N8O3/c1-17-4-3-5-26(34-17)35-31(42)29-20-6-8-22(11-20)39(29)28(40)16-37-15-24(30(32)41)23-12-19(7-9-25(23)37)21-13-33-27-10-18(2)36-38(27)14-21/h3-5,7,9-10,12-15,20,22,29H,6,8,11,16H2,1-2H3,(H2,32,41)(H,34,35,42)	LRQLDDGUQBWBTA-UHFFFAOYSA-N	386738	5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1-(2-((1R,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 691::US10287301, Compound 730::US10822352, Comp No. 730	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386738&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654094	404855882							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976918	CC(=O)c1cn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C29H27N7O3/c1-17-5-4-6-26(31-17)32-29(39)25-9-10-35(25)28(38)16-34-15-23(19(3)37)22-12-20(7-8-24(22)34)21-13-30-27-11-18(2)33-36(27)14-21/h4-8,11-15,25H,9-10,16H2,1-3H3,(H,31,32,39)/t25-/m0/s1	VEDNQXCVOGWSFU-VWLOTQADSA-N	386739	(S)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 692::US10822352, Comp No. 692	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386739&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642945	404855883							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976919	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnn2CCCc12	InChI=1S/C27H25BrFN7O3/c1-15(37)26-18-10-16(19-12-30-35-9-3-4-20(19)35)7-8-21(18)36(33-26)14-25(38)34-13-17(29)11-22(34)27(39)32-24-6-2-5-23(28)31-24/h2,5-8,10,12,17,22H,3-4,9,11,13-14H2,1H3,(H,31,32,39)/t17-,22+/m1/s1	IJWCVHKCMRLWFQ-VGSWGCGISA-N	386740	(2S,4R)-1-(2-(3- acetyl-5-(5,6- dihydro-4H- pyrrolo[1,2- b]pyrazol-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 693::US10822352, Comp No. 693	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386740&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623267	404855884							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976920	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc3ncccn23)n1	InChI=1S/C30H28N8O3/c1-17-4-2-5-25(34-17)35-29(41)27-19-6-8-20(12-19)38(27)26(39)16-36-15-22(28(31)40)21-13-18(7-9-23(21)36)24-14-33-30-32-10-3-11-37(24)30/h2-5,7,9-11,13-15,19-20,27H,6,8,12,16H2,1H3,(H2,31,40)(H,34,35,41)/t19?,20?,27-/m0/s1	VVVFCLJPWITULG-IRQSHYTFSA-N	386741	5-(imidazo[1,2- a]pyrimidin-3-yl)- 1-(2-((1R,3S,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 695::US10822352, Comp No. 695	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386741&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126653870	404855885							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976921	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnn(c1)-c1ncccn1	InChI=1S/C28H23BrFN9O3/c1-16(40)26-20-10-17(18-12-33-39(13-18)28-31-8-3-9-32-28)6-7-21(20)38(36-26)15-25(41)37-14-19(30)11-22(37)27(42)35-24-5-2-4-23(29)34-24/h2-10,12-13,19,22H,11,14-15H2,1H3,(H,34,35,42)/t19-,22+/m1/s1	QVFGLICGBWILRN-KNQAVFIVSA-N	386742	(2S,4R)-1-(2-(3- acetyl-5-(1- (pyrimidin-2-yl)- 1H-pyrazol-4-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 696::US10822352, Comp No. 696	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386742&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643089	404855886							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976922	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2CCNS(=O)(=O)c2ccccc2)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C31H31FN6O4S/c1-20-12-30-33-15-23(16-38(30)35-20)22-8-9-29-27(13-22)28(21(2)39)18-36(29)19-31(40)37-17-24(32)14-25(37)10-11-34-43(41,42)26-6-4-3-5-7-26/h3-9,12-13,15-16,18,24-25,34H,10-11,14,17,19H2,1-2H3/t24-,25-/m1/s1	KNPPRNDFSBROEV-JWQCQUIFSA-N	386743	N-(2-((2R,4R)-1- (2-(3-acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)acetyl)-4- fluoropyrrolidin- 2-yl)ethyl) benzenesulfonamide::US10287301, Compound 697::US10822352, Comp No. 697	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386743&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642992	404855887							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976923	Cc1cccc(NC(=O)C2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2cnc3CCCCn23)n1	InChI=1S/C31H33N7O3/c1-18-5-4-6-26(34-18)35-31(41)29-20-8-10-21(13-20)38(29)28(39)17-36-16-23(30(32)40)22-14-19(9-11-24(22)36)25-15-33-27-7-2-3-12-37(25)27/h4-6,9,11,14-16,20-21,29H,2-3,7-8,10,12-13,17H2,1H3,(H2,32,40)(H,34,35,41)	JTSZRCGGZHYTBB-UHFFFAOYSA-N	386744	1-(2-((1R,3R,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5- (5,6,7,8- tetrahydroimidazo [1,2-a]pyridin-3- yl)-1H-indole-3- carboxamide::US10287301, Compound 698::US10822352, Comp No. 698	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386744&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654096	404855888							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976924	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnn(c1)-c1ncc(F)cn1	InChI=1S/C28H22BrF2N9O3/c1-15(41)26-20-7-16(17-9-34-40(12-17)28-32-10-19(31)11-33-28)5-6-21(20)39(37-26)14-25(42)38-13-18(30)8-22(38)27(43)36-24-4-2-3-23(29)35-24/h2-7,9-12,18,22H,8,13-14H2,1H3,(H,35,36,43)/t18-,22+/m1/s1	WOFVUHHNZXMURH-GCJKJVERSA-N	386745	(2S,4R)-1-(2-(3- acetyl-5-(1-(5- fluoropyrimidin- 2-yl)-1H-pyrazol- 4-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 699::US10822352, Comp No. 699	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386745&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642830	404855889							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976925	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc2CCCCn12	InChI=1S/C29H31N7O3/c1-18-7-5-9-25(31-18)32-29(39)23-8-6-14-35(23)27(38)17-36-22-12-11-20(15-21(22)28(33-36)19(2)37)24-16-30-26-10-3-4-13-34(24)26/h5,7,9,11-12,15-16,23H,3-4,6,8,10,13-14,17H2,1-2H3,(H,31,32,39)/t23-/m0/s1	BFOIGDIAKKZVBQ-QHCPKHFHSA-N	386746	(S)-1-(2-(3- acetyl-5-(5,6,7,8- tetrahydroimidazo [1,2-a]pyridin-3- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 700::US10822352, Comp No. 700	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386746&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623295	404855890							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976926	CC(=O)c1cn(CCN2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C31H27F5N6O3/c1-17-10-28-37-13-20(14-42(28)39-17)19-6-7-25-22(11-19)23(18(2)43)16-41(25)9-8-40-15-21(32)12-26(40)30(44)38-24-4-3-5-27(29(24)33)45-31(34,35)36/h3-7,10-11,13-14,16,21,26H,8-9,12,15H2,1-2H3,(H,38,44)/t21-,26+/m1/s1	WOKMCYLUDIUVOX-RLWLMLJZSA-N	386747	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indol-1- yl)ethyl)-4- fluoro-N-(2- fluoro-3- (trifluoromethoxy) phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 701::US10822352, Comp No. 701	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386747&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623261	404855891							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976927	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)C1=CNC(=O)[N](C)=C1	InChI=1S/C26H24BrFN7O4/c1-14(36)24-18-8-15(16-10-29-26(39)33(2)11-16)6-7-19(18)35(32-24)13-23(37)34-12-17(28)9-20(34)25(38)31-22-5-3-4-21(27)30-22/h3-8,10-11,17,20H,9,12-13H2,1-2H3,(H,29,39)(H,30,31,38)/t17-,20+/m1/s1	UDKJZXDQYHZZIY-XLIONFOSSA-N	472428	(2S,4R)-1-(2-(3- acetyl-5-(1- methyl-2-oxo-1,2- dihydropyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 702	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472428&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698578	441611417							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976928	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(ccc23)-c2n[nH]c3ccsc23)n1			472429	1-(2-((1R,3S,4S)-3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-5-(1H- thieno[3,2-c]pyrazol- 3-yl)-1H-indole-3- carboxamide::US10822352, Comp No. 704	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472429&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654097	441611418							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976929	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc2CCCCn12	InChI=1S/C28H29N7O3/c1-17-6-5-7-24(30-17)31-28(38)22-11-13-34(22)26(37)16-35-21-10-9-19(14-20(21)27(32-35)18(2)36)23-15-29-25-8-3-4-12-33(23)25/h5-7,9-10,14-15,22H,3-4,8,11-13,16H2,1-2H3,(H,30,31,38)/t22-/m0/s1	JNINGJNIQIFLOJ-QFIPXVFZSA-N	386750	(S)-1-(2-(3- acetyl-5-(5,6,7,8- tetrahydroimidazo [1,2-a]pyridin-3- yl)-1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 705::US10822352, Comp No. 705	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386750&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623502	404855894							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976930	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnn(c1)C1CC1	InChI=1S/C27H25BrFN7O3/c1-15(37)26-20-9-16(17-11-30-35(12-17)19-6-7-19)5-8-21(20)36(33-26)14-25(38)34-13-18(29)10-22(34)27(39)32-24-4-2-3-23(28)31-24/h2-5,8-9,11-12,18-19,22H,6-7,10,13-14H2,1H3,(H,31,32,39)/t18-,22+/m1/s1	KRWWNHDEECIRMQ-GCJKJVERSA-N	386751	(2S,4R)-1-(2-(3- acetyl-5-(1- cyclopropyl-1H- pyrazol-4-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 706::US10822352, Comp No. 706	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386751&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622955	404855895							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976931	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cn[nH]c1			386752	(2S,4R)-1-(2-(3- acetyl-5-(1H- pyrazol-4-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 707::US10822352, Comp No. 707	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386752&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643094	404855896							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976932	CC(=O)c1nn(CC(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc2ncccn12	InChI=1S/C28H26N8O3/c1-17-6-3-8-24(31-17)32-27(39)22-7-4-12-34(22)25(38)16-36-21-10-9-19(14-20(21)26(33-36)18(2)37)23-15-30-28-29-11-5-13-35(23)28/h3,5-6,8-11,13-15,22H,4,7,12,16H2,1-2H3,(H,31,32,39)/t22-/m0/s1	GKDKPLVUSBPPBW-QFIPXVFZSA-N	386753	(S)-1-(2-(3- acetyl-5- (imidazo[1,2- a]pyrimidin-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 708::US10822352, Comp No. 708	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386753&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642802	404855897							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976933	CC(=O)c1nn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(cc12)-c1cnc2ncccn12	InChI=1S/C27H24N8O3/c1-16-5-3-6-23(30-16)31-26(38)21-9-12-33(21)24(37)15-35-20-8-7-18(13-19(20)25(32-35)17(2)36)22-14-29-27-28-10-4-11-34(22)27/h3-8,10-11,13-14,21H,9,12,15H2,1-2H3,(H,30,31,38)/t21-/m0/s1	IHPQNQYTWMDVTG-NRFANRHFSA-N	386754	(S)-1-(2-(3- acetyl-5- (imidazo[1,2- a]pyrimidin-3-yl)- 1H-indazol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10287301, Compound 709::US10822352, Comp No. 709	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386754&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623672	404855898							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976934	CC(=O)n1cc(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClF2N5O3/c1-19-38-15-23(16-39-19)21-10-11-25-22(17-41(20(2)43)30(25)12-21)13-32(44)42-18-24(36)14-31(42)34(45)40-29-9-5-7-27(33(29)37)26-6-3-4-8-28(26)35/h3-12,15-17,24,31H,13-14,18H2,1-2H3,(H,40,45)/t24-,31+/m1/s1	UVOFUJVKIBWNER-XJFCNFDWSA-N	386755	(2S,4R)-1-(2-(1- acetyl-6-(2- methylpyrimidin- 5-yl)-1H-indol-3- yl)acetyl)-N-(2''- chloro-2-fluoro- [1,1''-biphenyl]-3- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 710::US10287301, Compound 746::US10807952, Cmp No. 60::US10822352, Comp No. 746	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386755&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623085	404855899							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976935	CC(=O)n1cc(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15-30-11-19(12-31-15)17-6-7-21-18(13-34(16(2)36)22(21)8-17)9-26(37)35-14-20(29)10-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,11-13,20,23H,9-10,14H2,1-2H3,(H,32,33,38)/t20-,23+/m1/s1	MEBASDZALZFGTO-OFNKIYASSA-N	386756	(2S,4R)-1-(2-(1- acetyl-6-(2- methylpyrimidin- 5-yl)-1H-indol-3- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 711::US10287301, Compound 747::US10807952, Cmp No. 61::US10822352, Comp No. 747	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386756&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623426	404855900							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976936	Cc1cc2ncc(cn2n1)-c1nc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(C)n3)nc(C(N)=O)c2s1	InChI=1S/C25H23FN10O3S/c1-12-4-3-5-17(29-12)30-24(39)16-7-15(26)10-34(16)19(37)11-36-23-21(20(33-36)22(27)38)40-25(31-23)14-8-28-18-6-13(2)32-35(18)9-14/h3-6,8-9,15-16H,7,10-11H2,1-2H3,(H2,27,38)(H,29,30,39)/t15-,16+/m1/s1	WBLJZHJGAVSBBB-CVEARBPZSA-N	472439	1-(2-((2S,4R)-4- fluoro-2-((6- methylpyridin-2- yl)carbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5-a] pyrimidin-6-yl)-1H- pyrazolo[3,4-d] thiazole-3-carboxamide::US10822352, Comp No. 714	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472439&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623092	441611428							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976937	Cc1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3sc(nc23)-c2cnc(C)nc2)n1	InChI=1S/C23H22FN9O3S/c1-11-4-3-5-16(28-11)29-22(36)15-6-14(24)9-32(15)17(34)10-33-21-19(18(31-33)20(25)35)37-23(30-21)13-7-26-12(2)27-8-13/h3-5,7-8,14-15H,6,9-10H2,1-2H3,(H2,25,35)(H,28,29,36)/t14-,15+/m1/s1	IRAAYGQACYUSPI-CABCVRRESA-N	386758	1-(2-((2S,4R)-4- fluoro-2-((6- methylpyridin-2- yl)carbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(2- methylpyrimidin- 5-yl)-1H- pyrazolo[3,4- d]thiazole-3- carboxamide::US10287301, Compound 715::US10822352, Comp No. 715	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386758&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642851	404855902							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976938	CC(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(N)=O)c3sc(nc23)-c2cnc3cc(C)nn3c2)c1F	InChI=1S/C34H27ClFN9O4S/c1-15-8-26-38-12-19(13-43(26)41-15)34-40-32-30(50-34)29(31(37)48)42-44(32)14-27(47)45-24-10-18(24)11-25(45)33(49)39-23-5-3-4-20(28(23)36)21-9-17(16(2)46)6-7-22(21)35/h3-9,12-13,18,24-25H,10-11,14H2,1-2H3,(H2,37,48)(H,39,49)/t18-,24-,25+/m1/s1	SSKKVINZQGUGIW-XYHYBEPMSA-N	386759	1-(2-((1R,3S,5R)- 3-((5'-acetyl-2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)carbamoyl)-2- azabicyclo[3.1.0] hexan-2-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H- pyrazolo[3,4- d]thiazole-3- carboxamide::US10287301, Compound 716::US10822352, Comp No. 716	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386759&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643099	404855903							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976939	CC(=O)c1ccc(Cl)c(c1)-c1cccc(NC(=O)[C@@H]2C[C@H]3C[C@H]3N2C(=O)Cn2nc(C(N)=O)c3sc(nc23)-c2cnc(C)nc2)c1F	InChI=1S/C32H26ClFN8O4S/c1-14(43)16-6-7-21(33)20(8-16)19-4-3-5-22(26(19)34)38-31(46)24-10-17-9-23(17)42(24)25(44)13-41-30-28(27(40-41)29(35)45)47-32(39-30)18-11-36-15(2)37-12-18/h3-8,11-12,17,23-24H,9-10,13H2,1-2H3,(H2,35,45)(H,38,46)/t17-,23-,24+/m1/s1	JOJJUWZQUJOUKA-VEYWIMSWSA-N	386760	1-(2-((1R,3S,5R)- 3-((5'-acetyl-2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)carbamoyl)-2- azabicyclo[3.1.0] hexan-2-yl)-2- oxoethyl)-5-(2- methylpyrimidin- 5-yl)-1H- pyrazolo[3,4- d]thiazole-3- carboxamide::US10287301, Compound 717::US10822352, Comp No. 717	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386760&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643157	404855904							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976940	COc1ccc(cc1)N1C[C@@H]2CC[C@H]1C=C2c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=O)c2c1	InChI=1S/C34H33BrFN7O4/c1-47-24-10-8-22(9-11-24)41-16-20-5-7-23(41)15-25(20)19-6-12-27-26(13-19)32(33(37)45)40-43(27)18-31(44)42-17-21(36)14-28(42)34(46)39-30-4-2-3-29(35)38-30/h2-4,6,8-13,15,20-21,23,28H,5,7,14,16-18H2,1H3,(H2,37,45)(H,38,39,46)/t20-,21+,23-,28-/m0/s1	RSJXDVXHCUHQOL-DDIPFFCFSA-N	472443	(2S,4R)-1-(2-(3-acetyl- 5-((1S,4R)-2-(4- methoxyphenyl)-2- azabicyclo[2.2.2] oct-5-en-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 721	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472443&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139313985	441611432							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976941	CN(C)C(=O)c1cc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C29H28BrFN8O4/c1-15(40)27-21-9-19(17-11-32-16(2)33-12-17)20(29(43)37(3)4)10-22(21)39(36-27)14-26(41)38-13-18(31)8-23(38)28(42)35-25-7-5-6-24(30)34-25/h5-7,9-12,18,23H,8,13-14H2,1-4H3,(H,34,35,42)/t18-,23+/m1/s1	DWNZCKJEWMHTPF-JPYJTQIMSA-N	386428	3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- N,N-dimethyl-5-(2- methylpyrimidin- 5-yl)-1H- indazole-6- carboxamide::US10287301, Compound 362::US10287301, Compound 722::US10822352, Comp No. 722	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386428&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623428	404855581							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976942	CNc1ncc2cc(ccc2n1)-c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)nc1C(N)=O	InChI=1S/C25H23BrFN9O3/c1-29-25-30-9-14-7-13(5-6-17(14)31-25)16-11-35(34-22(16)23(28)38)12-21(37)36-10-15(27)8-18(36)24(39)33-20-4-2-3-19(26)32-20/h2-7,9,11,15,18H,8,10,12H2,1H3,(H2,28,38)(H,29,30,31)(H,32,33,39)/t15-,18+/m1/s1	TYGWZVJBBFNBGO-QAPCUYQASA-N	386763	1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)- 4-fluoropyrrolidin- 1-yl)-2-oxoethyl)- 4-(2-(methylamino) quinazolin-6-yl)-1H- pyrazole-3- carboxamide::US10287301, Compound 723::US10822352, Comp No. 723	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386763&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642865	404855906							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976943	Cc1cc2ncc(cn2n1)-c1nc2n(CC(=O)C3C[C@H](F)C[C@H]3C(=O)Nc3cccc(C)n3)nc(C(N)=O)c2s1	InChI=1S/C26H24FN9O3S/c1-12-4-3-5-19(30-12)31-25(39)17-8-15(27)7-16(17)18(37)11-36-24-22(21(34-36)23(28)38)40-26(32-24)14-9-29-20-6-13(2)33-35(20)10-14/h3-6,9-10,15-17H,7-8,11H2,1-2H3,(H2,28,38)(H,30,31,39)/t15-,16?,17+/m0/s1	KGFZGDYWUKYART-RPCGPGEBSA-N	472447	1-(2-((2S,4R)-4- fluoro-2-((6- methylpyridin-2- yl)carbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(2- methylpyrazolo[1,5-a] pyrimidin-6-yl)-1H- pyrazolo[3,4-d] thiazole-3-carboxamide::US10822352, Comp No. 724	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472447&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139314036	441611436							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976944	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)cc1-c1cnn(c1)C1CC1	InChI=1S/C22H22BrFN8O3/c23-17-2-1-3-18(27-17)28-22(35)16-6-13(24)9-31(16)19(33)11-30-10-15(20(29-30)21(25)34)12-7-26-32(8-12)14-4-5-14/h1-3,7-8,10,13-14,16H,4-6,9,11H2,(H2,25,34)(H,27,28,35)/t13-,16+/m1/s1	FEWJMTHPZGUOBP-CJNGLKHVSA-N	386765	1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)- 4-fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1'-cyclopropyl- 1H, 1'H-[4,4'- bipyrazole]-3- carboxamide::US10287301, Compound 726::US10822352, Comp No. 726	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386765&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643246	404855908							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976945	CC(=O)N1CCC(=CC1)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)nc1C(N)=O	InChI=1S/C23H25BrFN7O4/c1-13(33)30-7-5-14(6-8-30)16-11-31(29-21(16)22(26)35)12-20(34)32-10-15(25)9-17(32)23(36)28-19-4-2-3-18(24)27-19/h2-5,11,15,17H,6-10,12H2,1H3,(H2,26,35)(H,27,28,36)/t15-,17+/m1/s1	ALIBQQZAYUWANS-WBVHZDCISA-N	386766	4-(1-acetyl- 1,2,3,6- tetrahydropyridin- 4-yl)-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-pyrazole-3- carboxamide::US10287301, Compound 727::US10822352, Comp No. 727	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386766&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623209	404855909							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976946	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)cc1-c1cnn(c1)-c1ncc(F)cn1	InChI=1S/C23H19BrF2N10O3/c24-17-2-1-3-18(31-17)32-22(39)16-4-13(25)9-35(16)19(37)11-34-10-15(20(33-34)21(27)38)12-5-30-36(8-12)23-28-6-14(26)7-29-23/h1-3,5-8,10,13,16H,4,9,11H2,(H2,27,38)(H,31,32,39)/t13-,16+/m1/s1	DOWYEVGAJMCVCX-CJNGLKHVSA-N	386767	1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)- 4-fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1'-(5- fluoropyrimidin- 2-yl)-1H, 1'H- [4,4'-bipyrazole]- 3-carboxamide::US10287301, Compound 729::US10822352, Comp No. 729	Complement factor D	Human		>10000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386767&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643035	404855910							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976947	Cc1cc2ncc(cn2n1)-c1ccc2n(CC(=O)N3C4CCC(C4)C3C(=O)Nc3cccc(C)n3)cc(C(N)=O)c2c1	InChI=1S/C31H30N8O3/c1-17-4-3-5-26(34-17)35-31(42)29-20-6-8-22(11-20)39(29)28(40)16-37-15-24(30(32)41)23-12-19(7-9-25(23)37)21-13-33-27-10-18(2)36-38(27)14-21/h3-5,7,9-10,12-15,20,22,29H,6,8,11,16H2,1-2H3,(H2,32,41)(H,34,35,42)	LRQLDDGUQBWBTA-UHFFFAOYSA-N	386738	5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1-(2-((1R,4S)- 3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10287301, Compound 691::US10287301, Compound 730::US10822352, Comp No. 730	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386738&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654094	404855882							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976948	C[C@@H]1CC[C@H](N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C28H28BrN7O3/c1-15-5-10-24(29)32-27(15)33-28(39)23-8-6-16(2)36(23)25(38)14-35-22-9-7-19(20-12-30-18(4)31-13-20)11-21(22)26(34-35)17(3)37/h5,7,9-13,16,23H,6,8,14H2,1-4H3,(H,32,33,39)/t16-,23+/m1/s1	FQNSKPLTBZGEGG-MWTRTKDXSA-N	386769	(2S,5R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5- methylpyrrolidine- 2-carboxamide::US10287301, Compound 731::US10822352, Comp No. 731	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386769&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623197	404855911							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976949	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)S(C)(=N)=O	InChI=1S/C26H24BrFN8O4S/c1-14(37)24-18-8-15(16-10-30-26(31-11-16)41(2,29)40)6-7-19(18)36(34-24)13-23(38)35-12-17(28)9-20(35)25(39)33-22-5-3-4-21(27)32-22/h3-8,10-11,17,20,29H,9,12-13H2,1-2H3,(H,32,33,39)/t17-,20+,41?/m1/s1	NHUPPDBZGMKLJW-TZLNYBTLSA-N	472455	(2S,4R)-1-(2-(3- acetyl-5-(2-(S- methylsulfonimid oyl)pyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10822352, Comp No. 732::US11001600, Cmp No. 46	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472455&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622279	441611443							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976950	CN(C)C[C@@]1(F)C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C1CC1	InChI=1S/C32H34BrFN8O3/c1-18(43)29-24-11-21(22-13-35-19(2)36-14-22)7-9-25(24)42(39-29)15-28(44)41-17-32(34,16-40(3)4)12-26(41)31(45)38-30-23(20-5-6-20)8-10-27(33)37-30/h7-11,13-14,20,26H,5-6,12,15-17H2,1-4H3,(H,37,38,45)/t26-,32-/m0/s1	UMGWOFQYKZNTSE-IEWVHIKDSA-N	386771	(1s,4s)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[2.2.2] octane-3- carboxamide::US10287301, Compound 733::US10822352, Comp No. 733	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386771&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623399	404855913							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976951	CC(=O)c1nn(CC(=O)N2C3CCC(C3)[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN7O3/c1-15(37)26-21-11-17(19-12-30-16(2)31-13-19)7-9-22(21)35(34-26)14-25(38)36-20-8-6-18(10-20)27(36)28(39)33-24-5-3-4-23(29)32-24/h3-5,7,9,11-13,18,20,27H,6,8,10,14H2,1-2H3,(H,32,33,39)/t18?,20?,27-/m0/s1	WMAUWVANJOKKMS-KBVTYMBASA-N	386535	(3S,4S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)-2- azabicyclo[2.2.1] heptane-3- carboxamide::US10287301, Compound 475::US10822352, Comp No. 734	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386535&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126654077	404855686							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976952	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1nc2ccccc2[nH]1			386773	(2S,4R)-1-(2-(3- acetyl-5-(1H- benzo[d]imidazol- 2-yl)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 735::US10822352, Comp No. 735	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386773&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642774	404855915							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976953	CN(C(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(CO)nc1)c1cccc(Br)n1	InChI=1S/C27H25BrFN7O4/c1-15(38)26-19-8-16(17-10-30-23(14-37)31-11-17)6-7-20(19)36(33-26)13-25(39)35-12-18(29)9-21(35)27(40)34(2)24-5-3-4-22(28)32-24/h3-8,10-11,18,21,37H,9,12-14H2,1-2H3/t18-,21+/m1/s1	JVKJYKVQARAEMI-NQIIRXRSSA-N	386774	(2S,4R)-1-(2-(3- acetyl-5-(2- (hydroxymethyl) pyrimidin-5-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4-fluoro-N- methylpyrrolidine- 2-carboxamide::US10287301, Compound 737::US10822352, Comp No. 737	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386774&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642889	404855916							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976954	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2C#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H23F4N7O4/c1-15(41)27-20-8-17(18-11-35-16(2)36-12-18)6-7-23(20)40(38-27)14-26(42)39-13-19(30)9-24(39)28(43)37-22-4-3-5-25(21(22)10-34)44-29(31,32)33/h3-8,11-12,19,24H,9,13-14H2,1-2H3,(H,37,43)/t19-,24+/m1/s1	LYKAGOTXJRALLK-DVECYGJZSA-N	386775	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(2- cyano-3- (trifluoromethoxy) phenyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 738::US10822352, Comp No. 738	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386775&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126622957	404855917							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976955	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2(CC2)C#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C25H24FN7O3/c1-14(34)23-19-7-16(17-9-28-15(2)29-10-17)3-4-20(19)33(31-23)12-22(35)32-11-18(26)8-21(32)24(36)30-25(13-27)5-6-25/h3-4,7,9-10,18,21H,5-6,8,11-12H2,1-2H3,(H,30,36)/t18-,21+/m1/s1	MMAAVSIZBSCEOO-NQIIRXRSSA-N	386776	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(1- cyanocyclopropyl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 739::US10822352, Comp No. 739	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386776&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643030	404855918							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976956	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(N)[n+]([O-])c1	InChI=1S/C25H22BrFN8O4/c1-13(36)23-17-7-14(15-9-29-25(28)35(39)10-15)5-6-18(17)34(32-23)12-22(37)33-11-16(27)8-19(33)24(38)31-21-4-2-3-20(26)30-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,28,29)(H,30,31,38)/t16-,19+/m1/s1	IKPBUXIYNOISJC-APWZRJJASA-N	386777	5-(3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5-yl)- 2-aminopyrimidine 1-oxide::US10287301, Compound 741::US10822352, Comp No. 741	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386777&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623006	404855919							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976957	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)[n+]([O-])c1	InChI=1S/C26H23BrFN7O4/c1-14(36)25-19-8-16(17-10-29-15(2)35(39)11-17)6-7-20(19)34(32-25)13-24(37)33-12-18(28)9-21(33)26(38)31-23-5-3-4-22(27)30-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,30,31,38)/t18-,21+/m1/s1	JKIDIWDLEQXUIU-NQIIRXRSSA-N	386778	5-(3-acetyl-1-(2- ((2S,4R)-2-((6- bromopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5-yl)- 2-methylpyrimidine 1-oxide::US10287301, Compound 742::US10822352, Comp No. 742	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386778&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623393	404855920							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976958	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)[n+]2[O-])c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O4/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)34(32-25)13-24(37)33-12-18(28)9-21(33)26(38)31-23-5-3-4-22(27)35(23)39/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,38)/t18-,21+/m1/s1	QDZNIDHGVVFGLW-NQIIRXRSSA-N	386779	2-((2S,4R)-1-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-4- fluoropyrrolidine- 2-carboxamido)- 6-bromopyridine 1-oxide::US10287301, Compound 743::US10822352, Comp No. 743	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386779&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642961	404855921							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976959	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)[n+]2[O-])c2ccc(cc12)-c1cnc(C)[n+]([O-])c1	InChI=1S/C26H23BrFN7O5/c1-14(36)25-19-8-16(17-10-29-15(2)34(39)11-17)6-7-20(19)33(31-25)13-24(37)32-12-18(28)9-21(32)26(38)30-23-5-3-4-22(27)35(23)40/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,30,38)/t18-,21+/m1/s1	QWUFFUAECHONDZ-NQIIRXRSSA-N	386780	5-(3-acetyl-1-(2- ((2S,4R)-2-((6- bromo-1- oxidopyridin-2- yl)carbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 1H-indazol-5-yl)- 2-methylpyrimidine 1-oxide::US10287301, Compound 744::US10822352, Comp No. 744	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386780&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642824	404855922							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976960	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(ccc2Cl)S(=O)(=O)NC2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H32ClF2N7O5S/c1-19(47)35-28-12-21(22-15-40-20(2)41-16-22)6-11-31(28)46(43-35)18-33(48)45-17-23(38)13-32(45)36(49)42-30-5-3-4-26(34(30)39)27-14-25(9-10-29(27)37)52(50,51)44-24-7-8-24/h3-6,9-12,14-16,23-24,32,44H,7-8,13,17-18H2,1-2H3,(H,42,49)/t23-,32+/m1/s1	KFBRCSODKHASSW-HEIROHQZSA-N	386781	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N- (2'-chloro-5'-(N- cyclopropylsulfamoyl)- 2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 745::US10822352, Comp No. 745::US11407738, Cmpd No. 521	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386781&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643045	404855923							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976961	CC(=O)n1cc(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClF2N5O3/c1-19-38-15-23(16-39-19)21-10-11-25-22(17-41(20(2)43)30(25)12-21)13-32(44)42-18-24(36)14-31(42)34(45)40-29-9-5-7-27(33(29)37)26-6-3-4-8-28(26)35/h3-12,15-17,24,31H,13-14,18H2,1-2H3,(H,40,45)/t24-,31+/m1/s1	UVOFUJVKIBWNER-XJFCNFDWSA-N	386755	(2S,4R)-1-(2-(1- acetyl-6-(2- methylpyrimidin- 5-yl)-1H-indol-3- yl)acetyl)-N-(2''- chloro-2-fluoro- [1,1''-biphenyl]-3- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 710::US10287301, Compound 746::US10807952, Cmp No. 60::US10822352, Comp No. 746	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386755&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623085	404855899							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976962	CC(=O)n1cc(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15-30-11-19(12-31-15)17-6-7-21-18(13-34(16(2)36)22(21)8-17)9-26(37)35-14-20(29)10-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,11-13,20,23H,9-10,14H2,1-2H3,(H,32,33,38)/t20-,23+/m1/s1	MEBASDZALZFGTO-OFNKIYASSA-N	386756	(2S,4R)-1-(2-(1- acetyl-6-(2- methylpyrimidin- 5-yl)-1H-indol-3- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10287301, Compound 711::US10287301, Compound 747::US10807952, Cmp No. 61::US10822352, Comp No. 747	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386756&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623426	404855900							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976963	CC(=O)c1nn(CC(=O)N2CCOC[C@@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN7O4/c1-15(35)25-19-10-17(18-11-28-16(2)29-12-18)6-7-20(19)34(32-25)13-24(36)33-8-9-38-14-21(33)26(37)31-23-5-3-4-22(27)30-23/h3-7,10-12,21H,8-9,13-14H2,1-2H3,(H,30,31,37)/t21-/m1/s1	JSUGIHPVHIWUQR-OAQYLSRUSA-N	386784	(R)-4-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)morpholine-3- carboxamide::US10287301, Compound 748::US10822352, Comp No. 748	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386784&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643229	404855924							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976964	CC(=O)c1nn(CC(=O)N2CCOC[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN7O4/c1-15(35)25-19-10-17(18-11-28-16(2)29-12-18)6-7-20(19)34(32-25)13-24(36)33-8-9-38-14-21(33)26(37)31-23-5-3-4-22(27)30-23/h3-7,10-12,21H,8-9,13-14H2,1-2H3,(H,30,31,37)/t21-/m0/s1	JSUGIHPVHIWUQR-NRFANRHFSA-N	386785	(S)-4-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromopyridin-2- yl)morpholine-3- carboxamide::US10287301, Compound 749::US10822352, Comp No. 749	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386785&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642913	404855925							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976965	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C2CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrN7O3/c1-15(39)27-23-9-18(20-11-32-16(2)33-12-20)5-7-24(23)38(36-27)14-26(40)37-13-19-10-22(19)28(37)30(41)35-29-21(17-3-4-17)6-8-25(31)34-29/h5-9,11-12,17,19,22,28H,3-4,10,13-14H2,1-2H3,(H,34,35,41)/t19-,22-,28+/m1/s1	OHSMWQGTXOBARC-VVDSWQSDSA-N	386688	(1R,2S,5S)-3-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- cyclopropylpyridin- 2-yl)-3- azabicyclo[3.1.0] hexane-2- carboxamide::US10287301, Compound 637::US10287301, Compound 750::US10822352, Comp No. 750	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386688&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642903	404855836							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976966	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCOCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35BrN8O4/c1-19-4-7-28(34)37-31(19)38-32(45)26-13-33(18-40-8-10-46-11-9-40)14-27(33)42(26)29(44)17-41-25-6-5-22(23-15-35-21(3)36-16-23)12-24(25)30(39-41)20(2)43/h4-7,12,15-16,26-27H,8-11,13-14,17-18H2,1-3H3,(H,37,38,45)/t26-,27?,33?/m0/s1	LMQSQBCLLPYNSR-NPBRFHNESA-N	386787	(3S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5- (morpholinomethyl)-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 751::US10287301, Compound 754::US10822352, Comp No. 751	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386787&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624023	404855926							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976967	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2)S(=O)(=O)C(F)(F)F)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H25F4N7O5S/c1-16-8-26-35-12-19(13-41(26)37-16)18-6-7-24-23(9-18)28(17(2)42)38-40(24)15-27(43)39-14-20(31)10-25(39)29(44)36-21-4-3-5-22(11-21)47(45,46)30(32,33)34/h3-9,11-13,20,25H,10,14-15H2,1-2H3,(H,36,44)/t20-,25+/m1/s1	ZYNDVTHTKBICLW-NLFFAJNJSA-N	386788	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrazolo[1,5- a]pyrimidin-6- yl)-1H-indazol-1- yl)acetyl)-4- fluoro-N-(3- ((trifluoromethyl) sulfonyl)phenyl) pyrrolidine-2- carboxamide::US10287301, Compound 752::US10822352, Comp No. 752	Complement factor D	Human		<1000							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386788&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643518	404855927							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976968	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCCC3)C[C@H]2C(=O)Nc2nc([Na])ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35N8O3.Na/c1-20-7-6-10-34-31(20)37-32(44)27-14-33(19-39-11-4-5-12-39)15-28(33)41(27)29(43)18-40-26-9-8-23(24-16-35-22(3)36-17-24)13-25(26)30(38-40)21(2)42;/h6-9,13,16-17,27-28H,4-5,11-12,14-15,18-19H2,1-3H3,(H,34,37,44);/t27-,28?,33?;/m0./s1	PWAUWEQUMYZZFK-UDWVDKPWSA-N	472477	(3S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-(pyrrolidin- 1-ylmethyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 753	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472477&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698582	441611464							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
976969	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCOCC3)C[C@H]2C(=O)Nc2nc([Na])ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35N8O4.Na/c1-20-5-4-8-34-31(20)37-32(44)27-14-33(19-39-9-11-45-12-10-39)15-28(33)41(27)29(43)18-40-26-7-6-23(24-16-35-22(3)36-17-24)13-25(26)30(38-40)21(2)42;/h4-7,13,16-17,27-28H,9-12,14-15,18-19H2,1-3H3,(H,34,37,44);/t27-,28?,33?;/m0./s1	MNSMLAJIZKTNKC-UDWVDKPWSA-N	472478	(3S)-2-(2-(3- acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5- (morpholinometh yl)-2-azabicyclo[3.1.0] hexane-3-carboxamide::US10822352, Comp No. 754	Complement factor D	Human		 5500							US Patent		10.7270/Q2Z322QB		aid1804983	US10822352	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	11/3/2020	6/21/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=472478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=472478&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			141698573	441611465							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4